{
"company_details": [
{
"company_id": "0000885462",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000885462.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000885462.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000885462.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000885462_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000885462_main_keyfigs.svg",
"name": "GULF Resources INC",
"rank": 1,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000885462.svg",
"report_text": "The relative strengths and weaknesses of GULF Resources INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of GULF Resources INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 117% points.The greatest weakness of GULF Resources INC is the variable Other Revenues, reducing the Economic Capital Ratio by 17% points.
The company's Economic Capital Ratio, given in the ranking table, is 267%, being 121% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000885462_2021_GULF_Resources_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "58.2",
"Liabilities": "78.6",
"Assets": "1.19",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "196",
"Liabilities, Non-Current": "18.5",
"Other Liabilities": "15.1",
"Property, Plant and Equipment, Net": "2.06",
"Assets, Non-Current": "2.81",
"Other Assets": "-0.918",
"General and Administrative Expense": "5.94",
"Expenses": "32.9",
"Revenues": "28.8",
"Net Income": "52.7",
"Research and Development": "15.6",
"Other Expenses": "12.3",
"Other Revenues": "28.8",
"Comprehensive Net Income": "55.8",
"Other Net Income": "-7.64",
"Other Compr. Net Income": "3.57",
"Economic Capital Ratio": "134"
},
"2012": {
"Liabilities, Current": "33.6",
"Liabilities": "57.9",
"Stockholders Equity": "119",
"ECR before LimitedLiability": "152",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "19.3",
"Assets, Current": "0.692",
"Assets": "9.77",
"Other Assets": "-4.46",
"Assets, Non-Current": "14.7",
"Property, Plant and Equipment, Net": "11.6",
"Goodwill": "-0.899",
"Other Expenses": "19.7",
"Expenses": "36.6",
"Revenues": "2.24",
"Net Income": "38.3",
"Research and Development": "12.9",
"General and Administrative Expense": "5.14",
"Other Revenues": "2.24",
"Comprehensive Net Income": "38.6",
"Economic Capital Ratio": "119"
},
"2013": {
"Liabilities, Current": "43.0",
"Liabilities": "68.3",
"Assets": "4.81",
"Stockholders Equity": "122",
"ECR before LimitedLiability": "169",
"Other Liabilities": "15.4",
"Liabilities, Non-Current": "21.8",
"Assets, Non-Current": "5.03",
"Property, Plant and Equipment, Net": "4.00",
"Other Assets": "-2.12",
"General and Administrative Expense": "1.75",
"Expenses": "35.7",
"Revenues": "8.78",
"Net Income": "41.5",
"Research and Development": "11.6",
"Other Expenses": "23.2",
"Other Revenues": "8.78",
"Other Net Income": "-2.47",
"Comprehensive Net Income": "43.4",
"Other Compr. Net Income": "2.17",
"Economic Capital Ratio": "129"
},
"2014": {
"Liabilities, Non-Current": "23.9",
"Liabilities": "82.0",
"Stockholders Equity": "148",
"ECR before LimitedLiability": "200",
"Liabilities, Current": "59.8",
"Other Liabilities": "13.0",
"Assets, Current": "2.40",
"Assets": "5.67",
"Other Assets": "-1.62",
"Assets, Non-Current": "3.31",
"Property, Plant and Equipment, Net": "2.58",
"Other Expenses": "15.6",
"Expenses": "36.2",
"Revenues": "7.48",
"Net Income": "44.2",
"Research and Development": "13.0",
"General and Administrative Expense": "8.84",
"Other Revenues": "7.48",
"Other Net Income": "1.45",
"Comprehensive Net Income": "44.1",
"Economic Capital Ratio": "150"
},
"2015": {
"Other Liabilities": "22.3",
"Liabilities": "88.5",
"Stockholders Equity": "130",
"ECR before LimitedLiability": "188",
"Liabilities, Current": "57.0",
"Liabilities, Non-Current": "29.4",
"Assets, Current": "2.57",
"Assets": "6.69",
"Other Assets": "-3.71",
"Assets, Non-Current": "8.19",
"Property, Plant and Equipment, Net": "4.00",
"Research and Development": "11.0",
"Expenses": "31.3",
"Revenues": "21.4",
"Net Income": "51.9",
"General and Administrative Expense": "-3.26",
"Other Expenses": "24.0",
"Other Revenues": "21.4",
"Comprehensive Net Income": "48.2",
"Other Compr. Net Income": "-4.21",
"Economic Capital Ratio": "142"
},
"2016": {
"Liabilities, Non-Current": "28.1",
"Liabilities": "78.6",
"Assets": "4.77",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "155",
"Liabilities, Current": "53.9",
"Other Liabilities": "10.9",
"Other Assets": "-2.26",
"Assets, Non-Current": "4.53",
"Assets, Current": "2.39",
"Research and Development": "14.7",
"Expenses": "34.2",
"Revenues": "14.3",
"Net Income": "45.5",
"General and Administrative Expense": "-2.38",
"Other Expenses": "22.6",
"Other Revenues": "14.3",
"Comprehensive Net Income": "41.2",
"Other Net Income": "-1.90",
"Other Compr. Net Income": "-4.95",
"Economic Capital Ratio": "135"
},
"2017": {
"Other Liabilities": "16.1",
"Liabilities": "79.4",
"Assets": "4.55",
"Stockholders Equity": "132",
"ECR before LimitedLiability": "152",
"Liabilities, Current": "55.5",
"Liabilities, Non-Current": "22.5",
"Assets, Non-Current": "3.08",
"Other Assets": "-1.46",
"Assets, Current": "2.85",
"Research and Development": "13.2",
"Expenses": "28.4",
"Revenues": "2.51",
"Net Income": "26.9",
"Other Expenses": "7.51",
"General and Administrative Expense": "8.43",
"Other Revenues": "2.51",
"Comprehensive Net Income": "31.1",
"Other Net Income": "-4.14",
"Other Compr. Net Income": "4.48",
"Economic Capital Ratio": "130"
},
"2018": {
"Liabilities, Non-Current": "15.0",
"Liabilities": "53.4",
"Stockholders Equity": "147",
"ECR before LimitedLiability": "121",
"Other Liabilities": "10.5",
"Liabilities, Current": "34.6",
"Property, Plant and Equipment, Net": "9.60",
"Assets": "47.1",
"Other Assets": "-9.33",
"Assets, Current": "24.4",
"Assets, Non-Current": "19.8",
"Other Expenses": "-20.2",
"Expenses": "20.0",
"Revenues": "-31.6",
"Net Income": "-9.64",
"Research and Development": "9.00",
"General and Administrative Expense": "29.9",
"Other Revenues": "-31.6",
"Comprehensive Net Income": "-14.0",
"Other Compr. Net Income": "-4.21",
"Economic Capital Ratio": "100"
},
"2019": {
"Liabilities, Non-Current": "7.47",
"Liabilities": "42.8",
"Stockholders Equity": "131",
"ECR before LimitedLiability": "146",
"Other Liabilities": "12.1",
"Liabilities, Current": "27.7",
"Assets, Non-Current": "37.4",
"Assets": "38.6",
"Property, Plant and Equipment, Net": "22.0",
"Other Assets": "-11.5",
"Assets, Current": "6.17",
"Research and Development": "6.39",
"Expenses": "30.9",
"Revenues": "-24.1",
"Net Income": "11.6",
"Other Expenses": "-2.47",
"General and Administrative Expense": "27.2",
"Other Revenues": "-24.1",
"Other Net Income": "2.84",
"Comprehensive Net Income": "10.4",
"Economic Capital Ratio": "116"
},
"2020": {
"Liabilities, Current": "34.0",
"Liabilities": "52.5",
"Assets": "17.6",
"Stockholders Equity": "117",
"ECR before LimitedLiability": "159",
"Liabilities, Non-Current": "18.6",
"Other Liabilities": "6.42",
"Other Assets": "-7.18",
"Assets, Non-Current": "25.1",
"Property, Plant and Equipment, Net": "13.5",
"Other Expenses": "2.75",
"Expenses": "28.0",
"Revenues": "-17.5",
"Net Income": "15.8",
"Research and Development": "5.87",
"General and Administrative Expense": "19.9",
"Other Revenues": "-17.5",
"Comprehensive Net Income": "20.5",
"Other Net Income": "4.02",
"Other Compr. Net Income": "4.89",
"Economic Capital Ratio": "121"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000885462_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "105,517",
"Assets, Non-Current": "152,811",
"General and Administrative Expense": "107,413",
"Goodwill": "0",
"Liabilities, Current": "12,178",
"Liabilities, Non-Current": "0",
"Other Assets": "-147,201",
"Other Compr. Net Income": "12,493",
"Other Expenses": "26,274",
"Other Liabilities": "3,037",
"Other Net Income": "57",
"Other Revenues": "164,980",
"Property, Plant and Equipment, Net": "147,201",
"Research and Development": "399"
},
"output_variables": {
"Liabilities": "15,215",
"Assets": "258,328",
"Expenses": "134,085",
"Revenues": "164,980",
"Stockholders Equity": "243,113",
"Net Income": "30,953",
"Comprehensive Net Income": "37,199",
"BaseVar": "292,579",
"ECR before LimitedLiability": "271%",
"Economic Capital Ratio": "287%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "107,259",
"Assets, Non-Current": "170,934",
"General and Administrative Expense": "80,231",
"Goodwill": "0",
"Liabilities, Current": "11,016",
"Liabilities, Non-Current": "0",
"Other Assets": "-165,943",
"Other Compr. Net Income": "733",
"Other Expenses": "6,622",
"Other Liabilities": "2,953",
"Other Net Income": "313",
"Other Revenues": "101,701",
"Property, Plant and Equipment, Net": "165,943",
"Research and Development": "165"
},
"output_variables": {
"Liabilities": "13,969",
"Assets": "278,193",
"Expenses": "87,018",
"Revenues": "101,701",
"Stockholders Equity": "264,224",
"Net Income": "14,996",
"Comprehensive Net Income": "15,362",
"BaseVar": "240,963",
"ECR before LimitedLiability": "258%",
"Economic Capital Ratio": "278%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "158,073",
"Assets, Non-Current": "151,172",
"General and Administrative Expense": "92,772",
"Goodwill": "0",
"Liabilities, Current": "11,306",
"Liabilities, Non-Current": "0",
"Other Assets": "-146,400",
"Other Compr. Net Income": "9,258",
"Other Expenses": "4,851",
"Other Liabilities": "2,944",
"Other Net Income": "340",
"Other Revenues": "118,392",
"Property, Plant and Equipment, Net": "146,400",
"Research and Development": "140"
},
"output_variables": {
"Liabilities": "14,250",
"Assets": "309,245",
"Expenses": "97,764",
"Revenues": "118,392",
"Stockholders Equity": "294,995",
"Net Income": "20,967",
"Comprehensive Net Income": "25,597",
"BaseVar": "274,624",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "283%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "194,128",
"Assets, Non-Current": "128,854",
"General and Administrative Expense": "88,899",
"Goodwill": "0",
"Liabilities, Current": "8,082",
"Liabilities, Non-Current": "0",
"Other Assets": "-124,351",
"Other Compr. Net Income": "-1,078",
"Other Expenses": "7,035",
"Other Liabilities": "2,826",
"Other Net Income": "280",
"Other Revenues": "113,660",
"Property, Plant and Equipment, Net": "124,351",
"Research and Development": "134"
},
"output_variables": {
"Liabilities": "10,909",
"Assets": "322,982",
"Expenses": "96,068",
"Revenues": "113,660",
"Stockholders Equity": "312,073",
"Net Income": "17,872",
"Comprehensive Net Income": "17,333",
"BaseVar": "272,488",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "284%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "190,821",
"Assets, Non-Current": "165,922",
"General and Administrative Expense": "115,705",
"Goodwill": "29,559",
"Liabilities, Current": "16,076",
"Liabilities, Non-Current": "0",
"Other Assets": "-157,430",
"Other Compr. Net Income": "-21,741",
"Other Expenses": "12,589",
"Other Liabilities": "2,556",
"Other Net Income": "275",
"Other Revenues": "162,317",
"Property, Plant and Equipment, Net": "127,871",
"Research and Development": "231"
},
"output_variables": {
"Liabilities": "18,632",
"Assets": "356,743",
"Expenses": "128,524",
"Revenues": "162,317",
"Stockholders Equity": "338,111",
"Net Income": "34,068",
"Comprehensive Net Income": "23,198",
"BaseVar": "344,116",
"ECR before LimitedLiability": "259%",
"Economic Capital Ratio": "278%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "221,767",
"Assets, Non-Current": "143,924",
"General and Administrative Expense": "100,564",
"Goodwill": "27,669",
"Liabilities, Current": "13,945",
"Liabilities, Non-Current": "0",
"Other Assets": "-136,400",
"Other Compr. Net Income": "-24,931",
"Other Expenses": "12,536",
"Other Liabilities": "2,285",
"Other Net Income": "313",
"Other Revenues": "149,275",
"Property, Plant and Equipment, Net": "108,731",
"Research and Development": "262"
},
"output_variables": {
"Liabilities": "16,230",
"Assets": "365,691",
"Expenses": "113,362",
"Revenues": "149,275",
"Stockholders Equity": "349,461",
"Net Income": "36,226",
"Comprehensive Net Income": "23,760",
"BaseVar": "334,901",
"ECR before LimitedLiability": "263%",
"Economic Capital Ratio": "281%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "241,513",
"Assets, Non-Current": "145,986",
"General and Administrative Expense": "71,972",
"Goodwill": "29,375",
"Liabilities, Current": "3,666",
"Liabilities, Non-Current": "7,273",
"Other Assets": "-124,489",
"Other Compr. Net Income": "24,157",
"Other Expenses": "33,195",
"Other Liabilities": "0",
"Other Net Income": "392",
"Other Revenues": "107,522",
"Property, Plant and Equipment, Net": "95,115",
"Research and Development": "195"
},
"output_variables": {
"Liabilities": "10,939",
"Assets": "387,499",
"Expenses": "105,363",
"Revenues": "107,522",
"Stockholders Equity": "376,560",
"Net Income": "2,551",
"Comprehensive Net Income": "14,630",
"BaseVar": "317,937",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "284%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "187,344",
"Assets, Non-Current": "111,203",
"General and Administrative Expense": "12,645",
"Goodwill": "0",
"Liabilities, Current": "2,624",
"Liabilities, Non-Current": "2,070",
"Other Assets": "-82,283",
"Other Compr. Net Income": "-18,641",
"Other Expenses": "60,414",
"Other Liabilities": "0",
"Other Net Income": "501",
"Other Revenues": "2,595",
"Property, Plant and Equipment, Net": "82,283",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,693",
"Assets": "298,547",
"Expenses": "73,060",
"Revenues": "2,595",
"Stockholders Equity": "293,853",
"Net Income": "-69,964",
"Comprehensive Net Income": "-79,284",
"BaseVar": "199,018",
"ECR before LimitedLiability": "213%",
"Economic Capital Ratio": "244%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "107,203",
"Assets, Non-Current": "172,048",
"General and Administrative Expense": "18,716",
"Goodwill": "0",
"Liabilities, Current": "6,306",
"Liabilities, Non-Current": "9,838",
"Other Assets": "-137,995",
"Other Compr. Net Income": "-5,014",
"Other Expenses": "18,128",
"Other Liabilities": "0",
"Other Net Income": "447",
"Other Revenues": "10,597",
"Property, Plant and Equipment, Net": "137,995",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,144",
"Assets": "279,251",
"Expenses": "36,843",
"Revenues": "10,597",
"Stockholders Equity": "263,107",
"Net Income": "-25,800",
"Comprehensive Net Income": "-28,307",
"BaseVar": "174,148",
"ECR before LimitedLiability": "225%",
"Economic Capital Ratio": "252%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "107,311",
"Assets, Non-Current": "186,727",
"General and Administrative Expense": "29,698",
"Goodwill": "0",
"Liabilities, Current": "7,102",
"Liabilities, Non-Current": "9,911",
"Other Assets": "-148,948",
"Other Compr. Net Income": "19,945",
"Other Expenses": "7,221",
"Other Liabilities": "0",
"Other Net Income": "291",
"Other Revenues": "28,207",
"Property, Plant and Equipment, Net": "148,948",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "17,014",
"Assets": "294,038",
"Expenses": "36,918",
"Revenues": "28,207",
"Stockholders Equity": "277,024",
"Net Income": "-8,420",
"Comprehensive Net Income": "1,552",
"BaseVar": "198,207",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "267%"
}
}
},
"top_rated": true,
"trend": 1.0,
"value": 2.673138372425708,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000885462.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000885462.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000885462.svg"
},
{
"company_id": "0001141240",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001141240.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001141240.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001141240.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001141240_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001141240_main_keyfigs.svg",
"name": "Liquidmetal Technologies INC",
"rank": 2,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001141240.svg",
"report_text": "The relative strengths and weaknesses of Liquidmetal Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Liquidmetal Technologies INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 131% points.The greatest weakness of Liquidmetal Technologies INC is the variable Other Revenues, reducing the Economic Capital Ratio by 23% points.
The company's Economic Capital Ratio, given in the ranking table, is 265%, being 119% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001141240_2021_Liquidmetal_Technologies_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-40.4",
"Liabilities": "-11.9",
"Stockholders Equity": "-217",
"ECR before LimitedLiability": "76.3",
"Liabilities, Non-Current": "-1.08",
"Other Liabilities": "24.7",
"Property, Plant and Equipment, Net": "-17.8",
"Assets": "-57.7",
"Assets, Non-Current": "-8.47",
"Goodwill": "-3.55",
"Assets, Current": "-48.1",
"General and Administrative Expense": "21.1",
"Expenses": "36.6",
"Revenues": "-96.1",
"Net Income": "132",
"Research and Development": "4.07",
"Other Expenses": "9.81",
"Other Revenues": "-96.1",
"Comprehensive Net Income": "132",
"Other Net Income": "155",
"Economic Capital Ratio": "14.3"
},
"2012": {
"Liabilities, Current": "-5.03",
"Liabilities": "-5.65",
"Stockholders Equity": "-38.6",
"ECR before LimitedLiability": "-80.0",
"Liabilities, Non-Current": "0.726",
"Other Liabilities": "-1.25",
"Assets, Current": "-20.1",
"Assets": "-37.0",
"Assets, Non-Current": "-8.45",
"Property, Plant and Equipment, Net": "-17.1",
"Goodwill": "-13.3",
"Other Expenses": "-38.3",
"Expenses": "-23.8",
"Revenues": "-33.7",
"Net Income": "-22.7",
"Research and Development": "6.92",
"General and Administrative Expense": "18.0",
"Other Revenues": "-33.7",
"Other Net Income": "31.7",
"Comprehensive Net Income": "-22.6",
"Economic Capital Ratio": "-112"
},
"2013": {
"Liabilities, Current": "-0.728",
"Liabilities": "1.82",
"Stockholders Equity": "-43.7",
"ECR before LimitedLiability": "-107",
"Other Liabilities": "3.09",
"Goodwill": "-4.36",
"Assets": "-41.9",
"Assets, Non-Current": "-0.769",
"Property, Plant and Equipment, Net": "-6.88",
"Other Assets": "-2.06",
"Assets, Current": "-21.6",
"General and Administrative Expense": "-2.65",
"Expenses": "-17.3",
"Revenues": "-11.9",
"Net Income": "-50.1",
"Research and Development": "0.0995",
"Other Expenses": "-12.4",
"Other Revenues": "-11.9",
"Other Net Income": "-4.15",
"Comprehensive Net Income": "-50.1",
"Economic Capital Ratio": "-147"
},
"2014": {
"Liabilities, Non-Current": "0.616",
"Liabilities": "11.9",
"Stockholders Equity": "59.9",
"ECR before LimitedLiability": "57.7",
"Liabilities, Current": "33.2",
"Other Liabilities": "-24.2",
"Assets, Current": "65.1",
"Assets": "59.9",
"Goodwill": "-6.11",
"Assets, Non-Current": "-3.75",
"Property, Plant and Equipment, Net": "1.03",
"Other Expenses": "44.2",
"Expenses": "5.01",
"Revenues": "-33.1",
"Net Income": "-27.4",
"Research and Development": "-3.60",
"General and Administrative Expense": "-29.4",
"Other Revenues": "-33.1",
"Other Net Income": "1.48",
"Comprehensive Net Income": "-27.4",
"Economic Capital Ratio": "8.24"
},
"2015": {
"Other Liabilities": "1.58",
"Liabilities": "1.72",
"Stockholders Equity": "11.7",
"ECR before LimitedLiability": "-6.56",
"Liabilities, Current": "0.317",
"Liabilities, Non-Current": "-0.195",
"Assets, Current": "17.4",
"Assets": "10.8",
"Other Assets": "-0.931",
"Goodwill": "-0.854",
"Assets, Non-Current": "-0.520",
"Property, Plant and Equipment, Net": "2.23",
"Research and Development": "-1.99",
"Expenses": "-16.5",
"Revenues": "-26.8",
"Net Income": "-60.4",
"General and Administrative Expense": "-58.0",
"Other Expenses": "15.9",
"Other Revenues": "-26.8",
"Comprehensive Net Income": "-60.1",
"Economic Capital Ratio": "-52.4"
},
"2016": {
"Liabilities, Non-Current": "11.7",
"Liabilities": "32.8",
"Stockholders Equity": "123",
"ECR before LimitedLiability": "85.3",
"Liabilities, Current": "24.1",
"Other Liabilities": "-1.74",
"Property, Plant and Equipment, Net": "-4.41",
"Assets": "64.1",
"Assets, Non-Current": "-1.44",
"Assets, Current": "127",
"Goodwill": "-4.20",
"Research and Development": "4.75",
"Expenses": "17.7",
"Revenues": "-28.8",
"Net Income": "-15.9",
"General and Administrative Expense": "8.50",
"Other Expenses": "4.46",
"Other Revenues": "-28.8",
"Comprehensive Net Income": "-15.8",
"Other Net Income": "-5.41",
"Economic Capital Ratio": "65.3"
},
"2017": {
"Other Liabilities": "-11.1",
"Liabilities": "42.6",
"Stockholders Equity": "138",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "36.6",
"Liabilities, Non-Current": "17.4",
"Assets, Non-Current": "-0.937",
"Assets": "50.2",
"Assets, Current": "44.1",
"Goodwill": "-2.62",
"Property, Plant and Equipment, Net": "5.84",
"Research and Development": "4.02",
"Expenses": "23.8",
"Revenues": "-26.1",
"Net Income": "-3.48",
"Other Expenses": "12.9",
"General and Administrative Expense": "7.23",
"Other Revenues": "-26.1",
"Comprehensive Net Income": "-3.68",
"Other Net Income": "-2.78",
"Economic Capital Ratio": "89.4"
},
"2018": {
"Liabilities, Non-Current": "15.7",
"Liabilities": "41.9",
"Stockholders Equity": "136",
"ECR before LimitedLiability": "125",
"Other Liabilities": "-6.45",
"Liabilities, Current": "34.2",
"Property, Plant and Equipment, Net": "7.23",
"Assets": "45.7",
"Other Assets": "-0.0264",
"Assets, Current": "36.1",
"Goodwill": "-2.00",
"Assets, Non-Current": "-1.58",
"Other Expenses": "11.2",
"Expenses": "25.3",
"Revenues": "-27.3",
"Net Income": "-0.159",
"Research and Development": "1.35",
"General and Administrative Expense": "13.1",
"Other Revenues": "-27.3",
"Economic Capital Ratio": "104",
"Other Compr. Net Income": "0.155"
},
"2019": {
"Liabilities, Non-Current": "12.7",
"Liabilities": "48.2",
"Stockholders Equity": "135",
"ECR before LimitedLiability": "140",
"Other Liabilities": "12.4",
"Liabilities, Current": "28.9",
"Assets, Non-Current": "-2.37",
"Assets": "41.7",
"Goodwill": "-2.45",
"Property, Plant and Equipment, Net": "5.55",
"Other Assets": "8.87",
"Assets, Current": "20.6",
"Research and Development": "2.32",
"Expenses": "21.5",
"Revenues": "-24.7",
"Comprehensive Net Income": "1.08",
"Other Expenses": "1.24",
"General and Administrative Expense": "18.1",
"Other Revenues": "-24.7",
"Other Net Income": "2.75",
"Economic Capital Ratio": "111"
},
"2020": {
"Liabilities, Current": "33.3",
"Liabilities": "51.8",
"Stockholders Equity": "131",
"ECR before LimitedLiability": "157",
"Liabilities, Non-Current": "19.0",
"Other Liabilities": "5.79",
"Goodwill": "-1.41",
"Assets": "24.8",
"Other Assets": "11.0",
"Assets, Current": "5.19",
"Property, Plant and Equipment, Net": "3.56",
"Other Expenses": "5.76",
"Expenses": "24.9",
"Revenues": "-23.5",
"Net Income": "8.37",
"Research and Development": "4.91",
"General and Administrative Expense": "14.8",
"Other Revenues": "-23.5",
"Comprehensive Net Income": "8.64",
"Other Net Income": "5.30",
"Economic Capital Ratio": "119"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001141240_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "811",
"Assets, Non-Current": "52",
"General and Administrative Expense": "4,616",
"Goodwill": "968",
"Liabilities, Current": "3,610",
"Liabilities, Non-Current": "609",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,803",
"Other Liabilities": "0",
"Other Net Income": "12,722",
"Other Revenues": "972",
"Property, Plant and Equipment, Net": "162",
"Research and Development": "1,120"
},
"output_variables": {
"Liabilities": "4,219",
"Assets": "1,993",
"Expenses": "7,539",
"Revenues": "972",
"Stockholders Equity": "-2,226",
"Net Income": "6,155",
"Comprehensive Net Income": "6,155",
"BaseVar": "13,722",
"ECR before LimitedLiability": "100%",
"Economic Capital Ratio": "168%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,915",
"Assets, Non-Current": "28",
"General and Administrative Expense": "5,204",
"Goodwill": "869",
"Liabilities, Current": "6,923",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "20,063",
"Other Liabilities": "2,766",
"Other Net Income": "11,535",
"Other Revenues": "650",
"Property, Plant and Equipment, Net": "161",
"Research and Development": "943"
},
"output_variables": {
"Liabilities": "10,545",
"Assets": "8,973",
"Expenses": "26,210",
"Revenues": "650",
"Stockholders Equity": "-1,572",
"Net Income": "-14,025",
"Comprehensive Net Income": "-14,025",
"BaseVar": "28,956",
"ECR before LimitedLiability": "-166%",
"Economic Capital Ratio": "46%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,689",
"Assets, Non-Current": "401",
"General and Administrative Expense": "5,931",
"Goodwill": "764",
"Liabilities, Current": "1,071",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,749",
"Other Liabilities": "4,921",
"Other Net Income": "-1,438",
"Other Revenues": "1,026",
"Property, Plant and Equipment, Net": "249",
"Research and Development": "1,156"
},
"output_variables": {
"Liabilities": "6,848",
"Assets": "4,103",
"Expenses": "13,836",
"Revenues": "1,026",
"Stockholders Equity": "-2,745",
"Net Income": "-14,248",
"Comprehensive Net Income": "-14,248",
"BaseVar": "13,626",
"ECR before LimitedLiability": "-329%",
"Economic Capital Ratio": "7.6%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "10,466",
"Assets, Non-Current": "31",
"General and Administrative Expense": "7,946",
"Goodwill": "669",
"Liabilities, Current": "860",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,327",
"Other Liabilities": "2,005",
"Other Net Income": "30",
"Other Revenues": "627",
"Property, Plant and Equipment, Net": "1,118",
"Research and Development": "1,596"
},
"output_variables": {
"Liabilities": "3,721",
"Assets": "12,284",
"Expenses": "7,215",
"Revenues": "627",
"Stockholders Equity": "8,563",
"Net Income": "-6,558",
"Comprehensive Net Income": "-6,558",
"BaseVar": "11,938",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "5,302",
"Assets, Non-Current": "31",
"General and Administrative Expense": "7,359",
"Goodwill": "570",
"Liabilities, Current": "1,974",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-1,942",
"Other Liabilities": "59",
"Other Net Income": "0",
"Other Revenues": "147",
"Property, Plant and Equipment, Net": "1,370",
"Research and Development": "2,047"
},
"output_variables": {
"Liabilities": "2,889",
"Assets": "7,273",
"Expenses": "7,464",
"Revenues": "147",
"Stockholders Equity": "4,384",
"Net Income": "-7,317",
"Comprehensive Net Income": "-7,317",
"BaseVar": "8,886",
"ECR before LimitedLiability": "-26%",
"Economic Capital Ratio": "83%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "59,698",
"Assets, Non-Current": "36",
"General and Administrative Expense": "8,025",
"Goodwill": "494",
"Liabilities, Current": "3,638",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,739",
"Other Liabilities": "2,047",
"Other Net Income": "-2,126",
"Other Revenues": "480",
"Property, Plant and Equipment, Net": "1,139",
"Research and Development": "2,342"
},
"output_variables": {
"Liabilities": "6,541",
"Assets": "61,367",
"Expenses": "17,106",
"Revenues": "480",
"Stockholders Equity": "54,826",
"Net Income": "-18,752",
"Comprehensive Net Income": "-18,752",
"BaseVar": "43,810",
"ECR before LimitedLiability": "166%",
"Economic Capital Ratio": "212%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "42,188",
"Assets, Non-Current": "14",
"General and Administrative Expense": "6,961",
"Goodwill": "408",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "143",
"Other Liabilities": "3,512",
"Other Net Income": "0",
"Other Revenues": "376",
"Property, Plant and Equipment, Net": "12,465",
"Research and Development": "1,962"
},
"output_variables": {
"Liabilities": "3,512",
"Assets": "55,075",
"Expenses": "9,066",
"Revenues": "376",
"Stockholders Equity": "51,563",
"Net Income": "-8,690",
"Comprehensive Net Income": "-8,690",
"BaseVar": "34,014",
"ECR before LimitedLiability": "211%",
"Economic Capital Ratio": "243%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "35,748",
"Assets, Non-Current": "14",
"General and Administrative Expense": "7,063",
"Goodwill": "322",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-1,267",
"Other Liabilities": "2,335",
"Other Net Income": "0",
"Other Revenues": "791",
"Property, Plant and Equipment, Net": "11,767",
"Research and Development": "2,429"
},
"output_variables": {
"Liabilities": "2,335",
"Assets": "47,851",
"Expenses": "8,225",
"Revenues": "791",
"Stockholders Equity": "45,516",
"Net Income": "-7,434",
"Comprehensive Net Income": "-7,434",
"BaseVar": "29,601",
"ECR before LimitedLiability": "219%",
"Economic Capital Ratio": "248%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "24,600",
"Assets, Non-Current": "14",
"General and Administrative Expense": "6,256",
"Goodwill": "239",
"Liabilities, Current": "907",
"Liabilities, Non-Current": "856",
"Other Assets": "7,659",
"Other Compr. Net Income": "3.0",
"Other Expenses": "1,665",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,832",
"Property, Plant and Equipment, Net": "8,819",
"Research and Development": "1,342"
},
"output_variables": {
"Liabilities": "1,763",
"Assets": "41,331",
"Expenses": "9,263",
"Revenues": "1,832",
"Stockholders Equity": "39,568",
"Net Income": "-7,431",
"Comprehensive Net Income": "-7,430",
"BaseVar": "27,096",
"ECR before LimitedLiability": "217%",
"Economic Capital Ratio": "247%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "17,018",
"Assets, Non-Current": "251",
"General and Administrative Expense": "4,419",
"Goodwill": "158",
"Liabilities, Current": "520",
"Liabilities, Non-Current": "899",
"Other Assets": "12,768",
"Other Compr. Net Income": "115",
"Other Expenses": "-35",
"Other Liabilities": "0",
"Other Net Income": "484",
"Other Revenues": "1,367",
"Property, Plant and Equipment, Net": "8,614",
"Research and Development": "110"
},
"output_variables": {
"Liabilities": "1,419",
"Assets": "38,809",
"Expenses": "4,494",
"Revenues": "1,367",
"Stockholders Equity": "37,390",
"Net Income": "-2,643",
"Comprehensive Net Income": "-2,586",
"BaseVar": "23,344",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "265%"
}
}
},
"top_rated": true,
"trend": 1.0,
"value": 2.6489250543763667,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001141240.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001141240.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001141240.svg"
},
{
"company_id": "0000711377",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000711377.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000711377.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000711377.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000711377_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000711377_main_keyfigs.svg",
"name": "Neogen CORP",
"rank": 3,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000711377.svg",
"report_text": "The relative strengths and weaknesses of Neogen CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Neogen CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 80% points.The greatest weakness of Neogen CORP is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 6.0% points.
The company's Economic Capital Ratio, given in the ranking table, is 265%, being 119% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000711377_2021_Neogen_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "46.8",
"Liabilities": "58.2",
"Stockholders Equity": "75.5",
"ECR before LimitedLiability": "161",
"Liabilities, Non-Current": "16.5",
"Property, Plant and Equipment, Net": "-0.558",
"Assets": "8.68",
"Assets, Non-Current": "11.8",
"Other Assets": "-6.01",
"Goodwill": "4.29",
"Assets, Current": "2.07",
"General and Administrative Expense": "38.8",
"Expenses": "22.5",
"Revenues": "33.8",
"Net Income": "48.0",
"Research and Development": "11.6",
"Other Expenses": "-30.7",
"Other Revenues": "33.8",
"Comprehensive Net Income": "48.3",
"Other Net Income": "-7.82",
"Economic Capital Ratio": "99.4"
},
"2012": {
"Liabilities, Current": "33.2",
"Liabilities": "54.6",
"Stockholders Equity": "73.6",
"ECR before LimitedLiability": "128",
"Liabilities, Non-Current": "16.3",
"Other Liabilities": "12.8",
"Assets, Current": "3.17",
"Assets": "8.82",
"Other Assets": "-6.41",
"Assets, Non-Current": "10.0",
"Goodwill": "4.58",
"Other Expenses": "23.3",
"Expenses": "23.2",
"Revenues": "27.8",
"Net Income": "49.2",
"Research and Development": "13.0",
"General and Administrative Expense": "-13.6",
"Other Revenues": "27.8",
"Other Net Income": "-0.548",
"Comprehensive Net Income": "49.1",
"Economic Capital Ratio": "95.3"
},
"2013": {
"Liabilities, Current": "45.4",
"Liabilities": "66.4",
"Stockholders Equity": "82.9",
"ECR before LimitedLiability": "146",
"Other Liabilities": "6.02",
"Liabilities, Non-Current": "24.5",
"Goodwill": "3.48",
"Assets": "7.39",
"Assets, Non-Current": "8.31",
"Other Assets": "-5.65",
"Assets, Current": "3.34",
"General and Administrative Expense": "-16.1",
"Expenses": "20.2",
"Revenues": "34.0",
"Net Income": "50.1",
"Research and Development": "10.7",
"Other Expenses": "24.7",
"Other Revenues": "34.0",
"Other Net Income": "-3.01",
"Comprehensive Net Income": "50.0",
"Economic Capital Ratio": "106"
},
"2014": {
"Liabilities, Non-Current": "27.6",
"Liabilities": "82.3",
"Stockholders Equity": "106",
"ECR before LimitedLiability": "175",
"Liabilities, Current": "60.7",
"Other Liabilities": "6.66",
"Assets, Current": "3.02",
"Assets": "9.76",
"Goodwill": "4.14",
"Other Assets": "-5.85",
"Assets, Non-Current": "10.4",
"Other Expenses": "18.2",
"Expenses": "21.2",
"Revenues": "34.6",
"Net Income": "55.6",
"Research and Development": "13.3",
"General and Administrative Expense": "-10.6",
"Other Revenues": "34.6",
"Other Net Income": "1.53",
"Comprehensive Net Income": "56.0",
"Economic Capital Ratio": "125"
},
"2015": {
"Other Liabilities": "15.4",
"Liabilities": "89.5",
"Stockholders Equity": "101",
"ECR before LimitedLiability": "171",
"Liabilities, Current": "60.1",
"Liabilities, Non-Current": "32.0",
"Assets, Current": "4.32",
"Assets": "6.65",
"Other Assets": "-6.55",
"Goodwill": "3.96",
"Assets, Non-Current": "8.56",
"Research and Development": "9.64",
"Expenses": "14.6",
"Revenues": "41.8",
"Net Income": "55.7",
"General and Administrative Expense": "-24.3",
"Other Expenses": "27.5",
"Other Revenues": "41.8",
"Comprehensive Net Income": "55.6",
"Other Net Income": "0.768",
"Economic Capital Ratio": "125"
},
"2016": {
"Liabilities, Non-Current": "30.0",
"Liabilities": "79.1",
"Stockholders Equity": "82.6",
"ECR before LimitedLiability": "135",
"Liabilities, Current": "56.8",
"Other Liabilities": "4.49",
"Assets": "4.70",
"Other Assets": "-5.93",
"Assets, Non-Current": "9.36",
"Assets, Current": "1.17",
"Goodwill": "5.02",
"Research and Development": "14.8",
"Expenses": "13.6",
"Revenues": "38.1",
"Net Income": "48.1",
"General and Administrative Expense": "-31.1",
"Other Expenses": "27.4",
"Other Revenues": "38.1",
"Comprehensive Net Income": "48.2",
"Other Net Income": "-2.70",
"Economic Capital Ratio": "115"
},
"2017": {
"Other Liabilities": "9.21",
"Liabilities": "79.1",
"Stockholders Equity": "85.4",
"ECR before LimitedLiability": "128",
"Liabilities, Current": "52.1",
"Liabilities, Non-Current": "31.8",
"Assets, Non-Current": "9.71",
"Assets": "5.52",
"Other Assets": "-6.19",
"Assets, Current": "3.53",
"Goodwill": "4.69",
"Research and Development": "14.3",
"Expenses": "9.97",
"Revenues": "38.3",
"Net Income": "42.9",
"Other Expenses": "20.1",
"General and Administrative Expense": "-26.2",
"Other Revenues": "38.3",
"Comprehensive Net Income": "42.1",
"Other Net Income": "-5.04",
"Economic Capital Ratio": "107"
},
"2018": {
"Liabilities, Non-Current": "27.2",
"Liabilities": "72.0",
"Stockholders Equity": "84.1",
"ECR before LimitedLiability": "144",
"Other Liabilities": "11.4",
"Liabilities, Current": "46.1",
"Property, Plant and Equipment, Net": "-0.652",
"Assets": "5.25",
"Assets, Current": "4.06",
"Goodwill": "-2.09",
"Assets, Non-Current": "4.60",
"Other Expenses": "12.2",
"Expenses": "17.2",
"Revenues": "33.8",
"Net Income": "50.1",
"Research and Development": "12.9",
"General and Administrative Expense": "-8.03",
"Other Revenues": "33.8",
"Comprehensive Net Income": "50.1",
"Other Net Income": "0.689",
"Economic Capital Ratio": "124"
},
"2019": {
"Liabilities, Non-Current": "31.0",
"Liabilities": "75.4",
"Stockholders Equity": "89.6",
"ECR before LimitedLiability": "163",
"Other Liabilities": "14.9",
"Liabilities, Current": "44.3",
"Assets, Non-Current": "2.90",
"Assets": "5.33",
"Goodwill": "-2.04",
"Property, Plant and Equipment, Net": "-0.694",
"Assets, Current": "5.85",
"Research and Development": "8.99",
"Expenses": "18.1",
"Revenues": "30.7",
"Net Income": "52.4",
"Other Expenses": "8.96",
"General and Administrative Expense": "0.438",
"Other Revenues": "30.7",
"Other Net Income": "5.70",
"Comprehensive Net Income": "52.3",
"Economic Capital Ratio": "133"
},
"2020": {
"Liabilities, Current": "35.8",
"Liabilities": "71.2",
"Stockholders Equity": "80.2",
"ECR before LimitedLiability": "156",
"Liabilities, Non-Current": "38.7",
"Other Liabilities": "9.38",
"Goodwill": "2.05",
"Assets": "5.18",
"Assets, Current": "6.60",
"Assets, Non-Current": "-1.87",
"Property, Plant and Equipment, Net": "-1.17",
"Other Expenses": "7.06",
"Expenses": "7.37",
"Revenues": "25.5",
"Net Income": "38.4",
"Research and Development": "6.21",
"General and Administrative Expense": "-6.01",
"Other Revenues": "25.5",
"Comprehensive Net Income": "37.8",
"Other Net Income": "6.58",
"Economic Capital Ratio": "119"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000711377_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "122,502",
"Assets, Non-Current": "74,820",
"General and Administrative Expense": "45,132",
"Goodwill": "51,584",
"Liabilities, Current": "17,797",
"Liabilities, Non-Current": "0",
"Other Assets": "-51,584",
"Other Compr. Net Income": "1,282",
"Other Expenses": "97,291",
"Other Liabilities": "12,887",
"Other Net Income": "-596",
"Other Revenues": "172,683",
"Property, Plant and Equipment, Net": "22,340",
"Research and Development": "6,825"
},
"output_variables": {
"Liabilities": "30,684",
"Assets": "219,662",
"Expenses": "149,248",
"Revenues": "172,683",
"Stockholders Equity": "188,978",
"Net Income": "22,839",
"Comprehensive Net Income": "23,480",
"BaseVar": "287,078",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "253%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "143,941",
"Assets, Non-Current": "77,726",
"General and Administrative Expense": "143,671",
"Goodwill": "63,878",
"Liabilities, Current": "19,979",
"Liabilities, Non-Current": "0",
"Other Assets": "-63,878",
"Other Compr. Net Income": "-709",
"Other Expenses": "11,450",
"Other Liabilities": "12,567",
"Other Net Income": "100",
"Other Revenues": "184,046",
"Property, Plant and Equipment, Net": "29,933",
"Research and Development": "6,636"
},
"output_variables": {
"Liabilities": "32,546",
"Assets": "251,600",
"Expenses": "161,757",
"Revenues": "184,046",
"Stockholders Equity": "219,054",
"Net Income": "22,389",
"Comprehensive Net Income": "22,034",
"BaseVar": "315,379",
"ECR before LimitedLiability": "227%",
"Economic Capital Ratio": "254%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "168,447",
"Assets, Non-Current": "87,766",
"General and Administrative Expense": "159,041",
"Goodwill": "71,836",
"Liabilities, Current": "17,719",
"Liabilities, Non-Current": "0",
"Other Assets": "-71,836",
"Other Compr. Net Income": "4.0",
"Other Expenses": "14,100",
"Other Liabilities": "14,552",
"Other Net Income": "435",
"Other Revenues": "207,528",
"Property, Plant and Equipment, Net": "34,345",
"Research and Development": "7,781"
},
"output_variables": {
"Liabilities": "32,271",
"Assets": "290,558",
"Expenses": "180,922",
"Revenues": "207,528",
"Stockholders Equity": "258,287",
"Net Income": "27,041",
"Comprehensive Net Income": "27,043",
"BaseVar": "355,859",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "261%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "188,746",
"Assets, Non-Current": "114,606",
"General and Administrative Expense": "195,688",
"Goodwill": "93,420",
"Liabilities, Current": "24,967",
"Liabilities, Non-Current": "0",
"Other Assets": "-93,420",
"Other Compr. Net Income": "1,870",
"Other Expenses": "15,000",
"Other Liabilities": "14,034",
"Other Net Income": "-360",
"Other Revenues": "247,405",
"Property, Plant and Equipment, Net": "41,949",
"Research and Development": "8,326"
},
"output_variables": {
"Liabilities": "39,001",
"Assets": "345,301",
"Expenses": "219,014",
"Revenues": "247,405",
"Stockholders Equity": "306,300",
"Net Income": "28,031",
"Comprehensive Net Income": "28,966",
"BaseVar": "426,476",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "259%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "231,195",
"Assets, Non-Current": "116,513",
"General and Administrative Expense": "220,379",
"Goodwill": "107,493",
"Liabilities, Current": "25,456",
"Liabilities, Non-Current": "0",
"Other Assets": "-107,493",
"Other Compr. Net Income": "-2,863",
"Other Expenses": "18,500",
"Other Liabilities": "15,762",
"Other Net Income": "-1,042",
"Other Revenues": "283,074",
"Property, Plant and Equipment, Net": "44,473",
"Research and Development": "9,577"
},
"output_variables": {
"Liabilities": "41,218",
"Assets": "392,181",
"Expenses": "248,456",
"Revenues": "283,074",
"Stockholders Equity": "350,963",
"Net Income": "33,576",
"Comprehensive Net Income": "32,144",
"BaseVar": "484,417",
"ECR before LimitedLiability": "237%",
"Economic Capital Ratio": "261%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "248,226",
"Assets, Non-Current": "147,031",
"General and Administrative Expense": "254,999",
"Goodwill": "137,861",
"Liabilities, Current": "28,598",
"Liabilities, Non-Current": "2,423",
"Other Assets": "-137,861",
"Other Compr. Net Income": "-1,478",
"Other Expenses": "18,975",
"Other Liabilities": "14,758",
"Other Net Income": "-873",
"Other Revenues": "321,275",
"Property, Plant and Equipment, Net": "54,683",
"Research and Development": "9,890"
},
"output_variables": {
"Liabilities": "45,779",
"Assets": "449,940",
"Expenses": "283,864",
"Revenues": "321,275",
"Stockholders Equity": "404,161",
"Net Income": "36,538",
"Comprehensive Net Income": "35,799",
"BaseVar": "551,604",
"ECR before LimitedLiability": "238%",
"Economic Capital Ratio": "262%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "292,961",
"Assets, Non-Current": "173,700",
"General and Administrative Expense": "286,264",
"Goodwill": "159,377",
"Liabilities, Current": "36,002",
"Liabilities, Non-Current": "3,602",
"Other Assets": "-159,377",
"Other Compr. Net Income": "-3,437",
"Other Expenses": "22,700",
"Other Liabilities": "17,048",
"Other Net Income": "1,728",
"Other Revenues": "361,594",
"Property, Plant and Equipment, Net": "61,748",
"Research and Development": "10,385"
},
"output_variables": {
"Liabilities": "56,652",
"Assets": "528,409",
"Expenses": "319,349",
"Revenues": "361,594",
"Stockholders Equity": "471,757",
"Net Income": "43,973",
"Comprehensive Net Income": "42,254",
"BaseVar": "635,584",
"ECR before LimitedLiability": "235%",
"Economic Capital Ratio": "260%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "375,789",
"Assets, Non-Current": "169,151",
"General and Administrative Expense": "316,881",
"Goodwill": "0",
"Liabilities, Current": "38,688",
"Liabilities, Non-Current": "5,043",
"Other Assets": "0",
"Other Compr. Net Income": "-2,613",
"Other Expenses": "10,250",
"Other Liabilities": "14,103",
"Other Net Income": "3,271",
"Other Revenues": "397,930",
"Property, Plant and Equipment, Net": "73,069",
"Research and Development": "10,855"
},
"output_variables": {
"Liabilities": "57,834",
"Assets": "618,009",
"Expenses": "337,986",
"Revenues": "397,930",
"Stockholders Equity": "560,175",
"Net Income": "63,215",
"Comprehensive Net Income": "61,908",
"BaseVar": "708,822",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "268%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "449,529",
"Assets, Non-Current": "171,364",
"General and Administrative Expense": "333,287",
"Goodwill": "0",
"Liabilities, Current": "38,251",
"Liabilities, Non-Current": "3,972",
"Other Assets": "0",
"Other Compr. Net Income": "-1,894",
"Other Expenses": "12,783",
"Other Liabilities": "15,618",
"Other Net Income": "4,865",
"Other Revenues": "414,186",
"Property, Plant and Equipment, Net": "74,847",
"Research and Development": "12,805"
},
"output_variables": {
"Liabilities": "57,841",
"Assets": "695,740",
"Expenses": "358,875",
"Revenues": "414,186",
"Stockholders Equity": "637,899",
"Net Income": "60,176",
"Comprehensive Net Income": "59,229",
"BaseVar": "766,700",
"ECR before LimitedLiability": "248%",
"Economic Capital Ratio": "269%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "537,406",
"Assets, Non-Current": "4,184",
"General and Administrative Expense": "335,897",
"Goodwill": "161,704",
"Liabilities, Current": "66,614",
"Liabilities, Non-Current": "5,391",
"Other Assets": "15,217",
"Other Compr. Net Income": "-8,069",
"Other Expenses": "12,830",
"Other Liabilities": "0",
"Other Net Income": "4,782",
"Other Revenues": "418,170",
"Property, Plant and Equipment, Net": "78,671",
"Research and Development": "14,750"
},
"output_variables": {
"Liabilities": "72,005",
"Assets": "797,182",
"Expenses": "363,477",
"Revenues": "418,170",
"Stockholders Equity": "725,177",
"Net Income": "59,475",
"Comprehensive Net Income": "55,440",
"BaseVar": "831,842",
"ECR before LimitedLiability": "241%",
"Economic Capital Ratio": "265%"
}
}
},
"top_rated": true,
"trend": -2.0,
"value": 2.6454970793221175,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000711377.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000711377.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000711377.svg"
},
{
"company_id": "0001374328",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001374328.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001374328.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001374328.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001374328_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001374328_main_keyfigs.svg",
"name": "Fitlife Brands INC",
"rank": 4,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001374328.svg",
"report_text": "The relative strengths and weaknesses of Fitlife Brands INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Fitlife Brands INC compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 93% points.The greatest weakness of Fitlife Brands INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 54% points.
The company's Economic Capital Ratio, given in the ranking table, is 259%, being 113% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001374328_2021_Fitlife_Brands_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "53.4",
"Liabilities": "95.2",
"Stockholders Equity": "-40.7",
"ECR before LimitedLiability": "108",
"Liabilities, Non-Current": "25.7",
"Other Liabilities": "27.0",
"Property, Plant and Equipment, Net": "-14.6",
"Assets": "-33.5",
"Assets, Non-Current": "-6.95",
"Goodwill": "2.56",
"Assets, Current": "-23.4",
"General and Administrative Expense": "53.1",
"Expenses": "-37.8",
"Revenues": "118",
"Net Income": "86.8",
"Research and Development": "30.1",
"Other Expenses": "-133",
"Other Revenues": "118",
"Comprehensive Net Income": "86.7",
"Other Net Income": "-11.4",
"Economic Capital Ratio": "45.6"
},
"2012": {
"Liabilities, Current": "46.1",
"Liabilities": "100",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "113",
"Liabilities, Non-Current": "29.3",
"Other Liabilities": "46.3",
"Assets, Current": "-8.09",
"Assets": "-18.3",
"Assets, Non-Current": "-4.12",
"Property, Plant and Equipment, Net": "-8.41",
"Goodwill": "-3.90",
"Other Expenses": "-134",
"Expenses": "-26.0",
"Revenues": "142",
"Net Income": "109",
"Research and Development": "31.9",
"General and Administrative Expense": "53.0",
"Other Revenues": "142",
"Other Net Income": "-1.19",
"Comprehensive Net Income": "109",
"Economic Capital Ratio": "80.5"
},
"2013": {
"Liabilities, Current": "39.7",
"Liabilities": "58.8",
"Stockholders Equity": "-47.1",
"ECR before LimitedLiability": "64.9",
"Other Liabilities": "26.2",
"Liabilities, Non-Current": "-5.15",
"Goodwill": "-11.0",
"Assets": "-35.1",
"Assets, Non-Current": "-7.12",
"Property, Plant and Equipment, Net": "-14.7",
"Assets, Current": "-11.0",
"General and Administrative Expense": "37.3",
"Expenses": "-18.4",
"Revenues": "96.8",
"Net Income": "93.1",
"Research and Development": "23.4",
"Other Expenses": "-76.7",
"Other Revenues": "96.8",
"Other Net Income": "-4.97",
"Comprehensive Net Income": "92.9",
"Economic Capital Ratio": "24.8"
},
"2014": {
"Liabilities, Non-Current": "10.1",
"Liabilities": "102",
"Stockholders Equity": "16.6",
"ECR before LimitedLiability": "126",
"Liabilities, Current": "76.5",
"Other Liabilities": "24.9",
"Assets, Current": "-1.12",
"Assets": "-20.0",
"Goodwill": "-8.50",
"Assets, Non-Current": "-4.51",
"Property, Plant and Equipment, Net": "-10.2",
"Other Expenses": "-102",
"Expenses": "-14.1",
"Revenues": "121",
"Net Income": "104",
"Research and Development": "25.9",
"General and Administrative Expense": "51.9",
"Other Revenues": "121",
"Other Net Income": "2.57",
"Comprehensive Net Income": "105",
"Economic Capital Ratio": "76.9"
},
"2015": {
"Other Liabilities": "22.1",
"Liabilities": "46.0",
"Stockholders Equity": "21.1",
"ECR before LimitedLiability": "79.3",
"Liabilities, Current": "8.24",
"Liabilities, Non-Current": "17.9",
"Assets, Current": "-6.68",
"Assets": "-9.20",
"Other Assets": "-3.37",
"Goodwill": "20.5",
"Assets, Non-Current": "-3.91",
"Property, Plant and Equipment, Net": "-11.0",
"Research and Development": "13.9",
"Expenses": "-2.00",
"Revenues": "49.7",
"Net Income": "48.7",
"General and Administrative Expense": "15.1",
"Other Expenses": "-29.2",
"Other Revenues": "49.7",
"Comprehensive Net Income": "49.2",
"Economic Capital Ratio": "33.4"
},
"2016": {
"Liabilities, Non-Current": "32.0",
"Liabilities": "79.6",
"Stockholders Equity": "-11.8",
"ECR before LimitedLiability": "71.4",
"Liabilities, Current": "39.0",
"Other Liabilities": "16.9",
"Property, Plant and Equipment, Net": "-14.8",
"Assets": "-25.1",
"Assets, Non-Current": "-4.52",
"Assets, Current": "-20.4",
"Goodwill": "12.9",
"Research and Development": "25.1",
"Expenses": "-23.7",
"Revenues": "98.1",
"Net Income": "62.6",
"General and Administrative Expense": "5.69",
"Other Expenses": "-55.9",
"Other Revenues": "98.1",
"Comprehensive Net Income": "63.1",
"Other Net Income": "-3.31",
"Economic Capital Ratio": "51.5"
},
"2017": {
"Other Liabilities": "4.91",
"Liabilities": "12.6",
"Stockholders Equity": "-70.6",
"ECR before LimitedLiability": "-74.7",
"Liabilities, Current": "1.21",
"Liabilities, Non-Current": "8.51",
"Assets, Non-Current": "-10.4",
"Assets": "-90.1",
"Assets, Current": "-25.4",
"Goodwill": "-22.9",
"Property, Plant and Equipment, Net": "-26.0",
"Research and Development": "16.5",
"Expenses": "-63.5",
"Revenues": "39.6",
"Net Income": "-16.9",
"Other Expenses": "-111",
"General and Administrative Expense": "4.46",
"Other Revenues": "39.6",
"Comprehensive Net Income": "-17.2",
"Other Net Income": "-5.70",
"Economic Capital Ratio": "-96.2"
},
"2018": {
"Liabilities, Non-Current": "45.3",
"Liabilities": "67.8",
"Stockholders Equity": "-111",
"ECR before LimitedLiability": "28.8",
"Other Liabilities": "28.0",
"Liabilities, Current": "15.2",
"Property, Plant and Equipment, Net": "-30.3",
"Assets": "-64.6",
"Assets, Current": "-30.8",
"Goodwill": "-23.9",
"Assets, Non-Current": "-19.5",
"Other Expenses": "32.4",
"Expenses": "-55.0",
"Revenues": "94.0",
"Net Income": "71.4",
"Research and Development": "36.2",
"General and Administrative Expense": "-115",
"Other Revenues": "94.0",
"Comprehensive Net Income": "71.6",
"Other Net Income": "-2.18",
"Economic Capital Ratio": "8.33"
},
"2019": {
"Liabilities, Non-Current": "50.0",
"Liabilities": "109",
"Stockholders Equity": "-110",
"ECR before LimitedLiability": "99.0",
"Other Liabilities": "36.9",
"Liabilities, Current": "37.9",
"Assets, Non-Current": "-13.8",
"Assets": "-40.8",
"Goodwill": "-15.5",
"Property, Plant and Equipment, Net": "-18.6",
"Assets, Current": "-17.2",
"Research and Development": "24.6",
"Expenses": "-50.7",
"Revenues": "137",
"Net Income": "124",
"Other Expenses": "23.7",
"General and Administrative Expense": "-109",
"Other Revenues": "137",
"Other Net Income": "11.7",
"Comprehensive Net Income": "124",
"Economic Capital Ratio": "69.6"
},
"2020": {
"Liabilities, Current": "21.0",
"Liabilities": "66.7",
"Stockholders Equity": "0.256",
"ECR before LimitedLiability": "151",
"Liabilities, Non-Current": "49.4",
"Other Liabilities": "4.95",
"Goodwill": "-3.59",
"Assets": "-5.67",
"Other Assets": "7.35",
"Assets, Non-Current": "-2.91",
"Property, Plant and Equipment, Net": "-4.68",
"Other Expenses": "40.6",
"Expenses": "4.73",
"Revenues": "80.7",
"Net Income": "92.8",
"Research and Development": "11.7",
"General and Administrative Expense": "-53.8",
"Other Revenues": "80.7",
"Comprehensive Net Income": "92.9",
"Other Net Income": "8.18",
"Economic Capital Ratio": "113"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001374328_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "3,296",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,675",
"Goodwill": "1,477",
"Liabilities, Current": "1,616",
"Liabilities, Non-Current": "0",
"Other Assets": "6.8",
"Other Compr. Net Income": "0",
"Other Expenses": "8,207",
"Other Liabilities": "0",
"Other Net Income": "118",
"Other Revenues": "12,092",
"Property, Plant and Equipment, Net": "43",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,616",
"Assets": "4,823",
"Expenses": "11,883",
"Revenues": "12,092",
"Stockholders Equity": "3,206",
"Net Income": "327",
"Comprehensive Net Income": "327",
"BaseVar": "15,266",
"ECR before LimitedLiability": "147%",
"Economic Capital Ratio": "199%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "6,397",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,400",
"Goodwill": "1,257",
"Liabilities, Current": "1,870",
"Liabilities, Non-Current": "0",
"Other Assets": "3.0",
"Other Compr. Net Income": "0",
"Other Expenses": "11,812",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "18,093",
"Property, Plant and Equipment, Net": "19",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,870",
"Assets": "7,676",
"Expenses": "16,212",
"Revenues": "18,093",
"Stockholders Equity": "5,805",
"Net Income": "1,881",
"Comprehensive Net Income": "1,881",
"BaseVar": "21,925",
"ECR before LimitedLiability": "206%",
"Economic Capital Ratio": "239%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "8,134",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,516",
"Goodwill": "1,037",
"Liabilities, Current": "2,475",
"Liabilities, Non-Current": "1,947",
"Other Assets": "53",
"Other Compr. Net Income": "0",
"Other Expenses": "12,781",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "19,684",
"Property, Plant and Equipment, Net": "6.0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,422",
"Assets": "9,230",
"Expenses": "18,296",
"Revenues": "19,684",
"Stockholders Equity": "4,809",
"Net Income": "1,388",
"Comprehensive Net Income": "1,388",
"BaseVar": "25,816",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "179%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "9,060",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,015",
"Goodwill": "1,037",
"Liabilities, Current": "1,950",
"Liabilities, Non-Current": "1,440",
"Other Assets": "3.0",
"Other Compr. Net Income": "0",
"Other Expenses": "13,094",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "19,960",
"Property, Plant and Equipment, Net": "3.1",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,390",
"Assets": "10,104",
"Expenses": "18,108",
"Revenues": "19,960",
"Stockholders Equity": "6,714",
"Net Income": "1,852",
"Comprehensive Net Income": "1,852",
"BaseVar": "25,781",
"ECR before LimitedLiability": "164%",
"Economic Capital Ratio": "210%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "9,536",
"Assets, Non-Current": "0",
"General and Administrative Expense": "7,068",
"Goodwill": "6,930",
"Liabilities, Current": "6,533",
"Liabilities, Non-Current": "914",
"Other Assets": "866",
"Other Compr. Net Income": "0",
"Other Expenses": "11,953",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "17,931",
"Property, Plant and Equipment, Net": "227",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,448",
"Assets": "17,558",
"Expenses": "19,021",
"Revenues": "17,931",
"Stockholders Equity": "10,111",
"Net Income": "-1,090",
"Comprehensive Net Income": "-1,090",
"BaseVar": "30,979",
"ECR before LimitedLiability": "102%",
"Economic Capital Ratio": "169%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "8,126",
"Assets, Non-Current": "0",
"General and Administrative Expense": "9,121",
"Goodwill": "6,508",
"Liabilities, Current": "4,644",
"Liabilities, Non-Current": "369",
"Other Assets": "742",
"Other Compr. Net Income": "0",
"Other Expenses": "15,721",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "25,314",
"Property, Plant and Equipment, Net": "171",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,013",
"Assets": "15,546",
"Expenses": "24,841",
"Revenues": "25,314",
"Stockholders Equity": "10,533",
"Net Income": "472",
"Comprehensive Net Income": "472",
"BaseVar": "35,357",
"ECR before LimitedLiability": "145%",
"Economic Capital Ratio": "198%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "6,320",
"Assets, Non-Current": "0",
"General and Administrative Expense": "7,705",
"Goodwill": "225",
"Liabilities, Current": "5,951",
"Liabilities, Non-Current": "0",
"Other Assets": "22",
"Other Compr. Net Income": "0",
"Other Expenses": "19,736",
"Other Liabilities": "0",
"Other Net Income": "-120",
"Other Revenues": "17,799",
"Property, Plant and Equipment, Net": "295",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,951",
"Assets": "6,862",
"Expenses": "27,441",
"Revenues": "17,799",
"Stockholders Equity": "912",
"Net Income": "-9,762",
"Comprehensive Net Income": "-9,762",
"BaseVar": "29,087",
"ECR before LimitedLiability": "-133%",
"Economic Capital Ratio": "57%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "5,438",
"Assets, Non-Current": "0",
"General and Administrative Expense": "16,355",
"Goodwill": "225",
"Liabilities, Current": "3,548",
"Liabilities, Non-Current": "0",
"Other Assets": "10",
"Other Compr. Net Income": "0",
"Other Expenses": "80",
"Other Liabilities": "0",
"Other Net Income": "-133",
"Other Revenues": "17,077",
"Property, Plant and Equipment, Net": "189",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,548",
"Assets": "5,862",
"Expenses": "16,435",
"Revenues": "17,077",
"Stockholders Equity": "2,314",
"Net Income": "509",
"Comprehensive Net Income": "509",
"BaseVar": "21,528",
"ECR before LimitedLiability": "78%",
"Economic Capital Ratio": "152%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "5,701",
"Assets, Non-Current": "254",
"General and Administrative Expense": "16,864",
"Goodwill": "225",
"Liabilities, Current": "2,776",
"Liabilities, Non-Current": "208",
"Other Assets": "10",
"Other Compr. Net Income": "0",
"Other Expenses": "59",
"Other Liabilities": "0",
"Other Net Income": "124",
"Other Revenues": "19,497",
"Property, Plant and Equipment, Net": "136",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,984",
"Assets": "6,326",
"Expenses": "16,923",
"Revenues": "19,497",
"Stockholders Equity": "3,342",
"Net Income": "2,698",
"Comprehensive Net Income": "2,698",
"BaseVar": "22,927",
"ECR before LimitedLiability": "156%",
"Economic Capital Ratio": "205%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "11,873",
"Assets, Non-Current": "208",
"General and Administrative Expense": "17,502",
"Goodwill": "225",
"Liabilities, Current": "4,129",
"Liabilities, Non-Current": "158",
"Other Assets": "4,370",
"Other Compr. Net Income": "0",
"Other Expenses": "-4,408",
"Other Liabilities": "453",
"Other Net Income": "64",
"Other Revenues": "21,744",
"Property, Plant and Equipment, Net": "98",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,740",
"Assets": "16,774",
"Expenses": "13,094",
"Revenues": "21,744",
"Stockholders Equity": "12,034",
"Net Income": "8,714",
"Comprehensive Net Income": "8,714",
"BaseVar": "28,208",
"ECR before LimitedLiability": "234%",
"Economic Capital Ratio": "259%"
}
}
},
"top_rated": true,
"trend": 6.0,
"value": 2.5926569673302335,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001374328.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001374328.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001374328.svg"
},
{
"company_id": "0001656472",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001656472.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001656472.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001656472.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001656472_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001656472_main_keyfigs.svg",
"name": "Cronos Group Inc",
"rank": 5,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001656472.svg",
"report_text": "The relative strengths and weaknesses of Cronos Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cronos Group Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 103% points.The greatest weakness of Cronos Group Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 24% points.
The company's Economic Capital Ratio, given in the ranking table, is 243%, being 97% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001656472_2021_Cronos_Group_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "5.96",
"Liabilities": "31.6",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "135",
"Liabilities, Non-Current": "22.7",
"Other Liabilities": "4.90",
"Goodwill": "2.25",
"Assets": "32.9",
"Other Assets": "1.83",
"Assets, Current": "27.0",
"Assets, Non-Current": "-1.70",
"Other Expenses": "-0.629",
"Expenses": "25.1",
"Revenues": "-24.5",
"Net Income": "12.4",
"Research and Development": "3.77",
"General and Administrative Expense": "22.1",
"Other Revenues": "-24.5",
"Comprehensive Net Income": "13.0",
"Other Net Income": "10.2",
"Economic Capital Ratio": "97.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001656472_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "1,372,172",
"Assets, Non-Current": "29,011",
"General and Administrative Expense": "114,915",
"Goodwill": "249,242",
"Liabilities, Current": "206,834",
"Liabilities, Non-Current": "8,492",
"Other Assets": "87,658",
"Other Compr. Net Income": "17,294",
"Other Expenses": "92,132",
"Other Liabilities": "2,188",
"Other Net Income": "105,424",
"Other Revenues": "46,719",
"Property, Plant and Equipment, Net": "187,599",
"Research and Development": "20,366"
},
"output_variables": {
"Liabilities": "217,514",
"Assets": "1,925,682",
"Expenses": "227,413",
"Revenues": "46,719",
"Stockholders Equity": "1,708,168",
"Net Income": "-75,270",
"Comprehensive Net Income": "-66,623",
"BaseVar": "1,270,023",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "243%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.432891294137216,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001656472.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001656472.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001656472.svg"
},
{
"company_id": "0000907654",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000907654.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000907654.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000907654.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000907654_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000907654_main_keyfigs.svg",
"name": "Oruka Therapeutics Inc",
"rank": 6,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000907654.svg",
"report_text": "The relative strengths and weaknesses of Oruka Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Oruka Therapeutics Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 118% points.The greatest weakness of Oruka Therapeutics Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 27% points.
The company's Economic Capital Ratio, given in the ranking table, is 234%, being 88% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000907654_2021_Oruka_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "0",
"Liabilities": "0",
"ECR before LimitedLiability": "-91.5",
"Liabilities, Non-Current": "0",
"Other Liabilities": "0",
"Property, Plant and Equipment, Net": "0",
"Assets": "-77.5",
"Stockholders Equity": "0",
"Assets, Non-Current": "0",
"Goodwill": "0",
"Assets, Current": "-23.3",
"General and Administrative Expense": "0",
"Expenses": "-50.4",
"Net Income": "-38.9",
"Research and Development": "-0.0791",
"Other Expenses": "0",
"Other Revenues": "0",
"Revenues": "0",
"Comprehensive Net Income": "-39.1",
"Other Net Income": "0",
"Economic Capital Ratio": "-153"
},
"2013": {
"Liabilities, Current": "103",
"Liabilities": "173",
"Stockholders Equity": "105",
"ECR before LimitedLiability": "359",
"Other Liabilities": "51.5",
"Liabilities, Non-Current": "59.5",
"Goodwill": "23.8",
"Assets": "-14.2",
"Assets, Non-Current": "8.49",
"Property, Plant and Equipment, Net": "20.4",
"Assets, Current": "-131",
"General and Administrative Expense": "51.2",
"Expenses": "118",
"Revenues": "-98.7",
"Net Income": "265",
"Research and Development": "-7.38",
"Other Expenses": "75.8",
"Other Revenues": "-98.7",
"Other Net Income": "249",
"Comprehensive Net Income": "265",
"Economic Capital Ratio": "319"
},
"2014": {
"Liabilities, Non-Current": "14.8",
"Liabilities": "50.2",
"Stockholders Equity": "104",
"ECR before LimitedLiability": "97.3",
"Liabilities, Current": "28.4",
"Other Liabilities": "9.86",
"Assets, Current": "119",
"Assets": "97.2",
"Goodwill": "-8.03",
"Assets, Non-Current": "0.826",
"Property, Plant and Equipment, Net": "-6.21",
"Other Expenses": "15.9",
"Expenses": "-6.77",
"Revenues": "-36.8",
"Net Income": "-42.6",
"Research and Development": "-31.9",
"General and Administrative Expense": "10.2",
"Other Revenues": "-36.8",
"Other Net Income": "1.07",
"Comprehensive Net Income": "-42.5",
"Economic Capital Ratio": "47.9"
},
"2015": {
"Other Liabilities": "13.9",
"Liabilities": "55.9",
"Stockholders Equity": "149",
"ECR before LimitedLiability": "144",
"Liabilities, Current": "32.5",
"Liabilities, Non-Current": "16.8",
"Assets, Current": "145",
"Assets": "63.8",
"Other Assets": "-1.67",
"Goodwill": "-3.43",
"Property, Plant and Equipment, Net": "-2.84",
"Research and Development": "-17.1",
"Expenses": "14.4",
"Revenues": "-29.1",
"Net Income": "-12.9",
"General and Administrative Expense": "12.7",
"Other Expenses": "18.1",
"Other Revenues": "-29.1",
"Comprehensive Net Income": "-12.7",
"Other Net Income": "0.597",
"Economic Capital Ratio": "97.7"
},
"2016": {
"Liabilities, Non-Current": "17.4",
"Liabilities": "45.8",
"Stockholders Equity": "89.4",
"ECR before LimitedLiability": "43.3",
"Liabilities, Current": "23.2",
"Other Liabilities": "7.46",
"Property, Plant and Equipment, Net": "-10.7",
"Assets": "77.5",
"Other Assets": "11.4",
"Assets, Current": "88.5",
"Goodwill": "-9.40",
"Research and Development": "-49.0",
"Expenses": "-17.4",
"Revenues": "-36.0",
"Net Income": "-54.7",
"General and Administrative Expense": "10.1",
"Other Expenses": "24.3",
"Other Revenues": "-36.0",
"Comprehensive Net Income": "-54.6",
"Other Net Income": "-1.64",
"Economic Capital Ratio": "23.4"
},
"2017": {
"Other Liabilities": "2.58",
"Liabilities": "12.1",
"Stockholders Equity": "28.1",
"ECR before LimitedLiability": "-53.9",
"Liabilities, Current": "4.86",
"Liabilities, Non-Current": "5.01",
"Assets, Non-Current": "-2.57",
"Assets": "6.20",
"Assets, Current": "69.3",
"Goodwill": "-5.95",
"Property, Plant and Equipment, Net": "-6.57",
"Research and Development": "-96.2",
"Expenses": "-65.7",
"Revenues": "-16.6",
"Net Income": "-121",
"Other Expenses": "10.0",
"General and Administrative Expense": "0.760",
"Other Revenues": "-16.6",
"Comprehensive Net Income": "-121",
"Other Net Income": "-1.55",
"Economic Capital Ratio": "-75.5"
},
"2018": {
"Liabilities, Non-Current": "8.90",
"Liabilities": "12.2",
"Stockholders Equity": "26.7",
"ECR before LimitedLiability": "-30.1",
"Other Liabilities": "8.62",
"Liabilities, Current": "9.04",
"Property, Plant and Equipment, Net": "-28.7",
"Assets": "13.2",
"Assets, Current": "72.3",
"Goodwill": "-23.3",
"Assets, Non-Current": "-16.4",
"Other Expenses": "8.80",
"Expenses": "-73.7",
"Revenues": "-56.4",
"Net Income": "-118",
"Research and Development": "-74.3",
"General and Administrative Expense": "-17.8",
"Other Revenues": "-56.4",
"Comprehensive Net Income": "-118",
"Other Compr. Net Income": "0.397",
"Economic Capital Ratio": "-50.5"
},
"2019": {
"Liabilities, Non-Current": "18.9",
"Liabilities": "41.8",
"Stockholders Equity": "88.5",
"ECR before LimitedLiability": "64.4",
"Other Liabilities": "12.3",
"Liabilities, Current": "12.6",
"Assets, Non-Current": "-8.08",
"Assets": "68.5",
"Goodwill": "-9.48",
"Property, Plant and Equipment, Net": "-11.1",
"Assets, Current": "121",
"Research and Development": "-17.9",
"Expenses": "-16.5",
"Revenues": "-33.5",
"Net Income": "-46.4",
"Other Expenses": "11.0",
"General and Administrative Expense": "-9.18",
"Other Revenues": "-33.5",
"Other Net Income": "3.46",
"Comprehensive Net Income": "-46.4",
"Economic Capital Ratio": "35.0"
},
"2020": {
"Liabilities, Current": "15.1",
"Liabilities": "37.3",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "126",
"Liabilities, Non-Current": "20.6",
"Other Liabilities": "4.95",
"Goodwill": "-3.27",
"Assets": "44.6",
"Assets, Current": "107",
"Assets, Non-Current": "-2.27",
"Property, Plant and Equipment, Net": "-4.14",
"Other Expenses": "5.26",
"Expenses": "14.7",
"Revenues": "-26.8",
"Net Income": "-7.67",
"Research and Development": "-7.75",
"General and Administrative Expense": "17.0",
"Other Revenues": "-26.8",
"Comprehensive Net Income": "-7.62",
"Other Net Income": "3.28",
"Economic Capital Ratio": "88.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000907654_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "6,212",
"Assets, Non-Current": "224",
"General and Administrative Expense": "39,356",
"Goodwill": "0",
"Liabilities, Current": "754",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "12,041",
"Other Liabilities": "16",
"Other Net Income": "27,282",
"Other Revenues": "2,026",
"Property, Plant and Equipment, Net": "66",
"Research and Development": "41,585"
},
"output_variables": {
"Liabilities": "770",
"Assets": "6,502",
"Expenses": "92,982",
"Revenues": "2,026",
"Stockholders Equity": "5,732",
"Net Income": "-63,674",
"Comprehensive Net Income": "-63,674",
"BaseVar": "64,781",
"ECR before LimitedLiability": "-1,535%",
"Economic Capital Ratio": "0.0000000000000000000015%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "16,925",
"Assets, Non-Current": "130",
"General and Administrative Expense": "4,012",
"Goodwill": "0",
"Liabilities, Current": "1,502",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,277",
"Other Liabilities": "1.0",
"Other Net Income": "27,282",
"Other Revenues": "5.0",
"Property, Plant and Equipment, Net": "29",
"Research and Development": "2,928"
},
"output_variables": {
"Liabilities": "1,503",
"Assets": "17,084",
"Expenses": "4,663",
"Revenues": "5.0",
"Stockholders Equity": "15,581",
"Net Income": "22,624",
"Comprehensive Net Income": "22,624",
"BaseVar": "25,268",
"ECR before LimitedLiability": "473%",
"Economic Capital Ratio": "474%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "15,488",
"Assets, Non-Current": "608",
"General and Administrative Expense": "4,068",
"Goodwill": "0",
"Liabilities, Current": "1,388",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3.0",
"Other Liabilities": "3.0",
"Other Net Income": "0",
"Other Revenues": "7.0",
"Property, Plant and Equipment, Net": "36",
"Research and Development": "5,625"
},
"output_variables": {
"Liabilities": "1,391",
"Assets": "16,132",
"Expenses": "9,696",
"Revenues": "7.0",
"Stockholders Equity": "14,741",
"Net Income": "-9,689",
"Comprehensive Net Income": "-9,689",
"BaseVar": "13,613",
"ECR before LimitedLiability": "120%",
"Economic Capital Ratio": "181%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "38,916",
"Assets, Non-Current": "630",
"General and Administrative Expense": "4,392",
"Goodwill": "0",
"Liabilities, Current": "1,504",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4.0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "14",
"Property, Plant and Equipment, Net": "28",
"Research and Development": "7,063"
},
"output_variables": {
"Liabilities": "1,504",
"Assets": "39,574",
"Expenses": "11,459",
"Revenues": "14",
"Stockholders Equity": "38,070",
"Net Income": "-11,445",
"Comprehensive Net Income": "-11,445",
"BaseVar": "26,276",
"ECR before LimitedLiability": "198%",
"Economic Capital Ratio": "234%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "21,445",
"Assets, Non-Current": "766",
"General and Administrative Expense": "4,265",
"Goodwill": "0",
"Liabilities, Current": "2,396",
"Liabilities, Non-Current": "0",
"Other Assets": "2,352",
"Other Compr. Net Income": "-19",
"Other Expenses": "0",
"Other Liabilities": "39",
"Other Net Income": "0",
"Other Revenues": "169",
"Property, Plant and Equipment, Net": "66",
"Research and Development": "12,348"
},
"output_variables": {
"Liabilities": "2,435",
"Assets": "24,629",
"Expenses": "16,613",
"Revenues": "169",
"Stockholders Equity": "22,194",
"Net Income": "-16,444",
"Comprehensive Net Income": "-16,454",
"BaseVar": "21,932",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "12,299",
"Assets, Non-Current": "24",
"General and Administrative Expense": "4,636",
"Goodwill": "0",
"Liabilities, Current": "2,070",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "17",
"Other Expenses": "-55",
"Other Liabilities": "20",
"Other Net Income": "0",
"Other Revenues": "167",
"Property, Plant and Equipment, Net": "42",
"Research and Development": "14,076"
},
"output_variables": {
"Liabilities": "2,090",
"Assets": "12,365",
"Expenses": "18,657",
"Revenues": "167",
"Stockholders Equity": "10,275",
"Net Income": "-18,490",
"Comprehensive Net Income": "-18,482",
"BaseVar": "16,648",
"ECR before LimitedLiability": "-61%",
"Economic Capital Ratio": "78%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,777",
"Assets, Non-Current": "24",
"General and Administrative Expense": "3,879",
"Goodwill": "0",
"Liabilities, Current": "793",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "2.0",
"Other Expenses": "-23",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "162",
"Property, Plant and Equipment, Net": "24",
"Research and Development": "4,239"
},
"output_variables": {
"Liabilities": "793",
"Assets": "6,825",
"Expenses": "8,095",
"Revenues": "162",
"Stockholders Equity": "6,032",
"Net Income": "-7,933",
"Comprehensive Net Income": "-7,932",
"BaseVar": "7,938",
"ECR before LimitedLiability": "8.7%",
"Economic Capital Ratio": "93%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "8,480",
"Assets, Non-Current": "46",
"General and Administrative Expense": "3,981",
"Goodwill": "0",
"Liabilities, Current": "926",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-160",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "172",
"Property, Plant and Equipment, Net": "10",
"Research and Development": "1,833"
},
"output_variables": {
"Liabilities": "926",
"Assets": "8,536",
"Expenses": "5,654",
"Revenues": "172",
"Stockholders Equity": "7,610",
"Net Income": "-5,482",
"Comprehensive Net Income": "-5,482",
"BaseVar": "7,644",
"ECR before LimitedLiability": "104%",
"Economic Capital Ratio": "171%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "49,968",
"Assets, Non-Current": "440",
"General and Administrative Expense": "4,774",
"Goodwill": "0",
"Liabilities, Current": "3,499",
"Liabilities, Non-Current": "409",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "28",
"Property, Plant and Equipment, Net": "21",
"Research and Development": "4,992"
},
"output_variables": {
"Liabilities": "3,908",
"Assets": "50,429",
"Expenses": "9,766",
"Revenues": "28",
"Stockholders Equity": "46,521",
"Net Income": "-9,738",
"Comprehensive Net Income": "-9,738",
"BaseVar": "32,066",
"ECR before LimitedLiability": "199%",
"Economic Capital Ratio": "234%"
}
}
},
"top_rated": true,
"trend": 12.0,
"value": 2.339251810012466,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000907654.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000907654.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000907654.svg"
},
{
"company_id": "0001054905",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001054905.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001054905.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001054905.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001054905_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001054905_main_keyfigs.svg",
"name": "Innospec INC",
"rank": 7,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001054905.svg",
"report_text": "The relative strengths and weaknesses of Innospec INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Innospec INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 68% points.The greatest weakness of Innospec INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 231%, being 85% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001054905_2021_Innospec_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "29.4",
"Liabilities": "60.0",
"Stockholders Equity": "21.0",
"ECR before LimitedLiability": "128",
"Liabilities, Non-Current": "18.6",
"Other Liabilities": "19.5",
"Property, Plant and Equipment, Net": "-4.79",
"Assets": "-7.47",
"Assets, Non-Current": "-3.61",
"Other Assets": "4.30",
"Goodwill": "6.41",
"Assets, Current": "-8.21",
"Other Revenues": "64.1",
"Revenues": "64.1",
"Net Income": "56.7",
"General and Administrative Expense": "55.2",
"Comprehensive Net Income": "57.8",
"Research and Development": "16.3",
"Other Net Income": "-8.06",
"Other Expenses": "-77.5",
"Economic Capital Ratio": "66.0"
},
"2012": {
"Liabilities, Current": "9.93",
"Liabilities": "53.3",
"Stockholders Equity": "17.3",
"ECR before LimitedLiability": "106",
"Liabilities, Non-Current": "19.1",
"Other Liabilities": "30.8",
"Assets, Current": "-7.25",
"Assets": "-5.35",
"Assets, Non-Current": "-2.98",
"Property, Plant and Equipment, Net": "-3.50",
"Goodwill": "9.79",
"Other Expenses": "-65.4",
"Expenses": "11.3",
"Revenues": "62.6",
"Net Income": "73.3",
"Research and Development": "16.9",
"General and Administrative Expense": "52.3",
"Other Revenues": "62.6",
"Other Net Income": "-1.02",
"Comprehensive Net Income": "73.4",
"Economic Capital Ratio": "74.0"
},
"2013": {
"Liabilities, Current": "23.2",
"Liabilities": "61.1",
"Stockholders Equity": "44.5",
"ECR before LimitedLiability": "121",
"Other Liabilities": "22.0",
"Liabilities, Non-Current": "25.4",
"General and Administrative Expense": "42.2",
"Expenses": "8.02",
"Net Income": "55.3",
"Research and Development": "12.9",
"Other Expenses": "-52.4",
"Other Revenues": "50.3",
"Revenues": "50.3",
"Goodwill": "12.2",
"Assets, Non-Current": "-2.38",
"Property, Plant and Equipment, Net": "-2.49",
"Other Assets": "-0.972",
"Assets, Current": "-3.40",
"Other Net Income": "-2.94",
"Comprehensive Net Income": "55.1",
"Economic Capital Ratio": "80.6"
},
"2014": {
"Liabilities, Non-Current": "26.9",
"Liabilities": "70.9",
"Stockholders Equity": "67.4",
"ECR before LimitedLiability": "145",
"Liabilities, Current": "36.5",
"Other Liabilities": "18.4",
"Assets, Current": "-5.99",
"Assets": "4.50",
"Goodwill": "17.1",
"Other Assets": "2.46",
"Assets, Non-Current": "-2.34",
"Other Expenses": "-54.6",
"Expenses": "13.8",
"Revenues": "43.9",
"Net Income": "59.8",
"Research and Development": "15.0",
"General and Administrative Expense": "48.3",
"Other Revenues": "43.9",
"Comprehensive Net Income": "62.2",
"Other Compr. Net Income": "2.31",
"Economic Capital Ratio": "95.2"
},
"2015": {
"Other Liabilities": "26.6",
"Liabilities": "80.9",
"Stockholders Equity": "66.2",
"ECR before LimitedLiability": "146",
"Liabilities, Current": "37.7",
"Liabilities, Non-Current": "31.7",
"Assets, Current": "-3.82",
"Assets": "1.29",
"Other Assets": "-0.904",
"Goodwill": "13.4",
"Assets, Non-Current": "-1.66",
"Property, Plant and Equipment, Net": "-2.57",
"Research and Development": "10.9",
"Expenses": "6.52",
"Revenues": "55.3",
"Net Income": "62.5",
"General and Administrative Expense": "31.1",
"Other Expenses": "-38.6",
"Other Revenues": "55.3",
"Comprehensive Net Income": "62.6",
"Economic Capital Ratio": "100"
},
"2016": {
"Liabilities, Non-Current": "28.7",
"Liabilities": "66.0",
"Stockholders Equity": "65.1",
"ECR before LimitedLiability": "116",
"Liabilities, Current": "34.4",
"Other Liabilities": "13.6",
"Assets": "4.90",
"Other Assets": "2.10",
"Assets, Non-Current": "-1.55",
"Assets, Current": "-5.48",
"Goodwill": "15.2",
"Research and Development": "14.4",
"Expenses": "12.0",
"Revenues": "35.9",
"Net Income": "44.9",
"General and Administrative Expense": "22.5",
"Other Expenses": "-26.7",
"Other Revenues": "35.9",
"Comprehensive Net Income": "44.4",
"Other Net Income": "-2.56",
"Economic Capital Ratio": "96.1"
},
"2017": {
"Other Liabilities": "19.5",
"Liabilities": "75.5",
"Stockholders Equity": "49.9",
"ECR before LimitedLiability": "104",
"Liabilities, Current": "34.6",
"Liabilities, Non-Current": "34.5",
"Other Revenues": "49.5",
"Revenues": "49.5",
"Net Income": "41.6",
"Assets, Non-Current": "-2.21",
"Other Assets": "3.96",
"Assets, Current": "-5.77",
"Goodwill": "9.43",
"Property, Plant and Equipment, Net": "-4.36",
"Comprehensive Net Income": "44.7",
"Other Compr. Net Income": "3.19",
"Other Expenses": "-55.2",
"Other Net Income": "-6.21",
"Research and Development": "16.2",
"General and Administrative Expense": "31.6",
"Economic Capital Ratio": "82.0"
},
"2018": {
"Liabilities, Non-Current": "29.7",
"Liabilities": "63.3",
"Stockholders Equity": "33.4",
"ECR before LimitedLiability": "104",
"Other Liabilities": "18.7",
"Liabilities, Current": "24.1",
"Property, Plant and Equipment, Net": "-3.47",
"Assets": "-3.87",
"Other Assets": "3.49",
"Assets, Current": "-6.44",
"Goodwill": "9.96",
"Assets, Non-Current": "-4.73",
"Other Expenses": "12.3",
"Expenses": "-1.27",
"Revenues": "51.6",
"Net Income": "50.2",
"Research and Development": "14.8",
"General and Administrative Expense": "-29.9",
"Other Revenues": "51.6",
"Comprehensive Net Income": "49.1",
"Economic Capital Ratio": "84.0"
},
"2019": {
"Liabilities, Non-Current": "33.9",
"Liabilities": "67.0",
"Stockholders Equity": "31.8",
"ECR before LimitedLiability": "123",
"Other Liabilities": "22.8",
"Liabilities, Current": "20.5",
"Assets, Non-Current": "-5.48",
"Assets": "-4.92",
"Goodwill": "7.67",
"Property, Plant and Equipment, Net": "-3.32",
"Other Assets": "4.65",
"Assets, Current": "-6.18",
"Other Revenues": "55.0",
"Revenues": "55.0",
"Net Income": "58.9",
"Research and Development": "10.8",
"Comprehensive Net Income": "59.1",
"General and Administrative Expense": "-24.0",
"Other Expenses": "10.5",
"Other Net Income": "5.56",
"Economic Capital Ratio": "94.0"
},
"2020": {
"Liabilities, Current": "24.0",
"Liabilities": "67.7",
"Stockholders Equity": "31.7",
"ECR before LimitedLiability": "123",
"Liabilities, Non-Current": "42.8",
"Other Liabilities": "9.90",
"Goodwill": "8.17",
"Assets": "-5.01",
"Other Assets": "4.37",
"Assets, Current": "-8.12",
"Assets, Non-Current": "-4.13",
"Other Expenses": "6.52",
"Expenses": "-15.6",
"Revenues": "44.3",
"Net Income": "36.5",
"Research and Development": "7.64",
"General and Administrative Expense": "-30.8",
"Other Revenues": "44.3",
"Comprehensive Net Income": "37.3",
"Other Net Income": "7.21",
"Economic Capital Ratio": "85.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001054905_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "320,300",
"Assets, Non-Current": "600",
"General and Administrative Expense": "155,900",
"Goodwill": "159,200",
"Liabilities, Current": "146,000",
"Liabilities, Non-Current": "0",
"Other Assets": "42,800",
"Other Compr. Net Income": "11,600",
"Other Expenses": "558,200",
"Other Liabilities": "0",
"Other Net Income": "6,900",
"Other Revenues": "774,400",
"Property, Plant and Equipment, Net": "45,900",
"Research and Development": "18,300"
},
"output_variables": {
"Liabilities": "146,000",
"Assets": "568,800",
"Expenses": "732,400",
"Revenues": "774,400",
"Stockholders Equity": "422,800",
"Net Income": "48,900",
"Comprehensive Net Income": "54,700",
"BaseVar": "1,120,050",
"ECR before LimitedLiability": "177%",
"Economic Capital Ratio": "219%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "296,600",
"Assets, Non-Current": "1,400",
"General and Administrative Expense": "117,100",
"Goodwill": "217,600",
"Liabilities, Current": "147,300",
"Liabilities, Non-Current": "0",
"Other Assets": "14,000",
"Other Compr. Net Income": "0",
"Other Expenses": "516,200",
"Other Liabilities": "0",
"Other Net Income": "-1,400",
"Other Revenues": "776,400",
"Property, Plant and Equipment, Net": "49,800",
"Research and Development": "19,600"
},
"output_variables": {
"Liabilities": "147,300",
"Assets": "579,400",
"Expenses": "652,900",
"Revenues": "776,400",
"Stockholders Equity": "432,100",
"Net Income": "122,100",
"Comprehensive Net Income": "122,100",
"BaseVar": "1,078,700",
"ECR before LimitedLiability": "197%",
"Economic Capital Ratio": "232%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "407,400",
"Assets, Non-Current": "1,800",
"General and Administrative Expense": "141,900",
"Goodwill": "314,700",
"Liabilities, Current": "155,600",
"Liabilities, Non-Current": "0",
"Other Assets": "10,400",
"Other Compr. Net Income": "-1,800",
"Other Expenses": "582,400",
"Other Liabilities": "0",
"Other Net Income": "4,500",
"Other Revenues": "818,800",
"Property, Plant and Equipment, Net": "60,400",
"Research and Development": "21,200"
},
"output_variables": {
"Liabilities": "155,600",
"Assets": "794,700",
"Expenses": "745,500",
"Revenues": "818,800",
"Stockholders Equity": "639,100",
"Net Income": "77,800",
"Comprehensive Net Income": "76,900",
"BaseVar": "1,260,450",
"ECR before LimitedLiability": "200%",
"Economic Capital Ratio": "235%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "414,200",
"Assets, Non-Current": "700",
"General and Administrative Expense": "169,200",
"Goodwill": "457,200",
"Liabilities, Current": "222,900",
"Liabilities, Non-Current": "0",
"Other Assets": "47,000",
"Other Compr. Net Income": "40,000",
"Other Expenses": "687,600",
"Other Liabilities": "0",
"Other Net Income": "2,200",
"Other Revenues": "960,900",
"Property, Plant and Equipment, Net": "80,800",
"Research and Development": "22,200"
},
"output_variables": {
"Liabilities": "222,900",
"Assets": "999,900",
"Expenses": "879,000",
"Revenues": "960,900",
"Stockholders Equity": "777,000",
"Net Income": "84,100",
"Comprehensive Net Income": "104,100",
"BaseVar": "1,552,450",
"ECR before LimitedLiability": "191%",
"Economic Capital Ratio": "229%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "458,700",
"Assets, Non-Current": "900",
"General and Administrative Expense": "206,700",
"Goodwill": "436,100",
"Liabilities, Current": "206,100",
"Liabilities, Non-Current": "0",
"Other Assets": "58,300",
"Other Compr. Net Income": "-4,600",
"Other Expenses": "656,800",
"Other Liabilities": "0",
"Other Net Income": "-4,000",
"Other Revenues": "1,012,300",
"Property, Plant and Equipment, Net": "76,000",
"Research and Development": "25,300"
},
"output_variables": {
"Liabilities": "206,100",
"Assets": "1,030,000",
"Expenses": "888,800",
"Revenues": "1,012,300",
"Stockholders Equity": "823,900",
"Net Income": "119,500",
"Comprehensive Net Income": "117,200",
"BaseVar": "1,572,900",
"ECR before LimitedLiability": "202%",
"Economic Capital Ratio": "236%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "441,100",
"Assets, Non-Current": "800",
"General and Administrative Expense": "209,500",
"Goodwill": "519,200",
"Liabilities, Current": "183,100",
"Liabilities, Non-Current": "0",
"Other Assets": "62,900",
"Other Compr. Net Income": "-15,300",
"Other Expenses": "564,900",
"Other Liabilities": "0",
"Other Net Income": "-2,300",
"Other Revenues": "883,400",
"Property, Plant and Equipment, Net": "157,400",
"Research and Development": "25,400"
},
"output_variables": {
"Liabilities": "183,100",
"Assets": "1,181,400",
"Expenses": "799,800",
"Revenues": "883,400",
"Stockholders Equity": "998,300",
"Net Income": "81,300",
"Comprehensive Net Income": "73,650",
"BaseVar": "1,532,650",
"ECR before LimitedLiability": "211%",
"Economic Capital Ratio": "243%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "561,500",
"Assets, Non-Current": "5,100",
"General and Administrative Expense": "239,500",
"Goodwill": "525,100",
"Liabilities, Current": "261,600",
"Liabilities, Non-Current": "0",
"Other Assets": "122,500",
"Other Compr. Net Income": "87,700",
"Other Expenses": "972,500",
"Other Liabilities": "0",
"Other Net Income": "-1,600",
"Other Revenues": "1,306,800",
"Property, Plant and Equipment, Net": "196,000",
"Research and Development": "31,400"
},
"output_variables": {
"Liabilities": "261,600",
"Assets": "1,410,200",
"Expenses": "1,243,400",
"Revenues": "1,306,800",
"Stockholders Equity": "1,148,600",
"Net Income": "61,800",
"Comprehensive Net Income": "105,650",
"BaseVar": "2,155,650",
"ECR before LimitedLiability": "201%",
"Economic Capital Ratio": "235%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "663,900",
"Assets, Non-Current": "7,200",
"General and Administrative Expense": "1,302,900",
"Goodwill": "501,200",
"Liabilities, Current": "296,600",
"Liabilities, Non-Current": "0",
"Other Assets": "104,700",
"Other Compr. Net Income": "-37,200",
"Other Expenses": "53,700",
"Other Liabilities": "0",
"Other Net Income": "-1,900",
"Other Revenues": "1,476,900",
"Property, Plant and Equipment, Net": "196,400",
"Research and Development": "33,400"
},
"output_variables": {
"Liabilities": "296,600",
"Assets": "1,473,400",
"Expenses": "1,390,000",
"Revenues": "1,476,900",
"Stockholders Equity": "1,176,800",
"Net Income": "85,000",
"Comprehensive Net Income": "66,400",
"BaseVar": "2,338,000",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "630,300",
"Assets, Non-Current": "38,300",
"General and Administrative Expense": "1,328,000",
"Goodwill": "476,500",
"Liabilities, Current": "303,500",
"Liabilities, Non-Current": "0",
"Other Assets": "125,000",
"Other Compr. Net Income": "1,300",
"Other Expenses": "38,200",
"Other Liabilities": "0",
"Other Net Income": "500",
"Other Revenues": "1,513,300",
"Property, Plant and Equipment, Net": "198,700",
"Research and Development": "35,400"
},
"output_variables": {
"Liabilities": "303,500",
"Assets": "1,468,800",
"Expenses": "1,401,600",
"Revenues": "1,513,300",
"Stockholders Equity": "1,165,300",
"Net Income": "112,200",
"Comprehensive Net Income": "112,850",
"BaseVar": "2,344,500",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "230%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "566,200",
"Assets, Non-Current": "48,300",
"General and Administrative Expense": "1,087,400",
"Goodwill": "446,500",
"Liabilities, Current": "252,400",
"Liabilities, Non-Current": "0",
"Other Assets": "125,600",
"Other Compr. Net Income": "17,100",
"Other Expenses": "52,100",
"Other Liabilities": "0",
"Other Net Income": "6,000",
"Other Revenues": "1,193,100",
"Property, Plant and Equipment, Net": "210,800",
"Research and Development": "30,900"
},
"output_variables": {
"Liabilities": "252,400",
"Assets": "1,397,400",
"Expenses": "1,170,400",
"Revenues": "1,193,100",
"Stockholders Equity": "1,145,000",
"Net Income": "28,700",
"Comprehensive Net Income": "37,250",
"BaseVar": "2,018,200",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "231%"
}
}
},
"top_rated": true,
"trend": -2.0,
"value": 2.3113237196832475,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001054905.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001054905.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001054905.svg"
},
{
"company_id": "0001652130",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001652130.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001652130.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001652130.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001652130_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001652130_main_keyfigs.svg",
"name": "Intellia Therapeutics Inc",
"rank": 8,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001652130.svg",
"report_text": "The relative strengths and weaknesses of Intellia Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Intellia Therapeutics Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 105% points.The greatest weakness of Intellia Therapeutics Inc is the variable Research and Development, reducing the Economic Capital Ratio by 23% points.
The company's Economic Capital Ratio, given in the ranking table, is 228%, being 82% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001652130_2021_Intellia_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "15.8",
"Liabilities": "32.9",
"Assets": "46.6",
"Stockholders Equity": "119",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "12.8",
"Other Liabilities": "7.24",
"Property, Plant and Equipment, Net": "-2.08",
"Assets, Current": "72.6",
"Goodwill": "-2.98",
"Research and Development": "-4.35",
"Expenses": "28.5",
"Revenues": "-29.6",
"Net Income": "6.91",
"General and Administrative Expense": "16.2",
"Other Expenses": "16.9",
"Other Revenues": "-29.6",
"Comprehensive Net Income": "7.04",
"Other Net Income": "5.91",
"Other Compr. Net Income": "0.135",
"Economic Capital Ratio": "90.8"
},
"2017": {
"Other Liabilities": "10.2",
"Liabilities": "43.0",
"Stockholders Equity": "126",
"ECR before LimitedLiability": "102",
"Liabilities, Current": "19.2",
"Liabilities, Non-Current": "18.5",
"Assets, Non-Current": "-0.491",
"Assets": "46.1",
"Assets, Current": "90.3",
"Goodwill": "-3.80",
"Property, Plant and Equipment, Net": "-3.37",
"Research and Development": "-13.5",
"Expenses": "18.1",
"Revenues": "-29.8",
"Net Income": "-3.71",
"Other Expenses": "14.5",
"General and Administrative Expense": "16.6",
"Other Revenues": "-29.8",
"Comprehensive Net Income": "-3.92",
"Other Net Income": "6.43",
"Economic Capital Ratio": "80.5"
},
"2018": {
"Liabilities, Non-Current": "15.9",
"Liabilities": "31.8",
"Stockholders Equity": "107",
"ECR before LimitedLiability": "93.0",
"Other Liabilities": "9.78",
"Liabilities, Current": "8.48",
"Property, Plant and Equipment, Net": "-3.17",
"Assets": "47.8",
"Assets, Current": "96.7",
"Goodwill": "-4.49",
"Assets, Non-Current": "-2.36",
"Other Expenses": "8.59",
"Expenses": "13.2",
"Revenues": "-21.6",
"Net Income": "-6.00",
"Research and Development": "-21.9",
"General and Administrative Expense": "25.9",
"Other Revenues": "-21.6",
"Comprehensive Net Income": "-5.83",
"Other Net Income": "1.87",
"Economic Capital Ratio": "72.6"
},
"2019": {
"Liabilities, Non-Current": "19.4",
"Liabilities": "40.8",
"Stockholders Equity": "106",
"ECR before LimitedLiability": "106",
"Other Liabilities": "12.8",
"Liabilities, Current": "12.3",
"Assets": "40.7",
"Goodwill": "-5.56",
"Property, Plant and Equipment, Net": "-3.60",
"Other Assets": "0.300",
"Assets, Current": "75.0",
"Research and Development": "-32.1",
"Expenses": "6.45",
"Revenues": "-18.8",
"Net Income": "-6.53",
"Other Expenses": "7.65",
"General and Administrative Expense": "29.9",
"Other Revenues": "-18.8",
"Other Net Income": "5.57",
"Comprehensive Net Income": "-6.42",
"Economic Capital Ratio": "76.9"
},
"2020": {
"Liabilities, Current": "12.8",
"Liabilities": "39.7",
"Stockholders Equity": "105",
"ECR before LimitedLiability": "120",
"Liabilities, Non-Current": "24.9",
"Other Liabilities": "5.45",
"Goodwill": "-4.06",
"Assets": "35.9",
"Assets, Current": "68.5",
"Assets, Non-Current": "-0.107",
"Property, Plant and Equipment, Net": "-4.11",
"Other Expenses": "5.91",
"Expenses": "8.87",
"Revenues": "-18.9",
"Net Income": "-5.46",
"Research and Development": "-22.6",
"General and Administrative Expense": "24.5",
"Other Revenues": "-18.9",
"Comprehensive Net Income": "-5.42",
"Other Net Income": "4.11",
"Economic Capital Ratio": "82.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001652130_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "281,306",
"Assets, Non-Current": "7,035",
"General and Administrative Expense": "16,798",
"Goodwill": "0",
"Liabilities, Current": "30,730",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "17,004",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "10,628",
"Research and Development": "31,840"
},
"output_variables": {
"Liabilities": "30,730",
"Assets": "298,969",
"Expenses": "48,638",
"Revenues": "0",
"Stockholders Equity": "268,239",
"Net Income": "-31,634",
"Comprehensive Net Income": "-31,634",
"BaseVar": "197,670",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "237%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "354,830",
"Assets, Non-Current": "6,133",
"General and Administrative Expense": "28,025",
"Goodwill": "0",
"Liabilities, Current": "31,359",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "28,129",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "15,272",
"Research and Development": "67,647"
},
"output_variables": {
"Liabilities": "31,359",
"Assets": "376,235",
"Expenses": "95,672",
"Revenues": "0",
"Stockholders Equity": "344,876",
"Net Income": "-67,543",
"Comprehensive Net Income": "-67,543",
"BaseVar": "265,698",
"ECR before LimitedLiability": "199%",
"Economic Capital Ratio": "234%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "324,977",
"Assets, Non-Current": "5,277",
"General and Administrative Expense": "32,189",
"Goodwill": "0",
"Liabilities, Current": "40,572",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-28",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "5,527",
"Other Revenues": "30,434",
"Property, Plant and Equipment, Net": "17,061",
"Research and Development": "89,115"
},
"output_variables": {
"Liabilities": "40,572",
"Assets": "347,315",
"Expenses": "121,304",
"Revenues": "30,434",
"Stockholders Equity": "306,743",
"Net Income": "-85,343",
"Comprehensive Net Income": "-85,357",
"BaseVar": "272,590",
"ECR before LimitedLiability": "173%",
"Economic Capital Ratio": "216%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "289,481",
"Assets, Non-Current": "26,803",
"General and Administrative Expense": "41,058",
"Goodwill": "0",
"Liabilities, Current": "35,633",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "289",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "6,835",
"Other Revenues": "43,103",
"Property, Plant and Equipment, Net": "17,996",
"Research and Development": "108,413"
},
"output_variables": {
"Liabilities": "35,633",
"Assets": "334,280",
"Expenses": "149,471",
"Revenues": "43,103",
"Stockholders Equity": "298,647",
"Net Income": "-99,533",
"Comprehensive Net Income": "-99,388",
"BaseVar": "284,806",
"ECR before LimitedLiability": "167%",
"Economic Capital Ratio": "213%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "616,517",
"Assets, Non-Current": "43,862",
"General and Administrative Expense": "44,169",
"Goodwill": "0",
"Liabilities, Current": "64,254",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-260",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "2,352",
"Other Revenues": "57,994",
"Property, Plant and Equipment, Net": "15,943",
"Research and Development": "150,408"
},
"output_variables": {
"Liabilities": "64,254",
"Assets": "676,322",
"Expenses": "194,577",
"Revenues": "57,994",
"Stockholders Equity": "612,068",
"Net Income": "-134,231",
"Comprehensive Net Income": "-134,361",
"BaseVar": "497,880",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.280563156760629,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001652130.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001652130.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001652130.svg"
},
{
"company_id": "0000073290",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000073290.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000073290.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000073290.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000073290_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000073290_main_keyfigs.svg",
"name": "Biomerica INC",
"rank": 9,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000073290.svg",
"report_text": "The relative strengths and weaknesses of Biomerica INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biomerica INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 60% points.The greatest weakness of Biomerica INC is the variable Property, Plant and Equipment, Net, reducing the Economic Capital Ratio by 7.4% points.
The company's Economic Capital Ratio, given in the ranking table, is 214%, being 68% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000073290_2021_Biomerica_INC.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "42.9",
"Liabilities": "81.9",
"Stockholders Equity": "59.8",
"ECR before LimitedLiability": "137",
"Liabilities, Non-Current": "22.0",
"Other Liabilities": "35.3",
"Other Expenses": "36.8",
"Expenses": "7.40",
"Net Income": "63.2",
"Research and Development": "13.7",
"General and Administrative Expense": "-48.4",
"Other Revenues": "55.0",
"Revenues": "55.0",
"Assets, Current": "5.42",
"Other Assets": "0.942",
"Assets, Non-Current": "-1.18",
"Property, Plant and Equipment, Net": "-1.04",
"Goodwill": "-2.57",
"Other Net Income": "1.82",
"Comprehensive Net Income": "63.3",
"Economic Capital Ratio": "104"
},
"2013": {
"Liabilities, Current": "54.1",
"Liabilities": "90.9",
"Stockholders Equity": "73.5",
"ECR before LimitedLiability": "153",
"Other Liabilities": "27.2",
"Liabilities, Non-Current": "31.3",
"Goodwill": "-2.31",
"Assets": "1.05",
"Assets, Non-Current": "-0.902",
"Property, Plant and Equipment, Net": "-0.566",
"Assets, Current": "6.44",
"General and Administrative Expense": "-48.7",
"Expenses": "4.65",
"Revenues": "59.0",
"Net Income": "59.7",
"Research and Development": "8.57",
"Other Expenses": "39.4",
"Other Revenues": "59.0",
"Other Net Income": "-3.92",
"Comprehensive Net Income": "59.5",
"Economic Capital Ratio": "113"
},
"2014": {
"Liabilities, Non-Current": "29.6",
"Liabilities": "94.7",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "168",
"Liabilities, Current": "63.5",
"Other Liabilities": "20.4",
"Assets, Current": "11.8",
"Assets": "8.34",
"Goodwill": "-2.72",
"Other Assets": "3.02",
"Assets, Non-Current": "-1.31",
"Other Expenses": "30.1",
"Expenses": "6.39",
"Revenues": "38.8",
"Net Income": "46.7",
"Research and Development": "6.29",
"General and Administrative Expense": "-32.7",
"Other Revenues": "38.8",
"Other Net Income": "2.25",
"Comprehensive Net Income": "46.8",
"Economic Capital Ratio": "119"
},
"2015": {
"Other Liabilities": "28.5",
"Liabilities": "101",
"Stockholders Equity": "101",
"ECR before LimitedLiability": "160",
"Liabilities, Current": "60.9",
"Liabilities, Non-Current": "33.9",
"Assets, Current": "9.81",
"Assets": "4.76",
"Other Assets": "2.92",
"Goodwill": "-3.21",
"Property, Plant and Equipment, Net": "-1.78",
"Research and Development": "-1.47",
"Expenses": "-4.61",
"Revenues": "46.4",
"Net Income": "43.8",
"General and Administrative Expense": "-52.1",
"Other Expenses": "43.0",
"Other Revenues": "46.4",
"Comprehensive Net Income": "44.2",
"Other Net Income": "1.76",
"Economic Capital Ratio": "114"
},
"2016": {
"Liabilities, Non-Current": "33.0",
"Liabilities": "94.8",
"Stockholders Equity": "64.8",
"ECR before LimitedLiability": "95.5",
"Liabilities, Current": "59.7",
"Other Liabilities": "15.6",
"Property, Plant and Equipment, Net": "-6.92",
"Assets": "-4.06",
"Assets, Non-Current": "-2.31",
"Assets, Current": "13.3",
"Goodwill": "-6.54",
"Research and Development": "4.44",
"Expenses": "-28.1",
"Revenues": "43.9",
"Net Income": "15.0",
"General and Administrative Expense": "-61.2",
"Other Expenses": "24.6",
"Other Revenues": "43.9",
"Comprehensive Net Income": "15.3",
"Other Net Income": "-2.19",
"Economic Capital Ratio": "75.5"
},
"2017": {
"Other Liabilities": "23.3",
"Liabilities": "109",
"Stockholders Equity": "51.9",
"ECR before LimitedLiability": "95.4",
"Liabilities, Current": "63.6",
"Liabilities, Non-Current": "41.1",
"Assets, Non-Current": "-2.47",
"Assets": "-10.1",
"Assets, Current": "11.8",
"Goodwill": "-8.27",
"Property, Plant and Equipment, Net": "-10.0",
"Research and Development": "-3.93",
"Expenses": "-41.9",
"Revenues": "70.8",
"Net Income": "24.6",
"Other Expenses": "35.6",
"General and Administrative Expense": "-80.3",
"Other Revenues": "70.8",
"Comprehensive Net Income": "24.0",
"Other Net Income": "-6.42",
"Economic Capital Ratio": "73.8"
},
"2018": {
"Liabilities, Non-Current": "31.3",
"Liabilities": "78.8",
"Stockholders Equity": "26.9",
"ECR before LimitedLiability": "75.2",
"Other Liabilities": "19.4",
"Liabilities, Current": "36.4",
"Property, Plant and Equipment, Net": "-10.8",
"Assets": "-14.1",
"Other Assets": "2.34",
"Assets, Current": "15.0",
"Goodwill": "-10.3",
"Assets, Non-Current": "-7.00",
"Other Expenses": "18.2",
"Expenses": "-33.8",
"Revenues": "54.3",
"Net Income": "19.1",
"Research and Development": "-10.2",
"General and Administrative Expense": "-42.0",
"Other Revenues": "54.3",
"Comprehensive Net Income": "19.4",
"Economic Capital Ratio": "54.7"
},
"2019": {
"Liabilities, Non-Current": "34.0",
"Liabilities": "71.0",
"Stockholders Equity": "13.5",
"ECR before LimitedLiability": "57.0",
"Other Liabilities": "22.3",
"Liabilities, Current": "19.6",
"Assets, Non-Current": "-14.1",
"Assets": "-23.6",
"Goodwill": "-16.1",
"Property, Plant and Equipment, Net": "-15.7",
"Assets, Current": "23.6",
"Research and Development": "-20.0",
"Expenses": "-40.0",
"Revenues": "47.5",
"Net Income": "8.40",
"Other Expenses": "15.9",
"General and Administrative Expense": "-35.1",
"Other Revenues": "47.5",
"Other Net Income": "7.58",
"Comprehensive Net Income": "8.39",
"Economic Capital Ratio": "27.5"
},
"2020": {
"Liabilities, Current": "26.3",
"Liabilities": "40.9",
"Stockholders Equity": "59.7",
"ECR before LimitedLiability": "106",
"Liabilities, Non-Current": "10.8",
"Other Liabilities": "6.70",
"Goodwill": "-5.95",
"Assets": "13.2",
"Assets, Current": "37.7",
"Assets, Non-Current": "0.818",
"Property, Plant and Equipment, Net": "-7.35",
"Other Expenses": "7.60",
"Expenses": "-1.71",
"Revenues": "6.01",
"Net Income": "9.52",
"Research and Development": "-5.25",
"General and Administrative Expense": "-4.13",
"Other Revenues": "6.01",
"Comprehensive Net Income": "9.59",
"Other Net Income": "5.22",
"Economic Capital Ratio": "67.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000073290_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "4,487",
"Assets, Non-Current": "79",
"General and Administrative Expense": "5,229",
"Goodwill": "195",
"Liabilities, Current": "592",
"Liabilities, Non-Current": "0",
"Other Assets": "226",
"Other Compr. Net Income": "-1.6",
"Other Expenses": "65",
"Other Liabilities": "0",
"Other Net Income": "108",
"Other Revenues": "6,081",
"Property, Plant and Equipment, Net": "585",
"Research and Development": "347"
},
"output_variables": {
"Liabilities": "592",
"Assets": "5,571",
"Expenses": "5,641",
"Revenues": "6,081",
"Stockholders Equity": "4,979",
"Net Income": "548",
"Comprehensive Net Income": "548",
"BaseVar": "8,998",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "263%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "5,253",
"Assets, Non-Current": "71",
"General and Administrative Expense": "5,500",
"Goodwill": "165",
"Liabilities, Current": "560",
"Liabilities, Non-Current": "0",
"Other Assets": "250",
"Other Compr. Net Income": "-3.0",
"Other Expenses": "-12",
"Other Liabilities": "0",
"Other Net Income": "10",
"Other Revenues": "6,473",
"Property, Plant and Equipment, Net": "655",
"Research and Development": "459"
},
"output_variables": {
"Liabilities": "560",
"Assets": "6,395",
"Expenses": "5,946",
"Revenues": "6,473",
"Stockholders Equity": "5,835",
"Net Income": "537",
"Comprehensive Net Income": "535",
"BaseVar": "9,694",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "268%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "4,913",
"Assets, Non-Current": "36",
"General and Administrative Expense": "4,977",
"Goodwill": "382",
"Liabilities, Current": "556",
"Liabilities, Non-Current": "0",
"Other Assets": "524",
"Other Compr. Net Income": "-1.1",
"Other Expenses": "-211",
"Other Liabilities": "0",
"Other Net Income": "20",
"Other Revenues": "5,120",
"Property, Plant and Equipment, Net": "614",
"Research and Development": "590"
},
"output_variables": {
"Liabilities": "556",
"Assets": "6,470",
"Expenses": "5,356",
"Revenues": "5,120",
"Stockholders Equity": "5,914",
"Net Income": "-216",
"Comprehensive Net Income": "-216",
"BaseVar": "8,762",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "252%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "4,392",
"Assets, Non-Current": "57",
"General and Administrative Expense": "4,899",
"Goodwill": "321",
"Liabilities, Current": "524",
"Liabilities, Non-Current": "0",
"Other Assets": "909",
"Other Compr. Net Income": "-2.1",
"Other Expenses": "-315",
"Other Liabilities": "0",
"Other Net Income": "24",
"Other Revenues": "4,962",
"Property, Plant and Equipment, Net": "445",
"Research and Development": "734"
},
"output_variables": {
"Liabilities": "524",
"Assets": "6,124",
"Expenses": "5,318",
"Revenues": "4,962",
"Stockholders Equity": "5,601",
"Net Income": "-331",
"Comprehensive Net Income": "-332",
"BaseVar": "8,477",
"ECR before LimitedLiability": "221%",
"Economic Capital Ratio": "249%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "4,835",
"Assets, Non-Current": "56",
"General and Administrative Expense": "5,186",
"Goodwill": "249",
"Liabilities, Current": "506",
"Liabilities, Non-Current": "0",
"Other Assets": "206",
"Other Compr. Net Income": "-1.3",
"Other Expenses": "704",
"Other Liabilities": "0",
"Other Net Income": "31",
"Other Revenues": "5,140",
"Property, Plant and Equipment, Net": "381",
"Research and Development": "780"
},
"output_variables": {
"Liabilities": "506",
"Assets": "5,727",
"Expenses": "6,671",
"Revenues": "5,140",
"Stockholders Equity": "5,220",
"Net Income": "-1,500",
"Comprehensive Net Income": "-1,500",
"BaseVar": "9,038",
"ECR before LimitedLiability": "181%",
"Economic Capital Ratio": "222%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "4,210",
"Assets, Non-Current": "95",
"General and Administrative Expense": "5,616",
"Goodwill": "174",
"Liabilities, Current": "529",
"Liabilities, Non-Current": "0",
"Other Assets": "206",
"Other Compr. Net Income": "-2.2",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "46",
"Other Revenues": "5,792",
"Property, Plant and Equipment, Net": "332",
"Research and Development": "1,131"
},
"output_variables": {
"Liabilities": "529",
"Assets": "5,018",
"Expenses": "6,746",
"Revenues": "5,792",
"Stockholders Equity": "4,489",
"Net Income": "-909",
"Comprehensive Net Income": "-910",
"BaseVar": "9,067",
"ECR before LimitedLiability": "189%",
"Economic Capital Ratio": "227%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "4,484",
"Assets, Non-Current": "113",
"General and Administrative Expense": "5,648",
"Goodwill": "99",
"Liabilities, Current": "897",
"Liabilities, Non-Current": "0",
"Other Assets": "175",
"Other Compr. Net Income": "-10",
"Other Expenses": "32",
"Other Liabilities": "0",
"Other Net Income": "48",
"Other Revenues": "5,564",
"Property, Plant and Equipment, Net": "351",
"Research and Development": "1,398"
},
"output_variables": {
"Liabilities": "897",
"Assets": "5,223",
"Expenses": "7,078",
"Revenues": "5,564",
"Stockholders Equity": "4,326",
"Net Income": "-1,466",
"Comprehensive Net Income": "-1,471",
"BaseVar": "9,410",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "198%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,495",
"Assets, Non-Current": "127",
"General and Administrative Expense": "5,934",
"Goodwill": "107",
"Liabilities, Current": "1,264",
"Liabilities, Non-Current": "0",
"Other Assets": "165",
"Other Compr. Net Income": "-10",
"Other Expenses": "24",
"Other Liabilities": "0",
"Other Net Income": "44",
"Other Revenues": "5,201",
"Property, Plant and Equipment, Net": "351",
"Research and Development": "1,679"
},
"output_variables": {
"Liabilities": "1,264",
"Assets": "5,245",
"Expenses": "7,638",
"Revenues": "5,201",
"Stockholders Equity": "3,981",
"Net Income": "-2,393",
"Comprehensive Net Income": "-2,398",
"BaseVar": "9,701",
"ECR before LimitedLiability": "94%",
"Economic Capital Ratio": "163%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "14,767",
"Assets, Non-Current": "1,880",
"General and Administrative Expense": "7,185",
"Goodwill": "169",
"Liabilities, Current": "1,477",
"Liabilities, Non-Current": "1,570",
"Other Assets": "165",
"Other Compr. Net Income": "-3.3",
"Other Expenses": "7.4",
"Other Liabilities": "0",
"Other Net Income": "71",
"Other Revenues": "6,693",
"Property, Plant and Equipment, Net": "279",
"Research and Development": "1,910"
},
"output_variables": {
"Liabilities": "3,047",
"Assets": "17,260",
"Expenses": "9,103",
"Revenues": "6,693",
"Stockholders Equity": "14,213",
"Net Income": "-2,339",
"Comprehensive Net Income": "-2,341",
"BaseVar": "18,088",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "214%"
}
}
},
"top_rated": true,
"trend": 11.0,
"value": 2.1367880282481817,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000073290.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000073290.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000073290.svg"
},
{
"company_id": "0000949858",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000949858.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000949858.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000949858.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000949858_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000949858_main_keyfigs.svg",
"name": "Achieve LIFE Sciences INC",
"rank": 10,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000949858.svg",
"report_text": "The relative strengths and weaknesses of Achieve LIFE Sciences INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Achieve LIFE Sciences INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 118% points.The greatest weakness of Achieve LIFE Sciences INC is the variable Other Revenues, reducing the Economic Capital Ratio by 29% points.
The company's Economic Capital Ratio, given in the ranking table, is 213%, being 67% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000949858_2021_Achieve_LIFE_Sciences_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-43.8",
"Liabilities": "-43.7",
"Stockholders Equity": "19.4",
"ECR before LimitedLiability": "40.7",
"Liabilities, Non-Current": "7.76",
"Other Liabilities": "-7.86",
"Property, Plant and Equipment, Net": "-10.3",
"Assets": "48.0",
"Assets, Non-Current": "-3.79",
"Goodwill": "-9.74",
"Assets, Current": "59.2",
"General and Administrative Expense": "39.1",
"Expenses": "34.1",
"Revenues": "-40.2",
"Net Income": "2.87",
"Research and Development": "-21.6",
"Other Expenses": "19.2",
"Other Revenues": "-40.2",
"Comprehensive Net Income": "2.83",
"Other Net Income": "15.9",
"Economic Capital Ratio": "-21.3"
},
"2012": {
"Liabilities, Current": "4.96",
"Liabilities": "19.5",
"Stockholders Equity": "77.5",
"ECR before LimitedLiability": "70.3",
"Liabilities, Non-Current": "9.90",
"Other Liabilities": "5.33",
"Assets, Current": "97.0",
"Assets": "40.6",
"Assets, Non-Current": "-2.01",
"Property, Plant and Equipment, Net": "-6.18",
"Goodwill": "-6.64",
"Other Expenses": "23.7",
"Expenses": "13.2",
"Revenues": "-47.0",
"Net Income": "0.352",
"Research and Development": "-42.8",
"General and Administrative Expense": "32.9",
"Other Revenues": "-47.0",
"Other Net Income": "34.2",
"Comprehensive Net Income": "0.405",
"Economic Capital Ratio": "37.8"
},
"2013": {
"Liabilities": "26.7",
"Stockholders Equity": "30.0",
"ECR before LimitedLiability": "17.0",
"Other Liabilities": "4.51",
"Liabilities, Non-Current": "19.7",
"Goodwill": "-18.4",
"Assets": "3.95",
"Assets, Non-Current": "-5.18",
"Property, Plant and Equipment, Net": "-15.3",
"Other Assets": "-3.95",
"Assets, Current": "49.4",
"General and Administrative Expense": "46.8",
"Expenses": "-21.6",
"Revenues": "-61.1",
"Net Income": "-21.3",
"Research and Development": "-89.9",
"Other Expenses": "40.9",
"Other Revenues": "-61.1",
"Other Net Income": "48.9",
"Comprehensive Net Income": "-21.4",
"Economic Capital Ratio": "-23.2"
},
"2014": {
"Liabilities, Non-Current": "20.4",
"Liabilities": "28.2",
"Stockholders Equity": "47.1",
"ECR before LimitedLiability": "47.6",
"Liabilities, Current": "-5.45",
"Other Liabilities": "13.5",
"Assets, Current": "53.1",
"Assets": "21.1",
"Goodwill": "-17.9",
"Assets, Non-Current": "-5.69",
"Property, Plant and Equipment, Net": "-14.0",
"Other Expenses": "27.9",
"Expenses": "-6.25",
"Revenues": "-54.8",
"Net Income": "-3.20",
"Research and Development": "-68.4",
"General and Administrative Expense": "47.1",
"Other Revenues": "-54.8",
"Other Net Income": "48.5",
"Comprehensive Net Income": "-3.13",
"Economic Capital Ratio": "-1.85"
},
"2015": {
"Other Liabilities": "15.3",
"Liabilities": "19.4",
"Stockholders Equity": "60.3",
"ECR before LimitedLiability": "68.8",
"Liabilities, Current": "-15.6",
"Liabilities, Non-Current": "18.9",
"Assets, Current": "78.2",
"Assets": "34.1",
"Other Assets": "-5.24",
"Goodwill": "-11.4",
"Property, Plant and Equipment, Net": "-8.72",
"Research and Development": "-34.3",
"Expenses": "7.53",
"Revenues": "-37.4",
"Net Income": "5.56",
"General and Administrative Expense": "18.1",
"Other Expenses": "27.8",
"Other Revenues": "-37.4",
"Comprehensive Net Income": "5.87",
"Other Net Income": "41.2",
"Economic Capital Ratio": "23.0"
},
"2016": {
"Liabilities, Non-Current": "21.0",
"Liabilities": "24.0",
"Stockholders Equity": "31.7",
"ECR before LimitedLiability": "-11.4",
"Liabilities, Current": "-6.18",
"Other Liabilities": "9.13",
"Property, Plant and Equipment, Net": "-20.8",
"Assets": "29.7",
"Assets, Non-Current": "-6.24",
"Assets, Current": "47.8",
"Goodwill": "-18.9",
"Research and Development": "-48.3",
"Expenses": "-26.7",
"Revenues": "-50.6",
"Net Income": "-51.3",
"General and Administrative Expense": "3.66",
"Other Expenses": "23.2",
"Other Revenues": "-50.6",
"Comprehensive Net Income": "-51.0",
"Other Net Income": "29.3",
"Economic Capital Ratio": "-31.3"
},
"2017": {
"Other Liabilities": "3.68",
"Liabilities": "6.08",
"Stockholders Equity": "18.8",
"ECR before LimitedLiability": "-43.7",
"Liabilities, Current": "3.59",
"Liabilities, Non-Current": "4.22",
"Assets, Non-Current": "-2.55",
"Assets": "9.76",
"Assets, Current": "7.53",
"Goodwill": "9.65",
"Property, Plant and Equipment, Net": "-32.4",
"Research and Development": "-29.6",
"Expenses": "6.94",
"Revenues": "-52.9",
"Net Income": "-107",
"Other Expenses": "14.4",
"General and Administrative Expense": "-3.75",
"Other Revenues": "-52.9",
"Comprehensive Net Income": "-108",
"Other Net Income": "-98.4",
"Economic Capital Ratio": "-65.2"
},
"2018": {
"Liabilities, Non-Current": "16.3",
"Liabilities": "26.7",
"Stockholders Equity": "71.1",
"ECR before LimitedLiability": "30.2",
"Other Liabilities": "9.76",
"Liabilities, Current": "1.15",
"Property, Plant and Equipment, Net": "-13.0",
"Assets": "69.0",
"Assets, Current": "72.9",
"Goodwill": "11.0",
"Assets, Non-Current": "-6.80",
"Other Expenses": "11.0",
"Expenses": "-15.6",
"Revenues": "-36.9",
"Net Income": "-50.6",
"Research and Development": "-26.0",
"General and Administrative Expense": "0.432",
"Other Revenues": "-36.9",
"Comprehensive Net Income": "-50.4",
"Other Net Income": "0.802",
"Economic Capital Ratio": "9.76"
},
"2019": {
"Liabilities, Non-Current": "18.4",
"Liabilities": "39.1",
"Stockholders Equity": "65.4",
"ECR before LimitedLiability": "38.8",
"Other Liabilities": "13.0",
"Liabilities, Current": "9.16",
"Assets, Non-Current": "-9.00",
"Assets": "60.9",
"Goodwill": "5.93",
"Property, Plant and Equipment, Net": "-15.0",
"Assets, Current": "70.4",
"Research and Development": "-47.3",
"Expenses": "-27.2",
"Revenues": "-39.9",
"Net Income": "-60.6",
"Other Expenses": "9.98",
"General and Administrative Expense": "13.5",
"Other Revenues": "-39.9",
"Other Net Income": "4.89",
"Comprehensive Net Income": "-60.5",
"Economic Capital Ratio": "9.32"
},
"2020": {
"Liabilities, Current": "16.9",
"Liabilities": "41.6",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "105",
"Liabilities, Non-Current": "22.9",
"Other Liabilities": "5.06",
"Goodwill": "-0.638",
"Assets": "49.7",
"Assets, Current": "103",
"Assets, Non-Current": "-3.56",
"Property, Plant and Equipment, Net": "-6.27",
"Other Expenses": "5.76",
"Expenses": "-1.70",
"Revenues": "-29.1",
"Net Income": "-27.0",
"Research and Development": "-15.8",
"General and Administrative Expense": "8.09",
"Other Revenues": "-29.1",
"Comprehensive Net Income": "-27.0",
"Other Net Income": "3.65",
"Economic Capital Ratio": "67.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000949858_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "67,326",
"Assets, Non-Current": "509",
"General and Administrative Expense": "6,230",
"Goodwill": "0",
"Liabilities, Current": "30,786",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "6,339",
"Other Net Income": "13,110",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "180",
"Research and Development": "21,553"
},
"output_variables": {
"Liabilities": "37,125",
"Assets": "68,015",
"Expenses": "27,783",
"Revenues": "0",
"Stockholders Equity": "30,890",
"Net Income": "-14,673",
"Comprehensive Net Income": "-14,673",
"BaseVar": "73,016",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "80,179",
"Assets, Non-Current": "1,152",
"General and Administrative Expense": "7,791",
"Goodwill": "0",
"Liabilities, Current": "11,556",
"Liabilities, Non-Current": "0",
"Other Assets": "314",
"Other Compr. Net Income": "1.0",
"Other Expenses": "-1,657",
"Other Liabilities": "4,253",
"Other Net Income": "24,984",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "371",
"Research and Development": "39,948"
},
"output_variables": {
"Liabilities": "15,809",
"Assets": "82,016",
"Expenses": "46,082",
"Revenues": "0",
"Stockholders Equity": "66,207",
"Net Income": "-21,098",
"Comprehensive Net Income": "-21,098",
"BaseVar": "84,446",
"ECR before LimitedLiability": "142%",
"Economic Capital Ratio": "196%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "53,867",
"Assets, Non-Current": "1,111",
"General and Administrative Expense": "9,892",
"Goodwill": "0",
"Liabilities, Current": "14,934",
"Liabilities, Non-Current": "0",
"Other Assets": "314",
"Other Compr. Net Income": "6.0",
"Other Expenses": "0",
"Other Liabilities": "3,544",
"Other Net Income": "33,360",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "397",
"Research and Development": "55,317"
},
"output_variables": {
"Liabilities": "18,478",
"Assets": "55,689",
"Expenses": "65,209",
"Revenues": "0",
"Stockholders Equity": "37,211",
"Net Income": "-31,849",
"Comprehensive Net Income": "-31,846",
"BaseVar": "86,371",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "131%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "55,761",
"Assets, Non-Current": "273",
"General and Administrative Expense": "10,625",
"Goodwill": "0",
"Liabilities, Current": "22,218",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-21",
"Other Expenses": "-267",
"Other Liabilities": "14",
"Other Net Income": "30,342",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "257",
"Research and Development": "46,224"
},
"output_variables": {
"Liabilities": "22,232",
"Assets": "56,291",
"Expenses": "56,582",
"Revenues": "0",
"Stockholders Equity": "34,059",
"Net Income": "-26,240",
"Comprehensive Net Income": "-26,250",
"BaseVar": "82,734",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "132%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "57,298",
"Assets, Non-Current": "37",
"General and Administrative Expense": "11,805",
"Goodwill": "0",
"Liabilities, Current": "20,664",
"Liabilities, Non-Current": "0",
"Other Assets": "272",
"Other Compr. Net Income": "10",
"Other Expenses": "0",
"Other Liabilities": "105",
"Other Net Income": "20,112",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "602",
"Research and Development": "25,108"
},
"output_variables": {
"Liabilities": "20,769",
"Assets": "58,209",
"Expenses": "36,913",
"Revenues": "0",
"Stockholders Equity": "37,440",
"Net Income": "-16,801",
"Comprehensive Net Income": "-16,796",
"BaseVar": "68,006",
"ECR before LimitedLiability": "87%",
"Economic Capital Ratio": "159%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "26,927",
"Assets, Non-Current": "13",
"General and Administrative Expense": "8,933",
"Goodwill": "0",
"Liabilities, Current": "8,455",
"Liabilities, Non-Current": "0",
"Other Assets": "272",
"Other Compr. Net Income": "8.0",
"Other Expenses": "2,533",
"Other Liabilities": "49",
"Other Net Income": "6,125",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "258",
"Research and Development": "14,788"
},
"output_variables": {
"Liabilities": "8,504",
"Assets": "27,470",
"Expenses": "26,254",
"Revenues": "0",
"Stockholders Equity": "18,966",
"Net Income": "-20,129",
"Comprehensive Net Income": "-20,125",
"BaseVar": "34,180",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "5,908",
"Assets, Non-Current": "309",
"General and Administrative Expense": "3,531",
"Goodwill": "3,566",
"Liabilities, Current": "2,013",
"Liabilities, Non-Current": "0",
"Other Assets": "50",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,051",
"Other Liabilities": "0",
"Other Net Income": "-7,002",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "59",
"Research and Development": "3,101"
},
"output_variables": {
"Liabilities": "2,013",
"Assets": "9,892",
"Expenses": "3,581",
"Revenues": "0",
"Stockholders Equity": "7,879",
"Net Income": "-10,583",
"Comprehensive Net Income": "-10,583",
"BaseVar": "11,244",
"ECR before LimitedLiability": "3.5%",
"Economic Capital Ratio": "88%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "15,537",
"Assets, Non-Current": "118",
"General and Administrative Expense": "6,945",
"Goodwill": "3,344",
"Liabilities, Current": "3,270",
"Liabilities, Non-Current": "0",
"Other Assets": "50",
"Other Compr. Net Income": "-1.0",
"Other Expenses": "0",
"Other Liabilities": "12",
"Other Net Income": "126",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "35",
"Research and Development": "5,868"
},
"output_variables": {
"Liabilities": "3,282",
"Assets": "19,084",
"Expenses": "12,813",
"Revenues": "0",
"Stockholders Equity": "15,802",
"Net Income": "-12,687",
"Comprehensive Net Income": "-12,688",
"BaseVar": "17,653",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "154%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "17,334",
"Assets, Non-Current": "516",
"General and Administrative Expense": "6,854",
"Goodwill": "3,121",
"Liabilities, Current": "2,869",
"Liabilities, Non-Current": "159",
"Other Assets": "50",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "133",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "57",
"Research and Development": "9,674"
},
"output_variables": {
"Liabilities": "3,028",
"Assets": "21,078",
"Expenses": "16,528",
"Revenues": "0",
"Stockholders Equity": "18,050",
"Net Income": "-16,395",
"Comprehensive Net Income": "-16,395",
"BaseVar": "20,384",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "36,975",
"Assets, Non-Current": "333",
"General and Administrative Expense": "7,868",
"Goodwill": "2,898",
"Liabilities, Current": "2,935",
"Liabilities, Non-Current": "77",
"Other Assets": "50",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "20",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "42",
"Research and Development": "6,882"
},
"output_variables": {
"Liabilities": "3,012",
"Assets": "40,298",
"Expenses": "14,750",
"Revenues": "0",
"Stockholders Equity": "37,286",
"Net Income": "-14,730",
"Comprehensive Net Income": "-14,730",
"BaseVar": "29,040",
"ECR before LimitedLiability": "168%",
"Economic Capital Ratio": "213%"
}
}
},
"top_rated": true,
"trend": 16.0,
"value": 2.131113580070631,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000949858.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000949858.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000949858.svg"
},
{
"company_id": "0000037785",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000037785.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000037785.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000037785.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000037785_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000037785_main_keyfigs.svg",
"name": "FMC CORP",
"rank": 11,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000037785.svg",
"report_text": "The relative strengths and weaknesses of FMC CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of FMC CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 38% points.The greatest weakness of FMC CORP is the variable Liabilities, Current, reducing the Economic Capital Ratio by 17% points.
The company's Economic Capital Ratio, given in the ranking table, is 211%, being 65% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000037785_2021_FMC_CORP.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "1.10",
"Liabilities": "-12.3",
"Stockholders Equity": "20.1",
"ECR before LimitedLiability": "9.42",
"Liabilities, Current": "-15.4",
"Other Liabilities": "1.64",
"Property, Plant and Equipment, Net": "6.68",
"Assets": "10.3",
"Other Assets": "4.39",
"Assets, Current": "-1.53",
"Goodwill": "0.287",
"General and Administrative Expense": "-28.3",
"Expenses": "12.9",
"Revenues": "-12.5",
"Comprehensive Net Income": "-0.188",
"Other Expenses": "39.8",
"Research and Development": "-0.0822",
"Other Revenues": "-12.5",
"Other Net Income": "-0.721",
"Other Compr. Net Income": "-0.157",
"Economic Capital Ratio": "8.70"
},
"2010": {
"Other Liabilities": "4.05",
"Liabilities": "23.4",
"Stockholders Equity": "10.1",
"ECR before LimitedLiability": "29.8",
"Liabilities, Current": "-21.9",
"Liabilities, Non-Current": "36.5",
"Other Expenses": "15.1",
"Expenses": "-3.63",
"Net Income": "14.6",
"General and Administrative Expense": "-24.5",
"Research and Development": "5.36",
"Other Revenues": "14.0",
"Revenues": "14.0",
"Goodwill": "-7.02",
"Property, Plant and Equipment, Net": "5.42",
"Assets, Current": "-4.49",
"Assets, Non-Current": "-2.70",
"Other Assets": "8.69",
"Other Net Income": "4.20",
"Comprehensive Net Income": "14.0",
"Economic Capital Ratio": "31.8"
},
"2011": {
"Liabilities, Current": "12.1",
"Liabilities": "38.3",
"Assets": "6.77",
"Stockholders Equity": "44.3",
"ECR before LimitedLiability": "130",
"Liabilities, Non-Current": "14.6",
"Other Liabilities": "15.3",
"Property, Plant and Equipment, Net": "7.10",
"Other Assets": "4.07",
"Assets, Current": "-3.03",
"General and Administrative Expense": "-12.1",
"Expenses": "20.0",
"Revenues": "34.4",
"Net Income": "46.8",
"Research and Development": "12.0",
"Other Expenses": "19.8",
"Other Revenues": "34.4",
"Comprehensive Net Income": "45.3",
"Other Net Income": "-8.00",
"Other Compr. Net Income": "-1.42",
"Economic Capital Ratio": "67.9"
},
"2012": {
"Liabilities, Current": "-7.79",
"Liabilities": "29.0",
"Stockholders Equity": "36.6",
"ECR before LimitedLiability": "92.7",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "23.0",
"Assets, Current": "-2.45",
"Assets": "6.71",
"Other Assets": "2.78",
"Property, Plant and Equipment, Net": "7.17",
"Goodwill": "-1.11",
"Other Expenses": "22.5",
"Expenses": "21.3",
"Revenues": "28.7",
"Net Income": "49.1",
"Research and Development": "12.8",
"General and Administrative Expense": "-14.3",
"Other Revenues": "28.7",
"Other Net Income": "-1.30",
"Comprehensive Net Income": "48.7",
"Economic Capital Ratio": "60.2"
},
"2013": {
"Liabilities, Current": "-25.8",
"Liabilities": "9.70",
"Assets": "8.11",
"Stockholders Equity": "21.7",
"ECR before LimitedLiability": "76.7",
"Other Liabilities": "14.8",
"Liabilities, Non-Current": "17.2",
"Goodwill": "-1.19",
"Property, Plant and Equipment, Net": "8.49",
"Assets, Current": "1.89",
"General and Administrative Expense": "-8.10",
"Expenses": "24.7",
"Revenues": "21.8",
"Net Income": "41.9",
"Research and Development": "9.95",
"Other Expenses": "22.8",
"Other Revenues": "21.8",
"Other Net Income": "-5.58",
"Comprehensive Net Income": "43.9",
"Other Compr. Net Income": "1.68",
"Economic Capital Ratio": "36.5"
},
"2014": {
"Liabilities, Non-Current": "20.0",
"Liabilities": "31.7",
"Stockholders Equity": "48.3",
"ECR before LimitedLiability": "108",
"Liabilities, Current": "-0.642",
"Other Liabilities": "13.5",
"Assets, Current": "2.63",
"Assets": "12.9",
"Goodwill": "-2.79",
"Other Assets": "2.87",
"Property, Plant and Equipment, Net": "9.21",
"Other Expenses": "17.0",
"Expenses": "24.0",
"Revenues": "24.5",
"Net Income": "50.4",
"Research and Development": "12.0",
"General and Administrative Expense": "-5.11",
"Other Revenues": "24.5",
"Comprehensive Net Income": "48.5",
"Other Compr. Net Income": "-1.64",
"Economic Capital Ratio": "58.5"
},
"2015": {
"Other Liabilities": "19.8",
"Liabilities": "50.9",
"Stockholders Equity": "72.7",
"ECR before LimitedLiability": "133",
"Liabilities, Current": "13.3",
"Liabilities, Non-Current": "23.8",
"Assets, Current": "2.04",
"Assets": "14.1",
"Goodwill": "6.74",
"Assets, Non-Current": "1.84",
"Property, Plant and Equipment, Net": "2.65",
"Research and Development": "7.85",
"Expenses": "19.6",
"Revenues": "14.5",
"Net Income": "46.5",
"General and Administrative Expense": "-9.50",
"Other Expenses": "21.0",
"Other Revenues": "14.5",
"Comprehensive Net Income": "46.0",
"Other Net Income": "12.5",
"Economic Capital Ratio": "87.6"
},
"2016": {
"Liabilities, Non-Current": "21.5",
"Liabilities": "33.8",
"Stockholders Equity": "57.3",
"ECR before LimitedLiability": "91.4",
"Liabilities, Current": "4.70",
"Other Liabilities": "9.94",
"Property, Plant and Equipment, Net": "0.974",
"Assets": "14.6",
"Other Assets": "2.15",
"Assets, Non-Current": "2.19",
"Goodwill": "7.93",
"Research and Development": "10.9",
"Expenses": "19.8",
"Revenues": "15.8",
"Net Income": "33.3",
"General and Administrative Expense": "-11.3",
"Other Expenses": "20.1",
"Other Revenues": "15.8",
"Comprehensive Net Income": "33.3",
"Other Net Income": "-2.37",
"Economic Capital Ratio": "71.5"
},
"2017": {
"Other Liabilities": "11.5",
"Liabilities": "25.4",
"Stockholders Equity": "66.5",
"ECR before LimitedLiability": "89.0",
"Liabilities, Current": "-6.92",
"Liabilities, Non-Current": "20.9",
"Assets, Non-Current": "0.578",
"Assets": "22.6",
"Other Assets": "1.42",
"Assets, Current": "2.27",
"Goodwill": "19.8",
"Property, Plant and Equipment, Net": "-2.44",
"Research and Development": "9.65",
"Expenses": "25.0",
"Net Income": "28.6",
"Other Net Income": "3.70",
"Other Expenses": "12.4",
"General and Administrative Expense": "3.10",
"Comprehensive Net Income": "29.7",
"Other Compr. Net Income": "1.12",
"Economic Capital Ratio": "67.4"
},
"2018": {
"Liabilities, Non-Current": "18.2",
"Liabilities": "11.1",
"Stockholders Equity": "42.4",
"ECR before LimitedLiability": "81.2",
"Other Liabilities": "11.2",
"Liabilities, Current": "-21.1",
"Property, Plant and Equipment, Net": "-2.50",
"Assets": "18.3",
"Other Assets": "1.61",
"Goodwill": "24.4",
"Assets, Non-Current": "-1.85",
"Other Expenses": "7.35",
"Expenses": "24.4",
"Revenues": "10.3",
"Net Income": "33.5",
"Research and Development": "7.98",
"General and Administrative Expense": "8.87",
"Other Revenues": "10.3",
"Comprehensive Net Income": "33.3",
"Other Net Income": "-1.47",
"Economic Capital Ratio": "60.7"
},
"2019": {
"Liabilities, Non-Current": "21.0",
"Liabilities": "18.4",
"Stockholders Equity": "47.4",
"ECR before LimitedLiability": "103",
"Other Liabilities": "13.9",
"Liabilities, Current": "-19.0",
"Assets, Non-Current": "-2.12",
"Assets": "17.1",
"Goodwill": "22.1",
"Property, Plant and Equipment, Net": "-3.70",
"Other Assets": "1.90",
"Research and Development": "5.34",
"Expenses": "23.4",
"Revenues": "10.9",
"Net Income": "37.5",
"Other Expenses": "3.72",
"General and Administrative Expense": "14.3",
"Other Revenues": "10.9",
"Other Net Income": "2.81",
"Comprehensive Net Income": "37.0",
"Economic Capital Ratio": "73.6"
},
"2020": {
"Liabilities, Current": "-17.1",
"Liabilities": "20.5",
"Stockholders Equity": "37.8",
"ECR before LimitedLiability": "103",
"Liabilities, Non-Current": "28.6",
"Other Liabilities": "6.25",
"Goodwill": "20.3",
"Assets": "10.9",
"Assets, Current": "-1.36",
"Assets, Non-Current": "-1.52",
"Property, Plant and Equipment, Net": "-4.38",
"Other Expenses": "2.60",
"Expenses": "13.0",
"Revenues": "11.7",
"Net Income": "29.0",
"Research and Development": "3.88",
"General and Administrative Expense": "6.53",
"Other Revenues": "11.7",
"Comprehensive Net Income": "29.7",
"Other Net Income": "4.20",
"Economic Capital Ratio": "64.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000037785_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "1,487,700",
"Assets, Non-Current": "211,400",
"General and Administrative Expense": "2,265,900",
"Goodwill": "209,500",
"Liabilities, Current": "709,200",
"Liabilities, Non-Current": "0",
"Other Assets": "263,100",
"Other Compr. Net Income": "-13,400",
"Other Expenses": "213,000",
"Other Liabilities": "0",
"Other Net Income": "-15,700",
"Other Revenues": "2,826,200",
"Property, Plant and Equipment, Net": "964,500",
"Research and Development": "92,800"
},
"output_variables": {
"Liabilities": "709,200",
"Assets": "3,136,200",
"Expenses": "2,571,700",
"Revenues": "2,826,200",
"Stockholders Equity": "2,427,000",
"Net Income": "238,800",
"Comprehensive Net Income": "232,100",
"BaseVar": "4,636,200",
"ECR before LimitedLiability": "185%",
"Economic Capital Ratio": "225%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,646,200",
"Assets, Non-Current": "223,700",
"General and Administrative Expense": "2,476,800",
"Goodwill": "194,400",
"Liabilities, Current": "963,400",
"Liabilities, Non-Current": "0",
"Other Assets": "337,100",
"Other Compr. Net Income": "-44,900",
"Other Expenses": "323,400",
"Other Liabilities": "0",
"Other Net Income": "36,500",
"Other Revenues": "3,116,300",
"Property, Plant and Equipment, Net": "918,500",
"Research and Development": "100,500"
},
"output_variables": {
"Liabilities": "963,400",
"Assets": "3,319,900",
"Expenses": "2,900,700",
"Revenues": "3,116,300",
"Stockholders Equity": "2,356,500",
"Net Income": "252,100",
"Comprehensive Net Income": "229,650",
"BaseVar": "5,190,850",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,869,400",
"Assets, Non-Current": "198,900",
"General and Administrative Expense": "2,653,000",
"Goodwill": "413,200",
"Liabilities, Current": "919,900",
"Liabilities, Non-Current": "0",
"Other Assets": "275,200",
"Other Compr. Net Income": "-94,600",
"Other Expenses": "208,400",
"Other Liabilities": "0",
"Other Net Income": "-29,100",
"Other Revenues": "3,377,900",
"Property, Plant and Equipment, Net": "986,800",
"Research and Development": "105,200"
},
"output_variables": {
"Liabilities": "919,900",
"Assets": "3,743,500",
"Expenses": "2,966,600",
"Revenues": "3,377,900",
"Stockholders Equity": "2,823,600",
"Net Income": "382,200",
"Comprehensive Net Income": "334,900",
"BaseVar": "5,565,800",
"ECR before LimitedLiability": "180%",
"Economic Capital Ratio": "221%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,181,800",
"Assets, Non-Current": "312,500",
"General and Administrative Expense": "2,934,200",
"Goodwill": "510,100",
"Liabilities, Current": "1,135,400",
"Liabilities, Non-Current": "0",
"Other Assets": "233,300",
"Other Compr. Net Income": "-38,400",
"Other Expenses": "230,200",
"Other Liabilities": "0",
"Other Net Income": "-30,400",
"Other Revenues": "3,748,300",
"Property, Plant and Equipment, Net": "1,136,200",
"Research and Development": "117,800"
},
"output_variables": {
"Liabilities": "1,135,400",
"Assets": "4,373,900",
"Expenses": "3,282,200",
"Revenues": "3,748,300",
"Stockholders Equity": "3,238,500",
"Net Income": "435,700",
"Comprehensive Net Income": "416,500",
"BaseVar": "6,304,300",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "219%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,945,000",
"Assets, Non-Current": "288,800",
"General and Administrative Expense": "3,050,200",
"Goodwill": "661,700",
"Liabilities, Current": "1,986,700",
"Liabilities, Non-Current": "0",
"Other Assets": "91,400",
"Other Compr. Net Income": "192,900",
"Other Expenses": "238,900",
"Other Liabilities": "0",
"Other Net Income": "-160,000",
"Other Revenues": "3,874,800",
"Property, Plant and Equipment, Net": "1,248,300",
"Research and Development": "117,700"
},
"output_variables": {
"Liabilities": "1,986,700",
"Assets": "5,235,200",
"Expenses": "3,406,800",
"Revenues": "3,874,800",
"Stockholders Equity": "3,248,500",
"Net Income": "308,000",
"Comprehensive Net Income": "404,450",
"BaseVar": "7,428,200",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "191%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "2,934,400",
"Assets, Non-Current": "298,100",
"General and Administrative Expense": "3,283,900",
"Goodwill": "599,400",
"Liabilities, Current": "1,910,400",
"Liabilities, Non-Current": "0",
"Other Assets": "200,100",
"Other Compr. Net Income": "-188,500",
"Other Expenses": "213,300",
"Other Liabilities": "0",
"Other Net Income": "-90,100",
"Other Revenues": "4,037,700",
"Property, Plant and Equipment, Net": "1,308,500",
"Research and Development": "128,300"
},
"output_variables": {
"Liabilities": "1,910,400",
"Assets": "5,340,500",
"Expenses": "3,625,500",
"Revenues": "4,037,700",
"Stockholders Equity": "3,430,100",
"Net Income": "322,100",
"Comprehensive Net Income": "227,850",
"BaseVar": "7,596,350",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "192%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "2,971,900",
"Assets, Non-Current": "437,600",
"General and Administrative Expense": "2,939,000",
"Goodwill": "1,613,100",
"Liabilities, Current": "1,453,300",
"Liabilities, Non-Current": "0",
"Other Assets": "286,900",
"Other Compr. Net Income": "-91,000",
"Other Expenses": "372,800",
"Other Liabilities": "0",
"Other Net Income": "677,500",
"Other Revenues": "3,276,500",
"Property, Plant and Equipment, Net": "1,016,400",
"Research and Development": "143,700"
},
"output_variables": {
"Liabilities": "1,453,300",
"Assets": "6,325,900",
"Expenses": "3,455,500",
"Revenues": "3,276,500",
"Stockholders Equity": "4,872,600",
"Net Income": "498,500",
"Comprehensive Net Income": "453,000",
"BaseVar": "7,639,850",
"ECR before LimitedLiability": "183%",
"Economic Capital Ratio": "223%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,849,200",
"Assets, Non-Current": "472,300",
"General and Administrative Expense": "2,612,100",
"Goodwill": "1,570,900",
"Liabilities, Current": "1,438,200",
"Liabilities, Non-Current": "0",
"Other Assets": "244,800",
"Other Compr. Net Income": "-23,700",
"Other Expenses": "284,500",
"Other Liabilities": "0",
"Other Net Income": "-32,600",
"Other Revenues": "3,282,400",
"Property, Plant and Equipment, Net": "1,002,100",
"Research and Development": "141,500"
},
"output_variables": {
"Liabilities": "1,438,200",
"Assets": "6,139,300",
"Expenses": "3,038,100",
"Revenues": "3,282,400",
"Stockholders Equity": "4,701,100",
"Net Income": "211,700",
"Comprehensive Net Income": "199,850",
"BaseVar": "6,977,150",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "218%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,652,700",
"Assets, Non-Current": "445,000",
"General and Administrative Expense": "2,395,900",
"Goodwill": "3,830,700",
"Liabilities, Current": "2,209,400",
"Liabilities, Non-Current": "0",
"Other Assets": "252,700",
"Other Compr. Net Income": "235,500",
"Other Expenses": "425,500",
"Other Liabilities": "0",
"Other Net Income": "622,700",
"Other Revenues": "2,878,600",
"Property, Plant and Equipment, Net": "1,025,200",
"Research and Development": "141,500"
},
"output_variables": {
"Liabilities": "2,209,400",
"Assets": "9,206,300",
"Expenses": "2,962,900",
"Revenues": "2,878,600",
"Stockholders Equity": "6,996,900",
"Net Income": "538,400",
"Comprehensive Net Income": "656,150",
"BaseVar": "9,057,700",
"ECR before LimitedLiability": "179%",
"Economic Capital Ratio": "221%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "4,030,200",
"Assets, Non-Current": "465,900",
"General and Administrative Expense": "3,492,100",
"Goodwill": "4,172,400",
"Liabilities, Current": "2,993,400",
"Liabilities, Non-Current": "0",
"Other Assets": "273,200",
"Other Compr. Net Income": "-78,000",
"Other Expenses": "290,800",
"Other Liabilities": "0",
"Other Net Income": "-141,900",
"Other Revenues": "4,727,800",
"Property, Plant and Equipment, Net": "1,032,600",
"Research and Development": "291,500"
},
"output_variables": {
"Liabilities": "2,993,400",
"Assets": "9,974,300",
"Expenses": "4,074,400",
"Revenues": "4,727,800",
"Stockholders Equity": "6,980,900",
"Net Income": "511,500",
"Comprehensive Net Income": "472,500",
"BaseVar": "10,994,900",
"ECR before LimitedLiability": "155%",
"Economic Capital Ratio": "204%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,074,800",
"Assets, Non-Current": "686,000",
"General and Administrative Expense": "3,319,100",
"Goodwill": "4,096,500",
"Liabilities, Current": "2,723,900",
"Liabilities, Non-Current": "0",
"Other Assets": "257,400",
"Other Compr. Net Income": "-91,800",
"Other Expenses": "451,000",
"Other Liabilities": "0",
"Other Net Income": "-61,400",
"Other Revenues": "4,609,800",
"Property, Plant and Equipment, Net": "758,000",
"Research and Development": "298,100"
},
"output_variables": {
"Liabilities": "2,723,900",
"Assets": "9,872,700",
"Expenses": "4,068,200",
"Revenues": "4,609,800",
"Stockholders Equity": "7,148,800",
"Net Income": "480,200",
"Comprehensive Net Income": "434,300",
"BaseVar": "10,713,900",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "209%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,375,600",
"Assets, Non-Current": "715,400",
"General and Administrative Expense": "3,319,800",
"Goodwill": "4,094,100",
"Liabilities, Current": "2,829,000",
"Liabilities, Non-Current": "0",
"Other Assets": "229,600",
"Other Compr. Net Income": "130,700",
"Other Expenses": "455,600",
"Other Liabilities": "0",
"Other Net Income": "-28,200",
"Other Revenues": "4,642,100",
"Property, Plant and Equipment, Net": "771,700",
"Research and Development": "287,900"
},
"output_variables": {
"Liabilities": "2,829,000",
"Assets": "10,186,400",
"Expenses": "4,063,300",
"Revenues": "4,642,100",
"Stockholders Equity": "7,357,400",
"Net Income": "550,600",
"Comprehensive Net Income": "615,950",
"BaseVar": "10,939,850",
"ECR before LimitedLiability": "164%",
"Economic Capital Ratio": "211%"
}
}
},
"top_rated": true,
"trend": -3.0,
"value": 2.107856581691048,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000037785.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000037785.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000037785.svg"
},
{
"company_id": "0000009326",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000009326.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000009326.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000009326.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000009326_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000009326_main_keyfigs.svg",
"name": "Balchem CORP",
"rank": 12,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000009326.svg",
"report_text": "The relative strengths and weaknesses of Balchem CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Balchem CORP compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 36% points.The greatest weakness of Balchem CORP is the variable Other Liabilities, reducing the Economic Capital Ratio by 34% points.
The company's Economic Capital Ratio, given in the ranking table, is 210%, being 64% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000009326_2021_Balchem_CORP.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "39.3",
"Liabilities": "70.0",
"Stockholders Equity": "61.8",
"ECR before LimitedLiability": "134",
"Liabilities, Non-Current": "19.9",
"Other Liabilities": "24.1",
"Assets, Current": "3.11",
"Assets": "2.38",
"Assets, Non-Current": "-1.45",
"Property, Plant and Equipment, Net": "0.767",
"Goodwill": "0.209",
"Other Expenses": "27.0",
"Expenses": "15.7",
"Revenues": "48.0",
"Net Income": "61.6",
"Research and Development": "18.3",
"General and Administrative Expense": "-32.2",
"Other Revenues": "48.0",
"Other Net Income": "-0.697",
"Comprehensive Net Income": "61.7",
"Economic Capital Ratio": "102"
},
"2013": {
"Liabilities, Current": "44.6",
"Liabilities": "74.2",
"Stockholders Equity": "71.5",
"ECR before LimitedLiability": "146",
"Other Liabilities": "16.4",
"Liabilities, Non-Current": "27.4",
"Goodwill": "-0.644",
"Assets": "3.47",
"Assets, Non-Current": "-1.24",
"Other Assets": "-0.777",
"Assets, Current": "6.39",
"General and Administrative Expense": "-30.5",
"Expenses": "14.5",
"Revenues": "47.8",
"Net Income": "57.8",
"Research and Development": "14.8",
"Other Expenses": "27.9",
"Other Revenues": "47.8",
"Other Net Income": "-3.56",
"Comprehensive Net Income": "57.9",
"Economic Capital Ratio": "106"
},
"2014": {
"Liabilities, Non-Current": "16.9",
"Liabilities": "-5.56",
"Stockholders Equity": "21.9",
"ECR before LimitedLiability": "75.4",
"Liabilities, Current": "36.8",
"Other Liabilities": "-76.0",
"Assets, Current": "-20.0",
"Assets": "20.3",
"Goodwill": "70.7",
"Assets, Non-Current": "-3.54",
"Property, Plant and Equipment, Net": "3.19",
"Other Expenses": "16.5",
"Expenses": "32.0",
"Revenues": "13.1",
"Net Income": "48.9",
"Research and Development": "12.9",
"General and Administrative Expense": "1.39",
"Other Revenues": "13.1",
"Other Net Income": "1.31",
"Comprehensive Net Income": "48.7",
"Economic Capital Ratio": "26.0"
},
"2015": {
"Other Liabilities": "-61.5",
"Liabilities": "8.99",
"Stockholders Equity": "27.7",
"ECR before LimitedLiability": "82.6",
"Liabilities, Current": "37.0",
"Liabilities, Non-Current": "19.7",
"Assets, Current": "-16.3",
"Assets": "13.8",
"Other Assets": "-5.07",
"Goodwill": "55.2",
"Assets, Non-Current": "-2.35",
"Property, Plant and Equipment, Net": "4.85",
"Research and Development": "9.27",
"Expenses": "23.7",
"Revenues": "19.7",
"Net Income": "46.6",
"General and Administrative Expense": "-8.86",
"Other Expenses": "23.5",
"Other Revenues": "19.7",
"Comprehensive Net Income": "46.8",
"Economic Capital Ratio": "36.7"
},
"2016": {
"Liabilities, Non-Current": "-25.3",
"Liabilities": "-1.50",
"Stockholders Equity": "15.8",
"ECR before LimitedLiability": "49.3",
"Liabilities, Current": "30.5",
"Other Liabilities": "-10.7",
"Property, Plant and Equipment, Net": "0.860",
"Assets": "10.8",
"Assets, Non-Current": "-2.55",
"Assets, Current": "-20.0",
"Goodwill": "61.8",
"Research and Development": "12.7",
"Expenses": "23.7",
"Revenues": "14.2",
"Net Income": "37.2",
"General and Administrative Expense": "-10.9",
"Other Expenses": "22.2",
"Other Revenues": "14.2",
"Comprehensive Net Income": "37.4",
"Other Net Income": "-1.82",
"Economic Capital Ratio": "29.3"
},
"2017": {
"Other Liabilities": "1.29",
"Liabilities": "17.6",
"Stockholders Equity": "32.4",
"ECR before LimitedLiability": "65.0",
"Liabilities, Current": "29.3",
"Liabilities, Non-Current": "-15.5",
"Assets, Non-Current": "-2.58",
"Assets": "10.4",
"Assets, Current": "-13.1",
"Goodwill": "43.0",
"Property, Plant and Equipment, Net": "-0.510",
"Research and Development": "12.1",
"Expenses": "18.2",
"Revenues": "21.4",
"Net Income": "36.1",
"Other Expenses": "19.6",
"General and Administrative Expense": "-13.4",
"Other Revenues": "21.4",
"Comprehensive Net Income": "36.0",
"Other Net Income": "-4.22",
"Economic Capital Ratio": "43.4"
},
"2019": {
"Liabilities, Non-Current": "20.3",
"Liabilities": "8.95",
"Stockholders Equity": "27.9",
"ECR before LimitedLiability": "88.3",
"Other Liabilities": "-34.7",
"Liabilities, Current": "17.3",
"Assets, Non-Current": "-6.33",
"Assets": "11.8",
"Goodwill": "45.4",
"Property, Plant and Equipment, Net": "1.87",
"Assets, Current": "-12.1",
"Research and Development": "7.89",
"Expenses": "22.2",
"Revenues": "15.4",
"Net Income": "41.9",
"Other Expenses": "7.40",
"General and Administrative Expense": "6.57",
"Other Revenues": "15.4",
"Other Net Income": "3.09",
"Comprehensive Net Income": "41.9",
"Economic Capital Ratio": "58.8"
},
"2020": {
"Liabilities, Current": "22.6",
"Liabilities": "27.4",
"Stockholders Equity": "27.1",
"ECR before LimitedLiability": "102",
"Liabilities, Non-Current": "31.6",
"Other Liabilities": "-34.0",
"Goodwill": "35.8",
"Assets": "3.42",
"Assets, Current": "-13.4",
"Assets, Non-Current": "-5.34",
"Property, Plant and Equipment, Net": "0.977",
"Other Expenses": "6.17",
"Expenses": "6.90",
"Revenues": "22.1",
"Net Income": "33.8",
"Research and Development": "6.72",
"General and Administrative Expense": "-6.02",
"Other Revenues": "22.1",
"Comprehensive Net Income": "34.3",
"Other Net Income": "4.61",
"Economic Capital Ratio": "63.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000009326_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "211,909",
"Assets, Non-Current": "538",
"General and Administrative Expense": "247,194",
"Goodwill": "47,373",
"Liabilities, Current": "30,234",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "179",
"Other Expenses": "19,849",
"Other Liabilities": "9,299",
"Other Net Income": "77",
"Other Revenues": "310,393",
"Property, Plant and Equipment, Net": "52,725",
"Research and Development": "3,422"
},
"output_variables": {
"Liabilities": "39,533",
"Assets": "312,545",
"Expenses": "270,465",
"Revenues": "310,393",
"Stockholders Equity": "273,012",
"Net Income": "40,005",
"Comprehensive Net Income": "40,094",
"BaseVar": "466,596",
"ECR before LimitedLiability": "235%",
"Economic Capital Ratio": "260%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "277,774",
"Assets, Non-Current": "541",
"General and Administrative Expense": "267,949",
"Goodwill": "43,641",
"Liabilities, Current": "35,753",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "957",
"Other Expenses": "20,968",
"Other Liabilities": "9,761",
"Other Net Income": "240",
"Other Revenues": "337,173",
"Property, Plant and Equipment, Net": "54,916",
"Research and Development": "3,622"
},
"output_variables": {
"Liabilities": "45,514",
"Assets": "376,872",
"Expenses": "292,539",
"Revenues": "337,173",
"Stockholders Equity": "331,358",
"Net Income": "44,874",
"Comprehensive Net Income": "45,352",
"BaseVar": "526,648",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "261%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "181,302",
"Assets, Non-Current": "4,341",
"General and Administrative Expense": "454,430",
"Goodwill": "544,040",
"Liabilities, Current": "95,522",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,849",
"Other Expenses": "29,371",
"Other Liabilities": "373,851",
"Other Net Income": "54",
"Other Revenues": "541,383",
"Property, Plant and Equipment, Net": "131,588",
"Research and Development": "4,810"
},
"output_variables": {
"Liabilities": "469,373",
"Assets": "861,271",
"Expenses": "488,611",
"Revenues": "541,383",
"Stockholders Equity": "391,898",
"Net Income": "52,826",
"Comprehensive Net Income": "51,402",
"BaseVar": "1,181,770",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "160%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "198,829",
"Assets, Non-Current": "5,062",
"General and Administrative Expense": "452,546",
"Goodwill": "518,817",
"Liabilities, Current": "81,120",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,463",
"Other Expenses": "33,934",
"Other Liabilities": "336,398",
"Other Net Income": "-300",
"Other Revenues": "552,492",
"Property, Plant and Equipment, Net": "158,515",
"Research and Development": "5,990"
},
"output_variables": {
"Liabilities": "417,518",
"Assets": "881,223",
"Expenses": "492,470",
"Revenues": "552,492",
"Stockholders Equity": "463,705",
"Net Income": "59,722",
"Comprehensive Net Income": "58,490",
"BaseVar": "1,173,233",
"ECR before LimitedLiability": "107%",
"Economic Capital Ratio": "173%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "188,442",
"Assets, Non-Current": "7,135",
"General and Administrative Expense": "455,041",
"Goodwill": "587,295",
"Liabilities, Current": "101,008",
"Liabilities, Non-Current": "226,490",
"Other Assets": "0",
"Other Compr. Net Income": "-1,735",
"Other Expenses": "34,227",
"Other Liabilities": "100,095",
"Other Net Income": "-639",
"Other Revenues": "553,204",
"Property, Plant and Equipment, Net": "165,754",
"Research and Development": "7,325"
},
"output_variables": {
"Liabilities": "427,593",
"Assets": "948,626",
"Expenses": "496,593",
"Revenues": "553,204",
"Stockholders Equity": "521,033",
"Net Income": "55,972",
"Comprehensive Net Income": "55,104",
"BaseVar": "1,214,195",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "176%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "199,336",
"Assets, Non-Current": "5,073",
"General and Administrative Expense": "488,230",
"Goodwill": "569,434",
"Liabilities, Current": "108,396",
"Liabilities, Non-Current": "183,964",
"Other Assets": "0",
"Other Compr. Net Income": "5,207",
"Other Expenses": "5,961",
"Other Liabilities": "54,395",
"Other Net Income": "-1,223",
"Other Revenues": "594,790",
"Property, Plant and Equipment, Net": "189,793",
"Research and Development": "9,305"
},
"output_variables": {
"Liabilities": "346,755",
"Assets": "963,636",
"Expenses": "503,496",
"Revenues": "594,790",
"Stockholders Equity": "616,881",
"Net Income": "90,071",
"Comprehensive Net Income": "92,674",
"BaseVar": "1,207,554",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "197%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "254,946",
"Assets, Non-Current": "15,955",
"General and Administrative Expense": "529,775",
"Goodwill": "667,922",
"Liabilities, Current": "148,689",
"Liabilities, Non-Current": "4,827",
"Other Assets": "0",
"Other Compr. Net Income": "-1,962",
"Other Expenses": "16,807",
"Other Liabilities": "258,499",
"Other Net Income": "-6,075",
"Other Revenues": "643,705",
"Property, Plant and Equipment, Net": "216,859",
"Research and Development": "11,377"
},
"output_variables": {
"Liabilities": "412,015",
"Assets": "1,155,682",
"Expenses": "557,959",
"Revenues": "643,705",
"Stockholders Equity": "743,667",
"Net Income": "79,671",
"Comprehensive Net Income": "78,690",
"BaseVar": "1,388,699",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "195%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "266,888",
"Assets, Non-Current": "11,326",
"General and Administrative Expense": "582,165",
"Goodwill": "651,123",
"Liabilities, Current": "145,787",
"Liabilities, Non-Current": "0",
"Other Assets": "8,410",
"Other Compr. Net Income": "9,737",
"Other Expenses": "21,794",
"Other Liabilities": "191,823",
"Other Net Income": "-4,730",
"Other Revenues": "703,644",
"Property, Plant and Equipment, Net": "228,096",
"Research and Development": "10,332"
},
"output_variables": {
"Liabilities": "337,610",
"Assets": "1,165,843",
"Expenses": "614,291",
"Revenues": "703,644",
"Stockholders Equity": "828,233",
"Net Income": "84,623",
"Comprehensive Net Income": "89,492",
"BaseVar": "1,417,928",
"ECR before LimitedLiability": "163%",
"Economic Capital Ratio": "210%"
}
}
},
"top_rated": true,
"trend": 1.0,
"value": 2.0979161312465986,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000009326.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000009326.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000009326.svg"
},
{
"company_id": "0001321834",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001321834.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001321834.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001321834.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001321834_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001321834_main_keyfigs.svg",
"name": "Q C Technologies INC",
"rank": 13,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001321834.svg",
"report_text": "The relative strengths and weaknesses of Q C Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Q C Technologies INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 125% points.The greatest weakness of Q C Technologies INC is the variable Net Income, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 203%, being 57% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001321834_2021_Q_C_Technologies_INC.pdf",
"shrinked_graph_json": {
"2014": {
"Liabilities, Non-Current": "17.8",
"Liabilities": "53.0",
"Stockholders Equity": "126",
"ECR before LimitedLiability": "141",
"Liabilities, Current": "29.3",
"Other Liabilities": "12.1",
"Assets, Current": "40.4",
"Assets": "41.6",
"Other Assets": "-6.74",
"Assets, Non-Current": "11.7",
"Property, Plant and Equipment, Net": "-3.37",
"Other Expenses": "4.87",
"Expenses": "16.5",
"Revenues": "-7.84",
"Net Income": "10.5",
"Research and Development": "4.74",
"General and Administrative Expense": "7.01",
"Other Revenues": "-7.84",
"Other Net Income": "1.70",
"Comprehensive Net Income": "10.6",
"Economic Capital Ratio": "91.5"
},
"2018": {
"Liabilities, Non-Current": "3.04",
"Liabilities": "6.50",
"Stockholders Equity": "6.83",
"ECR before LimitedLiability": "-39.9",
"Other Liabilities": "1.70",
"Liabilities, Current": "0.849",
"Property, Plant and Equipment, Net": "-14.8",
"Assets": "-0.886",
"Other Assets": "-0.794",
"Assets, Current": "18.6",
"Goodwill": "-2.18",
"Assets, Non-Current": "1.03",
"Other Expenses": "-0.883",
"Expenses": "-62.3",
"Revenues": "-22.9",
"Net Income": "-86.1",
"General and Administrative Expense": "-55.0",
"Other Revenues": "-22.9",
"Comprehensive Net Income": "-85.7",
"Other Net Income": "2.01",
"Economic Capital Ratio": "-60.4"
},
"2019": {
"Liabilities, Non-Current": "18.9",
"Liabilities": "35.0",
"Stockholders Equity": "97.2",
"ECR before LimitedLiability": "89.8",
"Other Liabilities": "12.4",
"Liabilities, Current": "5.64",
"Assets, Non-Current": "-2.67",
"Assets": "43.4",
"Goodwill": "-5.94",
"Property, Plant and Equipment, Net": "-8.03",
"Assets, Current": "112",
"Research and Development": "4.93",
"Expenses": "2.62",
"Revenues": "-18.0",
"Net Income": "-12.7",
"Other Expenses": "5.92",
"General and Administrative Expense": "-8.20",
"Other Revenues": "-18.0",
"Other Net Income": "2.59",
"Comprehensive Net Income": "-12.5",
"Economic Capital Ratio": "60.4"
},
"2020": {
"Liabilities, Current": "21.4",
"Liabilities": "47.5",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "94.8",
"Liabilities, Non-Current": "24.4",
"Other Liabilities": "5.25",
"Goodwill": "-6.09",
"Assets": "51.2",
"Assets, Current": "125",
"Assets, Non-Current": "-4.95",
"Property, Plant and Equipment, Net": "-7.71",
"Other Expenses": "6.20",
"Expenses": "5.27",
"Revenues": "-30.9",
"Net Income": "-40.1",
"Research and Development": "-21.1",
"General and Administrative Expense": "20.1",
"Other Revenues": "-30.9",
"Comprehensive Net Income": "-40.1",
"Other Net Income": "-14.0",
"Economic Capital Ratio": "57.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001321834_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "13,060",
"Assets, Non-Current": "3,591",
"General and Administrative Expense": "5,086",
"Goodwill": "2,176",
"Liabilities, Current": "1,844",
"Liabilities, Non-Current": "0",
"Other Assets": "-2,378",
"Other Compr. Net Income": "0",
"Other Expenses": "1,613",
"Other Liabilities": "0",
"Other Net Income": "77",
"Other Revenues": "4,427",
"Property, Plant and Equipment, Net": "201",
"Research and Development": "916"
},
"output_variables": {
"Liabilities": "1,844",
"Assets": "16,651",
"Expenses": "7,616",
"Revenues": "4,427",
"Stockholders Equity": "14,807",
"Net Income": "-3,111",
"Comprehensive Net Income": "-3,111",
"BaseVar": "15,307",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "225%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,670",
"Assets, Non-Current": "1,137",
"General and Administrative Expense": "8,987",
"Goodwill": "243",
"Liabilities, Current": "1,974",
"Liabilities, Non-Current": "0",
"Other Assets": "-327",
"Other Compr. Net Income": "0",
"Other Expenses": "1,676",
"Other Liabilities": "0",
"Other Net Income": "789",
"Other Revenues": "1,666",
"Property, Plant and Equipment, Net": "83",
"Research and Development": "1,063"
},
"output_variables": {
"Liabilities": "1,974",
"Assets": "7,807",
"Expenses": "11,726",
"Revenues": "1,666",
"Stockholders Equity": "5,834",
"Net Income": "-9,272",
"Comprehensive Net Income": "-9,272",
"BaseVar": "11,980",
"ECR before LimitedLiability": "-26%",
"Economic Capital Ratio": "83%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "10,311",
"Assets, Non-Current": "574",
"General and Administrative Expense": "5,065",
"Goodwill": "170",
"Liabilities, Current": "1,530",
"Liabilities, Non-Current": "0",
"Other Assets": "-204",
"Other Compr. Net Income": "44",
"Other Expenses": "181",
"Other Liabilities": "0",
"Other Net Income": "-58",
"Other Revenues": "1,577",
"Property, Plant and Equipment, Net": "34",
"Research and Development": "277"
},
"output_variables": {
"Liabilities": "1,530",
"Assets": "10,885",
"Expenses": "5,523",
"Revenues": "1,577",
"Stockholders Equity": "9,355",
"Net Income": "-4,004",
"Comprehensive Net Income": "-3,982",
"BaseVar": "9,808",
"ECR before LimitedLiability": "142%",
"Economic Capital Ratio": "196%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "36,843",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,322",
"Goodwill": "0",
"Liabilities, Current": "2,263",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-5,295",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "7,964"
},
"output_variables": {
"Liabilities": "2,263",
"Assets": "36,843",
"Expenses": "12,286",
"Revenues": "0",
"Stockholders Equity": "34,579",
"Net Income": "-17,581",
"Comprehensive Net Income": "-17,581",
"BaseVar": "28,343",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "203%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 2.0288984458361856,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001321834.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001321834.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001321834.svg"
},
{
"company_id": "0001038133",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001038133.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001038133.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001038133.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001038133_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001038133_main_keyfigs.svg",
"name": "Heska CORP",
"rank": 14,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001038133.svg",
"report_text": "The relative strengths and weaknesses of Heska CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Heska CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 31% points.The greatest weakness of Heska CORP is the variable Other Liabilities, reducing the Economic Capital Ratio by 25% points.
The company's Economic Capital Ratio, given in the ranking table, is 202%, being 56% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001038133_2021_Heska_CORP.pdf",
"shrinked_graph_json": {
"2015": {
"Other Liabilities": "1.40",
"Liabilities": "63.3",
"Stockholders Equity": "50.0",
"ECR before LimitedLiability": "120",
"Liabilities, Current": "39.4",
"Liabilities, Non-Current": "27.6",
"Research and Development": "11.1",
"Expenses": "4.31",
"Net Income": "53.9",
"General and Administrative Expense": "-39.4",
"Other Expenses": "31.3",
"Other Revenues": "47.9",
"Revenues": "47.9",
"Assets, Current": "-9.24",
"Other Assets": "28.9",
"Goodwill": "-8.75",
"Assets, Non-Current": "-0.859",
"Property, Plant and Equipment, Net": "0.755",
"Comprehensive Net Income": "54.1",
"Other Net Income": "1.10",
"Economic Capital Ratio": "73.8"
},
"2016": {
"Liabilities, Non-Current": "26.3",
"Liabilities": "41.5",
"Stockholders Equity": "16.3",
"ECR before LimitedLiability": "74.3",
"Liabilities, Current": "22.3",
"Other Liabilities": "-5.68",
"Property, Plant and Equipment, Net": "-4.67",
"Assets": "-6.01",
"Other Assets": "11.2",
"Assets, Current": "-12.8",
"Goodwill": "2.96",
"Research and Development": "15.9",
"Expenses": "6.87",
"Revenues": "45.2",
"Net Income": "50.3",
"General and Administrative Expense": "-39.5",
"Other Expenses": "30.2",
"Other Revenues": "45.2",
"Comprehensive Net Income": "49.8",
"Other Net Income": "-2.34",
"Economic Capital Ratio": "54.3"
},
"2017": {
"Other Liabilities": "1.61",
"Liabilities": "57.7",
"Stockholders Equity": "34.8",
"ECR before LimitedLiability": "84.2",
"Liabilities, Current": "30.5",
"Liabilities, Non-Current": "30.7",
"Assets, Non-Current": "-0.989",
"Assets": "-2.92",
"Other Assets": "9.64",
"Assets, Current": "-4.71",
"Goodwill": "1.32",
"Property, Plant and Equipment, Net": "-6.18",
"Other Revenues": "48.7",
"Revenues": "48.7",
"Net Income": "42.2",
"Comprehensive Net Income": "42.0",
"Other Expenses": "19.9",
"Other Net Income": "-5.55",
"Research and Development": "15.8",
"General and Administrative Expense": "-38.3",
"Economic Capital Ratio": "62.6"
},
"2018": {
"Liabilities, Non-Current": "16.8",
"Liabilities": "48.7",
"Stockholders Equity": "40.3",
"ECR before LimitedLiability": "99.4",
"Other Liabilities": "5.70",
"Liabilities, Current": "30.7",
"Property, Plant and Equipment, Net": "-4.01",
"Assets": "1.98",
"Other Assets": "13.2",
"Assets, Current": "-6.13",
"Goodwill": "4.94",
"Assets, Non-Current": "-2.49",
"Other Expenses": "15.6",
"Expenses": "5.34",
"Revenues": "37.0",
"Net Income": "42.2",
"Research and Development": "12.7",
"General and Administrative Expense": "-24.0",
"Other Revenues": "37.0",
"Comprehensive Net Income": "42.5",
"Economic Capital Ratio": "78.9"
},
"2019": {
"Liabilities, Non-Current": "16.3",
"Liabilities": "5.89",
"Stockholders Equity": "27.4",
"ECR before LimitedLiability": "78.9",
"Other Liabilities": "-30.5",
"Liabilities, Current": "16.0",
"Assets, Non-Current": "-4.36",
"Assets": "14.0",
"Goodwill": "4.83",
"Property, Plant and Equipment, Net": "-6.38",
"Other Assets": "9.76",
"Assets, Current": "11.4",
"Research and Development": "5.50",
"Expenses": "19.3",
"Revenues": "10.4",
"Net Income": "34.1",
"Other Expenses": "8.22",
"General and Administrative Expense": "5.29",
"Other Revenues": "10.4",
"Comprehensive Net Income": "34.3",
"Economic Capital Ratio": "49.4"
},
"2020": {
"Liabilities, Current": "18.6",
"Liabilities": "25.4",
"Stockholders Equity": "31.4",
"ECR before LimitedLiability": "93.5",
"Liabilities, Non-Current": "27.8",
"Other Liabilities": "-24.8",
"Goodwill": "17.7",
"Assets": "6.36",
"Other Assets": "5.85",
"Assets, Non-Current": "-4.30",
"Property, Plant and Equipment, Net": "-4.95",
"Other Expenses": "6.32",
"Expenses": "4.46",
"Revenues": "12.4",
"Net Income": "21.6",
"Research and Development": "5.12",
"General and Administrative Expense": "-6.97",
"Other Revenues": "12.4",
"Comprehensive Net Income": "23.6",
"Other Net Income": "4.67",
"Economic Capital Ratio": "55.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001038133_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "41,262",
"Assets, Non-Current": "3,072",
"General and Administrative Expense": "94,382",
"Goodwill": "0",
"Liabilities, Current": "18,803",
"Liabilities, Non-Current": "69",
"Other Assets": "48,365",
"Other Compr. Net Income": "-376",
"Other Expenses": "3,038",
"Other Liabilities": "11,572",
"Other Net Income": "0",
"Other Revenues": "104,597",
"Property, Plant and Equipment, Net": "17,020",
"Research and Development": "1,658"
},
"output_variables": {
"Liabilities": "30,444",
"Assets": "109,719",
"Expenses": "99,078",
"Revenues": "104,597",
"Stockholders Equity": "79,275",
"Net Income": "5,519",
"Comprehensive Net Income": "5,331",
"BaseVar": "172,107",
"ECR before LimitedLiability": "163%",
"Economic Capital Ratio": "210%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "55,273",
"Assets, Non-Current": "8,875",
"General and Administrative Expense": "111,403",
"Goodwill": "28,993",
"Liabilities, Current": "32,414",
"Liabilities, Non-Current": "0",
"Other Assets": "21,122",
"Other Compr. Net Income": "-1,747",
"Other Expenses": "4,368",
"Other Liabilities": "11,455",
"Other Net Income": "0",
"Other Revenues": "130,083",
"Property, Plant and Equipment, Net": "16,581",
"Research and Development": "2,147"
},
"output_variables": {
"Liabilities": "43,869",
"Assets": "130,844",
"Expenses": "117,918",
"Revenues": "130,083",
"Stockholders Equity": "86,975",
"Net Income": "12,165",
"Comprehensive Net Income": "11,292",
"BaseVar": "212,230",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "201%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "62,912",
"Assets, Non-Current": "5,407",
"General and Administrative Expense": "109,118",
"Goodwill": "28,645",
"Liabilities, Current": "25,726",
"Liabilities, Non-Current": "0",
"Other Assets": "21,492",
"Other Compr. Net Income": "632",
"Other Expenses": "8,763",
"Other Liabilities": "9,621",
"Other Net Income": "0",
"Other Revenues": "129,341",
"Property, Plant and Equipment, Net": "17,331",
"Research and Development": "2,004"
},
"output_variables": {
"Liabilities": "35,347",
"Assets": "135,787",
"Expenses": "119,885",
"Revenues": "129,341",
"Stockholders Equity": "100,440",
"Net Income": "9,456",
"Comprehensive Net Income": "9,772",
"BaseVar": "210,496",
"ECR before LimitedLiability": "172%",
"Economic Capital Ratio": "216%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "62,407",
"Assets, Non-Current": "7,574",
"General and Administrative Expense": "120,318",
"Goodwill": "36,443",
"Liabilities, Current": "20,363",
"Liabilities, Non-Current": "6,598",
"Other Assets": "34,047",
"Other Compr. Net Income": "45",
"Other Expenses": "-2,133",
"Other Liabilities": "7,082",
"Other Net Income": "-72",
"Other Revenues": "127,446",
"Property, Plant and Equipment, Net": "15,981",
"Research and Development": "3,334"
},
"output_variables": {
"Liabilities": "34,043",
"Assets": "156,452",
"Expenses": "121,519",
"Revenues": "127,446",
"Stockholders Equity": "122,409",
"Net Income": "5,855",
"Comprehensive Net Income": "5,878",
"BaseVar": "219,788",
"ECR before LimitedLiability": "182%",
"Economic Capital Ratio": "223%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "139,867",
"Assets, Non-Current": "13,252",
"General and Administrative Expense": "114,094",
"Goodwill": "47,676",
"Liabilities, Current": "32,199",
"Liabilities, Non-Current": "5,686",
"Other Assets": "28,160",
"Other Compr. Net Income": "502",
"Other Expenses": "1,460",
"Other Liabilities": "52,005",
"Other Net Income": "-594",
"Other Revenues": "122,661",
"Property, Plant and Equipment, Net": "15,469",
"Research and Development": "8,240"
},
"output_variables": {
"Liabilities": "89,890",
"Assets": "244,424",
"Expenses": "123,794",
"Revenues": "122,661",
"Stockholders Equity": "154,534",
"Net Income": "-1,727",
"Comprehensive Net Income": "-1,476",
"BaseVar": "290,932",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "185%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "171,275",
"Assets, Non-Current": "13,896",
"General and Administrative Expense": "196,743",
"Goodwill": "144,268",
"Liabilities, Current": "53,971",
"Liabilities, Non-Current": "5,135",
"Other Assets": "34,858",
"Other Compr. Net Income": "14,009",
"Other Expenses": "5,840",
"Other Liabilities": "53,680",
"Other Net Income": "-720",
"Other Revenues": "197,323",
"Property, Plant and Equipment, Net": "35,542",
"Research and Development": "8,772"
},
"output_variables": {
"Liabilities": "112,786",
"Assets": "399,839",
"Expenses": "211,355",
"Revenues": "197,323",
"Stockholders Equity": "287,053",
"Net Income": "-14,752",
"Comprehensive Net Income": "-7,748",
"BaseVar": "468,016",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "202%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 2.015982807606534,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001038133.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001038133.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001038133.svg"
},
{
"company_id": "0000744218",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000744218.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000744218.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000744218.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000744218_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000744218_main_keyfigs.svg",
"name": "Celldex Therapeutics Inc",
"rank": 15,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000744218.svg",
"report_text": "The relative strengths and weaknesses of Celldex Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Celldex Therapeutics Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 97% points.The greatest weakness of Celldex Therapeutics Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 202%, being 56% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000744218_2021_Celldex_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "9.86",
"Liabilities": "-3.63",
"Stockholders Equity": "67.0",
"ECR before LimitedLiability": "60.1",
"Liabilities, Non-Current": "-3.93",
"Other Liabilities": "-9.89",
"Property, Plant and Equipment, Net": "0.343",
"Assets": "67.5",
"Assets, Non-Current": "-3.70",
"Goodwill": "40.9",
"Assets, Current": "26.4",
"General and Administrative Expense": "37.3",
"Expenses": "10.4",
"Revenues": "-30.9",
"Net Income": "-25.8",
"Research and Development": "-26.0",
"Other Expenses": "3.29",
"Other Revenues": "-30.9",
"Comprehensive Net Income": "-25.9",
"Other Net Income": "-4.47",
"Economic Capital Ratio": "-1.92"
},
"2012": {
"Liabilities, Current": "1.74",
"Liabilities": "4.57",
"Stockholders Equity": "78.6",
"ECR before LimitedLiability": "37.3",
"Liabilities, Non-Current": "-2.06",
"Other Liabilities": "4.88",
"Assets, Current": "49.6",
"Assets": "78.6",
"Assets, Non-Current": "-3.55",
"Property, Plant and Equipment, Net": "-3.08",
"Goodwill": "21.4",
"Other Expenses": "9.36",
"Expenses": "8.36",
"Revenues": "-32.0",
"Net Income": "-24.8",
"Research and Development": "-30.8",
"General and Administrative Expense": "33.5",
"Other Revenues": "-32.0",
"Other Net Income": "-0.401",
"Comprehensive Net Income": "-25.1",
"Economic Capital Ratio": "4.79"
},
"2013": {
"Liabilities, Current": "17.3",
"Liabilities": "31.9",
"Stockholders Equity": "133",
"ECR before LimitedLiability": "114",
"Other Liabilities": "10.4",
"Liabilities, Non-Current": "6.72",
"Goodwill": "1.26",
"Assets": "65.4",
"Assets, Non-Current": "-1.30",
"Property, Plant and Equipment, Net": "-1.50",
"Assets, Current": "79.0",
"General and Administrative Expense": "23.7",
"Expenses": "22.1",
"Revenues": "-30.5",
"Net Income": "-8.50",
"Research and Development": "-17.4",
"Other Expenses": "15.1",
"Other Revenues": "-30.5",
"Other Net Income": "-1.65",
"Comprehensive Net Income": "-8.59",
"Economic Capital Ratio": "73.7"
},
"2014": {
"Liabilities, Non-Current": "3.49",
"Liabilities": "35.9",
"Stockholders Equity": "99.6",
"ECR before LimitedLiability": "96.9",
"Liabilities, Current": "24.3",
"Other Liabilities": "9.38",
"Assets, Current": "96.6",
"Assets": "96.4",
"Goodwill": "3.01",
"Assets, Non-Current": "-1.97",
"Property, Plant and Equipment, Net": "-2.60",
"Other Expenses": "14.6",
"Expenses": "4.42",
"Revenues": "-33.2",
"Net Income": "-27.9",
"Research and Development": "-38.6",
"General and Administrative Expense": "30.8",
"Other Revenues": "-33.2",
"Comprehensive Net Income": "-26.9",
"Other Compr. Net Income": "1.06",
"Economic Capital Ratio": "47.5"
},
"2015": {
"Other Liabilities": "12.8",
"Liabilities": "36.3",
"Stockholders Equity": "111",
"ECR before LimitedLiability": "105",
"Liabilities, Current": "21.4",
"Liabilities, Non-Current": "3.92",
"Assets, Current": "110",
"Assets": "78.5",
"Other Assets": "-3.01",
"Assets, Non-Current": "-1.32",
"Property, Plant and Equipment, Net": "-2.77",
"Research and Development": "-27.3",
"Expenses": "8.22",
"Revenues": "-26.9",
"Net Income": "-18.0",
"General and Administrative Expense": "16.9",
"Other Expenses": "18.9",
"Other Revenues": "-26.9",
"Comprehensive Net Income": "-17.5",
"Other Net Income": "0.613",
"Economic Capital Ratio": "58.7"
},
"2016": {
"Liabilities, Non-Current": "-30.8",
"Liabilities": "-2.70",
"Stockholders Equity": "70.5",
"ECR before LimitedLiability": "36.2",
"Liabilities, Current": "19.0",
"Other Liabilities": "6.30",
"Property, Plant and Equipment, Net": "-6.84",
"Assets": "71.0",
"Assets, Non-Current": "-2.15",
"Assets, Current": "18.5",
"Goodwill": "54.6",
"Research and Development": "-18.5",
"Expenses": "16.3",
"Revenues": "-28.3",
"Net Income": "-14.8",
"General and Administrative Expense": "16.5",
"Other Expenses": "19.6",
"Other Revenues": "-28.3",
"Comprehensive Net Income": "-14.0",
"Other Net Income": "-1.35",
"Economic Capital Ratio": "16.2"
},
"2017": {
"Other Liabilities": "8.57",
"Liabilities": "9.71",
"Stockholders Equity": "84.0",
"ECR before LimitedLiability": "47.5",
"Liabilities, Current": "18.3",
"Liabilities, Non-Current": "-18.9",
"Assets, Non-Current": "-2.08",
"Assets": "64.0",
"Assets, Current": "16.1",
"Goodwill": "55.7",
"Property, Plant and Equipment, Net": "-7.96",
"Research and Development": "-22.9",
"Expenses": "13.1",
"Revenues": "-22.2",
"Net Income": "-12.6",
"Other Expenses": "19.0",
"General and Administrative Expense": "18.1",
"Other Revenues": "-22.2",
"Comprehensive Net Income": "-12.8",
"Other Net Income": "-3.01",
"Economic Capital Ratio": "26.0"
},
"2018": {
"Liabilities, Non-Current": "-6.30",
"Liabilities": "19.8",
"Stockholders Equity": "26.6",
"ECR before LimitedLiability": "-19.4",
"Other Liabilities": "12.7",
"Liabilities, Current": "19.5",
"Property, Plant and Equipment, Net": "-19.9",
"Assets": "20.8",
"Assets, Current": "20.7",
"Goodwill": "20.8",
"Assets, Non-Current": "-12.7",
"Other Expenses": "-54.4",
"Expenses": "-50.5",
"Revenues": "-42.9",
"Net Income": "-85.9",
"Research and Development": "-43.3",
"General and Administrative Expense": "21.8",
"Other Revenues": "-42.9",
"Comprehensive Net Income": "-85.6",
"Other Compr. Net Income": "0.343",
"Economic Capital Ratio": "-39.8"
},
"2019": {
"Liabilities, Non-Current": "-12.7",
"Liabilities": "12.8",
"Stockholders Equity": "80.2",
"ECR before LimitedLiability": "63.2",
"Other Liabilities": "11.0",
"Liabilities, Current": "13.9",
"Assets, Non-Current": "-5.39",
"Assets": "59.5",
"Goodwill": "41.0",
"Property, Plant and Equipment, Net": "-7.58",
"Assets, Current": "27.2",
"Research and Development": "-30.4",
"Expenses": "5.15",
"Revenues": "-25.4",
"Net Income": "-17.6",
"Other Expenses": "7.13",
"General and Administrative Expense": "31.4",
"Other Revenues": "-25.4",
"Other Net Income": "3.09",
"Comprehensive Net Income": "-17.5",
"Economic Capital Ratio": "33.7"
},
"2020": {
"Liabilities, Current": "24.1",
"Liabilities": "41.0",
"Stockholders Equity": "96.8",
"ECR before LimitedLiability": "93.4",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "5.51",
"Goodwill": "2.53",
"Assets": "36.7",
"Assets, Current": "66.0",
"Assets, Non-Current": "-4.34",
"Property, Plant and Equipment, Net": "-7.27",
"Expenses": "14.4",
"Net Income": "-8.83",
"Research and Development": "-15.2",
"General and Administrative Expense": "29.7",
"Other Revenues": "-27.5",
"Revenues": "-27.5",
"Other Compr. Net Income": "-15.0",
"Comprehensive Net Income": "-24.0",
"Other Net Income": "4.06",
"Economic Capital Ratio": "55.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000744218_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "54,684",
"Assets, Non-Current": "329",
"General and Administrative Expense": "9,243",
"Goodwill": "33,888",
"Liabilities, Current": "14,298",
"Liabilities, Non-Current": "5,966",
"Other Assets": "0",
"Other Compr. Net Income": "-99",
"Other Expenses": "12,778",
"Other Liabilities": "9,008",
"Other Net Income": "396",
"Other Revenues": "9,265",
"Property, Plant and Equipment, Net": "9,093",
"Research and Development": "32,439"
},
"output_variables": {
"Liabilities": "29,272",
"Assets": "97,994",
"Expenses": "54,460",
"Revenues": "9,265",
"Stockholders Equity": "68,722",
"Net Income": "-44,799",
"Comprehensive Net Income": "-44,848",
"BaseVar": "95,743",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "152%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "85,114",
"Assets, Non-Current": "424",
"General and Administrative Expense": "10,016",
"Goodwill": "32,798",
"Liabilities, Current": "17,685",
"Liabilities, Non-Current": "6,336",
"Other Assets": "0",
"Other Compr. Net Income": "-953",
"Other Expenses": "11,865",
"Other Liabilities": "5,746",
"Other Net Income": "0",
"Other Revenues": "11,202",
"Property, Plant and Equipment, Net": "7,205",
"Research and Development": "47,398"
},
"output_variables": {
"Liabilities": "29,767",
"Assets": "125,541",
"Expenses": "69,279",
"Revenues": "11,202",
"Stockholders Equity": "95,774",
"Net Income": "-58,077",
"Comprehensive Net Income": "-58,554",
"BaseVar": "118,371",
"ECR before LimitedLiability": "94%",
"Economic Capital Ratio": "163%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "305,189",
"Assets, Non-Current": "148",
"General and Administrative Expense": "14,805",
"Goodwill": "31,785",
"Liabilities, Current": "20,350",
"Liabilities, Non-Current": "6,950",
"Other Assets": "0",
"Other Compr. Net Income": "-185",
"Other Expenses": "3,347",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,111",
"Property, Plant and Equipment, Net": "9,973",
"Research and Development": "67,401"
},
"output_variables": {
"Liabilities": "27,300",
"Assets": "347,095",
"Expenses": "85,553",
"Revenues": "4,111",
"Stockholders Equity": "319,795",
"Net Income": "-81,442",
"Comprehensive Net Income": "-81,534",
"BaseVar": "232,122",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "204,985",
"Assets, Non-Current": "1,722",
"General and Administrative Expense": "20,622",
"Goodwill": "30,772",
"Liabilities, Current": "24,491",
"Liabilities, Non-Current": "11,863",
"Other Assets": "0",
"Other Compr. Net Income": "4,272",
"Other Expenses": "1,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "3,586",
"Property, Plant and Equipment, Net": "10,535",
"Research and Development": "104,381"
},
"output_variables": {
"Liabilities": "36,354",
"Assets": "248,014",
"Expenses": "126,016",
"Revenues": "3,586",
"Stockholders Equity": "211,660",
"Net Income": "-122,430",
"Comprehensive Net Income": "-120,294",
"BaseVar": "209,121",
"ECR before LimitedLiability": "119%",
"Economic Capital Ratio": "181%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "294,936",
"Assets, Non-Current": "1,428",
"General and Administrative Expense": "33,837",
"Goodwill": "29,759",
"Liabilities, Current": "30,240",
"Liabilities, Non-Current": "17,239",
"Other Assets": "0",
"Other Compr. Net Income": "2,061",
"Other Expenses": "1,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "5,480",
"Property, Plant and Equipment, Net": "11,461",
"Research and Development": "100,171"
},
"output_variables": {
"Liabilities": "47,479",
"Assets": "337,584",
"Expenses": "135,021",
"Revenues": "5,480",
"Stockholders Equity": "290,105",
"Net Income": "-129,541",
"Comprehensive Net Income": "-128,510",
"BaseVar": "263,812",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "195%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "195,569",
"Assets, Non-Current": "2,134",
"General and Administrative Expense": "35,979",
"Goodwill": "172,463",
"Liabilities, Current": "35,223",
"Liabilities, Non-Current": "82,704",
"Other Assets": "0",
"Other Compr. Net Income": "4,620",
"Other Expenses": "997",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "6,786",
"Property, Plant and Equipment, Net": "13,192",
"Research and Development": "102,726"
},
"output_variables": {
"Liabilities": "117,927",
"Assets": "383,358",
"Expenses": "139,702",
"Revenues": "6,786",
"Stockholders Equity": "265,431",
"Net Income": "-132,916",
"Comprehensive Net Income": "-130,606",
"BaseVar": "326,196",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "163%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "144,756",
"Assets, Non-Current": "1,929",
"General and Administrative Expense": "25,003",
"Goodwill": "158,567",
"Liabilities, Current": "27,736",
"Liabilities, Non-Current": "51,519",
"Other Assets": "0",
"Other Compr. Net Income": "23",
"Other Expenses": "-11,186",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "16,957",
"Property, Plant and Equipment, Net": "10,372",
"Research and Development": "96,171"
},
"output_variables": {
"Liabilities": "79,255",
"Assets": "315,624",
"Expenses": "109,988",
"Revenues": "16,957",
"Stockholders Equity": "236,369",
"Net Income": "-93,031",
"Comprehensive Net Income": "-93,020",
"BaseVar": "260,924",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "179%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "99,079",
"Assets, Non-Current": "1,929",
"General and Administrative Expense": "19,269",
"Goodwill": "48,690",
"Liabilities, Current": "12,602",
"Liabilities, Non-Current": "19,147",
"Other Assets": "0",
"Other Compr. Net Income": "19",
"Other Expenses": "79,491",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "14,025",
"Property, Plant and Equipment, Net": "6,111",
"Research and Development": "66,449"
},
"output_variables": {
"Liabilities": "31,749",
"Assets": "155,809",
"Expenses": "165,209",
"Revenues": "14,025",
"Stockholders Equity": "124,060",
"Net Income": "-151,184",
"Comprehensive Net Income": "-151,174",
"BaseVar": "183,406",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "66,698",
"Assets, Non-Current": "3,514",
"General and Administrative Expense": "15,426",
"Goodwill": "48,690",
"Liabilities, Current": "11,643",
"Liabilities, Non-Current": "17,264",
"Other Assets": "0",
"Other Compr. Net Income": "36",
"Other Expenses": "506",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "7,726",
"Property, Plant and Equipment, Net": "4,031",
"Research and Development": "42,672"
},
"output_variables": {
"Liabilities": "28,907",
"Assets": "122,933",
"Expenses": "58,604",
"Revenues": "7,726",
"Stockholders Equity": "94,026",
"Net Income": "-50,878",
"Comprehensive Net Income": "-50,860",
"BaseVar": "109,103",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "197,843",
"Assets, Non-Current": "3,490",
"General and Administrative Expense": "14,456",
"Goodwill": "30,690",
"Liabilities, Current": "14,206",
"Liabilities, Non-Current": "12,275",
"Other Assets": "0",
"Other Compr. Net Income": "-59,810",
"Other Expenses": "12,615",
"Other Liabilities": "0",
"Other Net Income": "-30",
"Other Revenues": "9,825",
"Property, Plant and Equipment, Net": "3,815",
"Research and Development": "42,534"
},
"output_variables": {
"Liabilities": "26,481",
"Assets": "235,838",
"Expenses": "69,605",
"Revenues": "9,825",
"Stockholders Equity": "209,357",
"Net Income": "-59,810",
"Comprehensive Net Income": "-89,715",
"BaseVar": "200,794",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "202%"
}
}
},
"top_rated": false,
"trend": 4.0,
"value": 2.015127196599359,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000744218.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000744218.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000744218.svg"
},
{
"company_id": "0001731348",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001731348.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001731348.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001731348.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001731348_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001731348_main_keyfigs.svg",
"name": "Tilray Brands Inc",
"rank": 16,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001731348.svg",
"report_text": "The relative strengths and weaknesses of Tilray Brands Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Tilray Brands Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Tilray Brands Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 12% points.
The company's Economic Capital Ratio, given in the ranking table, is 201%, being 55% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001731348_2021_Tilray_Brands_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "12.2",
"Liabilities": "-68.6",
"Stockholders Equity": "-7.05",
"ECR before LimitedLiability": "-4.71",
"Other Liabilities": "-124",
"Liabilities, Current": "22.2",
"Assets": "34.9",
"Other Assets": "3.20",
"Assets, Current": "39.7",
"Goodwill": "-10.2",
"Assets, Non-Current": "-7.84",
"Other Expenses": "6.64",
"Expenses": "34.3",
"Revenues": "-25.1",
"Net Income": "14.5",
"Research and Development": "9.20",
"General and Administrative Expense": "29.2",
"Other Revenues": "-25.1",
"Comprehensive Net Income": "14.7",
"Other Net Income": "-2.27",
"Economic Capital Ratio": "-25.2"
},
"2019": {
"Liabilities, Non-Current": "13.4",
"Liabilities": "-54.2",
"Stockholders Equity": "-11.7",
"ECR before LimitedLiability": "10.8",
"Other Liabilities": "-93.3",
"Liabilities, Current": "15.4",
"Assets, Non-Current": "-8.91",
"Assets": "32.6",
"Goodwill": "33.4",
"Property, Plant and Equipment, Net": "7.73",
"Other Assets": "5.38",
"Assets, Current": "-12.6",
"Research and Development": "8.02",
"Expenses": "32.7",
"Revenues": "-18.0",
"Net Income": "18.3",
"Other Expenses": "-4.72",
"General and Administrative Expense": "32.6",
"Other Revenues": "-18.0",
"Comprehensive Net Income": "18.7",
"Economic Capital Ratio": "-18.7"
},
"2020": {
"Liabilities, Current": "15.9",
"Liabilities": "10.0",
"Stockholders Equity": "52.5",
"ECR before LimitedLiability": "92.7",
"Liabilities, Non-Current": "-11.5",
"Other Liabilities": "4.58",
"Goodwill": "26.6",
"Assets": "26.3",
"Assets, Current": "-2.80",
"Assets, Non-Current": "12.2",
"Property, Plant and Equipment, Net": "-7.75",
"Other Expenses": "1.46",
"Expenses": "15.7",
"Revenues": "-5.52",
"Net Income": "13.6",
"Research and Development": "5.61",
"General and Administrative Expense": "8.58",
"Other Revenues": "-5.52",
"Comprehensive Net Income": "13.5",
"Other Net Income": "3.46",
"Economic Capital Ratio": "54.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001731348_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "554,302",
"Assets, Non-Current": "0",
"General and Administrative Expense": "75,528",
"Goodwill": "4,486",
"Liabilities, Current": "25,937",
"Liabilities, Non-Current": "0",
"Other Assets": "17,665",
"Other Compr. Net Income": "-103",
"Other Expenses": "16,537",
"Other Liabilities": "433,077",
"Other Net Income": "-14,524",
"Other Revenues": "43,130",
"Property, Plant and Equipment, Net": "80,214",
"Research and Development": "4,264"
},
"output_variables": {
"Liabilities": "459,014",
"Assets": "656,667",
"Expenses": "96,329",
"Revenues": "43,130",
"Stockholders Equity": "197,653",
"Net Income": "-67,723",
"Comprehensive Net Income": "-67,774",
"BaseVar": "634,884",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "119%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "259,027",
"Assets, Non-Current": "28,962",
"General and Administrative Expense": "143,052",
"Goodwill": "392,079",
"Liabilities, Current": "92,427",
"Liabilities, Non-Current": "15,341",
"Other Assets": "32,045",
"Other Compr. Net Income": "5,153",
"Other Expenses": "115,642",
"Other Liabilities": "503,291",
"Other Net Income": "-32,421",
"Other Revenues": "166,979",
"Property, Plant and Equipment, Net": "184,217",
"Research and Development": "6,558"
},
"output_variables": {
"Liabilities": "611,059",
"Assets": "896,330",
"Expenses": "265,252",
"Revenues": "166,979",
"Stockholders Equity": "285,271",
"Net Income": "-130,694",
"Comprehensive Net Income": "-128,118",
"BaseVar": "988,597",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "117%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "581,627",
"Assets, Non-Current": "426,062",
"General and Administrative Expense": "422,037",
"Goodwill": "710,648",
"Liabilities, Current": "168,341",
"Liabilities, Non-Current": "290,433",
"Other Assets": "19,595",
"Other Compr. Net Income": "-8,041",
"Other Expenses": "77,030",
"Other Liabilities": "4,227",
"Other Net Income": "-5,176",
"Other Revenues": "405,326",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "1,916"
},
"output_variables": {
"Liabilities": "463,001",
"Assets": "1,737,932",
"Expenses": "500,983",
"Revenues": "405,326",
"Stockholders Equity": "1,274,931",
"Net Income": "-100,833",
"Comprehensive Net Income": "-104,854",
"BaseVar": "1,560,230",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "201%"
}
}
},
"top_rated": false,
"trend": 15.0,
"value": 2.0079787628677743,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001731348.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001731348.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001731348.svg"
},
{
"company_id": "0000811641",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000811641.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000811641.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000811641.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000811641_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000811641_main_keyfigs.svg",
"name": "Immucell CORP DE",
"rank": 17,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000811641.svg",
"report_text": "The relative strengths and weaknesses of Immucell CORP DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Immucell CORP DE compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 59% points.The greatest weakness of Immucell CORP DE is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 25% points.
The company's Economic Capital Ratio, given in the ranking table, is 197%, being 51% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000811641_2021_Immucell_CORP_DE.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "35.7",
"Liabilities": "30.0",
"Stockholders Equity": "78.7",
"ECR before LimitedLiability": "133",
"Liabilities, Non-Current": "11.4",
"Other Liabilities": "-21.1",
"Property, Plant and Equipment, Net": "7.45",
"Assets": "26.7",
"Assets, Non-Current": "-1.95",
"Other Assets": "6.85",
"Goodwill": "-4.32",
"Assets, Current": "15.6",
"General and Administrative Expense": "30.8",
"Expenses": "23.8",
"Revenues": "5.42",
"Net Income": "23.1",
"Research and Development": "-6.31",
"Other Revenues": "5.42",
"Comprehensive Net Income": "23.1",
"Other Net Income": "-6.15",
"Economic Capital Ratio": "70.7"
},
"2012": {
"Liabilities, Current": "26.9",
"Liabilities": "30.9",
"Stockholders Equity": "75.1",
"ECR before LimitedLiability": "107",
"Liabilities, Non-Current": "12.2",
"Other Liabilities": "-7.99",
"Assets, Current": "15.0",
"Assets": "21.8",
"Other Assets": "5.55",
"Assets, Non-Current": "-1.68",
"Property, Plant and Equipment, Net": "5.68",
"Goodwill": "-4.29",
"Other Expenses": "-3.33",
"Expenses": "25.9",
"Revenues": "6.62",
"Net Income": "31.9",
"Research and Development": "3.13",
"General and Administrative Expense": "26.1",
"Other Revenues": "6.62",
"Comprehensive Net Income": "31.9",
"Economic Capital Ratio": "74.4"
},
"2013": {
"Liabilities, Current": "36.6",
"Liabilities": "47.1",
"Stockholders Equity": "80.5",
"ECR before LimitedLiability": "126",
"Other Liabilities": "-6.91",
"Liabilities, Non-Current": "19.7",
"Goodwill": "-4.23",
"Assets": "16.4",
"Assets, Non-Current": "-1.64",
"Property, Plant and Equipment, Net": "6.13",
"Other Assets": "3.48",
"Assets, Current": "12.4",
"General and Administrative Expense": "25.6",
"Expenses": "20.4",
"Revenues": "17.0",
"Net Income": "34.3",
"Other Expenses": "-4.65",
"Other Revenues": "17.0",
"Other Net Income": "-2.68",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "85.4"
},
"2014": {
"Liabilities, Non-Current": "6.58",
"Liabilities": "67.0",
"Stockholders Equity": "92.2",
"ECR before LimitedLiability": "147",
"Liabilities, Current": "50.9",
"Other Liabilities": "16.2",
"Assets, Current": "1.73",
"Assets": "14.8",
"Goodwill": "-5.84",
"Other Assets": "8.55",
"Assets, Non-Current": "-1.91",
"Property, Plant and Equipment, Net": "13.8",
"Other Expenses": "-10.9",
"Expenses": "14.3",
"Revenues": "26.4",
"Net Income": "41.8",
"Research and Development": "-7.90",
"General and Administrative Expense": "32.2",
"Other Revenues": "26.4",
"Comprehensive Net Income": "41.9",
"Economic Capital Ratio": "97.7"
},
"2015": {
"Other Liabilities": "19.8",
"Liabilities": "46.8",
"Stockholders Equity": "60.7",
"ECR before LimitedLiability": "124",
"Liabilities, Current": "48.9",
"Liabilities, Non-Current": "-27.0",
"Assets, Current": "4.49",
"Assets": "11.1",
"Goodwill": "-6.99",
"Assets, Non-Current": "-1.71",
"Property, Plant and Equipment, Net": "18.9",
"Research and Development": "1.79",
"Expenses": "16.9",
"Revenues": "29.9",
"Net Income": "48.4",
"General and Administrative Expense": "21.6",
"Other Expenses": "-6.51",
"Other Revenues": "29.9",
"Comprehensive Net Income": "48.7",
"Other Net Income": "0.915",
"Economic Capital Ratio": "78.3"
},
"2016": {
"Liabilities, Non-Current": "-9.49",
"Liabilities": "31.1",
"Stockholders Equity": "72.8",
"ECR before LimitedLiability": "98.4",
"Liabilities, Current": "30.8",
"Other Liabilities": "9.12",
"Property, Plant and Equipment, Net": "17.4",
"Assets": "22.6",
"Assets, Non-Current": "-1.48",
"Assets, Current": "10.3",
"Goodwill": "-4.38",
"Research and Development": "6.30",
"Expenses": "24.2",
"Revenues": "6.02",
"Net Income": "28.5",
"General and Administrative Expense": "15.9",
"Other Expenses": "2.15",
"Other Revenues": "6.02",
"Comprehensive Net Income": "28.8",
"Other Net Income": "-1.61",
"Economic Capital Ratio": "78.4"
},
"2017": {
"Other Liabilities": "9.79",
"Liabilities": "7.22",
"Stockholders Equity": "55.6",
"ECR before LimitedLiability": "64.9",
"Liabilities, Current": "28.4",
"Liabilities, Non-Current": "-38.9",
"Assets, Non-Current": "-2.32",
"Assets": "31.4",
"Other Assets": "0.900",
"Assets, Current": "-7.63",
"Goodwill": "-6.60",
"Property, Plant and Equipment, Net": "82.2",
"Research and Development": "4.37",
"Expenses": "24.0",
"Revenues": "-0.236",
"Net Income": "20.4",
"Other Expenses": "0.864",
"General and Administrative Expense": "18.6",
"Other Revenues": "-0.236",
"Comprehensive Net Income": "20.2",
"Other Net Income": "-3.27",
"Economic Capital Ratio": "43.3"
},
"2018": {
"Liabilities, Non-Current": "-39.5",
"Liabilities": "-0.508",
"Stockholders Equity": "41.6",
"ECR before LimitedLiability": "62.0",
"Other Liabilities": "9.84",
"Liabilities, Current": "22.6",
"Property, Plant and Equipment, Net": "101",
"Assets": "28.3",
"Assets, Current": "-12.7",
"Goodwill": "-6.74",
"Assets, Non-Current": "-5.12",
"Other Expenses": "9.14",
"Expenses": "20.9",
"Revenues": "-1.56",
"Net Income": "19.2",
"Research and Development": "-0.554",
"General and Administrative Expense": "12.0",
"Other Revenues": "-1.56",
"Comprehensive Net Income": "19.5",
"Other Compr. Net Income": "0.238",
"Economic Capital Ratio": "41.5"
},
"2019": {
"Liabilities, Non-Current": "-23.5",
"Liabilities": "17.8",
"Stockholders Equity": "57.9",
"ECR before LimitedLiability": "101",
"Other Liabilities": "12.9",
"Liabilities, Current": "24.6",
"Assets, Non-Current": "-5.53",
"Assets": "24.3",
"Goodwill": "-5.90",
"Property, Plant and Equipment, Net": "56.3",
"Assets, Current": "-1.28",
"Research and Development": "-2.11",
"Expenses": "21.0",
"Revenues": "2.33",
"Net Income": "26.6",
"Other Expenses": "6.97",
"General and Administrative Expense": "16.1",
"Other Revenues": "2.33",
"Other Net Income": "3.23",
"Comprehensive Net Income": "26.6",
"Economic Capital Ratio": "71.1"
},
"2020": {
"Liabilities, Current": "28.8",
"Liabilities": "13.8",
"Stockholders Equity": "36.2",
"ECR before LimitedLiability": "89.2",
"Liabilities, Non-Current": "-25.0",
"Other Liabilities": "5.75",
"Goodwill": "-6.94",
"Assets": "14.3",
"Assets, Current": "-8.50",
"Assets, Non-Current": "-4.06",
"Property, Plant and Equipment, Net": "59.0",
"Other Expenses": "6.97",
"Expenses": "10.2",
"Revenues": "4.55",
"Net Income": "20.1",
"Research and Development": "-4.40",
"General and Administrative Expense": "7.58",
"Other Revenues": "4.55",
"Comprehensive Net Income": "20.2",
"Other Net Income": "5.19",
"Economic Capital Ratio": "51.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000811641_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "7,151",
"Assets, Non-Current": "19",
"General and Administrative Expense": "1,726",
"Goodwill": "0",
"Liabilities, Current": "635",
"Liabilities, Non-Current": "0",
"Other Assets": "1,306",
"Other Compr. Net Income": "0",
"Other Expenses": "2,010",
"Other Liabilities": "1,336",
"Other Net Income": "-64",
"Other Revenues": "5,111",
"Property, Plant and Equipment, Net": "2,515",
"Research and Development": "1,720"
},
"output_variables": {
"Liabilities": "1,971",
"Assets": "10,991",
"Expenses": "5,457",
"Revenues": "5,111",
"Stockholders Equity": "9,020",
"Net Income": "-410",
"Comprehensive Net Income": "-410",
"BaseVar": "11,797",
"ECR before LimitedLiability": "184%",
"Economic Capital Ratio": "224%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,363",
"Assets, Non-Current": "64",
"General and Administrative Expense": "1,892",
"Goodwill": "0",
"Liabilities, Current": "666",
"Liabilities, Non-Current": "0",
"Other Assets": "1,246",
"Other Compr. Net Income": "0",
"Other Expenses": "2,491",
"Other Liabilities": "1,170",
"Other Net Income": "0",
"Other Revenues": "5,390",
"Property, Plant and Equipment, Net": "2,358",
"Research and Development": "918"
},
"output_variables": {
"Liabilities": "1,836",
"Assets": "11,030",
"Expenses": "5,300",
"Revenues": "5,390",
"Stockholders Equity": "9,195",
"Net Income": "90",
"Comprehensive Net Income": "90",
"BaseVar": "11,778",
"ECR before LimitedLiability": "197%",
"Economic Capital Ratio": "233%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "7,268",
"Assets, Non-Current": "14",
"General and Administrative Expense": "1,926",
"Goodwill": "0",
"Liabilities, Current": "636",
"Liabilities, Non-Current": "0",
"Other Assets": "1,155",
"Other Compr. Net Income": "0",
"Other Expenses": "2,810",
"Other Liabilities": "929",
"Other Net Income": "0",
"Other Revenues": "6,007",
"Property, Plant and Equipment, Net": "2,525",
"Research and Development": "1,154"
},
"output_variables": {
"Liabilities": "1,565",
"Assets": "10,961",
"Expenses": "5,890",
"Revenues": "6,007",
"Stockholders Equity": "9,396",
"Net Income": "117",
"Comprehensive Net Income": "117",
"BaseVar": "12,211",
"ECR before LimitedLiability": "207%",
"Economic Capital Ratio": "240%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "5,469",
"Assets, Non-Current": "19",
"General and Administrative Expense": "2,476",
"Goodwill": "0",
"Liabilities, Current": "1,009",
"Liabilities, Non-Current": "785",
"Other Assets": "1,726",
"Other Compr. Net Income": "-3.5",
"Other Expenses": "3,109",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "7,597",
"Property, Plant and Equipment, Net": "3,838",
"Research and Development": "2,179"
},
"output_variables": {
"Liabilities": "1,793",
"Assets": "11,052",
"Expenses": "7,764",
"Revenues": "7,597",
"Stockholders Equity": "9,258",
"Net Income": "-167",
"Comprehensive Net Income": "-169",
"BaseVar": "14,105",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "231%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "7,873",
"Assets, Non-Current": "50",
"General and Administrative Expense": "2,893",
"Goodwill": "0",
"Liabilities, Current": "818",
"Liabilities, Non-Current": "3,169",
"Other Assets": "959",
"Other Compr. Net Income": "-27",
"Other Expenses": "4,887",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,229",
"Property, Plant and Equipment, Net": "5,719",
"Research and Development": "1,235"
},
"output_variables": {
"Liabilities": "3,987",
"Assets": "14,601",
"Expenses": "9,015",
"Revenues": "10,229",
"Stockholders Equity": "10,614",
"Net Income": "1,213",
"Comprehensive Net Income": "1,200",
"BaseVar": "18,929",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "214%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "14,348",
"Assets, Non-Current": "34",
"General and Administrative Expense": "3,286",
"Goodwill": "267",
"Liabilities, Current": "2,059",
"Liabilities, Non-Current": "2,916",
"Other Assets": "201",
"Other Compr. Net Income": "26",
"Other Expenses": "4,505",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "9,544",
"Property, Plant and Equipment, Net": "9,846",
"Research and Development": "1,244"
},
"output_variables": {
"Liabilities": "4,975",
"Assets": "24,697",
"Expenses": "9,036",
"Revenues": "9,544",
"Stockholders Equity": "19,722",
"Net Income": "508",
"Comprehensive Net Income": "522",
"BaseVar": "24,139",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "225%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "7,507",
"Assets, Non-Current": "0.92",
"General and Administrative Expense": "3,418",
"Goodwill": "248",
"Liabilities, Current": "2,064",
"Liabilities, Non-Current": "8,640",
"Other Assets": "473",
"Other Compr. Net Income": "23",
"Other Expenses": "5,135",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,431",
"Property, Plant and Equipment, Net": "26,070",
"Research and Development": "2,047"
},
"output_variables": {
"Liabilities": "10,704",
"Assets": "34,299",
"Expenses": "10,599",
"Revenues": "10,431",
"Stockholders Equity": "23,595",
"Net Income": "-168",
"Comprehensive Net Income": "-157",
"BaseVar": "33,028",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "197%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,421",
"Assets, Non-Current": "13",
"General and Administrative Expense": "9,616",
"Goodwill": "229",
"Liabilities, Current": "2,565",
"Liabilities, Non-Current": "8,421",
"Other Assets": "40",
"Other Compr. Net Income": "31",
"Other Expenses": "175",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,986",
"Property, Plant and Equipment, Net": "26,028",
"Research and Development": "3,517"
},
"output_variables": {
"Liabilities": "10,986",
"Assets": "32,731",
"Expenses": "13,308",
"Revenues": "10,986",
"Stockholders Equity": "21,744",
"Net Income": "-2,322",
"Comprehensive Net Income": "-2,306",
"BaseVar": "34,021",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "185%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "13,189",
"Assets, Non-Current": "27",
"General and Administrative Expense": "10,989",
"Goodwill": "210",
"Liabilities, Current": "2,495",
"Liabilities, Non-Current": "7,205",
"Other Assets": "0",
"Other Compr. Net Income": "-74",
"Other Expenses": "342",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "13,723",
"Property, Plant and Equipment, Net": "25,266",
"Research and Development": "3,688"
},
"output_variables": {
"Liabilities": "9,701",
"Assets": "38,692",
"Expenses": "15,018",
"Revenues": "13,723",
"Stockholders Equity": "28,991",
"Net Income": "-1,296",
"Comprehensive Net Income": "-1,333",
"BaseVar": "38,604",
"ECR before LimitedLiability": "159%",
"Economic Capital Ratio": "207%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "12,157",
"Assets, Non-Current": "1,247",
"General and Administrative Expense": "12,368",
"Goodwill": "191",
"Liabilities, Current": "2,211",
"Liabilities, Non-Current": "9,872",
"Other Assets": "0",
"Other Compr. Net Income": "44",
"Other Expenses": "-10",
"Other Liabilities": "0",
"Other Net Income": "348",
"Other Revenues": "15,342",
"Property, Plant and Equipment, Net": "26,755",
"Research and Development": "4,355"
},
"output_variables": {
"Liabilities": "12,083",
"Assets": "40,350",
"Expenses": "16,712",
"Revenues": "15,342",
"Stockholders Equity": "28,266",
"Net Income": "-1,022",
"Comprehensive Net Income": "-1,000",
"BaseVar": "42,440",
"ECR before LimitedLiability": "144%",
"Economic Capital Ratio": "197%"
}
}
},
"top_rated": false,
"trend": -8.0,
"value": 1.9731345211013074,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000811641.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000811641.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000811641.svg"
},
{
"company_id": "0000794172",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000794172.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000794172.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000794172.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000794172_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000794172_main_keyfigs.svg",
"name": "Meridian Bioscience INC",
"rank": 18,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000794172.svg",
"report_text": "The relative strengths and weaknesses of Meridian Bioscience INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Meridian Bioscience INC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 39% points.The greatest weakness of Meridian Bioscience INC is the variable Other Assets, reducing the Economic Capital Ratio by 23% points.
The company's Economic Capital Ratio, given in the ranking table, is 193%, being 47% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000794172_2021_Meridian_Bioscience_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "1.55",
"Liabilities": "21.8",
"Stockholders Equity": "51.4",
"ECR before LimitedLiability": "62.8",
"Liabilities, Current": "18.5",
"Other Liabilities": "2.31",
"Property, Plant and Equipment, Net": "-0.449",
"Assets": "2.99",
"Other Assets": "-1.08",
"Assets, Current": "3.82",
"Assets, Non-Current": "0.609",
"Goodwill": "0.588",
"General and Administrative Expense": "29.9",
"Expenses": "20.1",
"Revenues": "-1.56",
"Net Income": "18.9",
"Other Expenses": "-6.87",
"Research and Development": "-3.78",
"Other Revenues": "-1.56",
"Comprehensive Net Income": "19.0",
"Economic Capital Ratio": "62.0"
},
"2010": {
"Other Liabilities": "6.11",
"Liabilities": "74.1",
"Stockholders Equity": "61.8",
"ECR before LimitedLiability": "99.5",
"Liabilities, Current": "29.2",
"Liabilities, Non-Current": "50.9",
"Goodwill": "0.732",
"Assets": "0.843",
"Assets, Current": "1.06",
"Assets, Non-Current": "1.69",
"Other Assets": "-1.80",
"Other Expenses": "-35.7",
"Expenses": "-1.55",
"Revenues": "29.3",
"Net Income": "31.7",
"General and Administrative Expense": "28.8",
"Research and Development": "2.56",
"Other Revenues": "29.3",
"Other Net Income": "4.05",
"Comprehensive Net Income": "31.8",
"Economic Capital Ratio": "101"
},
"2011": {
"Liabilities, Current": "58.6",
"Liabilities": "85.5",
"Stockholders Equity": "78.4",
"ECR before LimitedLiability": "185",
"Liabilities, Non-Current": "21.8",
"Other Liabilities": "22.8",
"Property, Plant and Equipment, Net": "0.429",
"Assets": "1.64",
"Assets, Non-Current": "2.86",
"Other Assets": "-2.25",
"Goodwill": "1.26",
"General and Administrative Expense": "39.3",
"Expenses": "17.5",
"Revenues": "58.2",
"Net Income": "65.8",
"Research and Development": "10.9",
"Other Expenses": "-36.3",
"Other Revenues": "58.2",
"Comprehensive Net Income": "65.8",
"Other Net Income": "-9.05",
"Economic Capital Ratio": "123"
},
"2012": {
"Liabilities, Current": "39.8",
"Liabilities": "79.5",
"Stockholders Equity": "64.2",
"ECR before LimitedLiability": "149",
"Liabilities, Non-Current": "22.2",
"Other Liabilities": "35.6",
"Assets": "0.880",
"Other Assets": "-2.35",
"Assets, Non-Current": "2.77",
"Property, Plant and Equipment, Net": "0.258",
"Goodwill": "0.840",
"Other Expenses": "-31.6",
"Expenses": "19.1",
"Revenues": "58.3",
"Net Income": "74.7",
"Research and Development": "12.8",
"General and Administrative Expense": "35.1",
"Other Revenues": "58.3",
"Other Net Income": "-0.427",
"Comprehensive Net Income": "74.8",
"Economic Capital Ratio": "116"
},
"2013": {
"Liabilities, Current": "46.1",
"Liabilities": "84.8",
"Stockholders Equity": "66.0",
"ECR before LimitedLiability": "159",
"Other Liabilities": "27.4",
"Liabilities, Non-Current": "31.5",
"Goodwill": "0.317",
"Assets": "0.688",
"Assets, Non-Current": "2.49",
"Other Assets": "-2.60",
"Assets, Current": "1.11",
"General and Administrative Expense": "30.8",
"Expenses": "15.5",
"Revenues": "64.2",
"Net Income": "74.3",
"Research and Development": "9.97",
"Other Expenses": "-27.5",
"Other Revenues": "64.2",
"Other Net Income": "-4.07",
"Comprehensive Net Income": "74.4",
"Economic Capital Ratio": "119"
},
"2014": {
"Liabilities, Non-Current": "34.4",
"Liabilities": "114",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "198",
"Liabilities, Current": "82.2",
"Other Liabilities": "26.3",
"Assets, Current": "0.686",
"Assets": "0.853",
"Other Assets": "0.236",
"Assets, Non-Current": "-0.327",
"Property, Plant and Equipment, Net": "0.187",
"Other Expenses": "-42.2",
"Expenses": "15.8",
"Revenues": "68.9",
"Net Income": "84.0",
"Research and Development": "12.0",
"General and Administrative Expense": "41.5",
"Other Revenues": "68.9",
"Other Net Income": "2.00",
"Comprehensive Net Income": "84.0",
"Economic Capital Ratio": "149"
},
"2015": {
"Other Liabilities": "35.8",
"Liabilities": "117",
"Assets": "0.339",
"Stockholders Equity": "94.1",
"ECR before LimitedLiability": "189",
"Liabilities, Current": "76.2",
"Liabilities, Non-Current": "39.1",
"Assets, Current": "1.40",
"Other Assets": "-0.503",
"Assets, Non-Current": "-0.368",
"Research and Development": "7.18",
"Expenses": "7.41",
"Revenues": "74.9",
"Net Income": "81.7",
"General and Administrative Expense": "25.7",
"Other Expenses": "-27.4",
"Other Revenues": "74.9",
"Comprehensive Net Income": "81.3",
"Other Net Income": "0.696",
"Other Compr. Net Income": "-0.515",
"Economic Capital Ratio": "143"
},
"2016": {
"Liabilities, Non-Current": "-31.2",
"Liabilities": "27.2",
"Stockholders Equity": "26.4",
"ECR before LimitedLiability": "77.0",
"Liabilities, Current": "40.9",
"Other Liabilities": "10.6",
"Property, Plant and Equipment, Net": "-3.23",
"Assets": "3.22",
"Assets, Non-Current": "-2.53",
"Assets, Current": "-3.95",
"Goodwill": "15.2",
"Research and Development": "9.54",
"Expenses": "18.2",
"Revenues": "30.4",
"Net Income": "47.4",
"General and Administrative Expense": "15.1",
"Other Expenses": "-6.51",
"Other Revenues": "30.4",
"Comprehensive Net Income": "47.0",
"Other Net Income": "-2.29",
"Economic Capital Ratio": "57.0"
},
"2017": {
"Other Liabilities": "14.5",
"Liabilities": "36.7",
"Stockholders Equity": "30.6",
"ECR before LimitedLiability": "72.6",
"Liabilities, Current": "40.6",
"Liabilities, Non-Current": "-22.0",
"Assets, Non-Current": "-2.98",
"Assets": "1.69",
"Assets, Current": "1.40",
"Goodwill": "10.4",
"Property, Plant and Equipment, Net": "-6.11",
"Research and Development": "8.96",
"Expenses": "9.22",
"Revenues": "35.4",
"Net Income": "39.7",
"Other Expenses": "-15.9",
"General and Administrative Expense": "16.1",
"Other Revenues": "35.4",
"Comprehensive Net Income": "39.9",
"Other Net Income": "-5.19",
"Economic Capital Ratio": "51.0"
},
"2018": {
"Liabilities, Non-Current": "-21.2",
"Liabilities": "32.3",
"Stockholders Equity": "23.3",
"ECR before LimitedLiability": "85.5",
"Other Liabilities": "14.8",
"Liabilities, Current": "35.4",
"Property, Plant and Equipment, Net": "-3.98",
"Assets": "0.240",
"Other Assets": "-14.5",
"Goodwill": "10.5",
"Assets, Non-Current": "15.5",
"Other Expenses": "5.70",
"Expenses": "10.5",
"Revenues": "36.6",
"Net Income": "47.3",
"Research and Development": "7.63",
"General and Administrative Expense": "-2.79",
"Other Revenues": "36.6",
"Comprehensive Net Income": "47.5",
"Other Net Income": "-0.526",
"Economic Capital Ratio": "65.0"
},
"2019": {
"Liabilities, Non-Current": "-51.5",
"Liabilities": "3.42",
"Stockholders Equity": "15.3",
"ECR before LimitedLiability": "77.7",
"Other Liabilities": "13.9",
"Liabilities, Current": "30.0",
"Assets, Non-Current": "32.5",
"Assets": "7.52",
"Goodwill": "30.2",
"Property, Plant and Equipment, Net": "-5.18",
"Other Assets": "-24.0",
"Research and Development": "4.00",
"Expenses": "21.3",
"Revenues": "18.2",
"Net Income": "45.0",
"Other Expenses": "5.31",
"General and Administrative Expense": "11.6",
"Other Revenues": "18.2",
"Other Net Income": "3.43",
"Comprehensive Net Income": "44.8",
"Economic Capital Ratio": "48.2"
},
"2020": {
"Liabilities, Current": "19.5",
"Liabilities": "10.2",
"Stockholders Equity": "9.38",
"ECR before LimitedLiability": "85.0",
"Liabilities, Non-Current": "-19.8",
"Other Liabilities": "8.15",
"Other Expenses": "4.69",
"Expenses": "10.8",
"Net Income": "37.7",
"Research and Development": "1.82",
"General and Administrative Expense": "4.20",
"Other Revenues": "21.5",
"Revenues": "21.5",
"Goodwill": "30.5",
"Other Assets": "-23.4",
"Assets, Current": "-7.98",
"Assets, Non-Current": "39.1",
"Property, Plant and Equipment, Net": "-6.57",
"Comprehensive Net Income": "38.2",
"Other Net Income": "4.40",
"Economic Capital Ratio": "47.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000794172_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "117,147",
"Assets, Non-Current": "18,376",
"General and Administrative Expense": "35,576",
"Goodwill": "17,183",
"Liabilities, Current": "16,752",
"Liabilities, Non-Current": "0",
"Other Assets": "-17,183",
"Other Compr. Net Income": "0",
"Other Expenses": "72,055",
"Other Liabilities": "0",
"Other Net Income": "544",
"Other Revenues": "148,274",
"Property, Plant and Equipment, Net": "20,474",
"Research and Development": "8,428"
},
"output_variables": {
"Liabilities": "16,752",
"Assets": "155,997",
"Expenses": "116,059",
"Revenues": "148,274",
"Stockholders Equity": "139,245",
"Net Income": "32,759",
"Comprehensive Net Income": "32,759",
"BaseVar": "218,813",
"ECR before LimitedLiability": "259%",
"Economic Capital Ratio": "278%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "94,020",
"Assets, Non-Current": "38,048",
"General and Administrative Expense": "37,527",
"Goodwill": "36,809",
"Liabilities, Current": "14,147",
"Liabilities, Non-Current": "0",
"Other Assets": "-36,809",
"Other Compr. Net Income": "0",
"Other Expenses": "70,518",
"Other Liabilities": "0",
"Other Net Income": "262",
"Other Revenues": "143,000",
"Property, Plant and Equipment, Net": "22,717",
"Research and Development": "8,570"
},
"output_variables": {
"Liabilities": "14,147",
"Assets": "154,785",
"Expenses": "116,615",
"Revenues": "143,000",
"Stockholders Equity": "140,638",
"Net Income": "26,647",
"Comprehensive Net Income": "26,647",
"BaseVar": "214,404",
"ECR before LimitedLiability": "260%",
"Economic Capital Ratio": "279%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "90,354",
"Assets, Non-Current": "38,600",
"General and Administrative Expense": "47,655",
"Goodwill": "34,071",
"Liabilities, Current": "15,264",
"Liabilities, Non-Current": "0",
"Other Assets": "-34,071",
"Other Compr. Net Income": "0",
"Other Expenses": "75,882",
"Other Liabilities": "0",
"Other Net Income": "467",
"Other Revenues": "159,723",
"Property, Plant and Equipment, Net": "26,539",
"Research and Development": "9,822"
},
"output_variables": {
"Liabilities": "15,264",
"Assets": "155,493",
"Expenses": "133,359",
"Revenues": "159,723",
"Stockholders Equity": "140,229",
"Net Income": "26,831",
"Comprehensive Net Income": "26,831",
"BaseVar": "232,153",
"ECR before LimitedLiability": "256%",
"Economic Capital Ratio": "276%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "96,590",
"Assets, Non-Current": "38,636",
"General and Administrative Expense": "49,294",
"Goodwill": "33,410",
"Liabilities, Current": "18,462",
"Liabilities, Non-Current": "0",
"Other Assets": "-33,410",
"Other Compr. Net Income": "0",
"Other Expenses": "81,022",
"Other Liabilities": "0",
"Other Net Income": "420",
"Other Revenues": "173,542",
"Property, Plant and Equipment, Net": "26,155",
"Research and Development": "10,275"
},
"output_variables": {
"Liabilities": "18,462",
"Assets": "161,381",
"Expenses": "140,591",
"Revenues": "173,542",
"Stockholders Equity": "142,919",
"Net Income": "33,371",
"Comprehensive Net Income": "33,371",
"BaseVar": "247,198",
"ECR before LimitedLiability": "255%",
"Economic Capital Ratio": "275%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "114,088",
"Assets, Non-Current": "36,569",
"General and Administrative Expense": "52,943",
"Goodwill": "31,172",
"Liabilities, Current": "21,703",
"Liabilities, Non-Current": "0",
"Other Assets": "-31,172",
"Other Compr. Net Income": "650",
"Other Expenses": "86,972",
"Other Liabilities": "0",
"Other Net Income": "48",
"Other Revenues": "188,686",
"Property, Plant and Equipment, Net": "26,091",
"Research and Development": "10,787"
},
"output_variables": {
"Liabilities": "21,703",
"Assets": "176,748",
"Expenses": "150,702",
"Revenues": "188,686",
"Stockholders Equity": "155,045",
"Net Income": "38,032",
"Comprehensive Net Income": "38,357",
"BaseVar": "269,268",
"ECR before LimitedLiability": "253%",
"Economic Capital Ratio": "273%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "112,748",
"Assets, Non-Current": "342",
"General and Administrative Expense": "52,299",
"Goodwill": "31,006",
"Liabilities, Current": "13,735",
"Liabilities, Non-Current": "2,165",
"Other Assets": "5,223",
"Other Compr. Net Income": "-436",
"Other Expenses": "88,954",
"Other Liabilities": "0",
"Other Net Income": "-284",
"Other Revenues": "188,832",
"Property, Plant and Equipment, Net": "27,610",
"Research and Development": "12,552"
},
"output_variables": {
"Liabilities": "15,900",
"Assets": "176,929",
"Expenses": "153,805",
"Revenues": "188,832",
"Stockholders Equity": "161,029",
"Net Income": "34,743",
"Comprehensive Net Income": "34,525",
"BaseVar": "268,093",
"ECR before LimitedLiability": "265%",
"Economic Capital Ratio": "282%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "122,853",
"Assets, Non-Current": "384",
"General and Administrative Expense": "53,217",
"Goodwill": "28,280",
"Liabilities, Current": "15,251",
"Liabilities, Non-Current": "2,158",
"Other Assets": "4,273",
"Other Compr. Net Income": "-2,639",
"Other Expenses": "92,471",
"Other Liabilities": "0",
"Other Net Income": "-997",
"Other Revenues": "194,830",
"Property, Plant and Equipment, Net": "27,492",
"Research and Development": "12,605"
},
"output_variables": {
"Liabilities": "17,409",
"Assets": "183,282",
"Expenses": "158,293",
"Revenues": "194,830",
"Stockholders Equity": "165,873",
"Net Income": "35,540",
"Comprehensive Net Income": "34,220",
"BaseVar": "278,725",
"ECR before LimitedLiability": "261%",
"Economic Capital Ratio": "279%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "126,791",
"Assets, Non-Current": "353",
"General and Administrative Expense": "60,436",
"Goodwill": "91,837",
"Liabilities, Current": "22,571",
"Liabilities, Non-Current": "62,780",
"Other Assets": "2,392",
"Other Compr. Net Income": "-3,186",
"Other Expenses": "88,868",
"Other Liabilities": "0",
"Other Net Income": "-734",
"Other Revenues": "196,082",
"Property, Plant and Equipment, Net": "30,450",
"Research and Development": "13,815"
},
"output_variables": {
"Liabilities": "85,351",
"Assets": "251,823",
"Expenses": "163,119",
"Revenues": "196,082",
"Stockholders Equity": "166,472",
"Net Income": "32,229",
"Comprehensive Net Income": "30,636",
"BaseVar": "350,148",
"ECR before LimitedLiability": "153%",
"Economic Capital Ratio": "204%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "133,875",
"Assets, Non-Current": "421",
"General and Administrative Expense": "64,381",
"Goodwill": "81,630",
"Liabilities, Current": "22,887",
"Liabilities, Non-Current": "57,305",
"Other Assets": "3,341",
"Other Compr. Net Income": "2,570",
"Other Expenses": "98,200",
"Other Liabilities": "0",
"Other Net Income": "-953",
"Other Revenues": "200,771",
"Property, Plant and Equipment, Net": "30,510",
"Research and Development": "15,680"
},
"output_variables": {
"Liabilities": "80,192",
"Assets": "249,777",
"Expenses": "178,261",
"Revenues": "200,771",
"Stockholders Equity": "169,585",
"Net Income": "21,557",
"Comprehensive Net Income": "22,842",
"BaseVar": "356,262",
"ECR before LimitedLiability": "155%",
"Economic Capital Ratio": "204%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "139,053",
"Assets, Non-Current": "82,329",
"General and Administrative Expense": "152,066",
"Goodwill": "77,750",
"Liabilities, Current": "24,173",
"Liabilities, Non-Current": "51,786",
"Other Assets": "-77,750",
"Other Compr. Net Income": "-431",
"Other Expenses": "19,582",
"Other Liabilities": "0",
"Other Net Income": "-1,204",
"Other Revenues": "213,571",
"Property, Plant and Equipment, Net": "29,995",
"Research and Development": "16,870"
},
"output_variables": {
"Liabilities": "75,959",
"Assets": "251,377",
"Expenses": "188,518",
"Revenues": "213,571",
"Stockholders Equity": "175,418",
"Net Income": "23,849",
"Comprehensive Net Income": "23,634",
"BaseVar": "365,530",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "144,761",
"Assets, Non-Current": "150,150",
"General and Administrative Expense": "144,137",
"Goodwill": "149,484",
"Liabilities, Current": "20,914",
"Liabilities, Non-Current": "113,597",
"Other Assets": "-149,484",
"Other Compr. Net Income": "-1,598",
"Other Expenses": "13,405",
"Other Liabilities": "0",
"Other Net Income": "-1,142",
"Other Revenues": "201,014",
"Property, Plant and Equipment, Net": "30,567",
"Research and Development": "17,948"
},
"output_variables": {
"Liabilities": "134,511",
"Assets": "325,478",
"Expenses": "175,490",
"Revenues": "201,014",
"Stockholders Equity": "190,967",
"Net Income": "24,382",
"Comprehensive Net Income": "23,583",
"BaseVar": "419,616",
"ECR before LimitedLiability": "124%",
"Economic Capital Ratio": "184%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "162,190",
"Assets, Non-Current": "211,951",
"General and Administrative Expense": "168,250",
"Goodwill": "197,383",
"Liabilities, Current": "56,328",
"Liabilities, Non-Current": "105,108",
"Other Assets": "-197,383",
"Other Compr. Net Income": "3,115",
"Other Expenses": "13,471",
"Other Liabilities": "-3,804",
"Other Net Income": "-2,031",
"Other Revenues": "253,667",
"Property, Plant and Equipment, Net": "31,120",
"Research and Development": "23,729"
},
"output_variables": {
"Liabilities": "157,632",
"Assets": "405,261",
"Expenses": "205,450",
"Revenues": "253,667",
"Stockholders Equity": "247,629",
"Net Income": "46,186",
"Comprehensive Net Income": "47,744",
"BaseVar": "513,578",
"ECR before LimitedLiability": "138%",
"Economic Capital Ratio": "193%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 1.9309859953166613,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000794172.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000794172.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000794172.svg"
},
{
"company_id": "0001737927",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001737927.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001737927.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001737927.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001737927_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001737927_main_keyfigs.svg",
"name": "Canopy Growth Corp",
"rank": 19,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001737927.svg",
"report_text": "The relative strengths and weaknesses of Canopy Growth Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Canopy Growth Corp compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 64% points.The greatest weakness of Canopy Growth Corp is the variable Other Revenues, reducing the Economic Capital Ratio by 22% points.
The company's Economic Capital Ratio, given in the ranking table, is 193%, being 47% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001737927_2021_Canopy_Growth_Corp.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "18.8",
"Liabilities": "9.26",
"Stockholders Equity": "64.1",
"ECR before LimitedLiability": "84.7",
"Liabilities, Non-Current": "3.07",
"Other Liabilities": "-14.1",
"Goodwill": "24.5",
"Assets": "38.3",
"Other Assets": "2.66",
"Assets, Non-Current": "-4.30",
"Property, Plant and Equipment, Net": "8.01",
"Other Expenses": "-7.00",
"Expenses": "12.9",
"Revenues": "-21.8",
"Net Income": "-3.02",
"Research and Development": "5.39",
"General and Administrative Expense": "14.5",
"Other Revenues": "-21.8",
"Other Net Income": "6.04",
"Economic Capital Ratio": "46.9",
"Other Compr. Net Income": "2.33"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001737927_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "2,564,373",
"Assets, Non-Current": "88,479",
"General and Administrative Expense": "1,124,193",
"Goodwill": "2,430,837",
"Liabilities, Current": "467,702",
"Liabilities, Non-Current": "639,682",
"Other Assets": "249,253",
"Other Compr. Net Income": "292,918",
"Other Expenses": "821,928",
"Other Liabilities": "572,491",
"Other Net Income": "159,909",
"Other Revenues": "398,772",
"Property, Plant and Equipment, Net": "1,524,803",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,679,875",
"Assets": "6,857,745",
"Expenses": "1,946,121",
"Revenues": "398,772",
"Stockholders Equity": "5,177,870",
"Net Income": "-1,387,440",
"Comprehensive Net Income": "-1,240,981",
"BaseVar": "5,667,670",
"ECR before LimitedLiability": "137%",
"Economic Capital Ratio": "193%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.928355077739933,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001737927.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001737927.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001737927.svg"
},
{
"company_id": "0001742924",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001742924.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001742924.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001742924.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001742924_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001742924_main_keyfigs.svg",
"name": "Livent Corp",
"rank": 20,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001742924.svg",
"report_text": "The relative strengths and weaknesses of Livent Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Livent Corp compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Livent Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 34% points.
The company's Economic Capital Ratio, given in the ranking table, is 179%, being 33% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001742924_2021_Livent_Corp.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "25.5",
"Liabilities": "47.1",
"Stockholders Equity": "61.3",
"ECR before LimitedLiability": "127",
"Other Liabilities": "16.0",
"Liabilities, Current": "11.7",
"Property, Plant and Equipment, Net": "10.7",
"Assets": "7.62",
"Other Assets": "0.103",
"Assets, Current": "0.438",
"Goodwill": "-3.47",
"Assets, Non-Current": "1.27",
"Other Expenses": "3.03",
"Expenses": "24.4",
"Revenues": "32.1",
"Net Income": "55.3",
"Research and Development": "13.0",
"General and Administrative Expense": "8.83",
"Other Revenues": "32.1",
"Comprehensive Net Income": "55.2",
"Economic Capital Ratio": "106"
},
"2019": {
"Assets, Non-Current": "1.31",
"Assets": "18.4",
"Stockholders Equity": "31.4",
"Liabilities, Non-Current": "-24.6",
"ECR before LimitedLiability": "85.3",
"Goodwill": "-7.50",
"Property, Plant and Equipment, Net": "39.5",
"Other Assets": "1.06",
"Assets, Current": "-5.38",
"Research and Development": "7.75",
"Expenses": "25.6",
"Revenues": "8.07",
"Net Income": "37.9",
"Other Expenses": "5.82",
"General and Administrative Expense": "11.6",
"Other Revenues": "8.07",
"Other Liabilities": "12.6",
"Liabilities, Current": "9.93",
"Other Net Income": "3.21",
"Comprehensive Net Income": "38.0",
"Economic Capital Ratio": "55.8"
},
"2020": {
"Liabilities, Current": "17.0",
"Liabilities": "-7.82",
"Stockholders Equity": "23.5",
"ECR before LimitedLiability": "70.6",
"Liabilities, Non-Current": "-33.7",
"Other Liabilities": "5.00",
"Goodwill": "-8.10",
"Assets": "19.6",
"Assets, Current": "-11.1",
"Assets, Non-Current": "3.53",
"Property, Plant and Equipment, Net": "52.8",
"Other Expenses": "5.76",
"Expenses": "16.9",
"Revenues": "-1.64",
"Net Income": "19.3",
"Research and Development": "5.71",
"General and Administrative Expense": "5.16",
"Other Revenues": "-1.64",
"Comprehensive Net Income": "19.6",
"Other Net Income": "3.95",
"Economic Capital Ratio": "32.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001742924_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "301,300",
"Assets, Non-Current": "80,000",
"General and Administrative Expense": "257,900",
"Goodwill": "0",
"Liabilities, Current": "120,400",
"Liabilities, Non-Current": "0",
"Other Assets": "3,000",
"Other Compr. Net Income": "-3,600",
"Other Expenses": "54,700",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "442,500",
"Property, Plant and Equipment, Net": "275,700",
"Research and Development": "3,800"
},
"output_variables": {
"Liabilities": "120,400",
"Assets": "660,000",
"Expenses": "316,400",
"Revenues": "442,500",
"Stockholders Equity": "539,600",
"Net Income": "126,100",
"Comprehensive Net Income": "124,300",
"BaseVar": "771,450",
"ECR before LimitedLiability": "221%",
"Economic Capital Ratio": "250%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "272,000",
"Assets, Non-Current": "110,600",
"General and Administrative Expense": "314,000",
"Goodwill": "0",
"Liabilities, Current": "129,200",
"Liabilities, Non-Current": "186,400",
"Other Assets": "8,200",
"Other Compr. Net Income": "900",
"Other Expenses": "20,100",
"Other Liabilities": "0",
"Other Net Income": "-800",
"Other Revenues": "388,400",
"Property, Plant and Equipment, Net": "468,800",
"Research and Development": "3,300"
},
"output_variables": {
"Liabilities": "315,600",
"Assets": "859,600",
"Expenses": "337,400",
"Revenues": "388,400",
"Stockholders Equity": "544,000",
"Net Income": "50,200",
"Comprehensive Net Income": "50,650",
"BaseVar": "951,350",
"ECR before LimitedLiability": "135%",
"Economic Capital Ratio": "192%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "249,800",
"Assets, Non-Current": "128,300",
"General and Administrative Expense": "296,000",
"Goodwill": "0",
"Liabilities, Current": "96,200",
"Liabilities, Non-Current": "274,800",
"Other Assets": "13,400",
"Other Compr. Net Income": "3,900",
"Other Expenses": "6,800",
"Other Liabilities": "0",
"Other Net Income": "-600",
"Other Revenues": "288,200",
"Property, Plant and Equipment, Net": "545,300",
"Research and Development": "3,700"
},
"output_variables": {
"Liabilities": "371,000",
"Assets": "936,800",
"Expenses": "306,500",
"Revenues": "288,200",
"Stockholders Equity": "565,800",
"Net Income": "-18,900",
"Comprehensive Net Income": "-16,950",
"BaseVar": "953,500",
"ECR before LimitedLiability": "116%",
"Economic Capital Ratio": "179%"
}
}
},
"top_rated": false,
"trend": -6.0,
"value": 1.7872168654340799,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001742924.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001742924.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001742924.svg"
},
{
"company_id": "0000787253",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000787253.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000787253.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000787253.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000787253_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000787253_main_keyfigs.svg",
"name": "Natural Alternatives International Inc",
"rank": 21,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000787253.svg",
"report_text": "The relative strengths and weaknesses of Natural Alternatives International Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Natural Alternatives International Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Natural Alternatives International Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 20% points.
The company's Economic Capital Ratio, given in the ranking table, is 177%, being 31% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000787253_2021_Natural_Alternatives_International_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "62.5",
"Liabilities": "88.8",
"Stockholders Equity": "49.0",
"ECR before LimitedLiability": "164",
"Liabilities, Non-Current": "23.3",
"Other Liabilities": "19.7",
"Property, Plant and Equipment, Net": "3.33",
"Assets": "-2.70",
"Assets, Non-Current": "-1.64",
"Other Assets": "1.14",
"Goodwill": "-3.98",
"Assets, Current": "-0.823",
"Other Revenues": "75.4",
"Revenues": "75.4",
"Net Income": "65.3",
"General and Administrative Expense": "65.6",
"Comprehensive Net Income": "65.2",
"Research and Development": "22.0",
"Other Net Income": "-10.7",
"Other Expenses": "-107",
"Economic Capital Ratio": "102"
},
"2012": {
"Liabilities, Current": "45.7",
"Liabilities": "88.2",
"Stockholders Equity": "23.3",
"ECR before LimitedLiability": "120",
"Liabilities, Non-Current": "24.5",
"Other Liabilities": "36.6",
"Assets, Current": "-2.03",
"Assets": "-7.96",
"Other Assets": "1.11",
"Assets, Non-Current": "-2.53",
"Property, Plant and Equipment, Net": "1.14",
"Goodwill": "-6.11",
"Other Expenses": "-126",
"Expenses": "-9.87",
"Revenues": "81.9",
"Net Income": "71.6",
"Research and Development": "25.5",
"General and Administrative Expense": "67.7",
"Other Revenues": "81.9",
"Comprehensive Net Income": "72.3",
"Economic Capital Ratio": "87.9"
},
"2014": {
"Liabilities, Non-Current": "34.7",
"Liabilities": "105",
"Stockholders Equity": "60.1",
"ECR before LimitedLiability": "146",
"Liabilities, Current": "65.3",
"Other Liabilities": "23.0",
"Assets, Current": "3.27",
"Assets": "-6.77",
"Goodwill": "-8.57",
"Other Assets": "1.71",
"Assets, Non-Current": "-2.24",
"Other Expenses": "-119",
"Expenses": "-10.1",
"Revenues": "80.3",
"Net Income": "71.7",
"Research and Development": "23.0",
"General and Administrative Expense": "67.4",
"Other Revenues": "80.3",
"Other Net Income": "2.09",
"Comprehensive Net Income": "71.8",
"Economic Capital Ratio": "96.9"
},
"2015": {
"Other Liabilities": "31.2",
"Liabilities": "116",
"Stockholders Equity": "49.8",
"ECR before LimitedLiability": "144",
"Liabilities, Current": "66.5",
"Liabilities, Non-Current": "40.9",
"Assets, Current": "3.86",
"Assets": "-10.6",
"Other Assets": "-3.08",
"Goodwill": "-8.35",
"Property, Plant and Equipment, Net": "-1.84",
"Research and Development": "18.3",
"Expenses": "-22.4",
"Revenues": "96.6",
"Net Income": "74.8",
"General and Administrative Expense": "50.8",
"Other Expenses": "-107",
"Other Revenues": "96.6",
"Comprehensive Net Income": "75.1",
"Other Net Income": "1.93",
"Economic Capital Ratio": "97.9"
},
"2016": {
"Liabilities, Non-Current": "36.9",
"Liabilities": "83.2",
"ECR before LimitedLiability": "91.8",
"Liabilities, Current": "43.5",
"Other Liabilities": "14.1",
"Property, Plant and Equipment, Net": "-3.32",
"Assets": "-17.5",
"Other Assets": "1.50",
"Assets, Non-Current": "-2.83",
"Assets, Current": "-5.92",
"Goodwill": "-10.1",
"Research and Development": "24.1",
"Expenses": "-16.3",
"Net Income": "69.3",
"General and Administrative Expense": "44.6",
"Other Expenses": "-96.0",
"Other Revenues": "89.9",
"Revenues": "89.9",
"Comprehensive Net Income": "69.8",
"Other Net Income": "-1.41",
"Economic Capital Ratio": "71.8"
},
"2017": {
"Other Liabilities": "25.5",
"Liabilities": "123",
"Stockholders Equity": "21.5",
"ECR before LimitedLiability": "114",
"Liabilities, Current": "74.5",
"Liabilities, Non-Current": "50.7",
"Assets, Non-Current": "-2.45",
"Assets": "-12.8",
"Assets, Current": "-2.81",
"Goodwill": "-7.80",
"Property, Plant and Equipment, Net": "-3.67",
"Research and Development": "28.2",
"Expenses": "-43.6",
"Revenues": "118",
"Net Income": "66.4",
"Other Expenses": "38.2",
"General and Administrative Expense": "-129",
"Other Revenues": "118",
"Comprehensive Net Income": "65.6",
"Other Net Income": "-8.63",
"Economic Capital Ratio": "92.8"
},
"2018": {
"Liabilities, Non-Current": "39.2",
"Liabilities": "93.3",
"Stockholders Equity": "3.38",
"ECR before LimitedLiability": "107",
"Other Liabilities": "17.9",
"Liabilities, Current": "52.0",
"Property, Plant and Equipment, Net": "-2.52",
"Assets": "-15.7",
"Assets, Current": "-2.02",
"Goodwill": "-8.53",
"Assets, Non-Current": "-5.91",
"Other Expenses": "14.8",
"Expenses": "-29.8",
"Revenues": "96.4",
"Net Income": "66.3",
"Research and Development": "23.4",
"General and Administrative Expense": "-74.7",
"Other Revenues": "96.4",
"Comprehensive Net Income": "67.0",
"Other Net Income": "1.37",
"Economic Capital Ratio": "86.4"
},
"2019": {
"Liabilities, Non-Current": "-5.51",
"Liabilities": "92.0",
"Assets": "-7.74",
"Stockholders Equity": "32.1",
"ECR before LimitedLiability": "137",
"Other Liabilities": "62.1",
"Liabilities, Current": "46.4",
"Goodwill": "-6.43",
"Property, Plant and Equipment, Net": "-1.88",
"Assets, Current": "-0.792",
"Research and Development": "16.1",
"Expenses": "-15.5",
"Revenues": "72.0",
"Net Income": "65.9",
"Other Expenses": "14.6",
"General and Administrative Expense": "-50.0",
"Other Revenues": "72.0",
"Other Net Income": "8.75",
"Comprehensive Net Income": "66.4",
"Other Compr. Net Income": "0.577",
"Economic Capital Ratio": "107"
},
"2020": {
"Liabilities, Current": "17.5",
"Liabilities": "33.0",
"Stockholders Equity": "-17.1",
"ECR before LimitedLiability": "68.6",
"Liabilities, Non-Current": "11.9",
"Other Liabilities": "4.85",
"Goodwill": "-13.0",
"Assets": "-20.0",
"Assets, Current": "-4.67",
"Assets, Non-Current": "0.545",
"Property, Plant and Equipment, Net": "-5.26",
"Other Expenses": "-5.56",
"Expenses": "-15.9",
"Revenues": "47.0",
"Net Income": "35.5",
"Research and Development": "10.3",
"General and Administrative Expense": "-20.3",
"Other Revenues": "47.0",
"Comprehensive Net Income": "35.0",
"Other Net Income": "6.54",
"Economic Capital Ratio": "30.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000787253_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "27,828",
"Assets, Non-Current": "453",
"General and Administrative Expense": "8,304",
"Goodwill": "0",
"Liabilities, Current": "4,947",
"Liabilities, Non-Current": "0",
"Other Assets": "1,452",
"Other Compr. Net Income": "50",
"Other Expenses": "42,517",
"Other Liabilities": "719",
"Other Net Income": "25",
"Other Revenues": "55,882",
"Property, Plant and Equipment, Net": "11,411",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,666",
"Assets": "41,144",
"Expenses": "50,821",
"Revenues": "55,882",
"Stockholders Equity": "35,478",
"Net Income": "5,086",
"Comprehensive Net Income": "5,111",
"BaseVar": "76,794",
"ECR before LimitedLiability": "230%",
"Economic Capital Ratio": "256%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "34,519",
"Assets, Non-Current": "471",
"General and Administrative Expense": "9,251",
"Goodwill": "0",
"Liabilities, Current": "6,836",
"Liabilities, Non-Current": "0",
"Other Assets": "1,560",
"Other Compr. Net Income": "464",
"Other Expenses": "59,455",
"Other Liabilities": "493",
"Other Net Income": "42",
"Other Revenues": "72,822",
"Property, Plant and Equipment, Net": "10,647",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,329",
"Assets": "47,197",
"Expenses": "68,706",
"Revenues": "72,822",
"Stockholders Equity": "39,868",
"Net Income": "4,158",
"Comprehensive Net Income": "4,390",
"BaseVar": "98,280",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "246%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "40,903",
"Assets, Non-Current": "951",
"General and Administrative Expense": "9,961",
"Goodwill": "0",
"Liabilities, Current": "9,600",
"Liabilities, Non-Current": "0",
"Other Assets": "1,593",
"Other Compr. Net Income": "-39",
"Other Expenses": "61,878",
"Other Liabilities": "220",
"Other Net Income": "-109",
"Other Revenues": "73,942",
"Property, Plant and Equipment, Net": "8,811",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,820",
"Assets": "52,258",
"Expenses": "71,839",
"Revenues": "73,942",
"Stockholders Equity": "42,438",
"Net Income": "1,994",
"Comprehensive Net Income": "1,974",
"BaseVar": "104,004",
"ECR before LimitedLiability": "194%",
"Economic Capital Ratio": "230%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "43,600",
"Assets, Non-Current": "920",
"General and Administrative Expense": "10,180",
"Goodwill": "0",
"Liabilities, Current": "9,093",
"Liabilities, Non-Current": "21",
"Other Assets": "1,663",
"Other Compr. Net Income": "-297",
"Other Expenses": "66,130",
"Other Liabilities": "842",
"Other Net Income": "148",
"Other Revenues": "79,508",
"Property, Plant and Equipment, Net": "7,633",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,956",
"Assets": "53,816",
"Expenses": "76,310",
"Revenues": "79,508",
"Stockholders Equity": "43,860",
"Net Income": "3,346",
"Comprehensive Net Income": "3,198",
"BaseVar": "110,018",
"ECR before LimitedLiability": "198%",
"Economic Capital Ratio": "234%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "55,882",
"Assets, Non-Current": "899",
"General and Administrative Expense": "13,000",
"Goodwill": "0",
"Liabilities, Current": "19,205",
"Liabilities, Non-Current": "0",
"Other Assets": "2,227",
"Other Compr. Net Income": "86",
"Other Expenses": "92,969",
"Other Liabilities": "1,244",
"Other Net Income": "1,314",
"Other Revenues": "114,201",
"Property, Plant and Equipment, Net": "15,167",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "20,449",
"Assets": "74,175",
"Expenses": "105,969",
"Revenues": "114,201",
"Stockholders Equity": "53,726",
"Net Income": "9,546",
"Comprehensive Net Income": "9,589",
"BaseVar": "158,097",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "218%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "51,699",
"Assets, Non-Current": "774",
"General and Administrative Expense": "112,244",
"Goodwill": "0",
"Liabilities, Current": "10,270",
"Liabilities, Non-Current": "0",
"Other Assets": "2,002",
"Other Compr. Net Income": "-225",
"Other Expenses": "2,876",
"Other Liabilities": "1,193",
"Other Net Income": "409",
"Other Revenues": "121,946",
"Property, Plant and Equipment, Net": "18,136",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "11,463",
"Assets": "72,611",
"Expenses": "115,120",
"Revenues": "121,946",
"Stockholders Equity": "61,148",
"Net Income": "7,235",
"Comprehensive Net Income": "7,122",
"BaseVar": "160,887",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "246%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "65,183",
"Assets, Non-Current": "734",
"General and Administrative Expense": "122,904",
"Goodwill": "0",
"Liabilities, Current": "14,280",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "327",
"Other Expenses": "5,562",
"Other Liabilities": "2,679",
"Other Net Income": "1,080",
"Other Revenues": "132,437",
"Property, Plant and Equipment, Net": "19,290",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,959",
"Assets": "85,207",
"Expenses": "128,466",
"Revenues": "132,437",
"Stockholders Equity": "68,248",
"Net Income": "5,051",
"Comprehensive Net Income": "5,214",
"BaseVar": "182,238",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "230%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "71,386",
"Assets, Non-Current": "21,793",
"General and Administrative Expense": "132,329",
"Goodwill": "0",
"Liabilities, Current": "15,370",
"Liabilities, Non-Current": "20,897",
"Other Assets": "0",
"Other Compr. Net Income": "870",
"Other Expenses": "1,412",
"Other Liabilities": "-18,861",
"Other Net Income": "1,992",
"Other Revenues": "138,290",
"Property, Plant and Equipment, Net": "21,085",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "17,406",
"Assets": "114,264",
"Expenses": "133,741",
"Revenues": "138,290",
"Stockholders Equity": "96,858",
"Net Income": "6,541",
"Comprehensive Net Income": "6,976",
"BaseVar": "203,282",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "243%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "79,024",
"Assets, Non-Current": "19,460",
"General and Administrative Expense": "100,005",
"Goodwill": "0",
"Liabilities, Current": "27,806",
"Liabilities, Non-Current": "18,782",
"Other Assets": "196",
"Other Compr. Net Income": "-1,347",
"Other Expenses": "20,287",
"Other Liabilities": "2,240",
"Other Net Income": "-229",
"Other Revenues": "118,876",
"Property, Plant and Equipment, Net": "21,523",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "48,828",
"Assets": "120,203",
"Expenses": "120,292",
"Revenues": "118,876",
"Stockholders Equity": "71,375",
"Net Income": "-1,645",
"Comprehensive Net Income": "-2,318",
"BaseVar": "204,888",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "177%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 1.766910561602268,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000787253.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000787253.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000787253.svg"
},
{
"company_id": "0000768408",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000768408.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000768408.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000768408.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000768408_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000768408_main_keyfigs.svg",
"name": "Cyanotech CORP",
"rank": 22,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000768408.svg",
"report_text": "The relative strengths and weaknesses of Cyanotech CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cyanotech CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Cyanotech CORP is the variable Stockholders Equity, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 163%, being 17% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000768408_2021_Cyanotech_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "44.2",
"Liabilities": "64.9",
"Stockholders Equity": "41.4",
"ECR before LimitedLiability": "146",
"Liabilities, Non-Current": "9.21",
"Other Liabilities": "19.9",
"General and Administrative Expense": "39.9",
"Expenses": "8.05",
"Net Income": "58.1",
"Research and Development": "16.6",
"Other Expenses": "-54.2",
"Other Revenues": "59.5",
"Revenues": "59.5",
"Property, Plant and Equipment, Net": "7.85",
"Assets, Non-Current": "-1.81",
"Other Assets": "1.74",
"Goodwill": "-5.37",
"Assets, Current": "-1.96",
"Comprehensive Net Income": "58.0",
"Other Net Income": "-9.70",
"Economic Capital Ratio": "84.2"
},
"2012": {
"Liabilities, Current": "27.7",
"Liabilities": "65.1",
"Stockholders Equity": "30.6",
"ECR before LimitedLiability": "119",
"Liabilities, Non-Current": "15.4",
"Other Liabilities": "32.9",
"Assets, Current": "-2.73",
"Assets": "-3.23",
"Other Assets": "2.44",
"Assets, Non-Current": "-1.64",
"Property, Plant and Equipment, Net": "5.43",
"Goodwill": "-5.30",
"Other Expenses": "-52.3",
"Expenses": "10.3",
"Revenues": "63.6",
"Net Income": "72.5",
"Research and Development": "19.4",
"General and Administrative Expense": "37.4",
"Other Revenues": "63.6",
"Comprehensive Net Income": "72.6",
"Economic Capital Ratio": "87.0"
},
"2013": {
"Liabilities, Current": "36.1",
"Liabilities": "35.1",
"Stockholders Equity": "29.5",
"ECR before LimitedLiability": "102",
"Other Liabilities": "18.2",
"Liabilities, Non-Current": "-22.9",
"Goodwill": "-7.31",
"Assets": "1.96",
"Property, Plant and Equipment, Net": "10.5",
"Other Assets": "12.4",
"Assets, Current": "-7.17",
"General and Administrative Expense": "25.2",
"Expenses": "16.7",
"Revenues": "41.5",
"Net Income": "55.5",
"Research and Development": "13.0",
"Other Expenses": "-22.2",
"Other Revenues": "41.5",
"Other Net Income": "-3.50",
"Comprehensive Net Income": "55.4",
"Economic Capital Ratio": "61.8"
},
"2014": {
"Liabilities, Non-Current": "-12.0",
"Liabilities": "51.7",
"Stockholders Equity": "50.3",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "47.8",
"Other Liabilities": "15.6",
"Assets, Current": "-9.36",
"Assets": "4.25",
"Goodwill": "-10.3",
"Other Assets": "4.38",
"Assets, Non-Current": "-1.65",
"Property, Plant and Equipment, Net": "33.6",
"Other Expenses": "-33.6",
"Expenses": "8.85",
"Revenues": "37.9",
"Net Income": "49.3",
"Research and Development": "15.1",
"General and Administrative Expense": "27.8",
"Other Revenues": "37.9",
"Comprehensive Net Income": "49.4",
"Economic Capital Ratio": "61.7"
},
"2015": {
"Other Liabilities": "24.3",
"Liabilities": "68.2",
"Stockholders Equity": "39.3",
"ECR before LimitedLiability": "109",
"Liabilities, Current": "50.4",
"Liabilities, Non-Current": "-3.00",
"Assets, Current": "-13.1",
"Assets": "-6.51",
"Other Assets": "1.58",
"Goodwill": "-10.8",
"Assets, Non-Current": "-1.31",
"Property, Plant and Equipment, Net": "27.8",
"Research and Development": "12.2",
"Expenses": "-3.97",
"Revenues": "57.9",
"Net Income": "54.2",
"General and Administrative Expense": "11.1",
"Other Expenses": "-27.4",
"Other Revenues": "57.9",
"Comprehensive Net Income": "54.7",
"Economic Capital Ratio": "62.7"
},
"2016": {
"Liabilities, Non-Current": "26.8",
"Liabilities": "34.1",
"Stockholders Equity": "-4.68",
"ECR before LimitedLiability": "34.1",
"Liabilities, Current": "35.7",
"Other Liabilities": "-32.1",
"Property, Plant and Equipment, Net": "45.6",
"Assets": "-17.8",
"Assets, Non-Current": "-3.28",
"Assets, Current": "-24.3",
"Goodwill": "-15.4",
"Research and Development": "18.5",
"Expenses": "-7.23",
"Revenues": "45.1",
"Net Income": "32.2",
"General and Administrative Expense": "13.0",
"Other Expenses": "-35.8",
"Other Revenues": "45.1",
"Comprehensive Net Income": "32.5",
"Other Net Income": "-3.54",
"Economic Capital Ratio": "14.2"
},
"2017": {
"Other Liabilities": "-25.7",
"Liabilities": "39.4",
"Stockholders Equity": "-2.55",
"ECR before LimitedLiability": "38.2",
"Liabilities, Current": "32.6",
"Liabilities, Non-Current": "30.0",
"Assets, Non-Current": "-4.88",
"Assets": "-17.2",
"Assets, Current": "-16.6",
"Goodwill": "-15.5",
"Property, Plant and Equipment, Net": "29.5",
"Research and Development": "17.6",
"Expenses": "-8.16",
"Revenues": "55.9",
"Net Income": "36.4",
"Other Expenses": "31.0",
"General and Administrative Expense": "-52.5",
"Other Revenues": "55.9",
"Comprehensive Net Income": "35.9",
"Other Net Income": "-7.68",
"Economic Capital Ratio": "16.7"
},
"2018": {
"Liabilities, Non-Current": "26.5",
"Liabilities": "34.4",
"Stockholders Equity": "-7.31",
"ECR before LimitedLiability": "61.6",
"Other Liabilities": "-22.5",
"Liabilities, Current": "28.0",
"Property, Plant and Equipment, Net": "26.9",
"Assets": "-15.0",
"Assets, Current": "-14.2",
"Goodwill": "-11.6",
"Assets, Non-Current": "-7.83",
"Other Expenses": "16.9",
"Expenses": "-2.32",
"Revenues": "55.9",
"Net Income": "51.0",
"Research and Development": "15.7",
"General and Administrative Expense": "-33.9",
"Other Revenues": "55.9",
"Comprehensive Net Income": "51.4",
"Other Net Income": "-1.66",
"Economic Capital Ratio": "41.1"
},
"2019": {
"Liabilities, Non-Current": "-1.24",
"Liabilities": "19.6",
"Stockholders Equity": "-21.5",
"ECR before LimitedLiability": "43.9",
"Other Liabilities": "18.5",
"Liabilities, Current": "2.35",
"Assets, Non-Current": "-14.8",
"Assets": "-22.3",
"Goodwill": "-17.0",
"Property, Plant and Equipment, Net": "32.8",
"Assets, Current": "-14.8",
"Research and Development": "11.0",
"Expenses": "-6.43",
"Revenues": "45.5",
"Net Income": "44.4",
"Other Expenses": "12.1",
"General and Administrative Expense": "-27.4",
"Other Revenues": "45.5",
"Other Net Income": "5.70",
"Comprehensive Net Income": "44.5",
"Economic Capital Ratio": "14.4"
},
"2020": {
"Liabilities, Current": "22.9",
"Liabilities": "18.4",
"Stockholders Equity": "-30.5",
"ECR before LimitedLiability": "54.4",
"Liabilities, Non-Current": "-13.2",
"Other Liabilities": "7.88",
"Goodwill": "-14.7",
"Assets": "-23.8",
"Assets, Current": "-19.4",
"Assets, Non-Current": "-2.73",
"Property, Plant and Equipment, Net": "15.2",
"Other Expenses": "8.95",
"Expenses": "-12.7",
"Revenues": "46.8",
"Net Income": "39.2",
"Research and Development": "8.50",
"General and Administrative Expense": "-28.9",
"Other Revenues": "46.8",
"Comprehensive Net Income": "39.3",
"Other Net Income": "6.79",
"Economic Capital Ratio": "16.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000768408_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "8,481",
"Assets, Non-Current": "287",
"General and Administrative Expense": "4,808",
"Goodwill": "0",
"Liabilities, Current": "2,196",
"Liabilities, Non-Current": "553",
"Other Assets": "535",
"Other Compr. Net Income": "0",
"Other Expenses": "9,941",
"Other Liabilities": "0",
"Other Net Income": "-66",
"Other Revenues": "16,827",
"Property, Plant and Equipment, Net": "4,557",
"Research and Development": "282"
},
"output_variables": {
"Liabilities": "2,749",
"Assets": "13,860",
"Expenses": "15,031",
"Revenues": "16,827",
"Stockholders Equity": "11,111",
"Net Income": "1,730",
"Comprehensive Net Income": "1,730",
"BaseVar": "24,266",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "238%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "11,419",
"Assets, Non-Current": "478",
"General and Administrative Expense": "6,494",
"Goodwill": "0",
"Liabilities, Current": "3,361",
"Liabilities, Non-Current": "400",
"Other Assets": "1,307",
"Other Compr. Net Income": "0",
"Other Expenses": "14,135",
"Other Liabilities": "12",
"Other Net Income": "-50",
"Other Revenues": "24,631",
"Property, Plant and Equipment, Net": "5,834",
"Research and Development": "320"
},
"output_variables": {
"Liabilities": "3,773",
"Assets": "19,038",
"Expenses": "20,949",
"Revenues": "24,631",
"Stockholders Equity": "15,265",
"Net Income": "3,632",
"Comprehensive Net Income": "3,632",
"BaseVar": "34,220",
"ECR before LimitedLiability": "215%",
"Economic Capital Ratio": "245%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "12,191",
"Assets, Non-Current": "772",
"General and Administrative Expense": "8,355",
"Goodwill": "0",
"Liabilities, Current": "2,885",
"Liabilities, Non-Current": "5,454",
"Other Assets": "6,789",
"Other Compr. Net Income": "0",
"Other Expenses": "14,648",
"Other Liabilities": "21",
"Other Net Income": "-111",
"Other Revenues": "27,581",
"Property, Plant and Equipment, Net": "8,835",
"Research and Development": "258"
},
"output_variables": {
"Liabilities": "8,360",
"Assets": "28,587",
"Expenses": "23,261",
"Revenues": "27,581",
"Stockholders Equity": "20,227",
"Net Income": "4,209",
"Comprehensive Net Income": "4,209",
"BaseVar": "43,950",
"ECR before LimitedLiability": "173%",
"Economic Capital Ratio": "216%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "12,584",
"Assets, Non-Current": "902",
"General and Administrative Expense": "10,884",
"Goodwill": "0",
"Liabilities, Current": "4,155",
"Liabilities, Non-Current": "5,263",
"Other Assets": "1,737",
"Other Compr. Net Income": "0",
"Other Expenses": "17,127",
"Other Liabilities": "8.0",
"Other Net Income": "-118",
"Other Revenues": "28,178",
"Property, Plant and Equipment, Net": "14,754",
"Research and Development": "469"
},
"output_variables": {
"Liabilities": "9,426",
"Assets": "29,977",
"Expenses": "28,480",
"Revenues": "28,178",
"Stockholders Equity": "20,551",
"Net Income": "-420",
"Comprehensive Net Income": "-420",
"BaseVar": "48,090",
"ECR before LimitedLiability": "141%",
"Economic Capital Ratio": "195%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "11,794",
"Assets, Non-Current": "846",
"General and Administrative Expense": "13,531",
"Goodwill": "0",
"Liabilities, Current": "4,315",
"Liabilities, Non-Current": "5,109",
"Other Assets": "3,521",
"Other Compr. Net Income": "0",
"Other Expenses": "19,692",
"Other Liabilities": "8.0",
"Other Net Income": "-93",
"Other Revenues": "33,809",
"Property, Plant and Equipment, Net": "14,754",
"Research and Development": "517"
},
"output_variables": {
"Liabilities": "9,432",
"Assets": "30,915",
"Expenses": "33,740",
"Revenues": "33,809",
"Stockholders Equity": "21,483",
"Net Income": "-24",
"Comprehensive Net Income": "-24",
"BaseVar": "53,994",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "199%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "12,655",
"Assets, Non-Current": "696",
"General and Administrative Expense": "12,018",
"Goodwill": "0",
"Liabilities, Current": "6,121",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "23,302",
"Other Liabilities": "7,198",
"Other Net Income": "-282",
"Other Revenues": "31,840",
"Property, Plant and Equipment, Net": "17,796",
"Research and Development": "633"
},
"output_variables": {
"Liabilities": "13,319",
"Assets": "31,147",
"Expenses": "35,953",
"Revenues": "31,840",
"Stockholders Equity": "17,828",
"Net Income": "-4,395",
"Comprehensive Net Income": "-4,395",
"BaseVar": "56,270",
"ECR before LimitedLiability": "90%",
"Economic Capital Ratio": "161%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "12,236",
"Assets, Non-Current": "213",
"General and Administrative Expense": "32,131",
"Goodwill": "0",
"Liabilities, Current": "6,032",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5.0",
"Other Liabilities": "6,522",
"Other Net Income": "-528",
"Other Revenues": "32,042",
"Property, Plant and Equipment, Net": "16,712",
"Research and Development": "593"
},
"output_variables": {
"Liabilities": "12,554",
"Assets": "29,161",
"Expenses": "32,729",
"Revenues": "32,042",
"Stockholders Equity": "16,607",
"Net Income": "-1,215",
"Comprehensive Net Income": "-1,215",
"BaseVar": "53,507",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,617",
"Assets, Non-Current": "291",
"General and Administrative Expense": "32,138",
"Goodwill": "0",
"Liabilities, Current": "5,707",
"Liabilities, Non-Current": "0",
"Other Assets": "65",
"Other Compr. Net Income": "0",
"Other Expenses": "-110",
"Other Liabilities": "5,893",
"Other Net Income": "-499",
"Other Revenues": "34,115",
"Property, Plant and Equipment, Net": "15,734",
"Research and Development": "563"
},
"output_variables": {
"Liabilities": "11,600",
"Assets": "29,707",
"Expenses": "32,591",
"Revenues": "34,115",
"Stockholders Equity": "18,107",
"Net Income": "1,025",
"Comprehensive Net Income": "1,025",
"BaseVar": "54,256",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "185%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "14,592",
"Assets, Non-Current": "282",
"General and Administrative Expense": "32,276",
"Goodwill": "0",
"Liabilities, Current": "9,488",
"Liabilities, Non-Current": "5,229",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "599",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "30,202",
"Property, Plant and Equipment, Net": "14,752",
"Research and Development": "923"
},
"output_variables": {
"Liabilities": "14,717",
"Assets": "29,626",
"Expenses": "33,798",
"Revenues": "30,202",
"Stockholders Equity": "14,909",
"Net Income": "-3,596",
"Comprehensive Net Income": "-3,596",
"BaseVar": "54,172",
"ECR before LimitedLiability": "76%",
"Economic Capital Ratio": "150%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "14,728",
"Assets, Non-Current": "4,017",
"General and Administrative Expense": "30,238",
"Goodwill": "0",
"Liabilities, Current": "6,359",
"Liabilities, Non-Current": "9,582",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "666",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "31,899",
"Property, Plant and Equipment, Net": "13,042",
"Research and Development": "608"
},
"output_variables": {
"Liabilities": "15,941",
"Assets": "31,787",
"Expenses": "31,512",
"Revenues": "31,899",
"Stockholders Equity": "15,846",
"Net Income": "387",
"Comprehensive Net Income": "387",
"BaseVar": "55,570",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "163%"
}
}
},
"top_rated": false,
"trend": 2.0,
"value": 1.6253966346006496,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000768408.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000768408.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000768408.svg"
},
{
"company_id": "0001644440",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001644440.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001644440.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001644440.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001644440_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001644440_main_keyfigs.svg",
"name": "GCP Applied Technologies Inc",
"rank": 23,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001644440.svg",
"report_text": "The relative strengths and weaknesses of GCP Applied Technologies Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of GCP Applied Technologies Inc compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 36% points.The greatest weakness of GCP Applied Technologies Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 26% points.
The company's Economic Capital Ratio, given in the ranking table, is 162%, being 16% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001644440_2021_GCP_Applied_Technologies_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-83.4",
"Liabilities": "-36.2",
"Stockholders Equity": "-86.3",
"Liabilities, Current": "2.08",
"Other Liabilities": "0.533",
"Property, Plant and Equipment, Net": "-0.224",
"Assets": "-44.1",
"Other Assets": "0.868",
"Assets, Non-Current": "-0.189",
"Assets, Current": "-35.0",
"Goodwill": "-0.625",
"Research and Development": "1.73",
"Expenses": "1.33",
"Revenues": "5.25",
"Net Income": "8.42",
"General and Administrative Expense": "-25.5",
"Other Expenses": "3.49",
"Other Revenues": "5.25",
"ECR before LimitedLiability": "-42.2",
"Comprehensive Net Income": "8.29",
"Economic Capital Ratio": "-62.2"
},
"2017": {
"Other Liabilities": "4.22",
"Liabilities": "-13.2",
"Stockholders Equity": "-29.7",
"ECR before LimitedLiability": "26.2",
"Liabilities, Current": "12.5",
"Liabilities, Non-Current": "-31.9",
"Assets, Non-Current": "-3.95",
"Assets": "-12.9",
"Other Assets": "2.81",
"Goodwill": "-3.02",
"Property, Plant and Equipment, Net": "-11.2",
"Research and Development": "15.3",
"Expenses": "25.1",
"Revenues": "7.20",
"Net Income": "68.4",
"Other Expenses": "14.1",
"General and Administrative Expense": "-4.66",
"Other Revenues": "7.20",
"Comprehensive Net Income": "70.0",
"Other Net Income": "30.0",
"Economic Capital Ratio": "4.70"
},
"2018": {
"Liabilities, Non-Current": "-30.8",
"Liabilities": "-12.0",
"Stockholders Equity": "-31.1",
"ECR before LimitedLiability": "17.3",
"Liabilities, Current": "16.3",
"Property, Plant and Equipment, Net": "-5.13",
"Assets": "-15.8",
"Other Assets": "3.78",
"Assets, Current": "-11.0",
"Goodwill": "6.12",
"Assets, Non-Current": "-9.37",
"Other Expenses": "6.67",
"Expenses": "12.0",
"Revenues": "30.6",
"Net Income": "47.3",
"Research and Development": "15.3",
"General and Administrative Expense": "-9.41",
"Other Revenues": "30.6",
"Comprehensive Net Income": "46.1",
"Other Net Income": "2.32",
"Economic Capital Ratio": "-3.13"
},
"2019": {
"Liabilities, Non-Current": "-35.9",
"Liabilities": "-10.6",
"Stockholders Equity": "-19.0",
"ECR before LimitedLiability": "44.4",
"Other Liabilities": "4.70",
"Liabilities, Current": "17.8",
"Assets, Non-Current": "-8.78",
"Assets": "-7.83",
"Goodwill": "4.87",
"Property, Plant and Equipment, Net": "-1.70",
"Other Assets": "4.68",
"Assets, Current": "-5.98",
"Research and Development": "9.98",
"Expenses": "16.6",
"Revenues": "25.9",
"Net Income": "50.9",
"Other Expenses": "7.51",
"Other Revenues": "25.9",
"Other Net Income": "4.99",
"Comprehensive Net Income": "51.1",
"Economic Capital Ratio": "14.9"
},
"2020": {
"Liabilities, Current": "15.8",
"Liabilities": "-10.2",
"Stockholders Equity": "-15.2",
"ECR before LimitedLiability": "53.8",
"Liabilities, Non-Current": "-25.5",
"Other Liabilities": "-2.19",
"Goodwill": "4.04",
"Assets": "-5.15",
"Other Assets": "2.27",
"Assets, Non-Current": "-5.74",
"Property, Plant and Equipment, Net": "-3.48",
"Other Expenses": "10.2",
"Expenses": "9.96",
"Revenues": "19.2",
"Net Income": "36.1",
"Research and Development": "6.73",
"General and Administrative Expense": "-6.75",
"Other Revenues": "19.2",
"Comprehensive Net Income": "36.4",
"Other Net Income": "5.18",
"Economic Capital Ratio": "16.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001644440_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "553,800",
"Assets, Non-Current": "27,000",
"General and Administrative Expense": "1,139,900",
"Goodwill": "172,300",
"Liabilities, Current": "320,400",
"Liabilities, Non-Current": "898,700",
"Other Assets": "104,500",
"Other Compr. Net Income": "-20,900",
"Other Expenses": "119,100",
"Other Liabilities": "9,700",
"Other Net Income": "0",
"Other Revenues": "1,355,800",
"Property, Plant and Equipment, Net": "232,200",
"Research and Development": "23,000"
},
"output_variables": {
"Liabilities": "1,228,800",
"Assets": "1,089,800",
"Expenses": "1,282,000",
"Revenues": "1,355,800",
"Stockholders Equity": "-139,000",
"Net Income": "73,800",
"Comprehensive Net Income": "63,350",
"BaseVar": "2,488,650",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,113,200",
"Assets, Non-Current": "23,800",
"General and Administrative Expense": "963,800",
"Goodwill": "290,000",
"Liabilities, Current": "497,500",
"Liabilities, Non-Current": "612,500",
"Other Assets": "59,400",
"Other Compr. Net Income": "61,400",
"Other Expenses": "211,000",
"Other Liabilities": "101,000",
"Other Net Income": "664,300",
"Other Revenues": "1,084,400",
"Property, Plant and Equipment, Net": "216,600",
"Research and Development": "20,000"
},
"output_variables": {
"Liabilities": "1,211,000",
"Assets": "1,703,000",
"Expenses": "1,194,800",
"Revenues": "1,084,400",
"Stockholders Equity": "492,000",
"Net Income": "553,900",
"Comprehensive Net Income": "584,600",
"BaseVar": "2,959,450",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "158%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "683,200",
"Assets, Non-Current": "28,000",
"General and Administrative Expense": "1,004,600",
"Goodwill": "296,900",
"Liabilities, Current": "289,900",
"Liabilities, Non-Current": "409,700",
"Other Assets": "48,700",
"Other Compr. Net Income": "-34,600",
"Other Expenses": "116,400",
"Other Liabilities": "100,900",
"Other Net Income": "31,300",
"Other Revenues": "1,125,400",
"Property, Plant and Equipment, Net": "225,100",
"Research and Development": "20,200"
},
"output_variables": {
"Liabilities": "800,500",
"Assets": "1,281,900",
"Expenses": "1,141,200",
"Revenues": "1,125,400",
"Stockholders Equity": "481,400",
"Net Income": "15,500",
"Comprehensive Net Income": "-1,800",
"BaseVar": "2,207,450",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "141%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "648,300",
"Assets, Non-Current": "67,300",
"General and Administrative Expense": "903,400",
"Goodwill": "289,600",
"Liabilities, Current": "225,900",
"Liabilities, Non-Current": "451,500",
"Other Assets": "51,600",
"Other Compr. Net Income": "2,600",
"Other Expenses": "50,700",
"Other Liabilities": "83,600",
"Other Net Income": "5,700",
"Other Revenues": "1,013,500",
"Property, Plant and Equipment, Net": "245,300",
"Research and Development": "18,400"
},
"output_variables": {
"Liabilities": "761,000",
"Assets": "1,302,100",
"Expenses": "972,500",
"Revenues": "1,013,500",
"Stockholders Equity": "541,100",
"Net Income": "46,700",
"Comprehensive Net Income": "48,000",
"BaseVar": "2,028,700",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "151%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "791,700",
"Assets, Non-Current": "75,100",
"General and Administrative Expense": "809,800",
"Goodwill": "285,900",
"Liabilities, Current": "239,300",
"Liabilities, Non-Current": "454,800",
"Other Assets": "39,300",
"Other Compr. Net Income": "6,000",
"Other Expenses": "-25,500",
"Other Liabilities": "69,400",
"Other Net Income": "-300",
"Other Revenues": "903,200",
"Property, Plant and Equipment, Net": "225,600",
"Research and Development": "17,900"
},
"output_variables": {
"Liabilities": "763,500",
"Assets": "1,417,600",
"Expenses": "802,200",
"Revenues": "903,200",
"Stockholders Equity": "654,100",
"Net Income": "100,700",
"Comprehensive Net Income": "103,700",
"BaseVar": "1,946,400",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "162%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.6188983070783702,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001644440.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001644440.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001644440.svg"
},
{
"company_id": "0001307954",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001307954.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001307954.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001307954.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001307954_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001307954_main_keyfigs.svg",
"name": "Huntsman CORP",
"rank": 24,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001307954.svg",
"report_text": "The relative strengths and weaknesses of Huntsman CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Huntsman CORP compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Huntsman CORP is the variable Stockholders Equity, reducing the Economic Capital Ratio by 26% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 14% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001307954_2021_Huntsman_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "-2.03",
"Liabilities": "-45.4",
"Stockholders Equity": "-67.7",
"ECR before LimitedLiability": "-63.6",
"Liabilities, Current": "2.22",
"Liabilities, Non-Current": "-45.6",
"Goodwill": "-21.9",
"Assets": "-28.8",
"Property, Plant and Equipment, Net": "24.7",
"Assets, Current": "-25.7",
"Assets, Non-Current": "-6.92",
"Other Assets": "7.77",
"Other Revenues": "5.95",
"Revenues": "5.95",
"Net Income": "8.75",
"Comprehensive Net Income": "8.76",
"Research and Development": "8.63",
"Other Net Income": "2.35",
"Other Expenses": "-53.9",
"General and Administrative Expense": "32.3",
"Economic Capital Ratio": "-61.6"
},
"2011": {
"Liabilities, Current": "30.9",
"Liabilities": "-25.6",
"Stockholders Equity": "-54.5",
"ECR before LimitedLiability": "24.0",
"Liabilities, Non-Current": "-77.2",
"Other Liabilities": "9.20",
"Property, Plant and Equipment, Net": "30.9",
"Assets": "-28.2",
"Other Assets": "3.25",
"Goodwill": "-16.8",
"Assets, Current": "-33.8",
"General and Administrative Expense": "36.1",
"Expenses": "18.4",
"Revenues": "31.4",
"Net Income": "32.1",
"Research and Development": "19.3",
"Other Expenses": "-66.2",
"Other Revenues": "31.4",
"Comprehensive Net Income": "31.9",
"Other Net Income": "-9.30",
"Economic Capital Ratio": "-38.0"
},
"2012": {
"Liabilities, Current": "13.8",
"Liabilities": "-31.2",
"Stockholders Equity": "-59.2",
"ECR before LimitedLiability": "-7.55",
"Liabilities, Non-Current": "-71.2",
"Other Liabilities": "19.2",
"Assets, Current": "-31.5",
"Assets": "-28.6",
"Other Assets": "2.75",
"Property, Plant and Equipment, Net": "31.2",
"Goodwill": "-18.5",
"Other Expenses": "-56.5",
"Expenses": "23.9",
"Revenues": "33.9",
"Net Income": "35.4",
"Research and Development": "20.7",
"General and Administrative Expense": "36.9",
"Other Revenues": "33.9",
"Other Net Income": "-4.05",
"Comprehensive Net Income": "35.2",
"Economic Capital Ratio": "-40.0"
},
"2013": {
"Liabilities, Current": "21.5",
"Liabilities": "-21.0",
"Stockholders Equity": "-52.4",
"ECR before LimitedLiability": "6.12",
"Other Liabilities": "12.2",
"Liabilities, Non-Current": "-60.4",
"Goodwill": "-18.7",
"Assets": "-28.2",
"Property, Plant and Equipment, Net": "33.3",
"Other Assets": "-2.40",
"Assets, Current": "-30.0",
"General and Administrative Expense": "37.9",
"Expenses": "16.6",
"Revenues": "36.1",
"Net Income": "36.8",
"Research and Development": "17.1",
"Other Expenses": "-54.6",
"Other Revenues": "36.1",
"Other Net Income": "-6.37",
"Comprehensive Net Income": "36.9",
"Economic Capital Ratio": "-34.0"
},
"2014": {
"Liabilities, Non-Current": "-71.6",
"Liabilities": "-13.1",
"Stockholders Equity": "-30.3",
"ECR before LimitedLiability": "26.7",
"Liabilities, Current": "26.5",
"Other Liabilities": "9.73",
"Assets, Current": "-25.2",
"Assets": "-16.6",
"Goodwill": "-20.4",
"Other Assets": "5.65",
"Property, Plant and Equipment, Net": "26.3",
"Other Expenses": "-52.5",
"Expenses": "26.2",
"Revenues": "26.4",
"Net Income": "29.2",
"Research and Development": "19.3",
"General and Administrative Expense": "30.4",
"Other Revenues": "26.4",
"Comprehensive Net Income": "28.9",
"Other Compr. Net Income": "-2.12",
"Economic Capital Ratio": "-22.7"
},
"2018": {
"Property, Plant and Equipment, Net": "13.3",
"Assets": "-28.2",
"Liabilities, Non-Current": "-43.5",
"Stockholders Equity": "-45.1",
"ECR before LimitedLiability": "17.4",
"Other Assets": "4.42",
"Assets, Current": "-29.2",
"Goodwill": "-12.5",
"Other Expenses": "16.1",
"Expenses": "10.1",
"Revenues": "53.8",
"Net Income": "56.2",
"Research and Development": "17.4",
"General and Administrative Expense": "-21.3",
"Other Revenues": "53.8",
"Other Liabilities": "15.2",
"Liabilities, Current": "21.9",
"Comprehensive Net Income": "56.1",
"Other Net Income": "-2.76",
"Other Compr. Net Income": "-2.64",
"Economic Capital Ratio": "-3.04"
},
"2019": {
"Liabilities, Non-Current": "-45.7",
"Liabilities": "-19.0",
"Stockholders Equity": "-30.6",
"ECR before LimitedLiability": "34.9",
"Other Liabilities": "15.1",
"Liabilities, Current": "8.16",
"Assets": "-12.2",
"Goodwill": "-11.0",
"Property, Plant and Equipment, Net": "7.38",
"Other Assets": "4.94",
"Assets, Current": "-12.3",
"Research and Development": "10.2",
"Expenses": "19.7",
"Revenues": "27.5",
"Net Income": "56.8",
"Other Expenses": "12.4",
"General and Administrative Expense": "-3.15",
"Other Revenues": "27.5",
"Other Net Income": "5.80",
"Comprehensive Net Income": "56.8",
"Economic Capital Ratio": "5.48"
},
"2020": {
"Liabilities, Current": "6.12",
"Liabilities": "-9.32",
"Stockholders Equity": "-25.8",
"ECR before LimitedLiability": "51.6",
"Liabilities, Non-Current": "-22.9",
"Other Liabilities": "6.44",
"Goodwill": "-4.59",
"Assets": "-12.1",
"Other Assets": "2.73",
"Assets, Current": "-16.1",
"Property, Plant and Equipment, Net": "6.04",
"Other Expenses": "11.2",
"Expenses": "7.95",
"Revenues": "20.3",
"Net Income": "43.9",
"Research and Development": "7.07",
"General and Administrative Expense": "-9.91",
"Other Revenues": "20.3",
"Comprehensive Net Income": "43.9",
"Other Net Income": "13.0",
"Economic Capital Ratio": "13.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001307954_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "4,008,000",
"Assets, Non-Current": "729,000",
"General and Administrative Expense": "861,000",
"Goodwill": "199,000",
"Liabilities, Current": "2,053,000",
"Liabilities, Non-Current": "4,493,000",
"Other Assets": "173,000",
"Other Compr. Net Income": "-15,000",
"Other Expenses": "8,086,000",
"Other Liabilities": "318,000",
"Other Net Income": "-122,000",
"Other Revenues": "9,252,000",
"Property, Plant and Equipment, Net": "3,605,000",
"Research and Development": "151,000"
},
"output_variables": {
"Liabilities": "6,864,000",
"Assets": "8,714,000",
"Expenses": "9,098,000",
"Revenues": "9,252,000",
"Stockholders Equity": "1,850,000",
"Net Income": "32,000",
"Comprehensive Net Income": "24,500",
"BaseVar": "17,032,500",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "3,946,000",
"Assets, Non-Current": "684,000",
"General and Administrative Expense": "921,000",
"Goodwill": "205,000",
"Liabilities, Current": "1,826,000",
"Liabilities, Non-Current": "4,742,000",
"Other Assets": "200,000",
"Other Compr. Net Income": "-269,000",
"Other Expenses": "9,886,000",
"Other Liabilities": "313,000",
"Other Net Income": "4,000",
"Other Revenues": "11,223,000",
"Property, Plant and Equipment, Net": "3,622,000",
"Research and Development": "166,000"
},
"output_variables": {
"Liabilities": "6,881,000",
"Assets": "8,657,000",
"Expenses": "10,973,000",
"Revenues": "11,223,000",
"Stockholders Equity": "1,776,000",
"Net Income": "254,000",
"Comprehensive Net Income": "119,500",
"BaseVar": "19,003,500",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4,119,000",
"Assets, Non-Current": "604,000",
"General and Administrative Expense": "951,000",
"Goodwill": "185,000",
"Liabilities, Current": "2,181,000",
"Liabilities, Non-Current": "4,575,000",
"Other Assets": "231,000",
"Other Compr. Net Income": "-195,000",
"Other Expenses": "9,408,000",
"Other Liabilities": "232,000",
"Other Net Income": "-303,000",
"Other Revenues": "11,187,000",
"Property, Plant and Equipment, Net": "3,745,000",
"Research and Development": "152,000"
},
"output_variables": {
"Liabilities": "6,988,000",
"Assets": "8,884,000",
"Expenses": "10,511,000",
"Revenues": "11,187,000",
"Stockholders Equity": "1,896,000",
"Net Income": "373,000",
"Comprehensive Net Income": "275,500",
"BaseVar": "19,034,000",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "118%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "4,159,000",
"Assets, Non-Current": "743,000",
"General and Administrative Expense": "942,000",
"Goodwill": "218,000",
"Liabilities, Current": "2,159,000",
"Liabilities, Non-Current": "4,581,000",
"Other Assets": "244,000",
"Other Compr. Net Income": "146,000",
"Other Expenses": "9,612,000",
"Other Liabilities": "319,000",
"Other Net Income": "-236,000",
"Other Revenues": "11,079,000",
"Property, Plant and Equipment, Net": "3,824,000",
"Research and Development": "140,000"
},
"output_variables": {
"Liabilities": "7,059,000",
"Assets": "9,188,000",
"Expenses": "10,694,000",
"Revenues": "11,079,000",
"Stockholders Equity": "2,129,000",
"Net Income": "149,000",
"Comprehensive Net Income": "222,000",
"BaseVar": "19,201,000",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "121%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "5,039,000",
"Assets, Non-Current": "888,000",
"General and Administrative Expense": "974,000",
"Goodwill": "217,000",
"Liabilities, Current": "2,332,000",
"Liabilities, Non-Current": "6,380,000",
"Other Assets": "435,000",
"Other Compr. Net Income": "-498,000",
"Other Expenses": "9,864,000",
"Other Liabilities": "339,000",
"Other Net Income": "-237,000",
"Other Revenues": "11,578,000",
"Property, Plant and Equipment, Net": "4,423,000",
"Research and Development": "158,000"
},
"output_variables": {
"Liabilities": "9,051,000",
"Assets": "11,002,000",
"Expenses": "10,996,000",
"Revenues": "11,578,000",
"Stockholders Equity": "1,951,000",
"Net Income": "345,000",
"Comprehensive Net Income": "96,000",
"BaseVar": "21,681,000",
"ECR before LimitedLiability": "28%",
"Economic Capital Ratio": "111%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "2,958,000",
"Assets, Non-Current": "1,079,000",
"General and Administrative Expense": "8,184,000",
"Goodwill": "494,000",
"Liabilities, Current": "1,907,000",
"Liabilities, Non-Current": "3,297,000",
"Other Assets": "358,000",
"Other Compr. Net Income": "-506,000",
"Other Expenses": "164,000",
"Other Liabilities": "0",
"Other Net Income": "-229,000",
"Other Revenues": "9,379,000",
"Property, Plant and Equipment, Net": "3,064,000",
"Research and Development": "152,000"
},
"output_variables": {
"Liabilities": "5,204,000",
"Assets": "7,953,000",
"Expenses": "8,500,000",
"Revenues": "9,379,000",
"Stockholders Equity": "2,749,000",
"Net Income": "650,000",
"Comprehensive Net Income": "397,000",
"BaseVar": "15,885,500",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "141%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "3,755,000",
"Assets, Non-Current": "1,383,000",
"General and Administrative Expense": "6,201,000",
"Goodwill": "473,000",
"Liabilities, Current": "2,037,000",
"Liabilities, Non-Current": "3,459,000",
"Other Assets": "326,000",
"Other Compr. Net Income": "-67,000",
"Other Expenses": "-48,000",
"Other Liabilities": "0",
"Other Net Income": "91,000",
"Other Revenues": "6,797,000",
"Property, Plant and Equipment, Net": "2,383,000",
"Research and Development": "137,000"
},
"output_variables": {
"Liabilities": "5,496,000",
"Assets": "8,320,000",
"Expenses": "6,290,000",
"Revenues": "6,797,000",
"Stockholders Equity": "2,824,000",
"Net Income": "598,000",
"Comprehensive Net Income": "564,500",
"BaseVar": "13,530,500",
"ECR before LimitedLiability": "64%",
"Economic Capital Ratio": "141%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,568,000",
"Assets, Non-Current": "1,366,000",
"General and Administrative Expense": "5,693,000",
"Goodwill": "986,000",
"Liabilities, Current": "2,191,000",
"Liabilities, Non-Current": "2,849,000",
"Other Assets": "288,000",
"Other Compr. Net Income": "-16,000",
"Other Expenses": "-197,000",
"Other Liabilities": "0",
"Other Net Income": "679,000",
"Other Revenues": "6,018,000",
"Property, Plant and Equipment, Net": "2,505,000",
"Research and Development": "135,000"
},
"output_variables": {
"Liabilities": "5,040,000",
"Assets": "8,713,000",
"Expenses": "5,631,000",
"Revenues": "6,018,000",
"Stockholders Equity": "3,673,000",
"Net Income": "1,066,000",
"Comprehensive Net Income": "1,058,000",
"BaseVar": "13,048,500",
"ECR before LimitedLiability": "89%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 1.5965457430937366,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001307954.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001307954.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001307954.svg"
},
{
"company_id": "0001056358",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001056358.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001056358.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001056358.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001056358_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001056358_main_keyfigs.svg",
"name": "Mannatech INC",
"rank": 25,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001056358.svg",
"report_text": "The relative strengths and weaknesses of Mannatech INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Mannatech INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 82% points.The greatest weakness of Mannatech INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 108% points.
The company's Economic Capital Ratio, given in the ranking table, is 154%, being 8.4% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001056358_2021_Mannatech_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "-3.85",
"Liabilities": "-9.05",
"Stockholders Equity": "-140",
"ECR before LimitedLiability": "-70.0",
"Other Liabilities": "-5.76",
"Property, Plant and Equipment, Net": "-17.3",
"Assets": "-58.1",
"Other Assets": "9.04",
"Assets, Current": "-42.8",
"Assets, Non-Current": "-13.3",
"Goodwill": "-14.0",
"General and Administrative Expense": "3.92",
"Expenses": "-62.6",
"Revenues": "34.1",
"Net Income": "-34.3",
"Other Expenses": "-72.3",
"Research and Development": "7.47",
"Other Revenues": "34.1",
"Comprehensive Net Income": "-34.2",
"Other Net Income": "1.13",
"Economic Capital Ratio": "-70.7"
},
"2010": {
"Liabilities": "65.1",
"Stockholders Equity": "-124",
"ECR before LimitedLiability": "-29.4",
"Liabilities, Current": "11.6",
"Liabilities, Non-Current": "59.2",
"Goodwill": "-32.3",
"Assets": "-66.0",
"Property, Plant and Equipment, Net": "-17.8",
"Assets, Current": "-42.4",
"Assets, Non-Current": "-19.2",
"Other Assets": "15.5",
"Other Expenses": "-110",
"Expenses": "-90.9",
"Revenues": "69.9",
"Net Income": "2.46",
"General and Administrative Expense": "0.961",
"Research and Development": "20.1",
"Other Revenues": "69.9",
"Other Net Income": "7.69",
"Comprehensive Net Income": "2.63",
"Economic Capital Ratio": "-27.4"
},
"2011": {
"Liabilities, Current": "21.5",
"Liabilities": "26.5",
"Stockholders Equity": "-120",
"ECR before LimitedLiability": "12.3",
"Liabilities, Non-Current": "15.7",
"Other Liabilities": "19.3",
"Property, Plant and Equipment, Net": "-28.7",
"Assets": "-95.4",
"Assets, Non-Current": "-15.7",
"Goodwill": "-40.1",
"Assets, Current": "-73.9",
"General and Administrative Expense": "19.8",
"Expenses": "-80.7",
"Revenues": "66.1",
"Net Income": "25.7",
"Research and Development": "21.0",
"Other Expenses": "-141",
"Other Revenues": "66.1",
"Comprehensive Net Income": "25.8",
"Other Net Income": "-23.1",
"Economic Capital Ratio": "-49.7"
},
"2012": {
"Liabilities, Current": "31.4",
"Liabilities": "63.0",
"Stockholders Equity": "-131",
"ECR before LimitedLiability": "19.9",
"Liabilities, Non-Current": "23.7",
"Other Liabilities": "47.8",
"Assets, Current": "-53.5",
"Assets": "-73.2",
"Other Assets": "8.93",
"Assets, Non-Current": "-10.5",
"Property, Plant and Equipment, Net": "-24.7",
"Goodwill": "-31.3",
"Other Expenses": "-119",
"Expenses": "-64.4",
"Revenues": "99.2",
"Net Income": "69.9",
"Research and Development": "49.9",
"General and Administrative Expense": "15.8",
"Other Revenues": "99.2",
"Comprehensive Net Income": "69.9",
"Economic Capital Ratio": "-12.6"
},
"2013": {
"Liabilities, Current": "28.6",
"Liabilities": "69.1",
"Stockholders Equity": "-101",
"ECR before LimitedLiability": "38.7",
"Other Liabilities": "33.1",
"Liabilities, Non-Current": "34.3",
"Goodwill": "-27.6",
"Assets": "-63.4",
"Assets, Non-Current": "-7.35",
"Property, Plant and Equipment, Net": "-20.9",
"Assets, Current": "-41.2",
"General and Administrative Expense": "12.7",
"Expenses": "-49.9",
"Revenues": "98.1",
"Net Income": "73.4",
"Research and Development": "35.2",
"Other Expenses": "-90.9",
"Other Revenues": "98.1",
"Other Net Income": "-10.2",
"Comprehensive Net Income": "73.4",
"Economic Capital Ratio": "-1.46"
},
"2014": {
"Liabilities, Non-Current": "37.3",
"Liabilities": "82.2",
"Stockholders Equity": "-34.5",
"ECR before LimitedLiability": "81.1",
"Liabilities, Current": "60.6",
"Other Liabilities": "26.3",
"Assets, Current": "-31.3",
"Assets": "-49.0",
"Goodwill": "-24.3",
"Other Assets": "22.4",
"Assets, Non-Current": "-5.37",
"Property, Plant and Equipment, Net": "-20.0",
"Other Expenses": "-92.9",
"Expenses": "-34.1",
"Revenues": "99.1",
"Net Income": "85.9",
"Research and Development": "36.0",
"General and Administrative Expense": "28.8",
"Other Revenues": "99.1",
"Comprehensive Net Income": "86.0",
"Economic Capital Ratio": "31.6"
},
"2015": {
"Other Liabilities": "35.8",
"Liabilities": "98.1",
"Stockholders Equity": "-29.5",
"ECR before LimitedLiability": "91.3",
"Liabilities, Current": "64.6",
"Liabilities, Non-Current": "43.2",
"Assets, Current": "-24.4",
"Assets": "-44.4",
"Other Assets": "3.61",
"Goodwill": "-20.6",
"Property, Plant and Equipment, Net": "-17.7",
"Research and Development": "25.2",
"Expenses": "-45.3",
"Revenues": "113",
"Net Income": "97.9",
"General and Administrative Expense": "3.64",
"Other Expenses": "-74.5",
"Other Revenues": "113",
"Comprehensive Net Income": "98.1",
"Other Net Income": "-3.27",
"Economic Capital Ratio": "45.4"
},
"2016": {
"Liabilities, Non-Current": "42.8",
"Liabilities": "85.7",
"Stockholders Equity": "-69.9",
"ECR before LimitedLiability": "43.2",
"Liabilities, Current": "51.0",
"Other Liabilities": "19.2",
"Property, Plant and Equipment, Net": "-25.7",
"Assets": "-52.3",
"Other Assets": "23.1",
"Assets, Current": "-34.8",
"Goodwill": "-22.5",
"Research and Development": "36.7",
"Expenses": "-51.3",
"Revenues": "99.8",
"Net Income": "85.2",
"General and Administrative Expense": "-10.3",
"Other Expenses": "-74.8",
"Other Revenues": "99.8",
"Comprehensive Net Income": "85.3",
"Other Net Income": "-6.72",
"Economic Capital Ratio": "23.2"
},
"2017": {
"Other Liabilities": "26.0",
"Liabilities": "82.7",
"Stockholders Equity": "-57.8",
"ECR before LimitedLiability": "35.1",
"Liabilities, Current": "35.7",
"Liabilities, Non-Current": "45.2",
"Assets, Non-Current": "-5.22",
"Assets": "-50.3",
"Other Assets": "21.4",
"Assets, Current": "-24.1",
"Goodwill": "-24.0",
"Property, Plant and Equipment, Net": "-30.2",
"Research and Development": "33.8",
"Expenses": "-53.8",
"Revenues": "94.1",
"Net Income": "70.2",
"Other Expenses": "-82.6",
"Other Revenues": "94.1",
"Comprehensive Net Income": "72.7",
"Other Net Income": "-9.87",
"Economic Capital Ratio": "13.5"
},
"2018": {
"Liabilities, Non-Current": "40.3",
"Liabilities": "55.4",
"Stockholders Equity": "-109",
"ECR before LimitedLiability": "15.3",
"Other Liabilities": "25.9",
"Liabilities, Current": "24.7",
"Property, Plant and Equipment, Net": "-36.3",
"Assets": "-71.9",
"Other Assets": "34.2",
"Assets, Current": "-46.7",
"Goodwill": "-29.7",
"Assets, Non-Current": "-17.7",
"Other Expenses": "-124",
"Expenses": "-63.7",
"Revenues": "82.2",
"Net Income": "57.7",
"Research and Development": "38.7",
"General and Administrative Expense": "36.9",
"Other Revenues": "82.2",
"Comprehensive Net Income": "57.6",
"Economic Capital Ratio": "-5.21"
},
"2019": {
"Liabilities, Non-Current": "32.4",
"Liabilities": "70.3",
"Stockholders Equity": "-90.3",
"ECR before LimitedLiability": "48.3",
"Other Liabilities": "29.6",
"Liabilities, Current": "22.1",
"Assets, Non-Current": "-13.5",
"Assets": "-58.8",
"Goodwill": "-25.2",
"Property, Plant and Equipment, Net": "-29.1",
"Other Assets": "23.4",
"Assets, Current": "-33.9",
"Research and Development": "24.4",
"Expenses": "-45.5",
"Revenues": "86.7",
"Net Income": "73.7",
"Other Expenses": "-106",
"General and Administrative Expense": "45.5",
"Other Revenues": "86.7",
"Comprehensive Net Income": "73.6",
"Economic Capital Ratio": "18.8"
},
"2020": {
"Liabilities, Current": "17.2",
"Liabilities": "69.7",
"Stockholders Equity": "-108",
"ECR before LimitedLiability": "46.2",
"Liabilities, Non-Current": "44.6",
"Other Liabilities": "12.7",
"Goodwill": "-24.4",
"Assets": "-61.0",
"Other Assets": "16.7",
"Assets, Current": "-38.8",
"Property, Plant and Equipment, Net": "-29.7",
"Other Expenses": "-90.7",
"Expenses": "-61.4",
"Revenues": "82.1",
"Net Income": "70.0",
"Research and Development": "18.2",
"General and Administrative Expense": "14.6",
"Other Revenues": "82.1",
"Comprehensive Net Income": "70.1",
"Other Net Income": "13.7",
"Economic Capital Ratio": "8.44"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001056358_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "64,485",
"Assets, Non-Current": "2,503",
"General and Administrative Expense": "116,810",
"Goodwill": "0",
"Liabilities, Current": "42,679",
"Liabilities, Non-Current": "3,348",
"Other Assets": "8,170",
"Other Compr. Net Income": "0",
"Other Expenses": "191,782",
"Other Liabilities": "4,991",
"Other Net Income": "1,519",
"Other Revenues": "289,705",
"Property, Plant and Equipment, Net": "27,144",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "51,018",
"Assets": "102,302",
"Expenses": "308,592",
"Revenues": "289,705",
"Stockholders Equity": "51,284",
"Net Income": "-17,368",
"Comprehensive Net Income": "-17,368",
"BaseVar": "376,568",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "55,215",
"Assets, Non-Current": "3,054",
"General and Administrative Expense": "95,411",
"Goodwill": "0",
"Liabilities, Current": "32,240",
"Liabilities, Non-Current": "4,996",
"Other Assets": "4,705",
"Other Compr. Net Income": "0",
"Other Expenses": "143,734",
"Other Liabilities": "3,107",
"Other Net Income": "441",
"Other Revenues": "228,088",
"Property, Plant and Equipment, Net": "18,449",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "40,343",
"Assets": "81,423",
"Expenses": "239,145",
"Revenues": "228,088",
"Stockholders Equity": "41,080",
"Net Income": "-10,616",
"Comprehensive Net Income": "-10,616",
"BaseVar": "294,720",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "150%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "41,731",
"Assets, Non-Current": "2,815",
"General and Administrative Expense": "86,118",
"Goodwill": "0",
"Liabilities, Current": "29,876",
"Liabilities, Non-Current": "5,382",
"Other Assets": "4,158",
"Other Compr. Net Income": "881",
"Other Expenses": "134,241",
"Other Liabilities": "1,359",
"Other Net Income": "-989",
"Other Revenues": "200,689",
"Property, Plant and Equipment, Net": "9,566",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,617",
"Assets": "58,270",
"Expenses": "220,359",
"Revenues": "200,689",
"Stockholders Equity": "21,653",
"Net Income": "-20,659",
"Comprehensive Net Income": "-20,218",
"BaseVar": "258,902",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "35,302",
"Assets, Non-Current": "3,187",
"General and Administrative Expense": "71,817",
"Goodwill": "0",
"Liabilities, Current": "24,221",
"Liabilities, Non-Current": "2,178",
"Other Assets": "4,246",
"Other Compr. Net Income": "-250",
"Other Expenses": "103,698",
"Other Liabilities": "940",
"Other Net Income": "680",
"Other Revenues": "173,447",
"Property, Plant and Equipment, Net": "4,825",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "27,339",
"Assets": "47,560",
"Expenses": "175,515",
"Revenues": "173,447",
"Stockholders Equity": "20,221",
"Net Income": "-1,388",
"Comprehensive Net Income": "-1,513",
"BaseVar": "212,396",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "146%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "43,674",
"Assets, Non-Current": "3,591",
"General and Administrative Expense": "69,855",
"Goodwill": "0",
"Liabilities, Current": "30,058",
"Liabilities, Non-Current": "2,101",
"Other Assets": "5,557",
"Other Compr. Net Income": "-66",
"Other Expenses": "102,447",
"Other Liabilities": "450",
"Other Net Income": "-1,947",
"Other Revenues": "177,423",
"Property, Plant and Equipment, Net": "3,239",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "32,609",
"Assets": "56,061",
"Expenses": "172,302",
"Revenues": "177,423",
"Stockholders Equity": "23,452",
"Net Income": "3,174",
"Comprehensive Net Income": "3,141",
"BaseVar": "220,204",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "153%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "49,363",
"Assets, Non-Current": "3,567",
"General and Administrative Expense": "74,543",
"Goodwill": "0",
"Liabilities, Current": "33,008",
"Liabilities, Non-Current": "2,136",
"Other Assets": "14,468",
"Other Compr. Net Income": "634",
"Other Expenses": "106,121",
"Other Liabilities": "878",
"Other Net Income": "-2,921",
"Other Revenues": "190,081",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,022",
"Assets": "67,398",
"Expenses": "180,664",
"Revenues": "190,081",
"Stockholders Equity": "31,376",
"Net Income": "6,496",
"Comprehensive Net Income": "6,813",
"BaseVar": "238,860",
"ECR before LimitedLiability": "96%",
"Economic Capital Ratio": "165%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "49,885",
"Assets, Non-Current": "3,759",
"General and Administrative Expense": "68,560",
"Goodwill": "0",
"Liabilities, Current": "26,379",
"Liabilities, Non-Current": "1,994",
"Other Assets": "14,998",
"Other Compr. Net Income": "795",
"Other Expenses": "101,923",
"Other Liabilities": "1,705",
"Other Net Income": "-3,945",
"Other Revenues": "180,267",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "30,078",
"Assets": "68,642",
"Expenses": "170,483",
"Revenues": "180,267",
"Stockholders Equity": "38,564",
"Net Income": "5,839",
"Comprehensive Net Income": "6,236",
"BaseVar": "227,105",
"ECR before LimitedLiability": "120%",
"Economic Capital Ratio": "181%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "50,762",
"Assets, Non-Current": "4,013",
"General and Administrative Expense": "73,744",
"Goodwill": "0",
"Liabilities, Current": "29,981",
"Liabilities, Non-Current": "1,465",
"Other Assets": "16,413",
"Other Compr. Net Income": "1,148",
"Other Expenses": "105,493",
"Other Liabilities": "857",
"Other Net Income": "-1,653",
"Other Revenues": "180,304",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "32,303",
"Assets": "71,188",
"Expenses": "179,237",
"Revenues": "180,304",
"Stockholders Equity": "38,885",
"Net Income": "-586",
"Comprehensive Net Income": "-12",
"BaseVar": "232,916",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "56,248",
"Assets, Non-Current": "3,876",
"General and Administrative Expense": "71,137",
"Goodwill": "0",
"Liabilities, Current": "34,592",
"Liabilities, Non-Current": "1,300",
"Other Assets": "16,118",
"Other Compr. Net Income": "4,150",
"Other Expenses": "107,287",
"Other Liabilities": "109",
"Other Net Income": "-59",
"Other Revenues": "176,696",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,001",
"Assets": "76,242",
"Expenses": "178,424",
"Revenues": "176,696",
"Stockholders Equity": "40,241",
"Net Income": "-1,787",
"Comprehensive Net Income": "288",
"BaseVar": "235,786",
"ECR before LimitedLiability": "99%",
"Economic Capital Ratio": "167%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "42,387",
"Assets, Non-Current": "3,894",
"General and Administrative Expense": "68,632",
"Goodwill": "0",
"Liabilities, Current": "33,617",
"Liabilities, Non-Current": "2,302",
"Other Assets": "15,917",
"Other Compr. Net Income": "-1,647",
"Other Expenses": "109,391",
"Other Liabilities": "955",
"Other Net Income": "579",
"Other Revenues": "173,558",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,874",
"Assets": "62,198",
"Expenses": "178,023",
"Revenues": "173,558",
"Stockholders Equity": "25,324",
"Net Income": "-3,886",
"Comprehensive Net Income": "-4,710",
"BaseVar": "226,440",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "139%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "41,029",
"Assets, Non-Current": "9,600",
"General and Administrative Expense": "62,374",
"Goodwill": "0",
"Liabilities, Current": "28,895",
"Liabilities, Non-Current": "6,200",
"Other Assets": "12,294",
"Other Compr. Net Income": "-580",
"Other Expenses": "91,368",
"Other Liabilities": "553",
"Other Net Income": "-697",
"Other Revenues": "157,700",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "35,648",
"Assets": "62,923",
"Expenses": "153,742",
"Revenues": "157,700",
"Stockholders Equity": "27,275",
"Net Income": "3,261",
"Comprehensive Net Income": "2,971",
"BaseVar": "205,645",
"ECR before LimitedLiability": "82%",
"Economic Capital Ratio": "155%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "42,477",
"Assets, Non-Current": "11,977",
"General and Administrative Expense": "63,350",
"Goodwill": "0",
"Liabilities, Current": "31,990",
"Liabilities, Non-Current": "7,245",
"Other Assets": "10,882",
"Other Compr. Net Income": "1,393",
"Other Expenses": "83,030",
"Other Liabilities": "129",
"Other Net Income": "1,234",
"Other Revenues": "151,407",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "39,364",
"Assets": "65,336",
"Expenses": "146,380",
"Revenues": "151,407",
"Stockholders Equity": "25,972",
"Net Income": "6,261",
"Comprehensive Net Income": "6,958",
"BaseVar": "202,557",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 1.5433773999005778,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001056358.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001056358.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001056358.svg"
},
{
"company_id": "0001697834",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001697834.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001697834.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001697834.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001697834_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001697834_main_keyfigs.svg",
"name": "Stem Holdings Inc",
"rank": 26,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001697834.svg",
"report_text": "The relative strengths and weaknesses of Stem Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Stem Holdings Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Stem Holdings Inc is the variable Assets, Current, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 153%, being 7.5% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001697834_2021_Stem_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "11.5",
"Liabilities": "65.0",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "57.8",
"Liabilities, Current": "37.4",
"Liabilities, Non-Current": "21.1",
"Assets": "59.0",
"Other Assets": "11.6",
"Assets, Current": "-14.5",
"Goodwill": "-8.94",
"Property, Plant and Equipment, Net": "112",
"Research and Development": "12.6",
"Expenses": "-24.5",
"Revenues": "-27.3",
"Net Income": "-56.7",
"Other Expenses": "-47.2",
"General and Administrative Expense": "9.94",
"Other Revenues": "-27.3",
"Comprehensive Net Income": "-57.0",
"Other Net Income": "-3.80",
"Economic Capital Ratio": "36.2"
},
"2018": {
"Liabilities, Non-Current": "-7.97",
"Liabilities": "-12.8",
"Stockholders Equity": "39.5",
"Economic Capital Ratio": "-19.0",
"Other Liabilities": "9.59",
"Liabilities, Current": "-14.7",
"Property, Plant and Equipment, Net": "44.9",
"Assets": "40.5",
"Other Assets": "40.1",
"Assets, Current": "-29.3",
"Goodwill": "-13.2",
"Assets, Non-Current": "1.63",
"Other Expenses": "-32.1",
"Expenses": "3.77",
"Revenues": "-30.0",
"Net Income": "-28.9",
"Research and Development": "12.7",
"General and Administrative Expense": "27.6",
"Other Revenues": "-30.0",
"Comprehensive Net Income": "-28.7",
"Other Net Income": "-2.40"
},
"2019": {
"Liabilities, Non-Current": "16.8",
"Liabilities": "17.1",
"Stockholders Equity": "22.5",
"ECR before LimitedLiability": "-5.09",
"Other Liabilities": "14.9",
"Liabilities, Current": "-6.33",
"Assets, Non-Current": "-10.5",
"Assets": "18.1",
"Goodwill": "16.8",
"Property, Plant and Equipment, Net": "25.7",
"Other Assets": "16.7",
"Assets, Current": "-38.9",
"Research and Development": "13.6",
"Expenses": "-15.0",
"Revenues": "-42.4",
"Net Income": "-75.9",
"Other Expenses": "-22.7",
"Other Revenues": "-42.4",
"Other Net Income": "-26.5",
"Comprehensive Net Income": "-75.8",
"Economic Capital Ratio": "-34.6"
},
"2020": {
"Liabilities, Current": "-19.8",
"Liabilities": "-1.07",
"Stockholders Equity": "16.6",
"ECR before LimitedLiability": "45.3",
"Liabilities, Non-Current": "12.1",
"Other Liabilities": "5.54",
"Goodwill": "48.3",
"Assets": "13.4",
"Other Assets": "4.95",
"Assets, Current": "-28.1",
"Assets, Non-Current": "-8.19",
"Property, Plant and Equipment, Net": "24.5",
"Other Expenses": "-4.02",
"Expenses": "3.40",
"Revenues": "-5.53",
"Net Income": "-1.63",
"Research and Development": "7.48",
"Other Revenues": "-5.53",
"Comprehensive Net Income": "-1.55",
"Other Net Income": "0.581",
"Economic Capital Ratio": "7.48"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001697834_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "598",
"Assets, Non-Current": "0",
"General and Administrative Expense": "828",
"Goodwill": "0",
"Liabilities, Current": "166",
"Liabilities, Non-Current": "0",
"Other Assets": "494",
"Other Compr. Net Income": "0",
"Other Expenses": "2,249",
"Other Liabilities": "0",
"Other Net Income": "4.2",
"Other Revenues": "326",
"Property, Plant and Equipment, Net": "3,259",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "166",
"Assets": "4,350",
"Expenses": "3,077",
"Revenues": "326",
"Stockholders Equity": "4,185",
"Net Income": "-2,747",
"Comprehensive Net Income": "-2,747",
"BaseVar": "3,962",
"ECR before LimitedLiability": "132%",
"Economic Capital Ratio": "190%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,905",
"Assets, Non-Current": "1,301",
"General and Administrative Expense": "3,021",
"Goodwill": "0",
"Liabilities, Current": "4,177",
"Liabilities, Non-Current": "1,913",
"Other Assets": "3,684",
"Other Compr. Net Income": "0",
"Other Expenses": "5,834",
"Other Liabilities": "0",
"Other Net Income": "-301",
"Other Revenues": "1,296",
"Property, Plant and Equipment, Net": "8,325",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,090",
"Assets": "15,215",
"Expenses": "8,855",
"Revenues": "1,296",
"Stockholders Equity": "9,125",
"Net Income": "-7,860",
"Comprehensive Net Income": "-7,860",
"BaseVar": "15,878",
"ECR before LimitedLiability": "44%",
"Economic Capital Ratio": "125%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,868",
"Assets, Non-Current": "1,771",
"General and Administrative Expense": "16,855",
"Goodwill": "7,386",
"Liabilities, Current": "7,503",
"Liabilities, Non-Current": "0",
"Other Assets": "2,366",
"Other Compr. Net Income": "0",
"Other Expenses": "7,659",
"Other Liabilities": "0",
"Other Net Income": "-6,922",
"Other Revenues": "2,451",
"Property, Plant and Equipment, Net": "14,706",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,503",
"Assets": "31,097",
"Expenses": "24,514",
"Revenues": "2,451",
"Stockholders Equity": "23,594",
"Net Income": "-28,985",
"Comprehensive Net Income": "-28,985",
"BaseVar": "36,244",
"ECR before LimitedLiability": "17%",
"Economic Capital Ratio": "101%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "5,265",
"Assets, Non-Current": "767",
"General and Administrative Expense": "18,568",
"Goodwill": "20,490",
"Liabilities, Current": "14,500",
"Liabilities, Non-Current": "3,685",
"Other Assets": "2,141",
"Other Compr. Net Income": "0",
"Other Expenses": "5,072",
"Other Liabilities": "0",
"Other Net Income": "-1,827",
"Other Revenues": "13,974",
"Property, Plant and Equipment, Net": "16,354",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "18,185",
"Assets": "45,017",
"Expenses": "23,640",
"Revenues": "13,974",
"Stockholders Equity": "26,832",
"Net Income": "-11,493",
"Comprehensive Net Income": "-11,493",
"BaseVar": "51,322",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "153%"
}
}
},
"top_rated": false,
"trend": 8.0,
"value": 1.5337646859928005,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001697834.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001697834.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001697834.svg"
},
{
"company_id": "0000874716",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000874716.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000874716.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000874716.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000874716_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000874716_main_keyfigs.svg",
"name": "Idexx Laboratories INC DE",
"rank": 27,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000874716.svg",
"report_text": "The relative strengths and weaknesses of Idexx Laboratories INC DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Idexx Laboratories INC DE compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 64% points.The greatest weakness of Idexx Laboratories INC DE is the variable Stockholders Equity, reducing the Economic Capital Ratio by 59% points.
The company's Economic Capital Ratio, given in the ranking table, is 148%, being 2.3% points above the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000874716_2021_Idexx_Laboratories_INC_DE.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "4.39",
"Liabilities": "21.9",
"Stockholders Equity": "-14.3",
"ECR before LimitedLiability": "23.6",
"Liabilities, Current": "-18.4",
"Liabilities, Non-Current": "32.6",
"Assets": "-11.3",
"Property, Plant and Equipment, Net": "0.217",
"Assets, Current": "-8.67",
"Assets, Non-Current": "28.2",
"Other Assets": "-18.8",
"Other Expenses": "21.1",
"Expenses": "-8.82",
"Revenues": "28.5",
"Net Income": "23.0",
"General and Administrative Expense": "-32.3",
"Research and Development": "1.98",
"Other Revenues": "28.5",
"Other Net Income": "3.49",
"Comprehensive Net Income": "23.1",
"Economic Capital Ratio": "25.6"
},
"2011": {
"Liabilities, Current": "-10.1",
"Liabilities": "9.33",
"Stockholders Equity": "-4.45",
"ECR before LimitedLiability": "88.9",
"Liabilities, Non-Current": "4.54",
"Other Liabilities": "14.3",
"Assets": "-5.93",
"Assets, Non-Current": "45.2",
"Other Assets": "-23.7",
"Goodwill": "5.99",
"Assets, Current": "-11.7",
"General and Administrative Expense": "-12.4",
"Expenses": "17.7",
"Revenues": "45.9",
"Net Income": "58.1",
"Research and Development": "9.32",
"Other Expenses": "21.3",
"Other Revenues": "45.9",
"Comprehensive Net Income": "58.1",
"Other Net Income": "-7.26",
"Economic Capital Ratio": "26.9"
},
"2012": {
"Liabilities, Current": "-16.6",
"Liabilities": "13.2",
"Stockholders Equity": "-4.10",
"ECR before LimitedLiability": "64.6",
"Liabilities, Non-Current": "4.25",
"Other Liabilities": "23.5",
"Assets, Current": "-9.87",
"Assets": "-6.33",
"Other Assets": "-21.8",
"Assets, Non-Current": "39.4",
"Property, Plant and Equipment, Net": "3.65",
"Goodwill": "2.84",
"Other Expenses": "24.4",
"Expenses": "17.1",
"Revenues": "43.6",
"Net Income": "63.1",
"Research and Development": "10.4",
"General and Administrative Expense": "-17.2",
"Other Revenues": "43.6",
"Comprehensive Net Income": "63.2",
"Economic Capital Ratio": "32.1"
},
"2013": {
"Liabilities, Current": "-9.09",
"Liabilities": "-3.70",
"Stockholders Equity": "-20.6",
"ECR before LimitedLiability": "47.9",
"Other Liabilities": "16.4",
"Liabilities, Non-Current": "-11.9",
"Assets": "-11.0",
"Assets, Non-Current": "48.7",
"Property, Plant and Equipment, Net": "6.04",
"Other Assets": "-28.2",
"Assets, Current": "-11.7",
"General and Administrative Expense": "-16.4",
"Expenses": "18.6",
"Revenues": "44.8",
"Net Income": "63.5",
"Research and Development": "8.33",
"Other Expenses": "28.2",
"Other Revenues": "44.8",
"Other Net Income": "-3.22",
"Comprehensive Net Income": "63.2",
"Economic Capital Ratio": "7.79"
},
"2014": {
"Liabilities, Non-Current": "-25.6",
"Liabilities": "-26.1",
"Stockholders Equity": "-39.5",
"ECR before LimitedLiability": "24.4",
"Liabilities, Current": "-14.6",
"Other Liabilities": "13.5",
"Assets, Current": "-16.9",
"Assets": "-16.4",
"Goodwill": "-4.01",
"Other Assets": "-35.5",
"Assets, Non-Current": "26.5",
"Property, Plant and Equipment, Net": "6.26",
"Other Expenses": "23.5",
"Expenses": "24.1",
"Revenues": "24.2",
"Net Income": "28.5",
"Research and Development": "12.8",
"General and Administrative Expense": "-3.18",
"Other Revenues": "24.2",
"Comprehensive Net Income": "28.4",
"Economic Capital Ratio": "-25.0"
},
"2015": {
"Other Liabilities": "4.32",
"Liabilities": "-34.1",
"Stockholders Equity": "-63.1",
"Liabilities, Current": "-12.6",
"Liabilities, Non-Current": "-42.3",
"Assets, Current": "-20.3",
"Assets": "-32.5",
"Other Assets": "-46.4",
"Goodwill": "-8.19",
"Assets, Non-Current": "10.1",
"Property, Plant and Equipment, Net": "3.92",
"Research and Development": "3.97",
"Expenses": "4.98",
"Revenues": "6.60",
"Net Income": "12.0",
"General and Administrative Expense": "-15.1",
"Other Expenses": "5.64",
"Other Revenues": "6.60",
"ECR before LimitedLiability": "-1.40",
"Comprehensive Net Income": "11.8",
"Economic Capital Ratio": "-47.3"
},
"2016": {
"Liabilities, Non-Current": "-39.4",
"Liabilities": "-47.8",
"Stockholders Equity": "-84.4",
"Liabilities, Current": "-18.5",
"Other Liabilities": "4.65",
"Property, Plant and Equipment, Net": "-4.73",
"Assets": "-43.0",
"Other Assets": "-38.0",
"Assets, Non-Current": "10.2",
"Assets, Current": "-33.4",
"Goodwill": "-9.97",
"Research and Development": "4.84",
"Expenses": "5.34",
"Revenues": "7.23",
"Net Income": "11.0",
"General and Administrative Expense": "-23.8",
"Other Expenses": "6.20",
"Other Revenues": "7.23",
"ECR before LimitedLiability": "-37.4",
"Comprehensive Net Income": "11.0",
"Economic Capital Ratio": "-57.3"
},
"2017": {
"Other Liabilities": "10.9",
"Liabilities": "-39.4",
"Stockholders Equity": "-76.4",
"Liabilities, Current": "-18.6",
"Liabilities, Non-Current": "-35.1",
"Assets, Non-Current": "14.5",
"Assets": "-40.0",
"Other Assets": "-35.4",
"Assets, Current": "-20.2",
"Goodwill": "-12.6",
"Property, Plant and Equipment, Net": "-13.8",
"Research and Development": "10.9",
"Expenses": "10.9",
"Revenues": "13.4",
"Net Income": "15.1",
"Other Expenses": "11.2",
"General and Administrative Expense": "-20.7",
"Other Revenues": "13.4",
"ECR before LimitedLiability": "-36.4",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "-57.9"
},
"2018": {
"Liabilities, Non-Current": "-45.8",
"Liabilities": "-37.4",
"Stockholders Equity": "-87.6",
"ECR before LimitedLiability": "-16.2",
"Other Liabilities": "17.4",
"Liabilities, Current": "-10.6",
"Property, Plant and Equipment, Net": "-2.65",
"Assets": "-46.7",
"Other Assets": "-38.6",
"Assets, Current": "-38.7",
"Goodwill": "-7.42",
"Assets, Non-Current": "25.5",
"Other Expenses": "13.0",
"Expenses": "15.9",
"Revenues": "25.7",
"Net Income": "28.7",
"Research and Development": "14.2",
"General and Administrative Expense": "-10.8",
"Other Revenues": "25.7",
"Comprehensive Net Income": "28.7",
"Economic Capital Ratio": "-36.7"
},
"2019": {
"Liabilities, Non-Current": "-46.6",
"Liabilities": "-26.9",
"Stockholders Equity": "-72.7",
"ECR before LimitedLiability": "13.8",
"Other Liabilities": "20.0",
"Liabilities, Current": "-3.05",
"Assets, Non-Current": "37.1",
"Assets": "-38.8",
"Goodwill": "-7.55",
"Property, Plant and Equipment, Net": "0.630",
"Other Assets": "-35.2",
"Assets, Current": "-33.2",
"Research and Development": "8.25",
"Expenses": "17.3",
"Revenues": "36.8",
"Net Income": "40.4",
"Other Expenses": "8.60",
"Other Revenues": "36.8",
"Other Net Income": "6.06",
"Comprehensive Net Income": "40.4",
"Economic Capital Ratio": "-15.6"
},
"2020": {
"Liabilities, Current": "16.4",
"Liabilities": "-8.44",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "40.1",
"Liabilities, Non-Current": "-36.0",
"Other Liabilities": "8.34",
"Goodwill": "-7.30",
"Assets": "-31.3",
"Other Assets": "-25.6",
"Assets, Current": "-24.2",
"Assets, Non-Current": "44.8",
"Property, Plant and Equipment, Net": "-3.39",
"Other Revenues": "56.6",
"Revenues": "56.6",
"Net Income": "63.6",
"Comprehensive Net Income": "63.6",
"General and Administrative Expense": "-10.4",
"Other Expenses": "6.71",
"Other Net Income": "6.90",
"Research and Development": "4.97",
"Economic Capital Ratio": "2.32"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000874716_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "460,591",
"Assets, Non-Current": "436,553",
"General and Administrative Expense": "830,914",
"Goodwill": "204,864",
"Liabilities, Current": "285,112",
"Liabilities, Non-Current": "37,751",
"Other Assets": "-406,589",
"Other Compr. Net Income": "0",
"Other Expenses": "63,224",
"Other Liabilities": "0",
"Other Net Income": "663",
"Other Revenues": "1,103,392",
"Property, Plant and Equipment, Net": "201,725",
"Research and Development": "68,597"
},
"output_variables": {
"Liabilities": "322,863",
"Assets": "897,144",
"Expenses": "962,735",
"Revenues": "1,103,392",
"Stockholders Equity": "574,281",
"Net Income": "141,320",
"Comprehensive Net Income": "141,320",
"BaseVar": "1,643,398",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "203%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "524,227",
"Assets, Non-Current": "506,587",
"General and Administrative Expense": "906,422",
"Goodwill": "241,819",
"Liabilities, Current": "436,879",
"Liabilities, Non-Current": "54,342",
"Other Assets": "-458,596",
"Other Compr. Net Income": "0",
"Other Expenses": "76,215",
"Other Liabilities": "0",
"Other Net Income": "1,744",
"Other Revenues": "1,218,689",
"Property, Plant and Equipment, Net": "216,777",
"Research and Development": "76,042"
},
"output_variables": {
"Liabilities": "491,221",
"Assets": "1,030,814",
"Expenses": "1,058,679",
"Revenues": "1,218,689",
"Stockholders Equity": "539,593",
"Net Income": "161,754",
"Comprehensive Net Income": "161,754",
"BaseVar": "1,900,574",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "180%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "569,537",
"Assets, Non-Current": "534,065",
"General and Administrative Expense": "948,761",
"Goodwill": "237,827",
"Liabilities, Current": "406,333",
"Liabilities, Non-Current": "61,012",
"Other Assets": "-483,004",
"Other Compr. Net Income": "491",
"Other Expenses": "86,178",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,295,240",
"Property, Plant and Equipment, Net": "245,177",
"Research and Development": "82,014"
},
"output_variables": {
"Liabilities": "467,345",
"Assets": "1,103,602",
"Expenses": "1,116,953",
"Revenues": "1,295,240",
"Stockholders Equity": "636,257",
"Net Income": "178,287",
"Comprehensive Net Income": "178,532",
"BaseVar": "1,991,816",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "191%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "652,706",
"Assets, Non-Current": "577,810",
"General and Administrative Expense": "1,022,293",
"Goodwill": "239,365",
"Liabilities, Current": "478,353",
"Liabilities, Non-Current": "233,949",
"Other Assets": "-520,579",
"Other Compr. Net Income": "-2,326",
"Other Expenses": "80,853",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,378,943",
"Property, Plant and Equipment, Net": "281,214",
"Research and Development": "88,003"
},
"output_variables": {
"Liabilities": "712,302",
"Assets": "1,230,516",
"Expenses": "1,191,149",
"Revenues": "1,378,943",
"Stockholders Equity": "518,214",
"Net Income": "187,794",
"Comprehensive Net Income": "186,631",
"BaseVar": "2,257,618",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "162%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "759,398",
"Assets, Non-Current": "624,813",
"General and Administrative Expense": "1,127,289",
"Goodwill": "249,572",
"Liabilities, Current": "820,906",
"Liabilities, Non-Current": "445,716",
"Other Assets": "-553,159",
"Other Compr. Net Income": "-21,738",
"Other Expenses": "80,033",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,487,536",
"Property, Plant and Equipment, Net": "303,587",
"Research and Development": "98,263"
},
"output_variables": {
"Liabilities": "1,266,622",
"Assets": "1,384,211",
"Expenses": "1,305,585",
"Revenues": "1,487,536",
"Stockholders Equity": "117,589",
"Net Income": "181,951",
"Comprehensive Net Income": "171,082",
"BaseVar": "2,732,846",
"ECR before LimitedLiability": "25%",
"Economic Capital Ratio": "109%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "821,634",
"Assets, Non-Current": "653,359",
"General and Administrative Expense": "1,194,087",
"Goodwill": "234,843",
"Liabilities, Current": "856,761",
"Liabilities, Non-Current": "702,227",
"Other Assets": "-567,869",
"Other Compr. Net Income": "-34,251",
"Other Expenses": "118,457",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,604,360",
"Property, Plant and Equipment, Net": "333,026",
"Research and Development": "99,681"
},
"output_variables": {
"Liabilities": "1,558,988",
"Assets": "1,474,993",
"Expenses": "1,412,225",
"Revenues": "1,604,360",
"Stockholders Equity": "-83,995",
"Net Income": "192,135",
"Comprehensive Net Income": "175,010",
"BaseVar": "3,042,408",
"ECR before LimitedLiability": "4.0%",
"Economic Capital Ratio": "89%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "845,584",
"Assets, Non-Current": "685,120",
"General and Administrative Expense": "1,324,062",
"Goodwill": "224,383",
"Liabilities, Current": "934,568",
"Liabilities, Non-Current": "704,349",
"Other Assets": "-581,805",
"Other Compr. Net Income": "-797",
"Other Expenses": "131,841",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,779,079",
"Property, Plant and Equipment, Net": "357,422",
"Research and Development": "101,122"
},
"output_variables": {
"Liabilities": "1,638,917",
"Assets": "1,530,704",
"Expenses": "1,557,025",
"Revenues": "1,779,079",
"Stockholders Equity": "-108,213",
"Net Income": "222,054",
"Comprehensive Net Income": "221,656",
"BaseVar": "3,253,261",
"ECR before LimitedLiability": "4.6%",
"Economic Capital Ratio": "89%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "971,985",
"Assets, Non-Current": "741,431",
"General and Administrative Expense": "1,446,848",
"Goodwill": "243,719",
"Liabilities, Current": "1,004,567",
"Liabilities, Non-Current": "762,691",
"Other Assets": "-622,815",
"Other Compr. Net Income": "6,458",
"Other Expenses": "155,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,974,312",
"Property, Plant and Equipment, Net": "379,096",
"Research and Development": "109,182"
},
"output_variables": {
"Liabilities": "1,767,258",
"Assets": "1,713,416",
"Expenses": "1,711,043",
"Revenues": "1,974,312",
"Stockholders Equity": "-53,842",
"Net Income": "263,269",
"Comprehensive Net Income": "266,498",
"BaseVar": "3,586,244",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "95%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "654,172",
"Assets, Non-Current": "883,177",
"General and Administrative Expense": "1,604,044",
"Goodwill": "256,314",
"Liabilities, Current": "799,711",
"Liabilities, Non-Current": "776,138",
"Other Assets": "-693,584",
"Other Compr. Net Income": "-5,337",
"Other Expenses": "115,439",
"Other Liabilities": "-29,267",
"Other Net Income": "0",
"Other Revenues": "2,214,393",
"Property, Plant and Equipment, Net": "437,270",
"Research and Development": "117,863"
},
"output_variables": {
"Liabilities": "1,546,582",
"Assets": "1,537,349",
"Expenses": "1,837,346",
"Revenues": "2,214,393",
"Stockholders Equity": "-9,233",
"Net Income": "377,047",
"Comprehensive Net Income": "374,378",
"BaseVar": "3,570,504",
"ECR before LimitedLiability": "23%",
"Economic Capital Ratio": "107%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "679,639",
"Assets, Non-Current": "1,152,836",
"General and Administrative Expense": "1,720,869",
"Goodwill": "298,192",
"Liabilities, Current": "758,361",
"Liabilities, Non-Current": "929,313",
"Other Assets": "-832,037",
"Other Compr. Net Income": "-4,463",
"Other Expenses": "125,481",
"Other Liabilities": "-33,024",
"Other Net Income": "0",
"Other Revenues": "2,407,335",
"Property, Plant and Equipment, Net": "533,845",
"Research and Development": "133,193"
},
"output_variables": {
"Liabilities": "1,654,650",
"Assets": "1,832,475",
"Expenses": "1,979,543",
"Revenues": "2,407,335",
"Stockholders Equity": "177,825",
"Net Income": "427,792",
"Comprehensive Net Income": "425,560",
"BaseVar": "3,939,233",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "120%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,062,738",
"Assets, Non-Current": "1,231,823",
"General and Administrative Expense": "1,870,882",
"Goodwill": "295,890",
"Liabilities, Current": "594,468",
"Liabilities, Non-Current": "1,079,005",
"Other Assets": "-851,057",
"Other Compr. Net Income": "-7,788",
"Other Expenses": "112,979",
"Other Liabilities": "-11,707",
"Other Net Income": "0",
"Other Revenues": "2,707,241",
"Property, Plant and Equipment, Net": "555,167",
"Research and Development": "141,249"
},
"output_variables": {
"Liabilities": "1,661,766",
"Assets": "2,294,561",
"Expenses": "2,125,110",
"Revenues": "2,707,241",
"Stockholders Equity": "632,795",
"Net Income": "582,131",
"Comprehensive Net Income": "578,237",
"BaseVar": "4,398,233",
"ECR before LimitedLiability": "73%",
"Economic Capital Ratio": "148%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 1.4821951000307578,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000874716.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000874716.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000874716.svg"
},
{
"company_id": "0001310630",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001310630.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001310630.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001310630_main_keyfigs.svg",
"name": "China Foods Holdings Ltd",
"rank": 28,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001310630.svg",
"report_text": "The relative strengths and weaknesses of China Foods Holdings Ltd are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of China Foods Holdings Ltd compared to the market average is the variable Liabilities, Non-Current, increasing the Economic Capital Ratio by 35% points.The greatest weakness of China Foods Holdings Ltd is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 141%, being 5.3% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001310630_2021_China_Foods_Holdings_Ltd.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-1.06",
"Liabilities": "-11.5",
"Stockholders Equity": "-72.1",
"ECR before LimitedLiability": "-71.8",
"Other Liabilities": "-4.85",
"Property, Plant and Equipment, Net": "-6.95",
"Assets": "-31.4",
"Assets, Non-Current": "-2.82",
"Other Assets": "11.4",
"Goodwill": "-6.35",
"Assets, Current": "-29.3",
"General and Administrative Expense": "3.53",
"Expenses": "7.12",
"Revenues": "-12.4",
"Net Income": "-3.76",
"Research and Development": "2.47",
"Other Expenses": "1.83",
"Other Revenues": "-12.4",
"Comprehensive Net Income": "-3.78",
"Other Net Income": "-1.24",
"Economic Capital Ratio": "-134"
},
"2012": {
"Liabilities, Current": "-0.547",
"Liabilities": "-6.29",
"Stockholders Equity": "-79.5",
"ECR before LimitedLiability": "-108",
"Other Liabilities": "-2.62",
"Assets, Current": "-28.9",
"Assets": "-34.1",
"Other Assets": "9.35",
"Assets, Non-Current": "-2.91",
"Property, Plant and Equipment, Net": "-6.78",
"Goodwill": "-6.98",
"Other Expenses": "2.11",
"Expenses": "6.71",
"Revenues": "-12.3",
"Net Income": "-2.71",
"Research and Development": "2.50",
"General and Administrative Expense": "2.85",
"Other Revenues": "-12.3",
"Other Net Income": "-0.0949",
"Comprehensive Net Income": "-2.70",
"Economic Capital Ratio": "-141"
},
"2013": {
"Liabilities, Current": "0.221",
"Liabilities": "0.706",
"Stockholders Equity": "-81.0",
"ECR before LimitedLiability": "-98.7",
"Other Liabilities": "0.110",
"Goodwill": "-6.94",
"Assets": "-36.7",
"Assets, Non-Current": "-2.51",
"Property, Plant and Equipment, Net": "-5.86",
"Other Assets": "5.65",
"Assets, Current": "-27.6",
"General and Administrative Expense": "2.35",
"Expenses": "7.31",
"Revenues": "-10.1",
"Net Income": "-2.17",
"Research and Development": "1.96",
"Other Expenses": "4.07",
"Other Revenues": "-10.1",
"Other Net Income": "-2.84",
"Comprehensive Net Income": "-2.19",
"Economic Capital Ratio": "-139"
},
"2014": {
"Liabilities": "2.73",
"Stockholders Equity": "-69.8",
"ECR before LimitedLiability": "-69.3",
"Liabilities, Current": "2.29",
"Other Liabilities": "0.103",
"Assets, Current": "-25.4",
"Assets": "-34.7",
"Goodwill": "-7.12",
"Other Assets": "5.31",
"Assets, Non-Current": "-2.14",
"Property, Plant and Equipment, Net": "-5.49",
"Other Expenses": "2.98",
"Expenses": "7.69",
"Revenues": "-9.32",
"Net Income": "-0.242",
"Research and Development": "2.11",
"General and Administrative Expense": "3.97",
"Other Revenues": "-9.32",
"Other Net Income": "-2.45",
"Comprehensive Net Income": "-0.231",
"Economic Capital Ratio": "-119"
},
"2015": {
"Other Liabilities": "0.105",
"Liabilities": "2.44",
"Stockholders Equity": "-70.0",
"ECR before LimitedLiability": "-75.1",
"Liabilities, Current": "2.08",
"Assets, Current": "-25.5",
"Assets": "-37.9",
"Other Assets": "2.91",
"Goodwill": "-7.24",
"Assets, Non-Current": "-1.72",
"Property, Plant and Equipment, Net": "-5.93",
"Research and Development": "1.66",
"Expenses": "5.21",
"Revenues": "-8.22",
"Net Income": "-0.817",
"General and Administrative Expense": "2.62",
"Other Expenses": "1.47",
"Other Revenues": "-8.22",
"Comprehensive Net Income": "-0.763",
"Other Net Income": "0.149",
"Economic Capital Ratio": "-121"
},
"2016": {
"Liabilities": "0.179",
"Stockholders Equity": "-87.7",
"ECR before LimitedLiability": "-111",
"Liabilities, Current": "0.152",
"Property, Plant and Equipment, Net": "-8.61",
"Assets": "-40.2",
"Other Assets": "5.92",
"Assets, Non-Current": "-2.08",
"Assets, Current": "-29.4",
"Goodwill": "-7.20",
"Research and Development": "2.34",
"Expenses": "5.92",
"Revenues": "-9.05",
"Net Income": "-1.12",
"General and Administrative Expense": "2.63",
"Other Expenses": "1.62",
"Other Revenues": "-9.05",
"Comprehensive Net Income": "-1.09",
"Other Net Income": "-0.334",
"Other Compr. Net Income": "0.0366",
"Economic Capital Ratio": "-131"
},
"2017": {
"Liabilities": "1.30",
"Stockholders Equity": "-87.4",
"ECR before LimitedLiability": "-116",
"Liabilities, Current": "1.27",
"Assets, Non-Current": "-2.36",
"Assets": "-40.5",
"Other Assets": "5.16",
"Assets, Current": "-25.2",
"Goodwill": "-7.92",
"Property, Plant and Equipment, Net": "-11.0",
"Research and Development": "2.24",
"Expenses": "5.48",
"Revenues": "-8.16",
"Net Income": "-1.43",
"Other Expenses": "0.752",
"General and Administrative Expense": "3.01",
"Other Revenues": "-8.16",
"Comprehensive Net Income": "-1.49",
"Other Net Income": "-0.759",
"Other Compr. Net Income": "-0.0532",
"Economic Capital Ratio": "-138"
},
"2019": {
"Liabilities": "5.14",
"Stockholders Equity": "-71.7",
"ECR before LimitedLiability": "-96.0",
"Other Liabilities": "9.28",
"Liabilities, Current": "-0.605",
"Assets, Non-Current": "-7.37",
"Assets": "-44.1",
"Goodwill": "-8.35",
"Property, Plant and Equipment, Net": "-10.3",
"Other Assets": "0.355",
"Assets, Current": "-13.7",
"Research and Development": "1.59",
"Expenses": "-3.69",
"Revenues": "-9.68",
"Net Income": "-14.1",
"Other Expenses": "1.59",
"General and Administrative Expense": "-8.40",
"Other Revenues": "-9.68",
"Other Net Income": "0.674",
"Comprehensive Net Income": "-14.1",
"Economic Capital Ratio": "-126"
},
"2020": {
"Liabilities, Current": "5.35",
"Liabilities": "16.4",
"Stockholders Equity": "-17.3",
"ECR before LimitedLiability": "32.5",
"Liabilities, Non-Current": "35.1",
"Other Liabilities": "-26.7",
"Goodwill": "-17.0",
"Assets": "-20.3",
"Other Assets": "-13.2",
"Assets, Current": "29.5",
"Property, Plant and Equipment, Net": "-10.7",
"Other Expenses": "10.7",
"Expenses": "-21.3",
"Revenues": "18.1",
"Net Income": "2.51",
"Research and Development": "10.6",
"General and Administrative Expense": "-39.6",
"Other Revenues": "18.1",
"Comprehensive Net Income": "4.74",
"Other Net Income": "7.62",
"Economic Capital Ratio": "-5.30"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001310630_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "14",
"Goodwill": "0",
"Liabilities, Current": "29",
"Liabilities, Non-Current": "0",
"Other Assets": "10.0",
"Other Compr. Net Income": "0",
"Other Expenses": "5.1",
"Other Liabilities": "50",
"Other Net Income": "0",
"Other Revenues": "0.050",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "79",
"Assets": "10.0",
"Expenses": "19",
"Revenues": "0.050",
"Stockholders Equity": "-69",
"Net Income": "-19",
"Comprehensive Net Income": "-19",
"BaseVar": "54",
"ECR before LimitedLiability": "-256%",
"Economic Capital Ratio": "20%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "18",
"Goodwill": "0",
"Liabilities, Current": "36",
"Liabilities, Non-Current": "0",
"Other Assets": "11",
"Other Compr. Net Income": "0",
"Other Expenses": "7.1",
"Other Liabilities": "70",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "106",
"Assets": "11",
"Expenses": "25",
"Revenues": "0",
"Stockholders Equity": "-95",
"Net Income": "-25",
"Comprehensive Net Income": "-25",
"BaseVar": "71",
"ECR before LimitedLiability": "-264%",
"Economic Capital Ratio": "18%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "21",
"Goodwill": "0",
"Liabilities, Current": "85",
"Liabilities, Non-Current": "0",
"Other Assets": "11",
"Other Compr. Net Income": "0",
"Other Expenses": "0.10",
"Other Liabilities": "50",
"Other Net Income": "-8.4",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "135",
"Assets": "11",
"Expenses": "21",
"Revenues": "0",
"Stockholders Equity": "-125",
"Net Income": "-30",
"Comprehensive Net Income": "-30",
"BaseVar": "88",
"ECR before LimitedLiability": "-275%",
"Economic Capital Ratio": "16%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "20",
"Goodwill": "0",
"Liabilities, Current": "147",
"Liabilities, Non-Current": "0",
"Other Assets": "9.8",
"Other Compr. Net Income": "0",
"Other Expenses": "0.10",
"Other Liabilities": "20",
"Other Net Income": "-12",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "167",
"Assets": "9.8",
"Expenses": "20",
"Revenues": "0",
"Stockholders Equity": "-157",
"Net Income": "-32",
"Comprehensive Net Income": "-32",
"BaseVar": "104",
"ECR before LimitedLiability": "-280%",
"Economic Capital Ratio": "15%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "26",
"Goodwill": "0",
"Liabilities, Current": "186",
"Liabilities, Non-Current": "0",
"Other Assets": "14",
"Other Compr. Net Income": "0",
"Other Expenses": "19",
"Other Liabilities": "30",
"Other Net Income": "0",
"Other Revenues": "0.011",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "216",
"Assets": "14",
"Expenses": "45",
"Revenues": "0.011",
"Stockholders Equity": "-202",
"Net Income": "-45",
"Comprehensive Net Income": "-45",
"BaseVar": "137",
"ECR before LimitedLiability": "-280%",
"Economic Capital Ratio": "15%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "27",
"Goodwill": "0",
"Liabilities, Current": "239",
"Liabilities, Non-Current": "0",
"Other Assets": "18",
"Other Compr. Net Income": "0",
"Other Expenses": "22",
"Other Liabilities": "30",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "269",
"Assets": "18",
"Expenses": "49",
"Revenues": "0",
"Stockholders Equity": "-251",
"Net Income": "-49",
"Comprehensive Net Income": "-49",
"BaseVar": "168",
"ECR before LimitedLiability": "-274%",
"Economic Capital Ratio": "16%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "29",
"Goodwill": "0",
"Liabilities, Current": "294",
"Liabilities, Non-Current": "0",
"Other Assets": "18",
"Other Compr. Net Income": "0",
"Other Expenses": "26",
"Other Liabilities": "30",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "324",
"Assets": "18",
"Expenses": "55",
"Revenues": "0",
"Stockholders Equity": "-306",
"Net Income": "-55",
"Comprehensive Net Income": "-55",
"BaseVar": "199",
"ECR before LimitedLiability": "-277%",
"Economic Capital Ratio": "15%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "23",
"Assets, Non-Current": "0",
"General and Administrative Expense": "89",
"Goodwill": "0",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "131",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "131",
"Assets": "23",
"Expenses": "89",
"Revenues": "0",
"Stockholders Equity": "-107",
"Net Income": "-89",
"Comprehensive Net Income": "-89",
"BaseVar": "122",
"ECR before LimitedLiability": "-307%",
"Economic Capital Ratio": "10%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,334",
"Assets, Non-Current": "198",
"General and Administrative Expense": "1,484",
"Goodwill": "4.4",
"Liabilities, Current": "418",
"Liabilities, Non-Current": "0",
"Other Assets": "-198",
"Other Compr. Net Income": "59",
"Other Expenses": "8.2",
"Other Liabilities": "280",
"Other Net Income": "9.6",
"Other Revenues": "1,013",
"Property, Plant and Equipment, Net": "194",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "697",
"Assets": "1,532",
"Expenses": "1,492",
"Revenues": "1,013",
"Stockholders Equity": "835",
"Net Income": "-469",
"Comprehensive Net Income": "-440",
"BaseVar": "2,402",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "141%"
}
}
},
"top_rated": false,
"trend": 19.0,
"value": 1.4059625678260623,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001310630.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001310630.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001310630.svg"
},
{
"company_id": "0001708035",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001708035.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001708035.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001708035.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001708035_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001708035_main_keyfigs.svg",
"name": "Ecovyst Inc",
"rank": 29,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001708035.svg",
"report_text": "The relative strengths and weaknesses of Ecovyst Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ecovyst Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Ecovyst Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 60% points.
The company's Economic Capital Ratio, given in the ranking table, is 136%, being 10% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001708035_2021_Ecovyst_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "9.19",
"Liabilities": "-37.3",
"ECR before LimitedLiability": "9.85",
"Liabilities, Current": "21.9",
"Liabilities, Non-Current": "-79.3",
"Assets, Non-Current": "8.57",
"Assets": "26.7",
"Assets, Current": "-23.3",
"Goodwill": "47.0",
"Property, Plant and Equipment, Net": "9.83",
"Research and Development": "12.1",
"Expenses": "35.2",
"Net Income": "26.2",
"Other Expenses": "-8.19",
"General and Administrative Expense": "31.2",
"Other Revenues": "-3.05",
"Revenues": "-3.05",
"Comprehensive Net Income": "26.6",
"Other Compr. Net Income": "0.353",
"Other Net Income": "-4.72",
"Economic Capital Ratio": "-11.7"
},
"2018": {
"Liabilities, Non-Current": "-80.9",
"Liabilities": "-41.6",
"Stockholders Equity": "-5.97",
"ECR before LimitedLiability": "19.8",
"Other Liabilities": "9.26",
"Liabilities, Current": "19.2",
"Property, Plant and Equipment, Net": "13.6",
"Assets": "22.6",
"Assets, Current": "-25.1",
"Goodwill": "47.5",
"Assets, Non-Current": "5.14",
"Other Expenses": "6.75",
"Expenses": "34.4",
"Revenues": "-2.65",
"Net Income": "31.8",
"Research and Development": "11.4",
"General and Administrative Expense": "14.6",
"Other Revenues": "-2.65",
"Comprehensive Net Income": "31.4",
"Other Net Income": "0.385",
"Economic Capital Ratio": "-0.700"
},
"2019": {
"Liabilities, Non-Current": "-71.3",
"Liabilities": "-35.1",
"Stockholders Equity": "-1.31",
"ECR before LimitedLiability": "42.5",
"Other Liabilities": "3.07",
"Liabilities, Current": "23.8",
"Assets, Non-Current": "3.03",
"Assets": "21.3",
"Goodwill": "41.8",
"Property, Plant and Equipment, Net": "12.8",
"Assets, Current": "-22.2",
"Research and Development": "8.47",
"Expenses": "33.6",
"Revenues": "-2.25",
"Net Income": "36.1",
"Other Expenses": "4.19",
"General and Administrative Expense": "19.5",
"Other Revenues": "-2.25",
"Other Net Income": "4.42",
"Comprehensive Net Income": "36.4",
"Economic Capital Ratio": "13.0"
},
"2020": {
"Liabilities, Current": "18.1",
"Liabilities": "-32.0",
"Stockholders Equity": "-14.3",
"ECR before LimitedLiability": "27.7",
"Liabilities, Non-Current": "-60.4",
"Other Liabilities": "5.16",
"Goodwill": "35.4",
"Assets": "8.82",
"Assets, Current": "-30.4",
"Assets, Non-Current": "7.02",
"Property, Plant and Equipment, Net": "16.2",
"Other Expenses": "-2.54",
"Expenses": "18.8",
"Revenues": "-3.37",
"Net Income": "16.9",
"Research and Development": "7.44",
"General and Administrative Expense": "13.6",
"Other Revenues": "-3.37",
"Comprehensive Net Income": "16.8",
"Other Net Income": "1.70",
"Economic Capital Ratio": "-10.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001708035_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "548,968",
"Assets, Non-Current": "544,003",
"General and Administrative Expense": "145,107",
"Goodwill": "2,092,100",
"Liabilities, Current": "477,745",
"Liabilities, Non-Current": "2,305,791",
"Other Assets": "0",
"Other Compr. Net Income": "57,062",
"Other Expenses": "1,219,337",
"Other Liabilities": "0",
"Other Net Income": "-49,094",
"Other Revenues": "1,472,101",
"Property, Plant and Equipment, Net": "1,230,384",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,783,536",
"Assets": "4,415,455",
"Expenses": "1,364,444",
"Revenues": "1,472,101",
"Stockholders Equity": "1,631,919",
"Net Income": "58,563",
"Comprehensive Net Income": "87,094",
"BaseVar": "5,070,846",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "558,616",
"Assets, Non-Current": "576,465",
"General and Administrative Expense": "1,395,148",
"Goodwill": "1,983,365",
"Liabilities, Current": "451,735",
"Liabilities, Non-Current": "2,211,545",
"Other Assets": "0",
"Other Compr. Net Income": "-44,736",
"Other Expenses": "172,168",
"Other Liabilities": "0",
"Other Net Income": "18,783",
"Other Revenues": "1,608,154",
"Property, Plant and Equipment, Net": "1,208,979",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,663,280",
"Assets": "4,327,425",
"Expenses": "1,567,316",
"Revenues": "1,608,154",
"Stockholders Equity": "1,664,145",
"Net Income": "59,621",
"Comprehensive Net Income": "37,253",
"BaseVar": "5,114,847",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "143%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "568,591",
"Assets, Non-Current": "629,294",
"General and Administrative Expense": "1,343,430",
"Goodwill": "1,936,190",
"Liabilities, Current": "269,468",
"Liabilities, Non-Current": "2,048,022",
"Other Assets": "0",
"Other Compr. Net Income": "21,111",
"Other Expenses": "188,064",
"Other Liabilities": "218,037",
"Other Net Income": "44,732",
"Other Revenues": "1,567,072",
"Property, Plant and Equipment, Net": "1,186,770",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,535,527",
"Assets": "4,320,845",
"Expenses": "1,531,494",
"Revenues": "1,567,072",
"Stockholders Equity": "1,785,318",
"Net Income": "80,310",
"Comprehensive Net Income": "90,866",
"BaseVar": "5,010,390",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "149%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "428,140",
"Assets, Non-Current": "542,405",
"General and Administrative Expense": "959,301",
"Goodwill": "1,244,041",
"Liabilities, Current": "377,239",
"Liabilities, Non-Current": "1,543,403",
"Other Assets": "0",
"Other Compr. Net Income": "-11,559",
"Other Expenses": "329,843",
"Other Liabilities": "0",
"Other Net Income": "-99,923",
"Other Revenues": "1,107,363",
"Property, Plant and Equipment, Net": "983,235",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,920,642",
"Assets": "3,197,821",
"Expenses": "1,289,144",
"Revenues": "1,107,363",
"Stockholders Equity": "1,277,179",
"Net Income": "-281,704",
"Comprehensive Net Income": "-287,484",
"BaseVar": "3,813,226",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "136%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 1.35842761715617,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001708035.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001708035.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001708035.svg"
},
{
"company_id": "0001653477",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001653477.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001653477.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001653477.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001653477_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001653477_main_keyfigs.svg",
"name": "Ingevity Corp",
"rank": 30,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001653477.svg",
"report_text": "The relative strengths and weaknesses of Ingevity Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ingevity Corp compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Ingevity Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 71% points.
The company's Economic Capital Ratio, given in the ranking table, is 132%, being 13% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001653477_2021_Ingevity_Corp.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-68.7",
"Liabilities": "-22.5",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "-14.4",
"Liabilities, Current": "27.8",
"Property, Plant and Equipment, Net": "27.7",
"Assets": "-33.1",
"Other Assets": "11.1",
"Assets, Non-Current": "-4.47",
"Assets, Current": "-40.4",
"Goodwill": "-19.7",
"Research and Development": "22.2",
"Expenses": "15.2",
"Revenues": "28.0",
"Net Income": "29.2",
"General and Administrative Expense": "28.1",
"Other Expenses": "-43.4",
"Other Revenues": "28.0",
"Comprehensive Net Income": "29.1",
"Other Net Income": "-2.29",
"Economic Capital Ratio": "-34.4"
},
"2017": {
"Other Liabilities": "13.9",
"Liabilities": "-6.60",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "10.8",
"Liabilities, Current": "27.6",
"Liabilities, Non-Current": "-54.9",
"Assets": "-19.5",
"Other Assets": "8.10",
"Assets, Current": "-20.4",
"Goodwill": "-16.5",
"Property, Plant and Equipment, Net": "19.1",
"Research and Development": "16.5",
"Expenses": "13.2",
"Revenues": "47.1",
"Net Income": "56.4",
"Other Expenses": "-38.4",
"General and Administrative Expense": "42.3",
"Other Revenues": "47.1",
"Comprehensive Net Income": "55.2",
"Other Net Income": "-5.38",
"Economic Capital Ratio": "-10.7"
},
"2018": {
"Liabilities, Non-Current": "-77.8",
"Liabilities": "-33.1",
"Stockholders Equity": "-40.7",
"ECR before LimitedLiability": "11.3",
"Other Liabilities": "12.2",
"Liabilities, Current": "22.4",
"Property, Plant and Equipment, Net": "20.8",
"Assets": "-13.2",
"Other Assets": "5.75",
"Assets, Current": "-25.2",
"Goodwill": "2.63",
"Assets, Non-Current": "-8.41",
"Other Expenses": "8.57",
"Expenses": "25.2",
"Revenues": "29.3",
"Net Income": "50.1",
"Research and Development": "14.1",
"General and Administrative Expense": "1.73",
"Other Revenues": "29.3",
"Comprehensive Net Income": "50.0",
"Economic Capital Ratio": "-9.18"
},
"2019": {
"Liabilities, Non-Current": "-83.7",
"Liabilities": "-43.7",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "22.7",
"Other Liabilities": "12.9",
"Liabilities, Current": "17.3",
"Research and Development": "9.63",
"Expenses": "33.2",
"Net Income": "44.6",
"Other Expenses": "4.69",
"General and Administrative Expense": "17.4",
"Other Revenues": "11.8",
"Revenues": "11.8",
"Assets, Non-Current": "-9.30",
"Goodwill": "29.9",
"Property, Plant and Equipment, Net": "13.9",
"Other Assets": "4.86",
"Assets, Current": "-26.2",
"Other Net Income": "4.77",
"Comprehensive Net Income": "44.6",
"Economic Capital Ratio": "-6.78"
},
"2020": {
"Liabilities, Current": "17.2",
"Liabilities": "-41.7",
"Stockholders Equity": "-35.7",
"ECR before LimitedLiability": "24.4",
"Liabilities, Non-Current": "-70.7",
"Other Liabilities": "5.43",
"Goodwill": "24.6",
"Assets": "-4.67",
"Other Assets": "3.60",
"Assets, Current": "-25.2",
"Assets, Non-Current": "-7.74",
"Property, Plant and Equipment, Net": "11.7",
"Expenses": "21.1",
"Revenues": "8.68",
"Net Income": "37.1",
"Research and Development": "7.01",
"General and Administrative Expense": "10.0",
"Other Revenues": "8.68",
"Comprehensive Net Income": "37.4",
"Other Net Income": "5.58",
"Economic Capital Ratio": "-13.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001653477_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "295,200",
"Assets, Non-Current": "22,000",
"General and Administrative Expense": "114,000",
"Goodwill": "19,700",
"Liabilities, Current": "136,900",
"Liabilities, Non-Current": "491,500",
"Other Assets": "73,100",
"Other Compr. Net Income": "-11,700",
"Other Expenses": "754,500",
"Other Liabilities": "69,800",
"Other Net Income": "4,600",
"Other Revenues": "908,300",
"Property, Plant and Equipment, Net": "422,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "698,200",
"Assets": "832,800",
"Expenses": "868,500",
"Revenues": "908,300",
"Stockholders Equity": "134,600",
"Net Income": "44,400",
"Comprehensive Net Income": "38,550",
"BaseVar": "1,662,050",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "112%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "368,700",
"Assets, Non-Current": "30,400",
"General and Administrative Expense": "106,400",
"Goodwill": "17,300",
"Liabilities, Current": "194,500",
"Liabilities, Non-Current": "457,200",
"Other Assets": "74,700",
"Other Compr. Net Income": "-11,100",
"Other Expenses": "702,800",
"Other Liabilities": "0",
"Other Net Income": "1,800",
"Other Revenues": "972,400",
"Property, Plant and Equipment, Net": "438,500",
"Research and Development": "19,800"
},
"output_variables": {
"Liabilities": "651,700",
"Assets": "929,600",
"Expenses": "829,000",
"Revenues": "972,400",
"Stockholders Equity": "277,900",
"Net Income": "145,200",
"Comprehensive Net Income": "139,650",
"BaseVar": "1,697,800",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "143%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "422,700",
"Assets, Non-Current": "38,300",
"General and Administrative Expense": "849,200",
"Goodwill": "256,300",
"Liabilities, Current": "220,200",
"Liabilities, Non-Current": "756,300",
"Other Assets": "74,100",
"Other Compr. Net Income": "-18,700",
"Other Expenses": "83,500",
"Other Liabilities": "0",
"Other Net Income": "2,400",
"Other Revenues": "1,133,600",
"Property, Plant and Equipment, Net": "523,800",
"Research and Development": "21,500"
},
"output_variables": {
"Liabilities": "976,500",
"Assets": "1,315,200",
"Expenses": "954,200",
"Revenues": "1,133,600",
"Stockholders Equity": "338,700",
"Net Income": "181,800",
"Comprehensive Net Income": "172,450",
"BaseVar": "2,200,300",
"ECR before LimitedLiability": "56%",
"Economic Capital Ratio": "135%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "463,200",
"Assets, Non-Current": "103,600",
"General and Administrative Expense": "974,000",
"Goodwill": "832,600",
"Liabilities, Current": "315,800",
"Liabilities, Non-Current": "1,295,100",
"Other Assets": "77,600",
"Other Compr. Net Income": "12,700",
"Other Expenses": "127,500",
"Other Liabilities": "0",
"Other Net Income": "12,000",
"Other Revenues": "1,292,900",
"Property, Plant and Equipment, Net": "664,700",
"Research and Development": "19,700"
},
"output_variables": {
"Liabilities": "1,610,900",
"Assets": "2,141,700",
"Expenses": "1,121,200",
"Revenues": "1,292,900",
"Stockholders Equity": "530,800",
"Net Income": "183,700",
"Comprehensive Net Income": "190,050",
"BaseVar": "3,095,700",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "628,700",
"Assets, Non-Current": "101,900",
"General and Administrative Expense": "900,000",
"Goodwill": "818,600",
"Liabilities, Current": "340,400",
"Liabilities, Non-Current": "1,352,000",
"Other Assets": "81,700",
"Other Compr. Net Income": "9,700",
"Other Expenses": "121,100",
"Other Liabilities": "0",
"Other Net Income": "9,000",
"Other Revenues": "1,216,100",
"Property, Plant and Equipment, Net": "703,600",
"Research and Development": "22,600"
},
"output_variables": {
"Liabilities": "1,692,400",
"Assets": "2,334,500",
"Expenses": "1,043,700",
"Revenues": "1,216,100",
"Stockholders Equity": "642,100",
"Net Income": "181,400",
"Comprehensive Net Income": "186,250",
"BaseVar": "3,152,700",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 1.324587400700676,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001653477.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001653477.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001653477.svg"
},
{
"company_id": "0001522767",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001522767.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001522767.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001522767.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001522767_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001522767_main_keyfigs.svg",
"name": "Marimed INC",
"rank": 31,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001522767.svg",
"report_text": "The relative strengths and weaknesses of Marimed INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Marimed INC compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Marimed INC is the variable Other Liabilities, reducing the Economic Capital Ratio by 50% points.
The company's Economic Capital Ratio, given in the ranking table, is 132%, being 14% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001522767_2021_Marimed_INC.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "-19.6",
"Liabilities": "-49.8",
"ECR before LimitedLiability": "13.6",
"Liabilities, Current": "-44.0",
"Liabilities, Non-Current": "14.0",
"Assets, Non-Current": "-1.95",
"Assets": "37.0",
"Other Assets": "1.70",
"Assets, Current": "-17.2",
"Goodwill": "-10.7",
"Property, Plant and Equipment, Net": "66.9",
"Research and Development": "10.5",
"Expenses": "44.2",
"Net Income": "32.5",
"Other Expenses": "5.96",
"General and Administrative Expense": "25.3",
"Other Revenues": "-12.6",
"Revenues": "-12.6",
"Comprehensive Net Income": "32.3",
"Other Net Income": "3.21",
"Economic Capital Ratio": "-7.96"
},
"2018": {
"Liabilities, Non-Current": "14.3",
"Liabilities": "3.94",
"Stockholders Equity": "64.9",
"ECR before LimitedLiability": "89.6",
"Other Liabilities": "-23.2",
"Liabilities, Current": "9.68",
"Property, Plant and Equipment, Net": "21.9",
"Assets": "35.2",
"Other Assets": "32.4",
"Assets, Current": "-6.79",
"Goodwill": "-4.43",
"Other Expenses": "4.51",
"Expenses": "30.8",
"Revenues": "-15.4",
"Net Income": "25.6",
"Research and Development": "8.77",
"General and Administrative Expense": "17.4",
"Other Revenues": "-15.4",
"Comprehensive Net Income": "25.7",
"Other Net Income": "10.0",
"Economic Capital Ratio": "69.1"
},
"2019": {
"Liabilities, Non-Current": "3.17",
"Liabilities": "-2.98",
"Stockholders Equity": "-24.5",
"ECR before LimitedLiability": "-46.8",
"Other Liabilities": "-1.91",
"Liabilities, Current": "-4.66",
"Assets, Non-Current": "-8.47",
"Assets": "-23.9",
"Goodwill": "-12.8",
"Property, Plant and Equipment, Net": "32.5",
"Other Assets": "4.61",
"Assets, Current": "-24.6",
"Other Revenues": "-1.53",
"Revenues": "-1.53",
"Net Income": "-19.2",
"Research and Development": "6.33",
"Comprehensive Net Income": "-19.2",
"General and Administrative Expense": "16.1",
"Other Expenses": "-19.2",
"Other Net Income": "-17.6",
"Economic Capital Ratio": "-76.2"
},
"2020": {
"Liabilities, Current": "-2.25",
"Liabilities": "-28.9",
"Stockholders Equity": "-40.8",
"ECR before LimitedLiability": "23.5",
"Liabilities, Non-Current": "19.9",
"Other Liabilities": "-49.8",
"Goodwill": "-13.5",
"Assets": "-15.3",
"Other Assets": "2.98",
"Assets, Current": "-29.5",
"Assets, Non-Current": "-6.74",
"Property, Plant and Equipment, Net": "47.2",
"Expenses": "23.4",
"Revenues": "18.8",
"Net Income": "36.2",
"Research and Development": "9.02",
"General and Administrative Expense": "15.8",
"Other Revenues": "18.8",
"Comprehensive Net Income": "36.3",
"Other Net Income": "-6.67",
"Economic Capital Ratio": "-14.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001522767_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "5,089",
"Assets, Non-Current": "580",
"General and Administrative Expense": "1,439",
"Goodwill": "0",
"Liabilities, Current": "15,422",
"Liabilities, Non-Current": "240",
"Other Assets": "579",
"Other Compr. Net Income": "0",
"Other Expenses": "3,423",
"Other Liabilities": "5,532",
"Other Net Income": "2,235",
"Other Revenues": "6,068",
"Property, Plant and Equipment, Net": "25,955",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "21,195",
"Assets": "32,202",
"Expenses": "4,862",
"Revenues": "6,068",
"Stockholders Equity": "11,007",
"Net Income": "3,441",
"Comprehensive Net Income": "3,441",
"BaseVar": "33,281",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "15,709",
"Assets, Non-Current": "83",
"General and Administrative Expense": "14,244",
"Goodwill": "185",
"Liabilities, Current": "9,889",
"Liabilities, Non-Current": "338",
"Other Assets": "32,884",
"Other Compr. Net Income": "0",
"Other Expenses": "2,964",
"Other Liabilities": "10,969",
"Other Net Income": "7,953",
"Other Revenues": "11,852",
"Property, Plant and Equipment, Net": "34,100",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "21,196",
"Assets": "82,961",
"Expenses": "17,208",
"Revenues": "11,852",
"Stockholders Equity": "61,764",
"Net Income": "2,597",
"Comprehensive Net Income": "2,597",
"BaseVar": "70,585",
"ECR before LimitedLiability": "167%",
"Economic Capital Ratio": "213%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "7,377",
"Assets, Non-Current": "5,963",
"General and Administrative Expense": "35,789",
"Goodwill": "2,364",
"Liabilities, Current": "36,720",
"Liabilities, Non-Current": "5,500",
"Other Assets": "3,075",
"Other Compr. Net Income": "0",
"Other Expenses": "51,414",
"Other Liabilities": "13,023",
"Other Net Income": "-40,283",
"Other Revenues": "45,605",
"Property, Plant and Equipment, Net": "42,792",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "55,244",
"Assets": "61,572",
"Expenses": "87,203",
"Revenues": "45,605",
"Stockholders Equity": "6,328",
"Net Income": "-81,881",
"Comprehensive Net Income": "-81,881",
"BaseVar": "144,953",
"ECR before LimitedLiability": "-125%",
"Economic Capital Ratio": "60%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "21,043",
"Assets, Non-Current": "5,328",
"General and Administrative Expense": "29,470",
"Goodwill": "2,229",
"Liabilities, Current": "23,227",
"Liabilities, Non-Current": "4,922",
"Other Assets": "2,209",
"Other Compr. Net Income": "0",
"Other Expenses": "8,962",
"Other Liabilities": "25,471",
"Other Net Income": "-10,034",
"Other Revenues": "50,895",
"Property, Plant and Equipment, Net": "45,637",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "53,620",
"Assets": "76,445",
"Expenses": "38,432",
"Revenues": "50,895",
"Stockholders Equity": "22,825",
"Net Income": "2,429",
"Comprehensive Net Income": "2,429",
"BaseVar": "114,713",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "132%"
}
}
},
"top_rated": false,
"trend": 12.0,
"value": 1.3154645169511892,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001522767.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001522767.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001522767.svg"
},
{
"company_id": "0001627223",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001627223.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001627223.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001627223.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001627223_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001627223_main_keyfigs.svg",
"name": "Chemours Co",
"rank": 32,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001627223.svg",
"report_text": "The relative strengths and weaknesses of Chemours Co are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Chemours Co compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 20% points.The greatest weakness of Chemours Co is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 75% points.
The company's Economic Capital Ratio, given in the ranking table, is 104%, being 42% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001627223_2021_Chemours_Co.pdf",
"shrinked_graph_json": {
"2015": {
"Other Liabilities": "0.356",
"Liabilities": "-30.9",
"Stockholders Equity": "-54.3",
"Liabilities, Current": "1.52",
"Liabilities, Non-Current": "-84.9",
"Assets, Current": "-35.4",
"Assets": "-26.5",
"Other Assets": "-12.3",
"Goodwill": "-21.8",
"Property, Plant and Equipment, Net": "5.56",
"Research and Development": "0.386",
"Expenses": "1.07",
"Revenues": "1.68",
"Net Income": "5.71",
"General and Administrative Expense": "4.89",
"Other Expenses": "-37.9",
"Other Revenues": "1.68",
"ECR before LimitedLiability": "-5.32",
"Comprehensive Net Income": "5.42",
"Other Compr. Net Income": "-0.949",
"Economic Capital Ratio": "-51.2"
},
"2016": {
"Liabilities, Non-Current": "-78.6",
"Liabilities": "-46.8",
"Stockholders Equity": "-73.5",
"Liabilities, Current": "2.62",
"Other Liabilities": "2.18",
"Property, Plant and Equipment, Net": "3.87",
"Assets": "-34.5",
"Other Assets": "2.14",
"Assets, Non-Current": "2.14",
"Assets, Current": "-39.5",
"Goodwill": "-24.4",
"Research and Development": "2.73",
"Expenses": "2.89",
"Revenues": "3.00",
"Net Income": "5.93",
"General and Administrative Expense": "4.73",
"Other Expenses": "-34.4",
"Other Revenues": "3.00",
"ECR before LimitedLiability": "-39.8",
"Comprehensive Net Income": "5.92",
"Economic Capital Ratio": "-59.8"
},
"2017": {
"Other Liabilities": "8.49",
"Liabilities": "-37.3",
"Stockholders Equity": "-51.5",
"ECR before LimitedLiability": "-19.6",
"Liabilities, Current": "21.5",
"Liabilities, Non-Current": "-74.2",
"Assets": "-20.1",
"Other Assets": "2.64",
"Assets, Current": "-16.0",
"Goodwill": "-21.1",
"Property, Plant and Equipment, Net": "16.0",
"Research and Development": "17.5",
"Expenses": "23.4",
"Revenues": "27.6",
"Net Income": "28.4",
"Other Expenses": "-33.2",
"General and Administrative Expense": "28.1",
"Other Revenues": "27.6",
"Comprehensive Net Income": "28.5",
"Other Net Income": "-4.15",
"Economic Capital Ratio": "-41.2"
},
"2018": {
"Liabilities, Non-Current": "-74.0",
"Liabilities": "-44.1",
"Stockholders Equity": "-58.1",
"ECR before LimitedLiability": "-6.77",
"Other Liabilities": "8.30",
"Liabilities, Current": "15.6",
"Property, Plant and Equipment, Net": "28.2",
"Assets": "-21.9",
"Other Assets": "2.59",
"Assets, Current": "-22.2",
"Goodwill": "-17.9",
"Assets, Non-Current": "-5.02",
"Other Expenses": "10.7",
"Expenses": "26.5",
"Revenues": "29.5",
"Net Income": "33.4",
"Research and Development": "16.1",
"Other Revenues": "29.5",
"Comprehensive Net Income": "33.3",
"Other Net Income": "2.10",
"Economic Capital Ratio": "-27.2"
},
"2019": {
"Liabilities, Non-Current": "-83.7",
"Liabilities": "-50.0",
"Stockholders Equity": "-63.1",
"ECR before LimitedLiability": "-7.65",
"Other Liabilities": "12.2",
"Liabilities, Current": "14.2",
"Assets, Non-Current": "-8.32",
"Assets": "-23.3",
"Goodwill": "-21.4",
"Property, Plant and Equipment, Net": "15.5",
"Other Assets": "4.43",
"Assets, Current": "-26.5",
"Research and Development": "12.2",
"Expenses": "14.6",
"Revenues": "14.2",
"Net Income": "16.7",
"Other Expenses": "10.1",
"General and Administrative Expense": "6.78",
"Other Revenues": "14.2",
"Comprehensive Net Income": "16.9",
"Economic Capital Ratio": "-37.1"
},
"2020": {
"Liabilities, Current": "15.0",
"Liabilities": "-48.6",
"Stockholders Equity": "-66.9",
"ECR before LimitedLiability": "-3.94",
"Liabilities, Non-Current": "-74.8",
"Other Liabilities": "6.15",
"Goodwill": "-18.0",
"Assets": "-27.3",
"Assets, Current": "-31.6",
"Assets, Non-Current": "-4.18",
"Property, Plant and Equipment, Net": "20.2",
"Other Expenses": "7.07",
"Expenses": "12.6",
"Revenues": "18.4",
"Net Income": "20.2",
"Research and Development": "8.70",
"General and Administrative Expense": "-3.22",
"Other Revenues": "18.4",
"Comprehensive Net Income": "20.3",
"Other Net Income": "6.88",
"Economic Capital Ratio": "-41.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001627223_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "2,301,000",
"Assets, Non-Current": "644,000",
"General and Administrative Expense": "632,000",
"Goodwill": "176,000",
"Liabilities, Current": "1,466,000",
"Liabilities, Non-Current": "4,468,000",
"Other Assets": "0",
"Other Compr. Net Income": "-244,000",
"Other Expenses": "5,154,000",
"Other Liabilities": "234,000",
"Other Net Income": "76,000",
"Other Revenues": "5,717,000",
"Property, Plant and Equipment, Net": "3,177,000",
"Research and Development": "97,000"
},
"output_variables": {
"Liabilities": "6,168,000",
"Assets": "6,298,000",
"Expenses": "5,883,000",
"Revenues": "5,717,000",
"Stockholders Equity": "130,000",
"Net Income": "-90,000",
"Comprehensive Net Income": "-212,000",
"BaseVar": "12,193,000",
"ECR before LimitedLiability": "-0.54%",
"Economic Capital Ratio": "85%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,553,000",
"Assets, Non-Current": "553,000",
"General and Administrative Expense": "934,000",
"Goodwill": "0",
"Liabilities, Current": "1,771,000",
"Liabilities, Non-Current": "4,053,000",
"Other Assets": "170,000",
"Other Compr. Net Income": "-41,000",
"Other Expenses": "4,655,000",
"Other Liabilities": "132,000",
"Other Net Income": "276,000",
"Other Revenues": "5,400,000",
"Property, Plant and Equipment, Net": "2,784,000",
"Research and Development": "80,000"
},
"output_variables": {
"Liabilities": "5,956,000",
"Assets": "6,060,000",
"Expenses": "5,669,000",
"Revenues": "5,400,000",
"Stockholders Equity": "104,000",
"Net Income": "7,000",
"Comprehensive Net Income": "-13,500",
"BaseVar": "11,701,000",
"ECR before LimitedLiability": "2.1%",
"Economic Capital Ratio": "87%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,493,000",
"Assets, Non-Current": "626,000",
"General and Administrative Expense": "602,000",
"Goodwill": "0",
"Liabilities, Current": "1,648,000",
"Liabilities, Non-Current": "4,572,000",
"Other Assets": "166,000",
"Other Compr. Net Income": "134,000",
"Other Expenses": "4,866,000",
"Other Liabilities": "208,000",
"Other Net Income": "112,000",
"Other Revenues": "6,183,000",
"Property, Plant and Equipment, Net": "3,008,000",
"Research and Development": "80,000"
},
"output_variables": {
"Liabilities": "6,428,000",
"Assets": "7,293,000",
"Expenses": "5,548,000",
"Revenues": "6,183,000",
"Stockholders Equity": "865,000",
"Net Income": "747,000",
"Comprehensive Net Income": "814,000",
"BaseVar": "12,849,000",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "112%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "3,293,000",
"Assets, Non-Current": "597,000",
"General and Administrative Expense": "5,324,000",
"Goodwill": "0",
"Liabilities, Current": "1,709,000",
"Liabilities, Non-Current": "4,416,000",
"Other Assets": "181,000",
"Other Compr. Net Income": "-123,000",
"Other Expenses": "403,000",
"Other Liabilities": "217,000",
"Other Net Income": "167,000",
"Other Revenues": "6,638,000",
"Property, Plant and Equipment, Net": "3,291,000",
"Research and Development": "82,000"
},
"output_variables": {
"Liabilities": "6,342,000",
"Assets": "7,362,000",
"Expenses": "5,809,000",
"Revenues": "6,638,000",
"Stockholders Equity": "1,020,000",
"Net Income": "996,000",
"Comprehensive Net Income": "934,500",
"BaseVar": "13,220,500",
"ECR before LimitedLiability": "34%",
"Economic Capital Ratio": "117%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,777,000",
"Assets, Non-Current": "748,000",
"General and Administrative Expense": "5,011,000",
"Goodwill": "0",
"Liabilities, Current": "1,541,000",
"Liabilities, Non-Current": "4,904,000",
"Other Assets": "174,000",
"Other Compr. Net Income": "215,000",
"Other Expenses": "223,000",
"Other Liabilities": "118,000",
"Other Net Income": "-264,000",
"Other Revenues": "5,526,000",
"Property, Plant and Equipment, Net": "3,559,000",
"Research and Development": "80,000"
},
"output_variables": {
"Liabilities": "6,563,000",
"Assets": "7,258,000",
"Expenses": "5,314,000",
"Revenues": "5,526,000",
"Stockholders Equity": "695,000",
"Net Income": "-52,000",
"Comprehensive Net Income": "55,500",
"BaseVar": "12,570,000",
"ECR before LimitedLiability": "15%",
"Economic Capital Ratio": "99%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "2,633,000",
"Assets, Non-Current": "808,000",
"General and Administrative Expense": "4,429,000",
"Goodwill": "153,000",
"Liabilities, Current": "1,478,000",
"Liabilities, Non-Current": "4,789,000",
"Other Assets": "14,000",
"Other Compr. Net Income": "39,000",
"Other Expenses": "250,000",
"Other Liabilities": "0",
"Other Net Income": "22,000",
"Other Revenues": "4,969,000",
"Property, Plant and Equipment, Net": "3,474,000",
"Research and Development": "93,000"
},
"output_variables": {
"Liabilities": "6,267,000",
"Assets": "7,082,000",
"Expenses": "4,772,000",
"Revenues": "4,969,000",
"Stockholders Equity": "815,000",
"Net Income": "219,000",
"Comprehensive Net Income": "238,500",
"BaseVar": "11,575,500",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 1.0415873748660436,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001627223.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001627223.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001627223.svg"
},
{
"company_id": "0000074303",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000074303.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000074303.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000074303.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000074303_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000074303_main_keyfigs.svg",
"name": "OLIN Corp",
"rank": 33,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000074303.svg",
"report_text": "The relative strengths and weaknesses of OLIN Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of OLIN Corp compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 14% points.The greatest weakness of OLIN Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 67% points.
The company's Economic Capital Ratio, given in the ranking table, is 98%, being 47% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000074303_2021_OLIN_Corp.pdf",
"shrinked_graph_json": {
"2010": {
"Liabilities": "-32.8",
"Stockholders Equity": "-28.9",
"ECR before LimitedLiability": "-30.5",
"Liabilities, Current": "1.73",
"Liabilities, Non-Current": "-36.2",
"Goodwill": "-4.33",
"Assets": "-4.43",
"Property, Plant and Equipment, Net": "15.0",
"Assets, Current": "-12.7",
"Assets, Non-Current": "-7.23",
"Other Assets": "9.43",
"Other Expenses": "21.0",
"Expenses": "8.06",
"Revenues": "-3.03",
"Net Income": "9.56",
"General and Administrative Expense": "-19.2",
"Research and Development": "8.02",
"Other Revenues": "-3.03",
"Other Net Income": "4.53",
"Comprehensive Net Income": "9.63",
"Economic Capital Ratio": "-28.5"
},
"2011": {
"Liabilities, Current": "25.7",
"Liabilities": "-22.1",
"Stockholders Equity": "-11.3",
"ECR before LimitedLiability": "63.0",
"Liabilities, Non-Current": "-61.5",
"Other Liabilities": "5.23",
"Property, Plant and Equipment, Net": "22.8",
"Assets": "3.43",
"Assets, Non-Current": "-2.36",
"Other Assets": "2.89",
"Goodwill": "11.7",
"Assets, Current": "-21.4",
"General and Administrative Expense": "-4.85",
"Expenses": "28.8",
"Revenues": "16.3",
"Net Income": "47.9",
"Research and Development": "14.7",
"Other Expenses": "18.4",
"Other Revenues": "16.3",
"Comprehensive Net Income": "47.8",
"Economic Capital Ratio": "0.966"
},
"2012": {
"Liabilities, Current": "15.1",
"Liabilities": "-34.4",
"Stockholders Equity": "-22.1",
"ECR before LimitedLiability": "16.0",
"Liabilities, Non-Current": "-69.6",
"Other Liabilities": "12.2",
"Assets, Current": "-26.2",
"Assets": "2.32",
"Assets, Non-Current": "1.50",
"Property, Plant and Equipment, Net": "27.3",
"Goodwill": "12.7",
"Other Expenses": "25.4",
"Expenses": "33.0",
"Revenues": "14.0",
"Net Income": "48.4",
"Research and Development": "16.2",
"General and Administrative Expense": "-8.75",
"Other Revenues": "14.0",
"Comprehensive Net Income": "46.8",
"Other Compr. Net Income": "-1.24",
"Economic Capital Ratio": "-16.5"
},
"2013": {
"Liabilities, Current": "25.1",
"Liabilities": "-16.8",
"Stockholders Equity": "-18.2",
"ECR before LimitedLiability": "35.3",
"Other Liabilities": "8.23",
"Liabilities, Non-Current": "-57.4",
"Goodwill": "9.75",
"Assets": "-4.23",
"Property, Plant and Equipment, Net": "23.4",
"Other Assets": "-2.99",
"Assets, Current": "-24.2",
"General and Administrative Expense": "-18.6",
"Expenses": "22.4",
"Revenues": "28.7",
"Net Income": "50.6",
"Research and Development": "14.3",
"Other Expenses": "28.6",
"Other Revenues": "28.7",
"Other Net Income": "-2.96",
"Comprehensive Net Income": "50.6",
"Economic Capital Ratio": "-4.82"
},
"2014": {
"Liabilities, Non-Current": "-58.3",
"Liabilities": "-1.31",
"Stockholders Equity": "3.36",
"ECR before LimitedLiability": "56.9",
"Liabilities, Current": "41.5",
"Other Liabilities": "6.72",
"Assets, Current": "-23.7",
"Assets": "3.47",
"Goodwill": "10.7",
"Assets, Non-Current": "1.43",
"Property, Plant and Equipment, Net": "25.0",
"Other Expenses": "18.1",
"Expenses": "25.8",
"Revenues": "24.3",
"Net Income": "55.5",
"Research and Development": "16.9",
"General and Administrative Expense": "-9.17",
"Other Revenues": "24.3",
"Other Net Income": "1.76",
"Comprehensive Net Income": "53.8",
"Economic Capital Ratio": "7.51"
},
"2015": {
"Other Liabilities": "-5.10",
"Liabilities": "-44.7",
"Stockholders Equity": "-3.52",
"ECR before LimitedLiability": "31.4",
"Liabilities, Current": "23.6",
"Liabilities, Non-Current": "-68.3",
"Assets, Current": "-21.1",
"Assets": "35.6",
"Other Assets": "-5.63",
"Goodwill": "23.8",
"Assets, Non-Current": "2.30",
"Property, Plant and Equipment, Net": "37.0",
"Research and Development": "9.38",
"Expenses": "36.8",
"Revenues": "-6.46",
"Net Income": "35.9",
"General and Administrative Expense": "8.62",
"Other Expenses": "22.4",
"Other Revenues": "-6.46",
"Comprehensive Net Income": "35.9",
"Economic Capital Ratio": "-14.5"
},
"2016": {
"Liabilities, Non-Current": "-66.8",
"Liabilities": "-35.4",
"Stockholders Equity": "-31.1",
"ECR before LimitedLiability": "-5.23",
"Liabilities, Current": "34.1",
"Other Liabilities": "-9.56",
"Property, Plant and Equipment, Net": "32.8",
"Assets": "-3.37",
"Assets, Non-Current": "2.84",
"Assets, Current": "-37.5",
"Goodwill": "19.8",
"Research and Development": "16.9",
"Expenses": "27.1",
"Revenues": "12.2",
"Net Income": "36.8",
"General and Administrative Expense": "-16.2",
"Other Expenses": "27.8",
"Other Revenues": "12.2",
"Comprehensive Net Income": "36.8",
"Other Net Income": "-2.11",
"Economic Capital Ratio": "-25.2"
},
"2017": {
"Other Liabilities": "11.6",
"Liabilities": "-25.3",
"Stockholders Equity": "-23.1",
"ECR before LimitedLiability": "0.975",
"Liabilities, Current": "25.2",
"Liabilities, Non-Current": "-71.0",
"Assets, Non-Current": "8.31",
"Assets": "-3.08",
"Assets, Current": "-29.2",
"Goodwill": "12.8",
"Property, Plant and Equipment, Net": "16.8",
"Research and Development": "16.0",
"Expenses": "21.7",
"Revenues": "19.9",
"Net Income": "38.0",
"Other Expenses": "25.3",
"General and Administrative Expense": "-17.9",
"Other Revenues": "19.9",
"Comprehensive Net Income": "37.7",
"Other Net Income": "-4.78",
"Economic Capital Ratio": "-20.6"
},
"2018": {
"Liabilities, Non-Current": "-66.1",
"Liabilities": "-27.7",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "8.83",
"Other Liabilities": "12.2",
"Liabilities, Current": "19.3",
"Property, Plant and Equipment, Net": "21.7",
"Assets": "-10.3",
"Assets, Current": "-33.4",
"Goodwill": "15.5",
"Assets, Non-Current": "1.48",
"Other Expenses": "8.51",
"Expenses": "19.2",
"Revenues": "23.2",
"Net Income": "44.5",
"Research and Development": "15.8",
"General and Administrative Expense": "-5.21",
"Other Revenues": "23.2",
"Comprehensive Net Income": "44.4",
"Other Compr. Net Income": "-0.146",
"Economic Capital Ratio": "-11.6"
},
"2019": {
"Liabilities, Non-Current": "-74.5",
"Liabilities": "-35.7",
"Stockholders Equity": "-37.2",
"ECR before LimitedLiability": "15.6",
"Other Liabilities": "13.9",
"Liabilities, Current": "17.3",
"Assets, Non-Current": "1.82",
"Assets": "-8.76",
"Goodwill": "13.7",
"Property, Plant and Equipment, Net": "20.7",
"Assets, Current": "-32.8",
"Research and Development": "11.8",
"Expenses": "24.9",
"Revenues": "15.4",
"Net Income": "37.6",
"Other Expenses": "8.45",
"General and Administrative Expense": "3.85",
"Other Revenues": "15.4",
"Other Net Income": "4.91",
"Comprehensive Net Income": "37.6",
"Economic Capital Ratio": "-13.9"
},
"2020": {
"Liabilities, Current": "13.9",
"Liabilities": "-37.9",
"Stockholders Equity": "-65.7",
"ECR before LimitedLiability": "-9.61",
"Liabilities, Non-Current": "-67.4",
"Other Liabilities": "6.52",
"Goodwill": "4.16",
"Assets": "-32.1",
"Assets, Current": "-47.5",
"Assets, Non-Current": "4.92",
"Property, Plant and Equipment, Net": "13.9",
"Expenses": "0.482",
"Net Income": "14.1",
"Research and Development": "10.9",
"General and Administrative Expense": "-9.58",
"Other Revenues": "13.9",
"Revenues": "13.9",
"Other Compr. Net Income": "0.832",
"Comprehensive Net Income": "14.1",
"Other Net Income": "7.13",
"Economic Capital Ratio": "-47.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000074303_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "882,800",
"Assets, Non-Current": "72,300",
"General and Administrative Expense": "1,484,300",
"Goodwill": "300,300",
"Liabilities, Current": "391,000",
"Liabilities, Non-Current": "803,900",
"Other Assets": "118,300",
"Other Compr. Net Income": "0",
"Other Expenses": "71,700",
"Other Liabilities": "23,500",
"Other Net Income": "34,900",
"Other Revenues": "1,585,900",
"Property, Plant and Equipment, Net": "675,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,218,400",
"Assets": "2,048,700",
"Expenses": "1,556,000",
"Revenues": "1,585,900",
"Stockholders Equity": "830,300",
"Net Income": "64,800",
"Comprehensive Net Income": "64,800",
"BaseVar": "3,221,950",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "149%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "780,300",
"Assets, Non-Current": "85,600",
"General and Administrative Expense": "1,735,300",
"Goodwill": "627,400",
"Liabilities, Current": "399,100",
"Liabilities, Non-Current": "965,100",
"Other Assets": "70,900",
"Other Compr. Net Income": "0",
"Other Expenses": "178,800",
"Other Liabilities": "99,600",
"Other Net Income": "185,900",
"Other Revenues": "1,969,900",
"Property, Plant and Equipment, Net": "885,400",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,463,800",
"Assets": "2,449,600",
"Expenses": "1,914,100",
"Revenues": "1,969,900",
"Stockholders Equity": "985,800",
"Net Income": "241,700",
"Comprehensive Net Income": "241,700",
"BaseVar": "3,991,650",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "749,100",
"Assets, Non-Current": "224,100",
"General and Administrative Expense": "1,916,600",
"Goodwill": "747,100",
"Liabilities, Current": "434,000",
"Liabilities, Non-Current": "1,234,900",
"Other Assets": "23,100",
"Other Compr. Net Income": "-77,100",
"Other Expenses": "118,800",
"Other Liabilities": "110,400",
"Other Net Income": "-7,300",
"Other Revenues": "2,192,300",
"Property, Plant and Equipment, Net": "1,034,300",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,779,300",
"Assets": "2,777,700",
"Expenses": "2,035,400",
"Revenues": "2,192,300",
"Stockholders Equity": "998,400",
"Net Income": "149,600",
"Comprehensive Net Income": "111,050",
"BaseVar": "4,434,550",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "839,900",
"Assets, Non-Current": "213,100",
"General and Administrative Expense": "2,223,700",
"Goodwill": "747,100",
"Liabilities, Current": "407,500",
"Liabilities, Non-Current": "1,176,600",
"Other Assets": "14,900",
"Other Compr. Net Income": "6,200",
"Other Expenses": "115,500",
"Other Liabilities": "117,600",
"Other Net Income": "2,100",
"Other Revenues": "2,515,700",
"Property, Plant and Equipment, Net": "987,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,701,700",
"Assets": "2,802,800",
"Expenses": "2,339,200",
"Revenues": "2,515,700",
"Stockholders Equity": "1,101,100",
"Net Income": "178,600",
"Comprehensive Net Income": "181,700",
"BaseVar": "4,683,850",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "150%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "816,100",
"Assets, Non-Current": "191,400",
"General and Administrative Expense": "2,023,600",
"Goodwill": "747,100",
"Liabilities, Current": "377,700",
"Liabilities, Non-Current": "1,200,000",
"Other Assets": "12,500",
"Other Compr. Net Income": "-78,000",
"Other Expenses": "176,100",
"Other Liabilities": "107,100",
"Other Net Income": "3,800",
"Other Revenues": "2,242,700",
"Property, Plant and Equipment, Net": "931,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,684,800",
"Assets": "2,698,100",
"Expenses": "2,199,700",
"Revenues": "2,242,700",
"Stockholders Equity": "1,013,300",
"Net Income": "46,800",
"Comprehensive Net Income": "7,800",
"BaseVar": "4,453,550",
"ECR before LimitedLiability": "64%",
"Economic Capital Ratio": "141%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,933,400",
"Assets, Non-Current": "487,500",
"General and Administrative Expense": "2,673,300",
"Goodwill": "2,851,600",
"Liabilities, Current": "1,147,700",
"Liabilities, Non-Current": "4,660,100",
"Other Assets": "95,900",
"Other Compr. Net Income": "-49,400",
"Other Expenses": "305,800",
"Other Liabilities": "1,095,200",
"Other Net Income": "3,000",
"Other Revenues": "2,900,100",
"Property, Plant and Equipment, Net": "3,953,400",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,903,000",
"Assets": "9,321,800",
"Expenses": "2,979,100",
"Revenues": "2,900,100",
"Stockholders Equity": "2,418,800",
"Net Income": "-76,000",
"Comprehensive Net Income": "-100,700",
"BaseVar": "11,078,200",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "121%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "1,546,200",
"Assets, Non-Current": "644,400",
"General and Administrative Expense": "5,246,900",
"Goodwill": "2,747,600",
"Liabilities, Current": "922,600",
"Liabilities, Non-Current": "4,534,500",
"Other Assets": "119,500",
"Other Compr. Net Income": "-17,500",
"Other Expenses": "400,600",
"Other Liabilities": "1,032,500",
"Other Net Income": "5,100",
"Other Revenues": "5,561,200",
"Property, Plant and Equipment, Net": "3,704,900",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,489,600",
"Assets": "8,762,600",
"Expenses": "5,647,500",
"Revenues": "5,561,200",
"Stockholders Equity": "2,273,000",
"Net Income": "-81,200",
"Comprehensive Net Income": "-89,950",
"BaseVar": "13,241,750",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "121%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,699,200",
"Assets, Non-Current": "1,208,400",
"General and Administrative Expense": "5,890,300",
"Goodwill": "2,698,500",
"Liabilities, Current": "1,465,500",
"Liabilities, Non-Current": "4,999,100",
"Other Assets": "36,400",
"Other Compr. Net Income": "25,400",
"Other Expenses": "-14,900",
"Other Liabilities": "0",
"Other Net Income": "3,600",
"Other Revenues": "6,271,700",
"Property, Plant and Equipment, Net": "3,575,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,464,600",
"Assets": "9,218,300",
"Expenses": "5,875,400",
"Revenues": "6,271,700",
"Stockholders Equity": "2,753,700",
"Net Income": "399,900",
"Comprehensive Net Income": "412,600",
"BaseVar": "13,929,500",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "133%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,707,400",
"Assets, Non-Current": "1,150,400",
"General and Administrative Expense": "6,252,700",
"Goodwill": "2,631,200",
"Liabilities, Current": "1,637,200",
"Liabilities, Non-Current": "4,528,000",
"Other Assets": "26,300",
"Other Compr. Net Income": "-80,500",
"Other Expenses": "562,700",
"Other Liabilities": "0",
"Other Net Income": "3,600",
"Other Revenues": "6,952,500",
"Property, Plant and Equipment, Net": "3,482,100",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,165,200",
"Assets": "8,997,400",
"Expenses": "6,815,400",
"Revenues": "6,952,500",
"Stockholders Equity": "2,832,200",
"Net Income": "140,700",
"Comprehensive Net Income": "100,450",
"BaseVar": "14,507,300",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,714,000",
"Assets, Non-Current": "1,546,900",
"General and Administrative Expense": "5,856,100",
"Goodwill": "2,567,800",
"Liabilities, Current": "1,536,700",
"Liabilities, Non-Current": "5,233,600",
"Other Assets": "35,300",
"Other Compr. Net Income": "-152,400",
"Other Expenses": "294,100",
"Other Liabilities": "0",
"Other Net Income": "17,300",
"Other Revenues": "6,121,600",
"Property, Plant and Equipment, Net": "3,323,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,770,300",
"Assets": "9,187,800",
"Expenses": "6,150,200",
"Revenues": "6,121,600",
"Stockholders Equity": "2,417,500",
"Net Income": "-11,300",
"Comprehensive Net Income": "-87,500",
"BaseVar": "14,199,800",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "122%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,717,100",
"Assets, Non-Current": "1,552,000",
"General and Administrative Expense": "5,796,600",
"Goodwill": "1,819,600",
"Liabilities, Current": "1,642,100",
"Liabilities, Non-Current": "5,178,000",
"Other Assets": "11,200",
"Other Compr. Net Income": "113,500",
"Other Expenses": "932,500",
"Other Liabilities": "0",
"Other Net Income": "500",
"Other Revenues": "5,758,700",
"Property, Plant and Equipment, Net": "3,171,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,820,100",
"Assets": "8,270,900",
"Expenses": "6,729,100",
"Revenues": "5,758,700",
"Stockholders Equity": "1,450,800",
"Net Income": "-969,900",
"Comprehensive Net Income": "-913,150",
"BaseVar": "13,846,400",
"ECR before LimitedLiability": "14%",
"Economic Capital Ratio": "98%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 0.9848752888730057,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000074303.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000074303.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000074303.svg"
},
{
"company_id": "0000093314",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000093314.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000093314.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000093314.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000093314_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000093314_main_keyfigs.svg",
"name": "Volitionrx LTD",
"rank": 34,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000093314.svg",
"report_text": "The relative strengths and weaknesses of Volitionrx LTD are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Volitionrx LTD compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 18% points.The greatest weakness of Volitionrx LTD is the variable Net Income, reducing the Economic Capital Ratio by 66% points.
The company's Economic Capital Ratio, given in the ranking table, is 95%, being 51% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000093314_2021_Volitionrx_LTD.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "-1.38",
"Liabilities": "-3.49",
"Stockholders Equity": "-12.6",
"ECR before LimitedLiability": "-79.6",
"Liabilities, Non-Current": "1.66",
"Other Liabilities": "-4.00",
"Assets, Current": "-25.6",
"Assets": "-7.11",
"Assets, Non-Current": "-6.42",
"Property, Plant and Equipment, Net": "-10.6",
"Goodwill": "40.5",
"Other Expenses": "-2.31",
"Expenses": "-27.4",
"Revenues": "-27.1",
"Net Income": "-45.5",
"Research and Development": "-36.7",
"General and Administrative Expense": "17.7",
"Other Revenues": "-27.1",
"Comprehensive Net Income": "-46.4",
"Other Compr. Net Income": "-0.333",
"Economic Capital Ratio": "-112"
},
"2013": {
"Goodwill": "24.7",
"Assets": "-24.4",
"Stockholders Equity": "-20.1",
"Other Liabilities": "-2.21",
"ECR before LimitedLiability": "-65.8",
"Assets, Non-Current": "-7.00",
"Property, Plant and Equipment, Net": "-12.6",
"Other Assets": "-4.27",
"Assets, Current": "-23.1",
"General and Administrative Expense": "20.8",
"Expenses": "-29.8",
"Revenues": "-28.1",
"Net Income": "-35.8",
"Research and Development": "-33.6",
"Other Expenses": "-14.7",
"Other Revenues": "-28.1",
"Liabilities, Current": "-1.64",
"Liabilities, Non-Current": "3.07",
"Other Net Income": "14.7",
"Comprehensive Net Income": "-35.8",
"Economic Capital Ratio": "-106"
},
"2014": {
"Liabilities, Non-Current": "0.713",
"Liabilities": "-0.453",
"Stockholders Equity": "-14.8",
"ECR before LimitedLiability": "-60.1",
"Liabilities, Current": "-1.44",
"Assets, Current": "-6.61",
"Assets": "-18.5",
"Other Assets": "0.401",
"Assets, Non-Current": "-5.21",
"Property, Plant and Equipment, Net": "-7.01",
"Other Expenses": "-4.16",
"Expenses": "-10.1",
"Revenues": "-25.0",
"Net Income": "-55.5",
"Research and Development": "-31.8",
"General and Administrative Expense": "15.2",
"Other Revenues": "-25.0",
"Other Net Income": "-20.4",
"Comprehensive Net Income": "-55.6",
"Other Compr. Net Income": "-0.142",
"Economic Capital Ratio": "-109"
},
"2015": {
"Liabilities": "13.4",
"Stockholders Equity": "30.8",
"ECR before LimitedLiability": "-25.2",
"Liabilities, Current": "8.27",
"Liabilities, Non-Current": "5.28",
"Assets, Current": "33.9",
"Assets": "2.13",
"Other Assets": "-6.99",
"Goodwill": "-6.83",
"Assets, Non-Current": "-3.96",
"Property, Plant and Equipment, Net": "-3.58",
"Research and Development": "-20.2",
"Expenses": "-51.8",
"Revenues": "-18.3",
"Net Income": "-105",
"General and Administrative Expense": "21.9",
"Other Expenses": "-19.7",
"Other Revenues": "-18.3",
"Comprehensive Net Income": "-105",
"Other Net Income": "3.80",
"Economic Capital Ratio": "-71.1"
},
"2016": {
"Liabilities, Non-Current": "11.9",
"Liabilities": "30.8",
"Stockholders Equity": "97.8",
"ECR before LimitedLiability": "55.2",
"Liabilities, Current": "22.6",
"Other Liabilities": "-3.05",
"Property, Plant and Equipment, Net": "-1.79",
"Assets": "72.0",
"Assets, Non-Current": "-2.38",
"Assets, Current": "98.0",
"Goodwill": "-5.53",
"Other Revenues": "-32.6",
"Revenues": "-32.6",
"Net Income": "-32.3",
"Research and Development": "-21.5",
"Comprehensive Net Income": "-32.4",
"Other Compr. Net Income": "-0.102",
"Other Net Income": "0.291",
"General and Administrative Expense": "24.9",
"Other Expenses": "-2.17",
"Economic Capital Ratio": "35.2"
},
"2017": {
"Other Liabilities": "-0.100",
"Liabilities": "1.58",
"Stockholders Equity": "9.40",
"Liabilities, Current": "1.41",
"Liabilities, Non-Current": "0.222",
"Assets, Non-Current": "-0.235",
"Assets": "6.25",
"Assets, Current": "14.9",
"Goodwill": "-9.48",
"Property, Plant and Equipment, Net": "0.599",
"Research and Development": "-55.1",
"Expenses": "-39.9",
"Revenues": "-42.2",
"Net Income": "-85.8",
"Other Expenses": "2.85",
"General and Administrative Expense": "-0.242",
"Other Revenues": "-42.2",
"ECR before LimitedLiability": "-47.4",
"Comprehensive Net Income": "-85.9",
"Other Net Income": "-0.117",
"Economic Capital Ratio": "-69.0"
},
"2018": {
"Liabilities, Non-Current": "-0.121",
"Liabilities": "0.888",
"Stockholders Equity": "7.63",
"Other Liabilities": "-0.0123",
"Liabilities, Current": "1.23",
"Property, Plant and Equipment, Net": "0.238",
"Assets": "6.29",
"Assets, Current": "21.0",
"Goodwill": "-8.40",
"Assets, Non-Current": "-6.70",
"Other Expenses": "1.07",
"Expenses": "-38.3",
"Revenues": "-46.0",
"Net Income": "-84.9",
"Research and Development": "-59.4",
"General and Administrative Expense": "0.612",
"Other Revenues": "-46.0",
"ECR before LimitedLiability": "-38.9",
"Comprehensive Net Income": "-83.6",
"Other Compr. Net Income": "0.0806",
"Economic Capital Ratio": "-59.3"
},
"2020": {
"Liabilities, Current": "-4.82",
"Liabilities": "2.23",
"Stockholders Equity": "11.2",
"Liabilities, Non-Current": "7.66",
"Other Liabilities": "-0.735",
"Goodwill": "-18.5",
"Assets": "11.1",
"ECR before LimitedLiability": "-13.0",
"Assets, Current": "18.1",
"Assets, Non-Current": "-14.8",
"Property, Plant and Equipment, Net": "6.57",
"Other Expenses": "10.3",
"Expenses": "-34.9",
"Revenues": "-44.7",
"Net Income": "-65.6",
"Research and Development": "-59.4",
"General and Administrative Expense": "10.7",
"Other Revenues": "-44.7",
"Comprehensive Net Income": "-65.5",
"Other Net Income": "10.5",
"Economic Capital Ratio": "-50.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000093314_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "695",
"Assets, Non-Current": "0",
"General and Administrative Expense": "448",
"Goodwill": "1,430",
"Liabilities, Current": "748",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-39",
"Other Expenses": "847",
"Other Liabilities": "635",
"Other Net Income": "0",
"Other Revenues": "55",
"Property, Plant and Equipment, Net": "91",
"Research and Development": "2,843"
},
"output_variables": {
"Liabilities": "1,383",
"Assets": "2,217",
"Expenses": "4,138",
"Revenues": "55",
"Stockholders Equity": "834",
"Net Income": "-4,083",
"Comprehensive Net Income": "-4,103",
"BaseVar": "3,916",
"ECR before LimitedLiability": "-164%",
"Economic Capital Ratio": "46%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,005",
"Assets, Non-Current": "0",
"General and Administrative Expense": "434",
"Goodwill": "1,002",
"Liabilities, Current": "957",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-26",
"Other Expenses": "1,638",
"Other Liabilities": "433",
"Other Net Income": "866",
"Other Revenues": "55",
"Property, Plant and Equipment, Net": "63",
"Research and Development": "2,504"
},
"output_variables": {
"Liabilities": "1,390",
"Assets": "2,071",
"Expenses": "4,576",
"Revenues": "55",
"Stockholders Equity": "681",
"Net Income": "-3,655",
"Comprehensive Net Income": "-3,668",
"BaseVar": "4,491",
"ECR before LimitedLiability": "-158%",
"Economic Capital Ratio": "49%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "2,336",
"Assets, Non-Current": "0",
"General and Administrative Expense": "299",
"Goodwill": "809",
"Liabilities, Current": "2,713",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-44",
"Other Expenses": "1,609",
"Other Liabilities": "352",
"Other Net Income": "-2,276",
"Other Revenues": "15",
"Property, Plant and Equipment, Net": "289",
"Research and Development": "4,044"
},
"output_variables": {
"Liabilities": "3,065",
"Assets": "3,433",
"Expenses": "5,952",
"Revenues": "15",
"Stockholders Equity": "368",
"Net Income": "-8,214",
"Comprehensive Net Income": "-8,236",
"BaseVar": "7,393",
"ECR before LimitedLiability": "-238%",
"Economic Capital Ratio": "24%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "6,223",
"Assets, Non-Current": "0",
"General and Administrative Expense": "669",
"Goodwill": "705",
"Liabilities, Current": "1,120",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "20",
"Other Expenses": "7,144",
"Other Liabilities": "548",
"Other Net Income": "471",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "784",
"Research and Development": "6,102"
},
"output_variables": {
"Liabilities": "1,668",
"Assets": "7,712",
"Expenses": "13,914",
"Revenues": "0",
"Stockholders Equity": "6,044",
"Net Income": "-13,443",
"Comprehensive Net Income": "-13,434",
"BaseVar": "11,892",
"ECR before LimitedLiability": "-110%",
"Economic Capital Ratio": "65%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "22,012",
"Assets, Non-Current": "0",
"General and Administrative Expense": "742",
"Goodwill": "602",
"Liabilities, Current": "2,033",
"Liabilities, Non-Current": "432",
"Other Assets": "0",
"Other Compr. Net Income": "-109",
"Other Expenses": "4,687",
"Other Liabilities": "1,092",
"Other Net Income": "361",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "2,119",
"Research and Development": "6,838"
},
"output_variables": {
"Liabilities": "3,558",
"Assets": "24,733",
"Expenses": "12,267",
"Revenues": "0",
"Stockholders Equity": "21,175",
"Net Income": "-11,905",
"Comprehensive Net Income": "-11,960",
"BaseVar": "20,514",
"ECR before LimitedLiability": "121%",
"Economic Capital Ratio": "182%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "10,567",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6,140",
"Goodwill": "576",
"Liabilities, Current": "2,290",
"Liabilities, Non-Current": "1,313",
"Other Assets": "0",
"Other Compr. Net Income": "64",
"Other Expenses": "0",
"Other Liabilities": "1,063",
"Other Net Income": "277",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,481",
"Research and Development": "8,906"
},
"output_variables": {
"Liabilities": "4,667",
"Assets": "14,624",
"Expenses": "15,046",
"Revenues": "0",
"Stockholders Equity": "9,958",
"Net Income": "-14,769",
"Comprehensive Net Income": "-14,737",
"BaseVar": "17,339",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,902",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6,991",
"Goodwill": "467",
"Liabilities, Current": "2,333",
"Liabilities, Non-Current": "1,984",
"Other Assets": "0",
"Other Compr. Net Income": "353",
"Other Expenses": "111",
"Other Liabilities": "1,031",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,120",
"Research and Development": "10,907"
},
"output_variables": {
"Liabilities": "5,349",
"Assets": "17,489",
"Expenses": "18,009",
"Revenues": "0",
"Stockholders Equity": "12,140",
"Net Income": "-18,009",
"Comprehensive Net Income": "-17,832",
"BaseVar": "20,600",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "20,332",
"Assets, Non-Current": "326",
"General and Administrative Expense": "6,727",
"Goodwill": "322",
"Liabilities, Current": "6,237",
"Liabilities, Non-Current": "2,759",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "862",
"Other Net Income": "849",
"Other Revenues": "13",
"Property, Plant and Equipment, Net": "5,171",
"Research and Development": "14,534"
},
"output_variables": {
"Liabilities": "9,857",
"Assets": "26,151",
"Expenses": "21,261",
"Revenues": "13",
"Stockholders Equity": "16,294",
"Net Income": "-20,399",
"Comprehensive Net Income": "-20,399",
"BaseVar": "29,065",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "95%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.9509582673209981,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000093314.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000093314.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000093314.svg"
},
{
"company_id": "0001386570",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001386570.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001386570.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001386570.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001386570_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001386570_main_keyfigs.svg",
"name": "Niagen Bioscience Inc",
"rank": 35,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001386570.svg",
"report_text": "The relative strengths and weaknesses of Niagen Bioscience Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Niagen Bioscience Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 20% points.The greatest weakness of Niagen Bioscience Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 101% points.
The company's Economic Capital Ratio, given in the ranking table, is 93%, being 53% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001386570_2021_Niagen_Bioscience_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities": "7.56",
"Stockholders Equity": "-10.8",
"ECR before LimitedLiability": "-18.3",
"Liabilities, Non-Current": "3.72",
"Other Liabilities": "3.91",
"Property, Plant and Equipment, Net": "-3.30",
"Assets": "-28.5",
"Assets, Non-Current": "-4.22",
"Other Assets": "-0.678",
"Goodwill": "-8.77",
"Assets, Current": "-9.16",
"General and Administrative Expense": "-102",
"Expenses": "-30.9",
"Revenues": "9.52",
"Net Income": "-15.5",
"Research and Development": "9.81",
"Other Expenses": "17.7",
"Other Revenues": "9.52",
"Comprehensive Net Income": "-15.6",
"Other Net Income": "-3.94",
"Economic Capital Ratio": "-80.3"
},
"2012": {
"Liabilities, Current": "-3.43",
"Liabilities": "6.79",
"Stockholders Equity": "-12.2",
"ECR before LimitedLiability": "-53.5",
"Liabilities, Non-Current": "3.82",
"Other Liabilities": "6.34",
"Assets, Current": "-7.18",
"Assets": "-34.0",
"Other Assets": "-1.13",
"Assets, Non-Current": "-4.98",
"Property, Plant and Equipment, Net": "-7.24",
"Goodwill": "-10.0",
"Other Expenses": "20.9",
"Expenses": "-31.1",
"Revenues": "7.55",
"Net Income": "-12.2",
"Research and Development": "11.0",
"General and Administrative Expense": "-110",
"Other Revenues": "7.55",
"Comprehensive Net Income": "-12.2",
"Economic Capital Ratio": "-86.0"
},
"2013": {
"Liabilities, Current": "10.9",
"Liabilities": "55.5",
"Stockholders Equity": "4.29",
"ECR before LimitedLiability": "29.8",
"Other Liabilities": "21.9",
"Liabilities, Non-Current": "25.6",
"Goodwill": "-18.8",
"Assets": "-26.0",
"Assets, Non-Current": "23.1",
"Property, Plant and Equipment, Net": "-6.61",
"Other Assets": "-7.78",
"Assets, Current": "-13.1",
"General and Administrative Expense": "-93.8",
"Expenses": "-35.4",
"Revenues": "50.9",
"Net Income": "2.23",
"Research and Development": "22.2",
"Other Expenses": "51.8",
"Other Revenues": "50.9",
"Other Net Income": "-5.03",
"Economic Capital Ratio": "-10.4"
},
"2019": {
"Liabilities, Non-Current": "3.11",
"Liabilities": "5.04",
"Stockholders Equity": "-43.1",
"Other Liabilities": "0.438",
"Liabilities, Current": "0.496",
"Assets, Non-Current": "-17.8",
"Assets": "-61.2",
"Goodwill": "-22.7",
"Property, Plant and Equipment, Net": "-21.4",
"Other Assets": "0.138",
"Research and Development": "0.572",
"Expenses": "-56.7",
"Revenues": "7.32",
"Net Income": "-5.67",
"Other Expenses": "2.12",
"General and Administrative Expense": "-79.9",
"Other Revenues": "7.32",
"ECR before LimitedLiability": "-22.2",
"Other Net Income": "0.425",
"Comprehensive Net Income": "-5.51",
"Economic Capital Ratio": "-51.6"
},
"2020": {
"Liabilities, Current": "8.43",
"Liabilities": "11.5",
"Stockholders Equity": "-92.5",
"ECR before LimitedLiability": "-15.1",
"Liabilities, Non-Current": "11.1",
"Other Liabilities": "-8.49",
"Goodwill": "-34.5",
"Assets": "-83.2",
"Assets, Current": "-33.4",
"Assets, Non-Current": "-25.9",
"Property, Plant and Equipment, Net": "-37.6",
"Other Expenses": "8.72",
"Expenses": "-81.6",
"Revenues": "20.4",
"Net Income": "3.13",
"Research and Development": "7.70",
"General and Administrative Expense": "-101",
"Other Revenues": "20.4",
"Comprehensive Net Income": "3.35",
"Other Net Income": "8.45",
"Economic Capital Ratio": "-52.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001386570_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "4,953",
"Assets, Non-Current": "144",
"General and Administrative Expense": "15,977",
"Goodwill": "100",
"Liabilities, Current": "3,343",
"Liabilities, Non-Current": "0",
"Other Assets": "-100",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-31",
"Other Revenues": "8,113",
"Property, Plant and Equipment, Net": "1,172",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,343",
"Assets": "6,270",
"Expenses": "15,977",
"Revenues": "8,113",
"Stockholders Equity": "2,927",
"Net Income": "-7,895",
"Comprehensive Net Income": "-7,895",
"BaseVar": "16,867",
"ECR before LimitedLiability": "-81%",
"Economic Capital Ratio": "73%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,927",
"Assets, Non-Current": "171",
"General and Administrative Expense": "23,247",
"Goodwill": "136",
"Liabilities, Current": "4,763",
"Liabilities, Non-Current": "0",
"Other Assets": "-136",
"Other Compr. Net Income": "0",
"Other Expenses": "-29",
"Other Liabilities": "0",
"Other Net Income": "-23",
"Other Revenues": "11,610",
"Property, Plant and Equipment, Net": "936",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,763",
"Assets": "9,035",
"Expenses": "23,218",
"Revenues": "11,610",
"Stockholders Equity": "4,272",
"Net Income": "-11,630",
"Comprehensive Net Income": "-11,630",
"BaseVar": "24,324",
"ECR before LimitedLiability": "-84%",
"Economic Capital Ratio": "72%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "5,791",
"Assets, Non-Current": "2,133",
"General and Administrative Expense": "14,502",
"Goodwill": "202",
"Liabilities, Current": "2,838",
"Liabilities, Non-Current": "0",
"Other Assets": "-202",
"Other Compr. Net Income": "0",
"Other Expenses": "45",
"Other Liabilities": "0",
"Other Net Income": "-33",
"Other Revenues": "10,161",
"Property, Plant and Equipment, Net": "1,063",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,838",
"Assets": "8,987",
"Expenses": "14,547",
"Revenues": "10,161",
"Stockholders Equity": "6,149",
"Net Income": "-4,420",
"Comprehensive Net Income": "-4,420",
"BaseVar": "18,283",
"ECR before LimitedLiability": "68%",
"Economic Capital Ratio": "144%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "33,518",
"Assets, Non-Current": "1,653",
"General and Administrative Expense": "73,046",
"Goodwill": "1,311",
"Liabilities, Current": "15,063",
"Liabilities, Non-Current": "848",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "125",
"Other Liabilities": "3,891",
"Other Net Income": "-847",
"Other Revenues": "46,291",
"Property, Plant and Equipment, Net": "3,765",
"Research and Development": "4,420"
},
"output_variables": {
"Liabilities": "19,802",
"Assets": "40,247",
"Expenses": "77,591",
"Revenues": "46,291",
"Stockholders Equity": "20,445",
"Net Income": "-32,147",
"Comprehensive Net Income": "-32,147",
"BaseVar": "92,389",
"ECR before LimitedLiability": "-14%",
"Economic Capital Ratio": "84%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "32,219",
"Assets, Non-Current": "1,851",
"General and Administrative Expense": "75,379",
"Goodwill": "1,082",
"Liabilities, Current": "16,476",
"Liabilities, Non-Current": "997",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "4,461",
"Other Net Income": "-71",
"Other Revenues": "59,257",
"Property, Plant and Equipment, Net": "3,206",
"Research and Development": "3,732"
},
"output_variables": {
"Liabilities": "21,934",
"Assets": "38,358",
"Expenses": "79,111",
"Revenues": "59,257",
"Stockholders Equity": "16,424",
"Net Income": "-19,925",
"Comprehensive Net Income": "-19,925",
"BaseVar": "99,366",
"ECR before LimitedLiability": "8.5%",
"Economic Capital Ratio": "93%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 0.930359234596522,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001386570.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001386570.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001386570.svg"
},
{
"company_id": "0001045309",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001045309.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001045309.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001045309.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001045309_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001045309_main_keyfigs.svg",
"name": "W R Grace CO",
"rank": 36,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001045309.svg",
"report_text": "The relative strengths and weaknesses of W R Grace CO are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of W R Grace CO compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 8.9% points.The greatest weakness of W R Grace CO is the variable Liabilities, reducing the Economic Capital Ratio by 68% points.
The company's Economic Capital Ratio, given in the ranking table, is 93%, being 53% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001045309_2021_W_R_Grace_CO.pdf",
"shrinked_graph_json": {
"2014": {
"Liabilities, Non-Current": "-77.1",
"Liabilities": "-40.6",
"Stockholders Equity": "-33.8",
"ECR before LimitedLiability": "19.4",
"Liabilities, Current": "18.8",
"Other Liabilities": "10.4",
"Other Expenses": "18.9",
"Expenses": "19.7",
"Net Income": "22.0",
"Research and Development": "15.7",
"General and Administrative Expense": "1.57",
"Other Revenues": "17.7",
"Revenues": "17.7",
"Assets, Current": "-21.7",
"Goodwill": "-0.777",
"Other Assets": "22.0",
"Assets, Non-Current": "-2.05",
"Property, Plant and Equipment, Net": "-16.2",
"Other Net Income": "1.70",
"Comprehensive Net Income": "21.9",
"Economic Capital Ratio": "-30.1"
},
"2015": {
"Other Liabilities": "11.4",
"Liabilities": "-35.1",
"Stockholders Equity": "-45.4",
"Liabilities, Current": "12.0",
"Liabilities, Non-Current": "-95.6",
"Assets, Current": "-32.5",
"Assets": "-15.8",
"Other Assets": "15.2",
"Goodwill": "-0.670",
"Property, Plant and Equipment, Net": "-18.6",
"Research and Development": "11.4",
"Expenses": "11.9",
"Revenues": "11.8",
"Net Income": "15.2",
"General and Administrative Expense": "-10.4",
"Other Expenses": "11.9",
"Other Revenues": "11.8",
"ECR before LimitedLiability": "6.03",
"Comprehensive Net Income": "15.2",
"Other Net Income": "1.20",
"Economic Capital Ratio": "-39.9"
},
"2016": {
"Liabilities, Non-Current": "-99.1",
"Liabilities": "-57.4",
"Stockholders Equity": "-44.3",
"ECR before LimitedLiability": "-20.8",
"Liabilities, Current": "21.2",
"Other Liabilities": "7.75",
"Research and Development": "14.5",
"Expenses": "21.8",
"Net Income": "21.9",
"General and Administrative Expense": "-1.38",
"Other Expenses": "21.2",
"Other Revenues": "4.85",
"Revenues": "4.85",
"Property, Plant and Equipment, Net": "8.17",
"Other Assets": "21.7",
"Assets, Non-Current": "0.634",
"Assets, Current": "-36.0",
"Goodwill": "9.05",
"Comprehensive Net Income": "21.9",
"Other Net Income": "-2.53",
"Economic Capital Ratio": "-40.7"
},
"2017": {
"Other Liabilities": "10.9",
"Liabilities": "-54.4",
"Stockholders Equity": "-49.6",
"ECR before LimitedLiability": "-34.6",
"Liabilities, Current": "12.9",
"Liabilities, Non-Current": "-102",
"Assets": "-6.86",
"Other Assets": "13.1",
"Assets, Current": "-32.0",
"Goodwill": "5.34",
"Property, Plant and Equipment, Net": "2.86",
"Research and Development": "12.6",
"Expenses": "13.2",
"Revenues": "9.95",
"Net Income": "13.5",
"Other Expenses": "12.6",
"General and Administrative Expense": "-1.17",
"Other Revenues": "9.95",
"Comprehensive Net Income": "13.4",
"Other Net Income": "-5.16",
"Economic Capital Ratio": "-56.2"
},
"2018": {
"Liabilities, Non-Current": "-84.6",
"Liabilities": "-68.4",
"Stockholders Equity": "-52.5",
"ECR before LimitedLiability": "-20.4",
"Other Liabilities": "-7.17",
"Liabilities, Current": "18.2",
"Property, Plant and Equipment, Net": "11.8",
"Assets": "-1.25",
"Other Assets": "18.2",
"Assets, Current": "-31.6",
"Goodwill": "13.8",
"Assets, Non-Current": "-3.50",
"Other Expenses": "7.09",
"Expenses": "19.0",
"Revenues": "4.28",
"Net Income": "19.4",
"Research and Development": "12.7",
"General and Administrative Expense": "17.5",
"Other Revenues": "4.28",
"Comprehensive Net Income": "19.4",
"Economic Capital Ratio": "-40.9"
},
"2019": {
"Liabilities, Non-Current": "-70.6",
"Liabilities": "-66.1",
"Stockholders Equity": "-50.4",
"ECR before LimitedLiability": "-4.16",
"Other Liabilities": "-6.79",
"Liabilities, Current": "10.2",
"Research and Development": "9.17",
"Expenses": "18.5",
"Net Income": "19.2",
"Other Expenses": "3.02",
"General and Administrative Expense": "17.8",
"Other Revenues": "2.04",
"Revenues": "2.04",
"Assets, Non-Current": "-9.59",
"Goodwill": "9.36",
"Property, Plant and Equipment, Net": "13.7",
"Other Assets": "17.7",
"Assets, Current": "-24.5",
"Other Net Income": "4.37",
"Comprehensive Net Income": "19.2",
"Economic Capital Ratio": "-33.6"
},
"2020": {
"Liabilities, Current": "8.12",
"Liabilities": "-68.2",
"Stockholders Equity": "-65.0",
"Liabilities, Non-Current": "-67.1",
"Other Liabilities": "-19.6",
"Goodwill": "7.97",
"Assets": "-13.7",
"Other Assets": "8.33",
"Assets, Current": "-38.4",
"Assets, Non-Current": "-8.73",
"Property, Plant and Equipment, Net": "8.08",
"Other Expenses": "2.19",
"Expenses": "8.49",
"Other Net Income": "5.87",
"Net Income": "8.95",
"Research and Development": "7.16",
"General and Administrative Expense": "8.06",
"ECR before LimitedLiability": "-15.5",
"Comprehensive Net Income": "8.90",
"Other Compr. Net Income": "-0.560",
"Economic Capital Ratio": "-53.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001045309_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "1,690,900",
"Assets, Non-Current": "173,800",
"General and Administrative Expense": "2,714,600",
"Goodwill": "740,900",
"Liabilities, Current": "1,182,100",
"Liabilities, Non-Current": "2,500,800",
"Other Assets": "1,489,600",
"Other Compr. Net Income": "-35,400",
"Other Expenses": "171,600",
"Other Liabilities": "43,300",
"Other Net Income": "0",
"Other Revenues": "3,243,000",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "79,500"
},
"output_variables": {
"Liabilities": "3,726,200",
"Assets": "4,095,200",
"Expenses": "2,965,700",
"Revenues": "3,243,000",
"Stockholders Equity": "369,000",
"Net Income": "277,300",
"Comprehensive Net Income": "259,600",
"BaseVar": "7,032,750",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "103%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,184,500",
"Assets, Non-Current": "176,900",
"General and Administrative Expense": "2,458,200",
"Goodwill": "699,800",
"Liabilities, Current": "707,400",
"Liabilities, Non-Current": "2,725,300",
"Other Assets": "1,614,800",
"Other Compr. Net Income": "-43,700",
"Other Expenses": "378,800",
"Other Liabilities": "30,800",
"Other Net Income": "0",
"Other Revenues": "3,051,500",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "69,600"
},
"output_variables": {
"Liabilities": "3,463,500",
"Assets": "3,676,000",
"Expenses": "2,906,600",
"Revenues": "3,051,500",
"Stockholders Equity": "212,500",
"Net Income": "144,900",
"Comprehensive Net Income": "123,050",
"BaseVar": "6,570,650",
"ECR before LimitedLiability": "12%",
"Economic Capital Ratio": "96%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "654,800",
"Assets, Non-Current": "154,700",
"General and Administrative Expense": "1,252,000",
"Goodwill": "663,300",
"Liabilities, Current": "480,800",
"Liabilities, Non-Current": "2,055,500",
"Other Assets": "709,400",
"Other Compr. Net Income": "-2,100",
"Other Expenses": "190,800",
"Other Liabilities": "3,100",
"Other Net Income": "-12,900",
"Other Revenues": "1,598,600",
"Property, Plant and Equipment, Net": "729,600",
"Research and Development": "48,800"
},
"output_variables": {
"Liabilities": "2,539,400",
"Assets": "2,911,800",
"Expenses": "1,491,600",
"Revenues": "1,598,600",
"Stockholders Equity": "372,400",
"Net Income": "94,100",
"Comprehensive Net Income": "93,050",
"BaseVar": "4,278,200",
"ECR before LimitedLiability": "22%",
"Economic Capital Ratio": "106%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "728,600",
"Assets, Non-Current": "165,000",
"General and Administrative Expense": "1,355,800",
"Goodwill": "657,800",
"Liabilities, Current": "448,200",
"Liabilities, Non-Current": "2,195,500",
"Other Assets": "556,500",
"Other Compr. Net Income": "-25,700",
"Other Expenses": "296,800",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,716,500",
"Property, Plant and Equipment, Net": "799,100",
"Research and Development": "53,500"
},
"output_variables": {
"Liabilities": "2,643,700",
"Assets": "2,907,000",
"Expenses": "1,706,100",
"Revenues": "1,716,500",
"Stockholders Equity": "263,300",
"Net Income": "10,400",
"Comprehensive Net Income": "-2,450",
"BaseVar": "4,499,500",
"ECR before LimitedLiability": "13%",
"Economic Capital Ratio": "97%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "857,300",
"Assets, Non-Current": "270,000",
"General and Administrative Expense": "1,472,400",
"Goodwill": "896,900",
"Liabilities, Current": "514,400",
"Liabilities, Non-Current": "2,280,800",
"Other Assets": "529,400",
"Other Compr. Net Income": "26,600",
"Other Expenses": "230,200",
"Other Liabilities": "433,100",
"Other Net Income": "0",
"Other Revenues": "1,932,100",
"Property, Plant and Equipment, Net": "1,011,700",
"Research and Development": "62,700"
},
"output_variables": {
"Liabilities": "3,228,300",
"Assets": "3,565,300",
"Expenses": "1,765,300",
"Revenues": "1,932,100",
"Stockholders Equity": "337,000",
"Net Income": "166,800",
"Comprehensive Net Income": "180,100",
"BaseVar": "5,258,800",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "103%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,134,900",
"Assets, Non-Current": "236,600",
"General and Administrative Expense": "1,463,400",
"Goodwill": "899,700",
"Liabilities, Current": "745,100",
"Liabilities, Non-Current": "2,265,500",
"Other Assets": "517,600",
"Other Compr. Net Income": "10,500",
"Other Expenses": "303,500",
"Other Liabilities": "519,800",
"Other Net Income": "0",
"Other Revenues": "1,958,100",
"Property, Plant and Equipment, Net": "1,143,800",
"Research and Development": "64,500"
},
"output_variables": {
"Liabilities": "3,530,400",
"Assets": "3,932,600",
"Expenses": "1,831,400",
"Revenues": "1,958,100",
"Stockholders Equity": "402,200",
"Net Income": "126,700",
"Comprehensive Net Income": "131,950",
"BaseVar": "5,631,500",
"ECR before LimitedLiability": "18%",
"Economic Capital Ratio": "102%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "875,300",
"Assets, Non-Current": "230,800",
"General and Administrative Expense": "1,396,200",
"Goodwill": "883,500",
"Liabilities, Current": "559,300",
"Liabilities, Non-Current": "2,322,700",
"Other Assets": "567,100",
"Other Compr. Net Income": "-49,600",
"Other Expenses": "269,400",
"Other Liabilities": "649,000",
"Other Net Income": "0",
"Other Revenues": "1,729,800",
"Property, Plant and Equipment, Net": "1,208,800",
"Research and Development": "65,900"
},
"output_variables": {
"Liabilities": "3,531,000",
"Assets": "3,765,500",
"Expenses": "1,731,500",
"Revenues": "1,729,800",
"Stockholders Equity": "234,500",
"Net Income": "-1,700",
"Comprehensive Net Income": "-26,500",
"BaseVar": "5,403,700",
"ECR before LimitedLiability": "8.1%",
"Economic Capital Ratio": "93%"
}
}
},
"top_rated": false,
"trend": -3.0,
"value": 0.9258538539566583,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001045309.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001045309.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001045309.svg"
},
{
"company_id": "0001351573",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001351573.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001351573.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001351573.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001351573_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001351573_main_keyfigs.svg",
"name": "Pure Harvest Corporate Group Inc",
"rank": 37,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001351573.svg",
"report_text": "The relative strengths and weaknesses of Pure Harvest Corporate Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pure Harvest Corporate Group Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 5.2% points.The greatest weakness of Pure Harvest Corporate Group Inc is the variable Liabilities, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 84%, being 61% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001351573_2021_Pure_Harvest_Corporate_Group_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "22.8",
"Liabilities": "73.9",
"Stockholders Equity": "133",
"ECR before LimitedLiability": "105",
"Liabilities, Current": "50.2",
"Other Liabilities": "10.6",
"Property, Plant and Equipment, Net": "17.3",
"Assets": "29.2",
"Assets, Non-Current": "-1.59",
"Assets, Current": "16.9",
"Goodwill": "-4.95",
"Research and Development": "13.6",
"Expenses": "-6.72",
"Revenues": "-45.8",
"Net Income": "-18.3",
"General and Administrative Expense": "-23.9",
"Other Expenses": "2.66",
"Other Revenues": "-45.8",
"Comprehensive Net Income": "-18.1",
"Other Net Income": "31.0",
"Economic Capital Ratio": "84.6"
},
"2017": {
"Other Liabilities": "12.4",
"Liabilities": "44.5",
"Stockholders Equity": "79.6",
"ECR before LimitedLiability": "39.5",
"Liabilities, Current": "11.3",
"Liabilities, Non-Current": "22.9",
"Assets, Non-Current": "-4.09",
"Assets": "25.6",
"Assets, Current": "37.6",
"Goodwill": "-12.0",
"Property, Plant and Equipment, Net": "12.7",
"Research and Development": "14.7",
"Expenses": "-15.8",
"Revenues": "-41.1",
"Net Income": "-24.7",
"Other Expenses": "-2.99",
"General and Administrative Expense": "-26.7",
"Other Revenues": "-41.1",
"Comprehensive Net Income": "-25.0",
"Other Net Income": "35.8",
"Economic Capital Ratio": "18.0"
},
"2019": {
"Liabilities, Non-Current": "14.1",
"Liabilities": "-3.31",
"Stockholders Equity": "75.6",
"ECR before LimitedLiability": "76.7",
"Other Liabilities": "9.20",
"Liabilities, Current": "-30.1",
"Assets, Non-Current": "-2.81",
"Assets": "67.7",
"Goodwill": "-4.13",
"Property, Plant and Equipment, Net": "-7.39",
"Other Assets": "93.5",
"Assets, Current": "9.59",
"Research and Development": "6.06",
"Expenses": "22.9",
"Revenues": "-25.4",
"Net Income": "-1.03",
"General and Administrative Expense": "16.8",
"Other Revenues": "-25.4",
"Other Net Income": "2.46",
"Comprehensive Net Income": "-0.993",
"Economic Capital Ratio": "47.2"
},
"2020": {
"Liabilities, Current": "-24.8",
"Liabilities": "-31.4",
"Stockholders Equity": "-13.1",
"Liabilities, Non-Current": "1.32",
"Other Liabilities": "-18.9",
"Goodwill": "5.23",
"Assets": "1.11",
"Other Assets": "4.50",
"Assets, Current": "-30.7",
"Assets, Non-Current": "-0.131",
"Property, Plant and Equipment, Net": "-0.122",
"Other Expenses": "0.284",
"Expenses": "0.766",
"Revenues": "-26.9",
"Net Income": "-29.2",
"Research and Development": "0.234",
"Other Revenues": "-26.9",
"ECR before LimitedLiability": "-23.6",
"Comprehensive Net Income": "-29.2",
"Other Net Income": "-6.38",
"Economic Capital Ratio": "-61.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001351573_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "138",
"Assets, Non-Current": "0",
"General and Administrative Expense": "96",
"Goodwill": "0",
"Liabilities, Current": "3.3",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "38",
"Other Liabilities": "0",
"Other Net Income": "55",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "81",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3.3",
"Assets": "219",
"Expenses": "133",
"Revenues": "0",
"Stockholders Equity": "215",
"Net Income": "-79",
"Comprehensive Net Income": "-79",
"BaseVar": "205",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "231%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "118",
"Assets, Non-Current": "0",
"General and Administrative Expense": "98",
"Goodwill": "0",
"Liabilities, Current": "34",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "37",
"Other Liabilities": "0",
"Other Net Income": "56",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "52",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "34",
"Assets": "170",
"Expenses": "135",
"Revenues": "0",
"Stockholders Equity": "136",
"Net Income": "-79",
"Comprehensive Net Income": "-79",
"BaseVar": "197",
"ECR before LimitedLiability": "105%",
"Economic Capital Ratio": "171%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,839",
"Assets, Non-Current": "185",
"General and Administrative Expense": "841",
"Goodwill": "141",
"Liabilities, Current": "1,290",
"Liabilities, Non-Current": "0",
"Other Assets": "2,641",
"Other Compr. Net Income": "0",
"Other Expenses": "281",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "39",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,290",
"Assets": "4,806",
"Expenses": "1,122",
"Revenues": "39",
"Stockholders Equity": "3,516",
"Net Income": "-1,084",
"Comprehensive Net Income": "-1,084",
"BaseVar": "3,628",
"ECR before LimitedLiability": "122%",
"Economic Capital Ratio": "183%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "2,345",
"Assets, Non-Current": "839",
"General and Administrative Expense": "4,542",
"Goodwill": "3,950",
"Liabilities, Current": "4,614",
"Liabilities, Non-Current": "294",
"Other Assets": "2,307",
"Other Compr. Net Income": "0",
"Other Expenses": "288",
"Other Liabilities": "2,112",
"Other Net Income": "-1,931",
"Other Revenues": "736",
"Property, Plant and Equipment, Net": "1,599",
"Research and Development": "321"
},
"output_variables": {
"Liabilities": "7,020",
"Assets": "11,040",
"Expenses": "5,151",
"Revenues": "736",
"Stockholders Equity": "4,020",
"Net Income": "-6,347",
"Comprehensive Net Income": "-6,347",
"BaseVar": "12,939",
"ECR before LimitedLiability": "-9.3%",
"Economic Capital Ratio": "84%"
}
}
},
"top_rated": false,
"trend": -20.0,
"value": 0.8446603351052244,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001351573.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001351573.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001351573.svg"
},
{
"company_id": "0000926617",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000926617.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000926617.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000926617.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000926617_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000926617_main_keyfigs.svg",
"name": "Aspira Women s Health Inc",
"rank": 38,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000926617.svg",
"report_text": "The relative strengths and weaknesses of Aspira Women s Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Aspira Women s Health Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 21% points.The greatest weakness of Aspira Women s Health Inc is the variable Net Income, reducing the Economic Capital Ratio by 47% points.
The company's Economic Capital Ratio, given in the ranking table, is 83%, being 63% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000926617_2021_Aspira_Women_s_Health_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-27.4",
"Liabilities": "-16.5",
"Stockholders Equity": "1.22",
"Liabilities, Non-Current": "0.717",
"Other Liabilities": "0.0331",
"Property, Plant and Equipment, Net": "-0.750",
"Assets": "10.6",
"Assets, Non-Current": "-0.512",
"Goodwill": "-0.750",
"Assets, Current": "38.8",
"General and Administrative Expense": "-0.698",
"Expenses": "-0.271",
"Revenues": "-30.5",
"Net Income": "-40.2",
"Research and Development": "-0.703",
"Other Expenses": "3.05",
"Other Revenues": "-30.5",
"ECR before LimitedLiability": "-7.59",
"Comprehensive Net Income": "-40.3",
"Other Net Income": "-0.448",
"Economic Capital Ratio": "-69.6"
},
"2012": {
"Assets, Current": "16.6",
"Assets": "-0.140",
"Other Liabilities": "0.301",
"Stockholders Equity": "-0.140",
"Assets, Non-Current": "-2.31",
"Property, Plant and Equipment, Net": "-14.0",
"Goodwill": "-17.1",
"Other Expenses": "4.58",
"Expenses": "-21.6",
"Revenues": "-44.6",
"Net Income": "-41.3",
"Research and Development": "-1.11",
"General and Administrative Expense": "-46.7",
"Other Revenues": "-44.6",
"ECR before LimitedLiability": "-41.5",
"Liabilities, Current": "-9.91",
"Liabilities, Non-Current": "0.785",
"Other Net Income": "3.96",
"Comprehensive Net Income": "-40.2",
"Other Compr. Net Income": "0.0563",
"Economic Capital Ratio": "-74.0"
},
"2013": {
"Liabilities, Current": "7.06",
"Liabilities": "26.4",
"Stockholders Equity": "113",
"ECR before LimitedLiability": "94.4",
"Other Liabilities": "8.35",
"Liabilities, Non-Current": "12.6",
"Goodwill": "-4.97",
"Assets": "62.6",
"Assets, Non-Current": "-1.95",
"Property, Plant and Equipment, Net": "-3.52",
"Assets, Current": "125",
"General and Administrative Expense": "-1.21",
"Expenses": "15.3",
"Revenues": "-24.5",
"Net Income": "-10.5",
"Research and Development": "-1.71",
"Other Expenses": "18.2",
"Other Revenues": "-24.5",
"Other Net Income": "-1.65",
"Comprehensive Net Income": "-10.5",
"Economic Capital Ratio": "54.3"
},
"2014": {
"Liabilities, Non-Current": "17.8",
"Liabilities": "43.3",
"Stockholders Equity": "55.7",
"ECR before LimitedLiability": "45.4",
"Liabilities, Current": "15.5",
"Other Liabilities": "11.9",
"Assets, Current": "82.0",
"Assets": "48.5",
"Goodwill": "-16.2",
"Assets, Non-Current": "-5.60",
"Property, Plant and Equipment, Net": "-10.3",
"Other Expenses": "16.2",
"Expenses": "-24.0",
"Revenues": "-36.7",
"Net Income": "-56.4",
"Research and Development": "-10.7",
"General and Administrative Expense": "-28.1",
"Other Revenues": "-36.7",
"Other Net Income": "1.56",
"Comprehensive Net Income": "-56.3",
"Economic Capital Ratio": "-4.05"
},
"2015": {
"Other Liabilities": "17.7",
"Liabilities": "38.3",
"Stockholders Equity": "51.8",
"ECR before LimitedLiability": "32.1",
"Liabilities, Current": "24.9",
"Liabilities, Non-Current": "22.2",
"Assets, Current": "69.1",
"Assets": "39.1",
"Other Assets": "-8.79",
"Goodwill": "-18.6",
"Assets, Non-Current": "-5.20",
"Property, Plant and Equipment, Net": "-5.31",
"Research and Development": "-12.7",
"Expenses": "-43.9",
"Revenues": "-35.3",
"Net Income": "-72.6",
"General and Administrative Expense": "-48.9",
"Other Expenses": "20.1",
"Other Revenues": "-35.3",
"Comprehensive Net Income": "-72.3",
"Economic Capital Ratio": "-13.8"
},
"2016": {
"Liabilities, Non-Current": "-1.04",
"Liabilities": "3.87",
"Stockholders Equity": "-12.9",
"ECR before LimitedLiability": "-78.7",
"Liabilities, Current": "3.11",
"Other Liabilities": "1.84",
"Property, Plant and Equipment, Net": "-1.99",
"Assets": "-27.2",
"Assets, Non-Current": "-6.15",
"Assets, Current": "-6.93",
"Goodwill": "-18.1",
"Research and Development": "-2.20",
"Expenses": "-34.8",
"Revenues": "-15.8",
"Net Income": "-55.4",
"General and Administrative Expense": "-52.6",
"Other Expenses": "17.5",
"Other Revenues": "-15.8",
"Comprehensive Net Income": "-55.0",
"Other Net Income": "-1.40",
"Economic Capital Ratio": "-98.6"
},
"2017": {
"Other Liabilities": "3.10",
"Liabilities": "4.38",
"Stockholders Equity": "-7.42",
"ECR before LimitedLiability": "-64.3",
"Liabilities, Current": "2.00",
"Liabilities, Non-Current": "-0.645",
"Assets, Non-Current": "-4.65",
"Assets": "-13.8",
"Assets, Current": "14.3",
"Goodwill": "-12.0",
"Property, Plant and Equipment, Net": "-8.98",
"Research and Development": "3.65",
"Expenses": "-17.0",
"Revenues": "-6.68",
"Net Income": "-44.0",
"Other Expenses": "13.1",
"General and Administrative Expense": "-60.2",
"Other Revenues": "-6.68",
"Comprehensive Net Income": "-44.5",
"Other Net Income": "-2.71",
"Economic Capital Ratio": "-85.8"
},
"2018": {
"Liabilities, Non-Current": "0.0605",
"Liabilities": "1.66",
"Stockholders Equity": "2.14",
"ECR before LimitedLiability": "-39.4",
"Other Liabilities": "1.21",
"Liabilities, Current": "0.256",
"Property, Plant and Equipment, Net": "-7.68",
"Assets": "0.0872",
"Assets, Current": "28.8",
"Goodwill": "-8.99",
"Assets, Non-Current": "-0.974",
"Other Expenses": "2.14",
"Expenses": "-37.2",
"Revenues": "-12.9",
"Net Income": "-63.8",
"Research and Development": "1.37",
"General and Administrative Expense": "-64.0",
"Other Revenues": "-12.9",
"Comprehensive Net Income": "-63.5",
"Other Net Income": "-0.0401",
"Economic Capital Ratio": "-59.9"
},
"2019": {
"Liabilities, Non-Current": "1.57",
"Liabilities": "4.10",
"Stockholders Equity": "1.77",
"ECR before LimitedLiability": "-24.0",
"Other Liabilities": "2.33",
"Assets, Non-Current": "-2.18",
"Assets": "-1.83",
"Goodwill": "-2.36",
"Property, Plant and Equipment, Net": "-3.98",
"Other Assets": "0.254",
"Assets, Current": "35.4",
"Research and Development": "0.897",
"Expenses": "-39.5",
"Revenues": "-2.14",
"Net Income": "-56.6",
"Other Expenses": "2.68",
"General and Administrative Expense": "-58.9",
"Other Revenues": "-2.14",
"Other Net Income": "1.04",
"Comprehensive Net Income": "-56.5",
"Economic Capital Ratio": "-53.5"
},
"2020": {
"Liabilities, Current": "-0.785",
"Liabilities": "0.0403",
"Stockholders Equity": "-1.65",
"ECR before LimitedLiability": "-25.3",
"Liabilities, Non-Current": "0.203",
"Other Liabilities": "0.751",
"Goodwill": "-1.80",
"Assets": "-1.68",
"Assets, Current": "21.0",
"Assets, Non-Current": "-1.60",
"Property, Plant and Equipment, Net": "-3.81",
"Other Expenses": "1.71",
"Expenses": "-28.5",
"Revenues": "-1.80",
"Net Income": "-47.0",
"Research and Development": "-0.270",
"General and Administrative Expense": "-37.3",
"Other Revenues": "-1.80",
"Comprehensive Net Income": "-46.9",
"Other Net Income": "1.07",
"Economic Capital Ratio": "-63.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000926617_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "22,893",
"Assets, Non-Current": "2.0",
"General and Administrative Expense": "14,177",
"Goodwill": "0",
"Liabilities, Current": "11,476",
"Liabilities, Non-Current": "52",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "114",
"Other Liabilities": "1,224",
"Other Net Income": "-35",
"Other Revenues": "1,923",
"Property, Plant and Equipment, Net": "216",
"Research and Development": "5,387"
},
"output_variables": {
"Liabilities": "12,752",
"Assets": "23,111",
"Expenses": "19,678",
"Revenues": "1,923",
"Stockholders Equity": "10,359",
"Net Income": "-17,790",
"Comprehensive Net Income": "-17,790",
"BaseVar": "28,750",
"ECR before LimitedLiability": "-20%",
"Economic Capital Ratio": "84%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "8,492",
"Assets, Non-Current": "0",
"General and Administrative Expense": "9,292",
"Goodwill": "0",
"Liabilities, Current": "3,197",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "153",
"Other Expenses": "118",
"Other Liabilities": "770",
"Other Net Income": "2,386",
"Other Revenues": "2,094",
"Property, Plant and Equipment, Net": "142",
"Research and Development": "2,216"
},
"output_variables": {
"Liabilities": "3,967",
"Assets": "8,634",
"Expenses": "11,626",
"Revenues": "2,094",
"Stockholders Equity": "4,667",
"Net Income": "-7,146",
"Comprehensive Net Income": "-7,070",
"BaseVar": "14,430",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "30,249",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,834",
"Goodwill": "0",
"Liabilities, Current": "3,558",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "316",
"Other Net Income": "44",
"Other Revenues": "2,566",
"Property, Plant and Equipment, Net": "391",
"Research and Development": "2,595"
},
"output_variables": {
"Liabilities": "3,874",
"Assets": "30,640",
"Expenses": "11,429",
"Revenues": "2,566",
"Stockholders Equity": "26,766",
"Net Income": "-8,819",
"Comprehensive Net Income": "-8,819",
"BaseVar": "24,276",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "23,666",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,835",
"Goodwill": "0",
"Liabilities, Current": "4,919",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,230",
"Other Liabilities": "0",
"Other Net Income": "2.0",
"Other Revenues": "2,521",
"Property, Plant and Equipment, Net": "508",
"Research and Development": "4,667"
},
"output_variables": {
"Liabilities": "4,919",
"Assets": "24,174",
"Expenses": "21,732",
"Revenues": "2,521",
"Stockholders Equity": "19,255",
"Net Income": "-19,209",
"Comprehensive Net Income": "-19,209",
"BaseVar": "26,674",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "19,366",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,366",
"Goodwill": "0",
"Liabilities, Current": "3,351",
"Liabilities, Non-Current": "0",
"Other Assets": "90",
"Other Compr. Net Income": "0",
"Other Expenses": "2,309",
"Other Liabilities": "63",
"Other Net Income": "134",
"Other Revenues": "2,177",
"Property, Plant and Equipment, Net": "1,504",
"Research and Development": "3,751"
},
"output_variables": {
"Liabilities": "3,414",
"Assets": "20,960",
"Expenses": "21,426",
"Revenues": "2,177",
"Stockholders Equity": "17,546",
"Net Income": "-19,115",
"Comprehensive Net Income": "-19,115",
"BaseVar": "24,056",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "122%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "6,108",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,424",
"Goodwill": "0",
"Liabilities, Current": "2,561",
"Liabilities, Non-Current": "1,696",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-14",
"Other Revenues": "2,642",
"Property, Plant and Equipment, Net": "1,911",
"Research and Development": "2,172"
},
"output_variables": {
"Liabilities": "4,257",
"Assets": "8,019",
"Expenses": "17,596",
"Revenues": "2,642",
"Stockholders Equity": "3,762",
"Net Income": "-14,968",
"Comprehensive Net Income": "-14,968",
"BaseVar": "16,264",
"ECR before LimitedLiability": "-160%",
"Economic Capital Ratio": "48%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "6,305",
"Assets, Non-Current": "11",
"General and Administrative Expense": "12,725",
"Goodwill": "0",
"Liabilities, Current": "2,609",
"Liabilities, Non-Current": "1,481",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-56",
"Other Revenues": "3,121",
"Property, Plant and Equipment, Net": "1,181",
"Research and Development": "837"
},
"output_variables": {
"Liabilities": "4,090",
"Assets": "7,497",
"Expenses": "13,562",
"Revenues": "3,121",
"Stockholders Equity": "3,407",
"Net Income": "-10,497",
"Comprehensive Net Income": "-10,497",
"BaseVar": "14,163",
"ECR before LimitedLiability": "-101%",
"Economic Capital Ratio": "68%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "10,788",
"Assets, Non-Current": "12",
"General and Administrative Expense": "13,836",
"Goodwill": "0",
"Liabilities, Current": "2,964",
"Liabilities, Non-Current": "1,292",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-38",
"Other Revenues": "3,053",
"Property, Plant and Equipment, Net": "608",
"Research and Development": "550"
},
"output_variables": {
"Liabilities": "4,256",
"Assets": "11,408",
"Expenses": "14,386",
"Revenues": "3,053",
"Stockholders Equity": "7,152",
"Net Income": "-11,371",
"Comprehensive Net Income": "-11,371",
"BaseVar": "16,570",
"ECR before LimitedLiability": "-20%",
"Economic Capital Ratio": "84%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "13,410",
"Assets, Non-Current": "65",
"General and Administrative Expense": "18,798",
"Goodwill": "0",
"Liabilities, Current": "3,978",
"Liabilities, Non-Current": "1,112",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "41",
"Other Revenues": "4,538",
"Property, Plant and Equipment, Net": "353",
"Research and Development": "1,018"
},
"output_variables": {
"Liabilities": "5,090",
"Assets": "13,828",
"Expenses": "19,816",
"Revenues": "4,538",
"Stockholders Equity": "8,738",
"Net Income": "-15,237",
"Comprehensive Net Income": "-15,237",
"BaseVar": "21,656",
"ECR before LimitedLiability": "-35%",
"Economic Capital Ratio": "82%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "18,603",
"Assets, Non-Current": "419",
"General and Administrative Expense": "20,528",
"Goodwill": "0",
"Liabilities, Current": "6,400",
"Liabilities, Non-Current": "3,486",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "76",
"Other Revenues": "4,651",
"Property, Plant and Equipment, Net": "583",
"Research and Development": "2,104"
},
"output_variables": {
"Liabilities": "9,886",
"Assets": "19,605",
"Expenses": "22,632",
"Revenues": "4,651",
"Stockholders Equity": "9,719",
"Net Income": "-17,905",
"Comprehensive Net Income": "-17,905",
"BaseVar": "28,425",
"ECR before LimitedLiability": "-31%",
"Economic Capital Ratio": "83%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 0.8282568036692955,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000926617.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000926617.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000926617.svg"
},
{
"company_id": "0001596946",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001596946.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001596946.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001596946.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001596946_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001596946_main_keyfigs.svg",
"name": "Quotient Ltd",
"rank": 39,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001596946.svg",
"report_text": "The relative strengths and weaknesses of Quotient Ltd are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Quotient Ltd compared to the market average is the variable General and Administrative Expense, increasing the Economic Capital Ratio by 4.9% points.The greatest weakness of Quotient Ltd is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 49% points.
The company's Economic Capital Ratio, given in the ranking table, is 80%, being 66% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001596946_2021_Quotient_Ltd.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "2.62",
"Liabilities": "-36.2",
"Stockholders Equity": "-36.8",
"ECR before LimitedLiability": "-27.7",
"Liabilities, Non-Current": "-49.3",
"Other Liabilities": "-1.09",
"Goodwill": "-3.05",
"Assets": "-1.71",
"Other Assets": "1.17",
"Assets, Current": "2.54",
"Property, Plant and Equipment, Net": "-0.676",
"Other Expenses": "1.60",
"Expenses": "3.39",
"Revenues": "-3.59",
"Net Income": "-2.34",
"Research and Development": "-2.22",
"General and Administrative Expense": "4.89",
"Other Revenues": "-3.59",
"Comprehensive Net Income": "-2.34",
"Other Net Income": "-0.634",
"Economic Capital Ratio": "-65.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001596946_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "150,472",
"Assets, Non-Current": "25,947",
"General and Administrative Expense": "59,603",
"Goodwill": "625",
"Liabilities, Current": "31,157",
"Liabilities, Non-Current": "179,291",
"Other Assets": "9,254",
"Other Compr. Net Income": "-271",
"Other Expenses": "661",
"Other Liabilities": "21,542",
"Other Net Income": "-21,421",
"Other Revenues": "32,656",
"Property, Plant and Equipment, Net": "40,165",
"Research and Development": "53,744"
},
"output_variables": {
"Liabilities": "231,990",
"Assets": "226,463",
"Expenses": "114,008",
"Revenues": "32,656",
"Stockholders Equity": "-5,527",
"Net Income": "-102,773",
"Comprehensive Net Income": "-102,908",
"BaseVar": "313,404",
"ECR before LimitedLiability": "-48%",
"Economic Capital Ratio": "80%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.8037064848879496,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001596946.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001596946.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001596946.svg"
},
{
"company_id": "0001421819",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001421819.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001421819.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001421819_main_keyfigs.svg",
"name": "Hanjiao Group Inc",
"rank": 40,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001421819.svg",
"report_text": "The relative strengths and weaknesses of Hanjiao Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Hanjiao Group Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 31% points.The greatest weakness of Hanjiao Group Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 68% points.
The company's Economic Capital Ratio, given in the ranking table, is 74%, being 72% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001421819_2021_Hanjiao_Group_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "-67.5",
"Liabilities": "-25.2",
"Stockholders Equity": "-32.3",
"ECR before LimitedLiability": "-34.2",
"Liabilities, Non-Current": "4.05",
"Goodwill": "-5.38",
"Assets": "-3.61",
"Other Assets": "30.8",
"Assets, Current": "-5.39",
"Assets, Non-Current": "-4.11",
"Property, Plant and Equipment, Net": "-4.66",
"Other Expenses": "2.41",
"Expenses": "6.60",
"Revenues": "-7.84",
"Net Income": "-5.61",
"Research and Development": "2.10",
"General and Administrative Expense": "1.72",
"Other Revenues": "-7.84",
"Comprehensive Net Income": "-5.65",
"Other Net Income": "-2.42",
"Economic Capital Ratio": "-72.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001421819_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "11,436",
"Assets, Non-Current": "341",
"General and Administrative Expense": "11,540",
"Goodwill": "0",
"Liabilities, Current": "31,307",
"Liabilities, Non-Current": "99",
"Other Assets": "12,384",
"Other Compr. Net Income": "-167",
"Other Expenses": "-190",
"Other Liabilities": "0",
"Other Net Income": "-4,346",
"Other Revenues": "675",
"Property, Plant and Equipment, Net": "1,920",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "31,406",
"Assets": "26,081",
"Expenses": "11,351",
"Revenues": "675",
"Stockholders Equity": "-5,325",
"Net Income": "-15,021",
"Comprehensive Net Income": "-15,104",
"BaseVar": "37,013",
"ECR before LimitedLiability": "-78%",
"Economic Capital Ratio": "74%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.7394393992901093,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001421819.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001421819.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001421819.svg"
},
{
"company_id": "0001586554",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001586554.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001586554.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001586554.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001586554_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001586554_main_keyfigs.svg",
"name": "Target Group Inc",
"rank": 41,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001586554.svg",
"report_text": "The relative strengths and weaknesses of Target Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Target Group Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 58% points.The greatest weakness of Target Group Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 35% points.
The company's Economic Capital Ratio, given in the ranking table, is 73%, being 73% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001586554_2021_Target_Group_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-0.514",
"Liabilities": "2.14",
"Stockholders Equity": "-68.5",
"ECR before LimitedLiability": "-124",
"Liabilities, Current": "2.32",
"Property, Plant and Equipment, Net": "-6.90",
"Assets": "-54.5",
"Other Assets": "-2.05",
"Assets, Non-Current": "0.513",
"Assets, Current": "-30.5",
"Goodwill": "-2.42",
"Research and Development": "0.575",
"Expenses": "-7.30",
"Revenues": "-5.81",
"Net Income": "-15.9",
"General and Administrative Expense": "1.65",
"Other Expenses": "-22.8",
"Other Revenues": "-5.81",
"Comprehensive Net Income": "-15.8",
"Other Net Income": "0.930",
"Economic Capital Ratio": "-144"
},
"2018": {
"Liabilities, Non-Current": "12.6",
"Liabilities": "-41.3",
"Stockholders Equity": "26.2",
"ECR before LimitedLiability": "8.36",
"Other Liabilities": "7.64",
"Liabilities, Current": "-66.6",
"Property, Plant and Equipment, Net": "-12.9",
"Assets": "48.1",
"Other Assets": "-42.9",
"Assets, Current": "-25.0",
"Goodwill": "49.9",
"Assets, Non-Current": "108",
"Other Expenses": "-9.27",
"Expenses": "40.1",
"Revenues": "-30.6",
"Comprehensive Net Income": "-6.29",
"Research and Development": "8.22",
"General and Administrative Expense": "41.8",
"Other Revenues": "-30.6",
"Other Net Income": "-9.70",
"Economic Capital Ratio": "-12.1"
},
"2019": {
"Liabilities": "-10.3",
"Stockholders Equity": "25.4",
"ECR before LimitedLiability": "2.93",
"Other Liabilities": "11.7",
"Liabilities, Current": "-25.0",
"Assets, Non-Current": "107",
"Assets": "27.2",
"Goodwill": "32.8",
"Property, Plant and Equipment, Net": "31.0",
"Other Assets": "-77.7",
"Assets, Current": "-41.7",
"Research and Development": "10.3",
"Expenses": "25.5",
"Revenues": "-40.4",
"Net Income": "-39.6",
"Other Expenses": "-21.6",
"General and Administrative Expense": "26.9",
"Other Revenues": "-40.4",
"Other Net Income": "-37.2",
"Comprehensive Net Income": "-41.2",
"Economic Capital Ratio": "-26.5"
},
"2020": {
"Liabilities, Current": "-2.25",
"Liabilities": "-29.3",
"Stockholders Equity": "-34.7",
"ECR before LimitedLiability": "-35.0",
"Liabilities, Non-Current": "-18.1",
"Other Liabilities": "0.835",
"Goodwill": "5.66",
"Assets": "-3.68",
"Other Assets": "-28.9",
"Assets, Current": "-11.3",
"Assets, Non-Current": "58.2",
"Property, Plant and Equipment, Net": "23.4",
"Expenses": "15.5",
"Revenues": "-8.37",
"Net Income": "-5.10",
"Research and Development": "2.09",
"General and Administrative Expense": "13.4",
"Other Revenues": "-8.37",
"Comprehensive Net Income": "-5.28",
"Other Net Income": "-7.15",
"Economic Capital Ratio": "-72.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001586554_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "156",
"Assets, Non-Current": "138",
"General and Administrative Expense": "15",
"Goodwill": "138",
"Liabilities, Current": "2,114",
"Liabilities, Non-Current": "0",
"Other Assets": "-138",
"Other Compr. Net Income": "0",
"Other Expenses": "2,593",
"Other Liabilities": "0",
"Other Net Income": "371",
"Other Revenues": "5.9",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "114"
},
"output_variables": {
"Liabilities": "2,114",
"Assets": "294",
"Expenses": "2,721",
"Revenues": "5.9",
"Stockholders Equity": "-1,820",
"Net Income": "-2,345",
"Comprehensive Net Income": "-2,345",
"BaseVar": "2,753",
"ECR before LimitedLiability": "-402%",
"Economic Capital Ratio": "2.3%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "559",
"Assets, Non-Current": "6,222",
"General and Administrative Expense": "34",
"Goodwill": "3,594",
"Liabilities, Current": "3,437",
"Liabilities, Non-Current": "0",
"Other Assets": "-3,594",
"Other Compr. Net Income": "-56",
"Other Expenses": "1,155",
"Other Liabilities": "0",
"Other Net Income": "-620",
"Other Revenues": "0.26",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "92"
},
"output_variables": {
"Liabilities": "3,437",
"Assets": "6,781",
"Expenses": "1,281",
"Revenues": "0.26",
"Stockholders Equity": "3,344",
"Net Income": "-1,900",
"Comprehensive Net Income": "-1,928",
"BaseVar": "6,087",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "132%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "213",
"Assets, Non-Current": "16,252",
"General and Administrative Expense": "535",
"Goodwill": "8,148",
"Liabilities, Current": "5,135",
"Liabilities, Non-Current": "1,394",
"Other Assets": "-16,252",
"Other Compr. Net Income": "-503",
"Other Expenses": "4,155",
"Other Liabilities": "0",
"Other Net Income": "-5,678",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "8,104",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,529",
"Assets": "16,464",
"Expenses": "4,690",
"Revenues": "0",
"Stockholders Equity": "9,935",
"Net Income": "-10,368",
"Comprehensive Net Income": "-10,619",
"BaseVar": "16,932",
"ECR before LimitedLiability": "26%",
"Economic Capital Ratio": "109%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "755",
"Assets, Non-Current": "12,282",
"General and Administrative Expense": "161",
"Goodwill": "3,666",
"Liabilities, Current": "4,873",
"Liabilities, Non-Current": "11,684",
"Other Assets": "-11,460",
"Other Compr. Net Income": "-278",
"Other Expenses": "1,433",
"Other Liabilities": "0",
"Other Net Income": "-5,509",
"Other Revenues": "30",
"Property, Plant and Equipment, Net": "7,794",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,557",
"Assets": "13,037",
"Expenses": "1,594",
"Revenues": "30",
"Stockholders Equity": "-3,520",
"Net Income": "-7,074",
"Comprehensive Net Income": "-7,213",
"BaseVar": "18,503",
"ECR before LimitedLiability": "-81%",
"Economic Capital Ratio": "73%"
}
}
},
"top_rated": false,
"trend": -9.0,
"value": 0.73057338090165,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001586554.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001586554.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001586554.svg"
},
{
"company_id": "0000810509",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0000810509.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0000810509.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000810509.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000810509_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000810509_main_keyfigs.svg",
"name": "Navidea Biopharmaceuticals Inc",
"rank": 42,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0000810509.svg",
"report_text": "The relative strengths and weaknesses of Navidea Biopharmaceuticals Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Navidea Biopharmaceuticals Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 11% points.The greatest weakness of Navidea Biopharmaceuticals Inc is the variable Net Income, reducing the Economic Capital Ratio by 23% points.
The company's Economic Capital Ratio, given in the ranking table, is 62%, being 84% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0000810509_2021_Navidea_Biopharmaceuticals_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "29.9",
"Liabilities": "10.3",
"Stockholders Equity": "39.4",
"ECR before LimitedLiability": "121",
"Liabilities, Non-Current": "9.91",
"Other Liabilities": "-38.6",
"Property, Plant and Equipment, Net": "-5.14",
"Assets": "15.4",
"Assets, Non-Current": "-1.57",
"Goodwill": "-5.25",
"Assets, Current": "39.7",
"General and Administrative Expense": "21.2",
"Expenses": "31.2",
"Revenues": "-53.2",
"Net Income": "47.8",
"Research and Development": "-37.8",
"Other Expenses": "46.8",
"Other Revenues": "-53.2",
"Comprehensive Net Income": "47.7",
"Other Net Income": "69.0",
"Economic Capital Ratio": "59.4"
},
"2012": {
"Liabilities, Current": "-0.559",
"Liabilities": "-2.16",
"Stockholders Equity": "-35.8",
"ECR before LimitedLiability": "-104",
"Liabilities, Non-Current": "0.244",
"Other Liabilities": "-1.72",
"Assets, Current": "1.12",
"Assets": "-24.6",
"Assets, Non-Current": "-4.04",
"Property, Plant and Equipment, Net": "-8.32",
"Goodwill": "-13.2",
"Other Expenses": "8.35",
"Expenses": "-23.5",
"Revenues": "-26.1",
"Net Income": "-53.7",
"Research and Development": "-34.5",
"General and Administrative Expense": "-1.92",
"Other Revenues": "-26.1",
"Other Net Income": "-2.51",
"Comprehensive Net Income": "-53.7",
"Economic Capital Ratio": "-136"
},
"2013": {
"Liabilities": "-17.0",
"Stockholders Equity": "-19.2",
"ECR before LimitedLiability": "-50.9",
"Other Liabilities": "-18.8",
"Liabilities, Non-Current": "1.46",
"Goodwill": "-8.26",
"Assets": "-0.428",
"Assets, Non-Current": "-2.50",
"Property, Plant and Equipment, Net": "-4.77",
"Other Assets": "-2.12",
"Assets, Current": "23.4",
"General and Administrative Expense": "5.62",
"Expenses": "1.24",
"Revenues": "-14.5",
"Net Income": "-16.4",
"Research and Development": "-12.1",
"Other Expenses": "9.77",
"Other Revenues": "-14.5",
"Other Net Income": "-4.08",
"Comprehensive Net Income": "-16.4",
"Economic Capital Ratio": "-91.1"
},
"2014": {
"Liabilities": "-3.68",
"Stockholders Equity": "-59.8",
"ECR before LimitedLiability": "-64.2",
"Liabilities, Current": "0.195",
"Other Liabilities": "-4.67",
"Assets, Current": "-19.8",
"Assets": "-36.1",
"Goodwill": "-11.7",
"Other Assets": "0.816",
"Assets, Non-Current": "-2.79",
"Property, Plant and Equipment, Net": "-3.40",
"Other Expenses": "4.21",
"Expenses": "-3.14",
"Revenues": "-10.1",
"Net Income": "-13.5",
"Research and Development": "-11.7",
"General and Administrative Expense": "2.42",
"Other Revenues": "-10.1",
"Other Net Income": "0.399",
"Comprehensive Net Income": "-13.5",
"Economic Capital Ratio": "-114"
},
"2015": {
"Other Liabilities": "-19.1",
"Liabilities": "-8.64",
"Stockholders Equity": "-61.3",
"ECR before LimitedLiability": "-66.9",
"Liabilities, Current": "0.848",
"Assets, Current": "-19.0",
"Assets": "-41.6",
"Other Assets": "-5.55",
"Goodwill": "-11.7",
"Assets, Non-Current": "-2.50",
"Property, Plant and Equipment, Net": "-6.77",
"Research and Development": "3.07",
"Expenses": "5.52",
"Revenues": "-5.47",
"Net Income": "-4.69",
"General and Administrative Expense": "10.6",
"Other Expenses": "-11.2",
"Other Revenues": "-5.47",
"Comprehensive Net Income": "-4.59",
"Other Net Income": "-5.68",
"Economic Capital Ratio": "-113"
},
"2016": {
"Liabilities, Non-Current": "0.664",
"Liabilities": "-18.4",
"Stockholders Equity": "-99.3",
"ECR before LimitedLiability": "-101",
"Liabilities, Current": "-17.4",
"Other Liabilities": "-0.915",
"Property, Plant and Equipment, Net": "-12.4",
"Assets": "-47.2",
"Assets, Non-Current": "-3.31",
"Assets, Current": "-28.8",
"Goodwill": "-11.8",
"Research and Development": "4.46",
"Expenses": "10.3",
"Revenues": "-2.17",
"Net Income": "2.27",
"General and Administrative Expense": "10.5",
"Other Expenses": "-5.21",
"Other Revenues": "-2.17",
"Comprehensive Net Income": "2.33",
"Other Net Income": "-8.16",
"Economic Capital Ratio": "-121"
},
"2017": {
"Other Liabilities": "72.6",
"Liabilities": "284",
"Stockholders Equity": "-78.4",
"ECR before LimitedLiability": "488",
"Liabilities, Current": "145",
"Liabilities, Non-Current": "150",
"Assets": "150",
"Other Assets": "-67.0",
"Assets, Current": "81.5",
"Goodwill": "68.0",
"Property, Plant and Equipment, Net": "88.7",
"Research and Development": "15.7",
"Expenses": "165",
"Revenues": "-125",
"Net Income": "516",
"Other Expenses": "98.5",
"General and Administrative Expense": "51.4",
"Other Revenues": "-125",
"Comprehensive Net Income": "515",
"Other Net Income": "482",
"Economic Capital Ratio": "466"
},
"2018": {
"Liabilities, Non-Current": "1.35",
"Liabilities": "0.268",
"Stockholders Equity": "-23.2",
"ECR before LimitedLiability": "-94.5",
"Other Liabilities": "-0.592",
"Liabilities, Current": "-0.696",
"Property, Plant and Equipment, Net": "-21.5",
"Assets": "-35.4",
"Assets, Current": "-1.27",
"Goodwill": "-13.1",
"Assets, Non-Current": "-2.77",
"Other Expenses": "6.33",
"Expenses": "-17.2",
"Revenues": "-21.5",
"Net Income": "-55.7",
"Research and Development": "-14.7",
"General and Administrative Expense": "-9.48",
"Other Revenues": "-21.5",
"Comprehensive Net Income": "-55.7",
"Other Net Income": "-29.5",
"Economic Capital Ratio": "-115"
},
"2019": {
"Liabilities, Non-Current": "0.0969",
"Liabilities": "-0.363",
"Stockholders Equity": "-43.1",
"ECR before LimitedLiability": "-88.6",
"Liabilities, Current": "-0.498",
"Assets, Non-Current": "-3.06",
"Assets": "-43.5",
"Goodwill": "-10.6",
"Property, Plant and Equipment, Net": "-18.9",
"Other Assets": "0.721",
"Assets, Current": "-13.2",
"Research and Development": "-28.0",
"Expenses": "-33.8",
"Revenues": "-16.6",
"Net Income": "-52.0",
"Other Expenses": "3.43",
"General and Administrative Expense": "-8.23",
"Other Revenues": "-16.6",
"Other Net Income": "1.53",
"Comprehensive Net Income": "-51.9",
"Economic Capital Ratio": "-118"
},
"2020": {
"Liabilities, Current": "-9.30",
"Liabilities": "-4.69",
"Stockholders Equity": "-18.4",
"ECR before LimitedLiability": "-45.8",
"Liabilities, Non-Current": "4.88",
"Other Liabilities": "-1.38",
"Goodwill": "-7.24",
"Assets": "-15.9",
"Assets, Current": "10.9",
"Assets, Non-Current": "-6.09",
"Property, Plant and Equipment, Net": "-13.2",
"Other Expenses": "4.16",
"Expenses": "-19.5",
"Revenues": "-13.8",
"Net Income": "-23.4",
"Research and Development": "-16.6",
"General and Administrative Expense": "-8.96",
"Other Revenues": "-13.8",
"Comprehensive Net Income": "-23.3",
"Other Net Income": "2.52",
"Economic Capital Ratio": "-83.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0000810509_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "30,047",
"Assets, Non-Current": "599",
"General and Administrative Expense": "9,548",
"Goodwill": "85",
"Liabilities, Current": "3,348",
"Liabilities, Non-Current": "257",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-7,880",
"Other Liabilities": "6,456",
"Other Net Income": "22,435",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "463",
"Research and Development": "15,154"
},
"output_variables": {
"Liabilities": "10,062",
"Assets": "31,194",
"Expenses": "16,822",
"Revenues": "0",
"Stockholders Equity": "21,132",
"Net Income": "5,613",
"Comprehensive Net Income": "5,613",
"BaseVar": "40,257",
"ECR before LimitedLiability": "168%",
"Economic Capital Ratio": "213%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "10,617",
"Assets, Non-Current": "328",
"General and Administrative Expense": "11,178",
"Goodwill": "92",
"Liabilities, Current": "6,191",
"Liabilities, Non-Current": "257",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "6,930",
"Other Net Income": "-1,168",
"Other Revenues": "79",
"Property, Plant and Equipment, Net": "935",
"Research and Development": "16,890"
},
"output_variables": {
"Liabilities": "13,378",
"Assets": "11,972",
"Expenses": "28,068",
"Revenues": "79",
"Stockholders Equity": "-1,405",
"Net Income": "-29,157",
"Comprehensive Net Income": "-29,157",
"BaseVar": "27,332",
"ECR before LimitedLiability": "-245%",
"Economic Capital Ratio": "22%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "37,331",
"Assets, Non-Current": "723",
"General and Administrative Expense": "15,526",
"Goodwill": "137",
"Liabilities, Current": "11,291",
"Liabilities, Non-Current": "1,770",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "333",
"Other Liabilities": "31,265",
"Other Net Income": "-4,261",
"Other Revenues": "1,131",
"Property, Plant and Equipment, Net": "2,125",
"Research and Development": "23,710"
},
"output_variables": {
"Liabilities": "44,326",
"Assets": "40,317",
"Expenses": "39,569",
"Revenues": "1,131",
"Stockholders Equity": "-4,010",
"Net Income": "-42,699",
"Comprehensive Net Income": "-42,699",
"BaseVar": "64,802",
"ECR before LimitedLiability": "-114%",
"Economic Capital Ratio": "63%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "8,599",
"Assets, Non-Current": "389",
"General and Administrative Expense": "15,542",
"Goodwill": "181",
"Liabilities, Current": "9,095",
"Liabilities, Non-Current": "3,089",
"Other Assets": "242",
"Other Compr. Net Income": "0",
"Other Expenses": "1,586",
"Other Liabilities": "29,539",
"Other Net Income": "0",
"Other Revenues": "6,275",
"Property, Plant and Equipment, Net": "2,510",
"Research and Development": "16,780"
},
"output_variables": {
"Liabilities": "41,724",
"Assets": "11,920",
"Expenses": "33,908",
"Revenues": "6,275",
"Stockholders Equity": "-29,803",
"Net Income": "-27,633",
"Comprehensive Net Income": "-27,633",
"BaseVar": "46,913",
"ECR before LimitedLiability": "-255%",
"Economic Capital Ratio": "20%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "12,577",
"Assets, Non-Current": "274",
"General and Administrative Expense": "0",
"Goodwill": "186",
"Liabilities, Current": "6,184",
"Liabilities, Non-Current": "1,678",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "31,364",
"Other Liabilities": "60,939",
"Other Net Income": "-9,449",
"Other Revenues": "13,249",
"Property, Plant and Equipment, Net": "1,928",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "68,800",
"Assets": "14,965",
"Expenses": "31,364",
"Revenues": "13,249",
"Stockholders Equity": "-53,836",
"Net Income": "-27,564",
"Comprehensive Net Income": "-27,564",
"BaseVar": "68,913",
"ECR before LimitedLiability": "-242%",
"Economic Capital Ratio": "23%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "10,826",
"Assets, Non-Current": "203",
"General and Administrative Expense": "0",
"Goodwill": "181",
"Liabilities, Current": "69,862",
"Liabilities, Non-Current": "599",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "24,193",
"Other Liabilities": "9,667",
"Other Net Income": "-12,086",
"Other Revenues": "21,970",
"Property, Plant and Equipment, Net": "1,252",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "80,128",
"Assets": "12,462",
"Expenses": "24,193",
"Revenues": "21,970",
"Stockholders Equity": "-67,666",
"Net Income": "-14,309",
"Comprehensive Net Income": "-14,309",
"BaseVar": "75,419",
"ECR before LimitedLiability": "-231%",
"Economic Capital Ratio": "26%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "13,832",
"Assets, Non-Current": "1,445",
"General and Administrative Expense": "11,170",
"Goodwill": "458",
"Liabilities, Current": "8,068",
"Liabilities, Non-Current": "77",
"Other Assets": "4,809",
"Other Compr. Net Income": "-2.4",
"Other Expenses": "-4,059",
"Other Liabilities": "588",
"Other Net Income": "84,760",
"Other Revenues": "1,810",
"Property, Plant and Equipment, Net": "237",
"Research and Development": "4,514"
},
"output_variables": {
"Liabilities": "8,733",
"Assets": "20,781",
"Expenses": "11,625",
"Revenues": "1,810",
"Stockholders Equity": "12,048",
"Net Income": "74,946",
"Comprehensive Net Income": "74,945",
"BaseVar": "63,856",
"ECR before LimitedLiability": "620%",
"Economic Capital Ratio": "620%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "5,596",
"Assets, Non-Current": "835",
"General and Administrative Expense": "7,795",
"Goodwill": "428",
"Liabilities, Current": "3,379",
"Liabilities, Non-Current": "64",
"Other Assets": "0",
"Other Compr. Net Income": "1.7",
"Other Expenses": "-9.8",
"Other Liabilities": "1,168",
"Other Net Income": "-5,277",
"Other Revenues": "1,169",
"Property, Plant and Equipment, Net": "162",
"Research and Development": "4,222"
},
"output_variables": {
"Liabilities": "4,611",
"Assets": "7,022",
"Expenses": "12,007",
"Revenues": "1,169",
"Stockholders Equity": "2,410",
"Net Income": "-16,114",
"Comprehensive Net Income": "-16,113",
"BaseVar": "15,044",
"ECR before LimitedLiability": "-220%",
"Economic Capital Ratio": "29%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,916",
"Assets, Non-Current": "820",
"General and Administrative Expense": "6,282",
"Goodwill": "385",
"Liabilities, Current": "3,820",
"Liabilities, Non-Current": "512",
"Other Assets": "0",
"Other Compr. Net Income": "0.73",
"Other Expenses": "0.71",
"Other Liabilities": "700",
"Other Net Income": "15",
"Other Revenues": "658",
"Property, Plant and Equipment, Net": "30",
"Research and Development": "5,338"
},
"output_variables": {
"Liabilities": "5,032",
"Assets": "4,151",
"Expenses": "11,621",
"Revenues": "658",
"Stockholders Equity": "-881",
"Net Income": "-10,948",
"Comprehensive Net Income": "-10,948",
"BaseVar": "10,739",
"ECR before LimitedLiability": "-265%",
"Economic Capital Ratio": "18%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "6,528",
"Assets, Non-Current": "477",
"General and Administrative Expense": "6,696",
"Goodwill": "620",
"Liabilities, Current": "4,715",
"Liabilities, Non-Current": "296",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "700",
"Other Net Income": "-11",
"Other Revenues": "915",
"Property, Plant and Equipment, Net": "132",
"Research and Development": "4,930"
},
"output_variables": {
"Liabilities": "5,711",
"Assets": "7,758",
"Expenses": "11,626",
"Revenues": "915",
"Stockholders Equity": "2,047",
"Net Income": "-10,722",
"Comprehensive Net Income": "-10,722",
"BaseVar": "13,010",
"ECR before LimitedLiability": "-118%",
"Economic Capital Ratio": "62%"
}
}
},
"top_rated": false,
"trend": 4.0,
"value": 0.6224822957310657,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0000810509.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0000810509.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0000810509.svg"
},
{
"company_id": "0001632275",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001632275.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001632275.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001632275_main_keyfigs.svg",
"name": "CAT9 Group Inc",
"rank": 43,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001632275.svg",
"report_text": "The relative strengths and weaknesses of CAT9 Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of CAT9 Group Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 23% points.The greatest weakness of CAT9 Group Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 152% points.
The company's Economic Capital Ratio, given in the ranking table, is 50%, being 96% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001632275_2021_CAT9_Group_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "2.53",
"Liabilities": "-3.39",
"Stockholders Equity": "-45.4",
"ECR before LimitedLiability": "-53.0",
"Liabilities, Current": "-22.1",
"Liabilities, Non-Current": "4.82",
"Assets, Non-Current": "-2.40",
"Assets": "-20.6",
"Assets, Current": "0.950",
"Goodwill": "-5.25",
"Property, Plant and Equipment, Net": "-4.70",
"Research and Development": "5.66",
"Expenses": "-4.25",
"Revenues": "6.15",
"Net Income": "-1.58",
"Other Expenses": "17.9",
"General and Administrative Expense": "-60.2",
"Other Revenues": "6.15",
"Comprehensive Net Income": "-1.68",
"Other Net Income": "-1.30",
"Economic Capital Ratio": "-74.5"
},
"2018": {
"Liabilities, Non-Current": "1.61",
"Liabilities": "-13.1",
"Stockholders Equity": "-60.7",
"ECR before LimitedLiability": "-90.0",
"Other Liabilities": "1.00",
"Liabilities, Current": "-23.2",
"Property, Plant and Equipment, Net": "-15.5",
"Assets": "-43.8",
"Other Assets": "-0.172",
"Assets, Current": "-17.3",
"Goodwill": "-14.9",
"Assets, Non-Current": "-10.5",
"Other Expenses": "-1.10",
"Expenses": "-10.6",
"Revenues": "-2.90",
"Net Income": "-13.8",
"Research and Development": "5.90",
"General and Administrative Expense": "-16.2",
"Other Revenues": "-2.90",
"Comprehensive Net Income": "-13.7",
"Economic Capital Ratio": "-110"
},
"2019": {
"Liabilities, Non-Current": "7.75",
"Liabilities": "11.9",
"Stockholders Equity": "-232",
"Other Liabilities": "4.38",
"Liabilities, Current": "-2.76",
"Assets, Non-Current": "-44.9",
"Assets": "-124",
"Goodwill": "-49.5",
"Property, Plant and Equipment, Net": "-56.3",
"Assets, Current": "-79.7",
"Research and Development": "5.32",
"Expenses": "-87.1",
"Revenues": "72.5",
"Net Income": "49.0",
"Other Expenses": "1.77",
"General and Administrative Expense": "-129",
"Other Revenues": "72.5",
"ECR before LimitedLiability": "-22.2",
"Other Net Income": "1.67",
"Comprehensive Net Income": "49.1",
"Economic Capital Ratio": "-51.6"
},
"2020": {
"Liabilities, Current": "-23.7",
"Liabilities": "-5.82",
"Stockholders Equity": "-152",
"ECR before LimitedLiability": "-58.4",
"Liabilities, Non-Current": "7.16",
"Other Liabilities": "1.70",
"Goodwill": "-21.9",
"Assets": "-87.4",
"Assets, Current": "-33.4",
"Assets, Non-Current": "-18.5",
"Property, Plant and Equipment, Net": "-25.6",
"Other Expenses": "-0.975",
"Expenses": "-27.6",
"Revenues": "23.0",
"Net Income": "9.19",
"Research and Development": "6.89",
"General and Administrative Expense": "-31.0",
"Other Revenues": "23.0",
"Comprehensive Net Income": "9.27",
"Other Net Income": "14.9",
"Economic Capital Ratio": "-96.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001632275_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "286",
"Assets, Non-Current": "0",
"General and Administrative Expense": "622",
"Goodwill": "0",
"Liabilities, Current": "336",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-93",
"Other Liabilities": "0",
"Other Net Income": "2.5",
"Other Revenues": "333",
"Property, Plant and Equipment, Net": "52",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "336",
"Assets": "338",
"Expenses": "529",
"Revenues": "333",
"Stockholders Equity": "2.4",
"Net Income": "-193",
"Comprehensive Net Income": "-193",
"BaseVar": "769",
"ECR before LimitedLiability": "-56%",
"Economic Capital Ratio": "79%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "411",
"Assets, Non-Current": "0",
"General and Administrative Expense": "1,004",
"Goodwill": "0",
"Liabilities, Current": "1,065",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "173",
"Other Liabilities": "0",
"Other Net Income": "-0.88",
"Other Revenues": "462",
"Property, Plant and Equipment, Net": "42",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,065",
"Assets": "453",
"Expenses": "1,177",
"Revenues": "462",
"Stockholders Equity": "-612",
"Net Income": "-716",
"Comprehensive Net Income": "-716",
"BaseVar": "1,580",
"ECR before LimitedLiability": "-205%",
"Economic Capital Ratio": "33%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "986",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,064",
"Goodwill": "0",
"Liabilities, Current": "1,352",
"Liabilities, Non-Current": "0",
"Other Assets": "13",
"Other Compr. Net Income": "0",
"Other Expenses": "261",
"Other Liabilities": "0",
"Other Net Income": "25",
"Other Revenues": "5,593",
"Property, Plant and Equipment, Net": "22",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,352",
"Assets": "1,022",
"Expenses": "5,326",
"Revenues": "5,593",
"Stockholders Equity": "-330",
"Net Income": "293",
"Comprehensive Net Income": "293",
"BaseVar": "6,659",
"ECR before LimitedLiability": "-13%",
"Economic Capital Ratio": "84%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "501",
"Assets, Non-Current": "0",
"General and Administrative Expense": "2,008",
"Goodwill": "0",
"Liabilities, Current": "1,238",
"Liabilities, Non-Current": "0",
"Other Assets": "4.2",
"Other Compr. Net Income": "0",
"Other Expenses": "215",
"Other Liabilities": "0",
"Other Net Income": "278",
"Other Revenues": "1,572",
"Property, Plant and Equipment, Net": "12",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,238",
"Assets": "518",
"Expenses": "2,223",
"Revenues": "1,572",
"Stockholders Equity": "-720",
"Net Income": "-373",
"Comprehensive Net Income": "-373",
"BaseVar": "2,914",
"ECR before LimitedLiability": "-155%",
"Economic Capital Ratio": "50%"
}
}
},
"top_rated": false,
"trend": -6.0,
"value": 0.49673341814541105,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001632275.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001632275.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001632275.svg"
},
{
"company_id": "0001134765",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001134765.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001134765.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001134765.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001134765_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001134765_main_keyfigs.svg",
"name": "Charlie s Holdings Inc",
"rank": 44,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001134765.svg",
"report_text": "The relative strengths and weaknesses of Charlie s Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Charlie s Holdings Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 23% points.The greatest weakness of Charlie s Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 125% points.
The company's Economic Capital Ratio, given in the ranking table, is 47%, being 99% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001134765_2021_Charlie_s_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "0.0772",
"Liabilities": "0.0755",
"Stockholders Equity": "-37.6",
"ECR before LimitedLiability": "-91.4",
"Liabilities, Non-Current": "-0.0549",
"Other Liabilities": "-0.0251",
"Property, Plant and Equipment, Net": "-1.14",
"Assets": "-55.6",
"Assets, Non-Current": "-0.226",
"Other Assets": "0",
"Goodwill": "-0.885",
"Assets, Current": "-23.9",
"General and Administrative Expense": "-1.71",
"Expenses": "-0.811",
"Revenues": "-0.117",
"Net Income": "-11.9",
"Research and Development": "0.0474",
"Other Revenues": "-0.117",
"Comprehensive Net Income": "-11.9",
"Other Net Income": "-0.996",
"Economic Capital Ratio": "-153"
},
"2012": {
"Liabilities, Current": "-6.69",
"Liabilities": "-5.98",
"Stockholders Equity": "58.2",
"ECR before LimitedLiability": "17.6",
"Liabilities, Non-Current": "9.03",
"Other Liabilities": "-8.56",
"Assets, Current": "-21.0",
"Assets": "59.1",
"Other Assets": "39.8",
"Assets, Non-Current": "-5.07",
"Property, Plant and Equipment, Net": "-10.5",
"Goodwill": "62.2",
"Other Expenses": "9.56",
"Expenses": "9.06",
"Revenues": "-29.7",
"Net Income": "-24.1",
"Research and Development": "13.2",
"General and Administrative Expense": "-12.9",
"Other Revenues": "-29.7",
"Comprehensive Net Income": "-24.0",
"Economic Capital Ratio": "-14.8"
},
"2013": {
"Liabilities, Current": "-30.3",
"Liabilities": "-1.06",
"ECR before LimitedLiability": "-30.9",
"Other Liabilities": "1.40",
"Liabilities, Non-Current": "1.67",
"Goodwill": "7.73",
"Assets": "2.45",
"Assets, Non-Current": "-0.749",
"Property, Plant and Equipment, Net": "-1.12",
"Other Assets": "3.23",
"Assets, Current": "-0.669",
"General and Administrative Expense": "-0.797",
"Expenses": "-0.983",
"Net Income": "-32.8",
"Research and Development": "1.99",
"Other Expenses": "-1.11",
"Other Revenues": "-10.3",
"Revenues": "-10.3",
"Other Net Income": "-0.658",
"Comprehensive Net Income": "-32.9",
"Economic Capital Ratio": "-71.0"
},
"2014": {
"Liabilities, Non-Current": "4.06",
"Liabilities": "-4.97",
"Stockholders Equity": "-14.6",
"ECR before LimitedLiability": "-17.2",
"Liabilities, Current": "-12.6",
"Other Liabilities": "2.73",
"Assets, Current": "-14.7",
"Assets": "-11.6",
"Goodwill": "14.4",
"Other Assets": "12.1",
"Assets, Non-Current": "-4.01",
"Property, Plant and Equipment, Net": "-8.76",
"Other Expenses": "-6.80",
"Expenses": "-8.05",
"Revenues": "-5.19",
"Net Income": "-10.4",
"Research and Development": "7.15",
"General and Administrative Expense": "-7.63",
"Other Revenues": "-5.19",
"Comprehensive Net Income": "-10.4",
"Economic Capital Ratio": "-66.6"
},
"2015": {
"Other Liabilities": "3.47",
"Liabilities": "-2.30",
"Stockholders Equity": "-25.1",
"ECR before LimitedLiability": "-36.3",
"Liabilities, Current": "-13.2",
"Liabilities, Non-Current": "4.15",
"Assets, Current": "-21.7",
"Assets": "-25.4",
"Goodwill": "10.1",
"Assets, Non-Current": "-4.45",
"Property, Plant and Equipment, Net": "-13.2",
"Research and Development": "6.34",
"Expenses": "-15.3",
"Revenues": "-2.13",
"Net Income": "-20.5",
"General and Administrative Expense": "-14.5",
"Other Expenses": "-7.08",
"Other Revenues": "-2.13",
"Comprehensive Net Income": "-20.4",
"Other Net Income": "-4.35",
"Economic Capital Ratio": "-82.2"
},
"2016": {
"Liabilities, Non-Current": "4.13",
"Liabilities": "-10.1",
"Stockholders Equity": "-47.2",
"ECR before LimitedLiability": "-71.9",
"Liabilities, Current": "-20.1",
"Property, Plant and Equipment, Net": "-17.0",
"Assets": "-28.9",
"Other Assets": "5.47",
"Assets, Non-Current": "-5.15",
"Assets, Current": "-29.1",
"Goodwill": "25.6",
"Research and Development": "8.74",
"Expenses": "-12.8",
"Revenues": "-12.2",
"Net Income": "-10.8",
"General and Administrative Expense": "-22.5",
"Other Expenses": "3.80",
"Other Revenues": "-12.2",
"Comprehensive Net Income": "-10.7",
"Other Net Income": "14.7",
"Economic Capital Ratio": "-91.9"
},
"2017": {
"Other Liabilities": "-0.193",
"Liabilities": "-0.684",
"Stockholders Equity": "-61.6",
"ECR before LimitedLiability": "-113",
"Liabilities, Current": "-0.917",
"Liabilities, Non-Current": "0.275",
"Assets, Non-Current": "-5.88",
"Assets": "-57.7",
"Assets, Current": "-44.3",
"Goodwill": "7.62",
"Property, Plant and Equipment, Net": "-26.7",
"Research and Development": "5.30",
"Expenses": "-27.1",
"Revenues": "-7.69",
"Net Income": "-32.0",
"Other Expenses": "-15.0",
"General and Administrative Expense": "-17.4",
"Other Revenues": "-7.69",
"Comprehensive Net Income": "-32.2",
"Other Net Income": "3.51",
"Economic Capital Ratio": "-135"
},
"2018": {
"Liabilities, Non-Current": "0.226",
"Liabilities": "-1.47",
"Stockholders Equity": "-132",
"ECR before LimitedLiability": "-105",
"Liabilities, Current": "-3.22",
"Property, Plant and Equipment, Net": "-23.9",
"Assets": "-66.0",
"Other Assets": "-0.186",
"Assets, Current": "-56.6",
"Goodwill": "-0.850",
"Assets, Non-Current": "-12.5",
"Other Expenses": "5.03",
"Expenses": "-13.4",
"Revenues": "-16.5",
"Net Income": "0.768",
"Research and Development": "5.30",
"General and Administrative Expense": "-31.1",
"Other Revenues": "-16.5",
"Comprehensive Net Income": "0.876",
"Other Net Income": "14.8",
"Economic Capital Ratio": "-126"
},
"2019": {
"Liabilities, Non-Current": "5.92",
"Liabilities": "10.3",
"Stockholders Equity": "-140",
"ECR before LimitedLiability": "-27.5",
"Other Liabilities": "5.96",
"Liabilities, Current": "-1.38",
"Assets, Non-Current": "-3.96",
"Assets": "-99.6",
"Goodwill": "-15.1",
"Property, Plant and Equipment, Net": "-18.3",
"Assets, Current": "-50.5",
"Research and Development": "4.55",
"Expenses": "-52.6",
"Revenues": "39.9",
"Net Income": "23.2",
"Other Expenses": "2.89",
"General and Administrative Expense": "-78.5",
"Other Revenues": "39.9",
"Other Net Income": "15.6",
"Comprehensive Net Income": "23.3",
"Economic Capital Ratio": "-57.0"
},
"2020": {
"Liabilities, Current": "-13.5",
"Liabilities": "-4.78",
"Stockholders Equity": "-125",
"ECR before LimitedLiability": "-60.8",
"Liabilities, Non-Current": "3.76",
"Goodwill": "-21.6",
"Assets": "-75.2",
"Other Assets": "-4.27",
"Assets, Current": "-35.1",
"Assets, Non-Current": "-6.77",
"Property, Plant and Equipment, Net": "-23.8",
"Other Expenses": "6.82",
"Expenses": "-29.0",
"Revenues": "23.1",
"Net Income": "-3.29",
"Research and Development": "-5.56",
"General and Administrative Expense": "-29.9",
"Other Revenues": "23.1",
"Comprehensive Net Income": "-3.22",
"Other Net Income": "2.80",
"Economic Capital Ratio": "-98.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001134765_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "238",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,369",
"Goodwill": "19",
"Liabilities, Current": "1,869",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "718",
"Other Liabilities": "103",
"Other Net Income": "-1,126",
"Other Revenues": "1,267",
"Property, Plant and Equipment, Net": "9.7",
"Research and Development": "0.29"
},
"output_variables": {
"Liabilities": "1,972",
"Assets": "267",
"Expenses": "4,087",
"Revenues": "1,267",
"Stockholders Equity": "-1,705",
"Net Income": "-3,946",
"Comprehensive Net Income": "-3,946",
"BaseVar": "4,359",
"ECR before LimitedLiability": "-561%",
"Economic Capital Ratio": "0.077%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,237",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,273",
"Goodwill": "3,573",
"Liabilities, Current": "1,292",
"Liabilities, Non-Current": "0",
"Other Assets": "1,579",
"Other Compr. Net Income": "0",
"Other Expenses": "750",
"Other Liabilities": "772",
"Other Net Income": "-118",
"Other Revenues": "1,022",
"Property, Plant and Equipment, Net": "25",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,064",
"Assets": "6,415",
"Expenses": "4,023",
"Revenues": "1,022",
"Stockholders Equity": "4,351",
"Net Income": "-3,119",
"Comprehensive Net Income": "-3,119",
"BaseVar": "6,821",
"ECR before LimitedLiability": "67%",
"Economic Capital Ratio": "144%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "4,960",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,926",
"Goodwill": "3,523",
"Liabilities, Current": "5,438",
"Liabilities, Non-Current": "0",
"Other Assets": "1,486",
"Other Compr. Net Income": "0",
"Other Expenses": "4,448",
"Other Liabilities": "0",
"Other Net Income": "-391",
"Other Revenues": "2,649",
"Property, Plant and Equipment, Net": "8.4",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,438",
"Assets": "9,977",
"Expenses": "10,374",
"Revenues": "2,649",
"Stockholders Equity": "4,539",
"Net Income": "-8,115",
"Comprehensive Net Income": "-8,115",
"BaseVar": "14,415",
"ECR before LimitedLiability": "-25%",
"Economic Capital Ratio": "83%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "3,004",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,838",
"Goodwill": "3,475",
"Liabilities, Current": "7,755",
"Liabilities, Non-Current": "0",
"Other Assets": "1,352",
"Other Compr. Net Income": "0",
"Other Expenses": "4,402",
"Other Liabilities": "0",
"Other Net Income": "430",
"Other Revenues": "4,693",
"Property, Plant and Equipment, Net": "4.6",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,755",
"Assets": "7,835",
"Expenses": "13,240",
"Revenues": "4,693",
"Stockholders Equity": "80",
"Net Income": "-8,117",
"Comprehensive Net Income": "-8,117",
"BaseVar": "16,977",
"ECR before LimitedLiability": "-103%",
"Economic Capital Ratio": "67%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "3,855",
"Assets, Non-Current": "0",
"General and Administrative Expense": "10,549",
"Goodwill": "3,475",
"Liabilities, Current": "9,159",
"Liabilities, Non-Current": "0",
"Other Assets": "1,280",
"Other Compr. Net Income": "0",
"Other Expenses": "6,282",
"Other Liabilities": "0",
"Other Net Income": "-1,281",
"Other Revenues": "6,121",
"Property, Plant and Equipment, Net": "4.5",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,159",
"Assets": "8,614",
"Expenses": "16,831",
"Revenues": "6,121",
"Stockholders Equity": "-545",
"Net Income": "-11,991",
"Comprehensive Net Income": "-11,991",
"BaseVar": "21,003",
"ECR before LimitedLiability": "-143%",
"Economic Capital Ratio": "54%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "998",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,608",
"Goodwill": "3,475",
"Liabilities, Current": "7,161",
"Liabilities, Non-Current": "0",
"Other Assets": "460",
"Other Compr. Net Income": "0",
"Other Expenses": "2,254",
"Other Liabilities": "0",
"Other Net Income": "2,841",
"Other Revenues": "2,575",
"Property, Plant and Equipment, Net": "11",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,161",
"Assets": "4,943",
"Expenses": "10,862",
"Revenues": "2,575",
"Stockholders Equity": "-2,217",
"Net Income": "-5,446",
"Comprehensive Net Income": "-5,446",
"BaseVar": "14,191",
"ECR before LimitedLiability": "-140%",
"Economic Capital Ratio": "55%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,389",
"Assets, Non-Current": "0",
"General and Administrative Expense": "10,699",
"Goodwill": "3,475",
"Liabilities, Current": "8,206",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "7,567",
"Other Liabilities": "2,050",
"Other Net Income": "1,996",
"Other Revenues": "3,823",
"Property, Plant and Equipment, Net": "5.9",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "10,256",
"Assets": "4,869",
"Expenses": "18,266",
"Revenues": "3,823",
"Stockholders Equity": "-5,386",
"Net Income": "-12,447",
"Comprehensive Net Income": "-12,447",
"BaseVar": "19,605",
"ECR before LimitedLiability": "-262%",
"Economic Capital Ratio": "18%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "53",
"Assets, Non-Current": "0",
"General and Administrative Expense": "12,638",
"Goodwill": "1,577",
"Liabilities, Current": "9,789",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "6,811",
"Other Revenues": "1,947",
"Property, Plant and Equipment, Net": "1.1",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,789",
"Assets": "1,631",
"Expenses": "12,638",
"Revenues": "1,947",
"Stockholders Equity": "-8,158",
"Net Income": "-3,879",
"Comprehensive Net Income": "-3,879",
"BaseVar": "16,408",
"ECR before LimitedLiability": "-264%",
"Economic Capital Ratio": "18%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "5,611",
"Assets, Non-Current": "2,237",
"General and Administrative Expense": "27,402",
"Goodwill": "0",
"Liabilities, Current": "7,177",
"Liabilities, Non-Current": "1,218",
"Other Assets": "-543",
"Other Compr. Net Income": "0",
"Other Expenses": "1,650",
"Other Liabilities": "0",
"Other Net Income": "3,618",
"Other Revenues": "22,740",
"Property, Plant and Equipment, Net": "543",
"Research and Development": "1,102"
},
"output_variables": {
"Liabilities": "8,395",
"Assets": "7,848",
"Expenses": "30,154",
"Revenues": "22,740",
"Stockholders Equity": "-547",
"Net Income": "-3,796",
"Comprehensive Net Income": "-3,796",
"BaseVar": "36,378",
"ECR before LimitedLiability": "-56%",
"Economic Capital Ratio": "79%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,723",
"Assets, Non-Current": "1,802",
"General and Administrative Expense": "20,084",
"Goodwill": "0",
"Liabilities, Current": "10,743",
"Liabilities, Non-Current": "1,778",
"Other Assets": "-531",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-417",
"Other Revenues": "16,692",
"Property, Plant and Equipment, Net": "531",
"Research and Development": "3,378"
},
"output_variables": {
"Liabilities": "12,521",
"Assets": "6,525",
"Expenses": "23,462",
"Revenues": "16,692",
"Stockholders Equity": "-5,996",
"Net Income": "-7,187",
"Comprehensive Net Income": "-7,187",
"BaseVar": "29,808",
"ECR before LimitedLiability": "-162%",
"Economic Capital Ratio": "47%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 0.47323870837923343,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001134765.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001134765.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001134765.svg"
},
{
"company_id": "0001590695",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001590695.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001590695.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001590695.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001590695_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001590695_main_keyfigs.svg",
"name": "Twinlab Consolidated Holdings Inc",
"rank": 45,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001590695.svg",
"report_text": "The relative strengths and weaknesses of Twinlab Consolidated Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Twinlab Consolidated Holdings Inc compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 7.2% points.The greatest weakness of Twinlab Consolidated Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 120% points.
The company's Economic Capital Ratio, given in the ranking table, is 41%, being 105% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001590695_2021_Twinlab_Consolidated_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2014": {
"Liabilities, Non-Current": "-3.39",
"Liabilities": "-0.909",
"Stockholders Equity": "-34.8",
"ECR before LimitedLiability": "-7.23",
"Liabilities, Current": "-0.530",
"Other Liabilities": "3.17",
"Assets, Current": "-6.92",
"Assets": "-24.7",
"Goodwill": "-3.67",
"Other Assets": "0.285",
"Assets, Non-Current": "-2.40",
"Property, Plant and Equipment, Net": "-4.88",
"Other Revenues": "13.8",
"Revenues": "13.8",
"Net Income": "8.05",
"Other Expenses": "-15.4",
"Comprehensive Net Income": "8.08",
"General and Administrative Expense": "12.6",
"Other Net Income": "-3.66",
"Research and Development": "7.23",
"Economic Capital Ratio": "-56.6"
},
"2015": {
"Other Liabilities": "2.98",
"Liabilities": "-2.28",
"Stockholders Equity": "-30.7",
"ECR before LimitedLiability": "-8.66",
"Liabilities, Current": "-4.86",
"Assets, Current": "-21.8",
"Assets": "-10.3",
"Other Assets": "-2.09",
"Goodwill": "21.9",
"Assets, Non-Current": "-0.933",
"Property, Plant and Equipment, Net": "-2.58",
"Research and Development": "3.06",
"Expenses": "3.54",
"Revenues": "5.06",
"Net Income": "3.85",
"General and Administrative Expense": "8.05",
"Other Expenses": "-3.25",
"Other Revenues": "5.06",
"Comprehensive Net Income": "3.97",
"Other Net Income": "-2.73",
"Economic Capital Ratio": "-54.5"
},
"2016": {
"Liabilities, Non-Current": "-61.3",
"Liabilities": "-39.5",
"Stockholders Equity": "-77.7",
"Liabilities, Current": "1.95",
"Other Liabilities": "2.02",
"Property, Plant and Equipment, Net": "-26.1",
"Assets": "-41.9",
"Assets, Non-Current": "-6.49",
"Assets, Current": "-48.4",
"Goodwill": "8.20",
"Research and Development": "2.69",
"Expenses": "2.26",
"Revenues": "2.72",
"Net Income": "6.11",
"General and Administrative Expense": "2.68",
"Other Expenses": "-27.3",
"Other Revenues": "2.72",
"ECR before LimitedLiability": "-40.1",
"Comprehensive Net Income": "6.17",
"Other Net Income": "2.03",
"Economic Capital Ratio": "-60.1"
},
"2017": {
"Other Liabilities": "2.68",
"Liabilities": "-8.67",
"Stockholders Equity": "-64.6",
"ECR before LimitedLiability": "-57.7",
"Liabilities, Current": "-24.5",
"Liabilities, Non-Current": "3.63",
"Assets, Non-Current": "-2.50",
"Assets": "-17.1",
"Assets, Current": "-10.2",
"Goodwill": "12.2",
"Property, Plant and Equipment, Net": "-8.88",
"Other Revenues": "8.56",
"Revenues": "8.56",
"Net Income": "3.20",
"Comprehensive Net Income": "3.05",
"Other Compr. Net Income": "-0.132",
"Other Expenses": "-9.37",
"Other Net Income": "-4.15",
"Research and Development": "6.44",
"General and Administrative Expense": "8.52",
"Economic Capital Ratio": "-79.2"
},
"2018": {
"Liabilities, Non-Current": "-0.563",
"Liabilities": "-12.9",
"Stockholders Equity": "-76.3",
"ECR before LimitedLiability": "-51.6",
"Other Liabilities": "2.35",
"Liabilities, Current": "-26.8",
"Property, Plant and Equipment, Net": "-8.74",
"Assets": "-12.7",
"Assets, Current": "-11.7",
"Goodwill": "14.5",
"Assets, Non-Current": "-4.98",
"Other Expenses": "5.11",
"Expenses": "5.17",
"Revenues": "4.22",
"Net Income": "7.58",
"Research and Development": "5.45",
"General and Administrative Expense": "-4.67",
"Other Revenues": "4.22",
"Comprehensive Net Income": "7.69",
"Other Net Income": "-1.85",
"Economic Capital Ratio": "-72.1"
},
"2019": {
"Liabilities, Non-Current": "1.38",
"Liabilities": "-11.1",
"Stockholders Equity": "-105",
"ECR before LimitedLiability": "-78.1",
"Other Liabilities": "0.923",
"Liabilities, Current": "-23.7",
"Assets, Non-Current": "-14.9",
"Assets": "-53.8",
"Goodwill": "-5.28",
"Property, Plant and Equipment, Net": "-20.7",
"Other Assets": "0.870",
"Assets, Current": "-37.7",
"Research and Development": "4.60",
"Expenses": "-4.83",
"Revenues": "5.93",
"Net Income": "1.51",
"Other Expenses": "-4.58",
"General and Administrative Expense": "-5.30",
"Other Revenues": "5.93",
"Comprehensive Net Income": "1.54",
"Economic Capital Ratio": "-108"
},
"2020": {
"Liabilities, Current": "-39.7",
"Liabilities": "-28.0",
"Stockholders Equity": "-120",
"ECR before LimitedLiability": "-66.7",
"Liabilities, Non-Current": "2.58",
"Other Liabilities": "0.742",
"Goodwill": "-5.15",
"Assets": "-42.1",
"Assets, Current": "-32.8",
"Assets, Non-Current": "-7.62",
"Property, Plant and Equipment, Net": "-18.4",
"Other Expenses": "3.90",
"Expenses": "2.35",
"Revenues": "5.78",
"Net Income": "7.12",
"Research and Development": "3.70",
"General and Administrative Expense": "-5.43",
"Other Revenues": "5.78",
"Comprehensive Net Income": "7.16",
"Other Net Income": "-0.959",
"Economic Capital Ratio": "-105"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001590695_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "28,279",
"Assets, Non-Current": "986",
"General and Administrative Expense": "25,924",
"Goodwill": "7,564",
"Liabilities, Current": "29,322",
"Liabilities, Non-Current": "14,824",
"Other Assets": "0",
"Other Compr. Net Income": "-31",
"Other Expenses": "47,715",
"Other Liabilities": "0",
"Other Net Income": "-8,917",
"Other Revenues": "61,426",
"Property, Plant and Equipment, Net": "2,680",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "44,146",
"Assets": "39,509",
"Expenses": "73,639",
"Revenues": "61,426",
"Stockholders Equity": "-4,637",
"Net Income": "-21,130",
"Comprehensive Net Income": "-21,146",
"BaseVar": "113,834",
"ECR before LimitedLiability": "-66%",
"Economic Capital Ratio": "77%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "24,504",
"Assets, Non-Current": "1,475",
"General and Administrative Expense": "25,521",
"Goodwill": "56,509",
"Liabilities, Current": "71,720",
"Liabilities, Non-Current": "14,751",
"Other Assets": "0",
"Other Compr. Net Income": "83",
"Other Expenses": "70,097",
"Other Liabilities": "0",
"Other Net Income": "-22,464",
"Other Revenues": "81,672",
"Property, Plant and Equipment, Net": "3,712",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "86,471",
"Assets": "86,200",
"Expenses": "95,618",
"Revenues": "81,672",
"Stockholders Equity": "-271",
"Net Income": "-36,410",
"Comprehensive Net Income": "-36,368",
"BaseVar": "186,254",
"ECR before LimitedLiability": "-43%",
"Economic Capital Ratio": "81%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "33,336",
"Assets, Non-Current": "1,667",
"General and Administrative Expense": "33,452",
"Goodwill": "54,295",
"Liabilities, Current": "37,386",
"Liabilities, Non-Current": "53,674",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "66,189",
"Other Liabilities": "0",
"Other Net Income": "12,634",
"Other Revenues": "86,323",
"Property, Plant and Equipment, Net": "3,528",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "91,060",
"Assets": "92,826",
"Expenses": "99,641",
"Revenues": "86,323",
"Stockholders Equity": "1,766",
"Net Income": "-684",
"Comprehensive Net Income": "-684",
"BaseVar": "191,242",
"ECR before LimitedLiability": "1.9%",
"Economic Capital Ratio": "87%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "27,302",
"Assets, Non-Current": "1,762",
"General and Administrative Expense": "29,032",
"Goodwill": "40,860",
"Liabilities, Current": "95,366",
"Liabilities, Non-Current": "4,948",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "76,651",
"Other Liabilities": "0",
"Other Net Income": "-9,309",
"Other Revenues": "85,501",
"Property, Plant and Equipment, Net": "3,169",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "100,314",
"Assets": "73,093",
"Expenses": "105,683",
"Revenues": "85,501",
"Stockholders Equity": "-27,221",
"Net Income": "-29,491",
"Comprehensive Net Income": "-29,491",
"BaseVar": "186,950",
"ECR before LimitedLiability": "-77%",
"Economic Capital Ratio": "74%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "29,298",
"Assets, Non-Current": "1,720",
"General and Administrative Expense": "87,281",
"Goodwill": "39,105",
"Liabilities, Current": "98,803",
"Liabilities, Non-Current": "16,324",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "29",
"Other Liabilities": "0",
"Other Net Income": "-6,390",
"Other Revenues": "73,291",
"Property, Plant and Equipment, Net": "1,117",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "115,127",
"Assets": "71,240",
"Expenses": "87,310",
"Revenues": "73,291",
"Stockholders Equity": "-43,887",
"Net Income": "-20,409",
"Comprehensive Net Income": "-20,409",
"BaseVar": "176,679",
"ECR before LimitedLiability": "-86%",
"Economic Capital Ratio": "72%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "16,300",
"Assets, Non-Current": "834",
"General and Administrative Expense": "87,820",
"Goodwill": "13,181",
"Liabilities, Current": "118,147",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "24,486",
"Other Liabilities": "0",
"Other Net Income": "-5,655",
"Other Revenues": "73,460",
"Property, Plant and Equipment, Net": "72",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "118,147",
"Assets": "30,387",
"Expenses": "112,306",
"Revenues": "73,460",
"Stockholders Equity": "-87,760",
"Net Income": "-44,501",
"Comprehensive Net Income": "-44,501",
"BaseVar": "169,978",
"ECR before LimitedLiability": "-222%",
"Economic Capital Ratio": "28%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "17,345",
"Assets, Non-Current": "5,470",
"General and Administrative Expense": "71,757",
"Goodwill": "12,071",
"Liabilities, Current": "132,032",
"Liabilities, Non-Current": "5,068",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "38",
"Other Liabilities": "0",
"Other Net Income": "-8,943",
"Other Revenues": "66,349",
"Property, Plant and Equipment, Net": "65",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "137,100",
"Assets": "34,951",
"Expenses": "71,795",
"Revenues": "66,349",
"Stockholders Equity": "-102,149",
"Net Income": "-14,389",
"Comprehensive Net Income": "-14,389",
"BaseVar": "159,569",
"ECR before LimitedLiability": "-179%",
"Economic Capital Ratio": "41%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 0.41389656029682076,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001590695.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001590695.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001590695.svg"
},
{
"company_id": "0001746563",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001746563.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001746563.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001746563.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001746563_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001746563_main_keyfigs.svg",
"name": "Diamond Wellness Holdings Inc",
"rank": 46,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001746563.svg",
"report_text": "The relative strengths and weaknesses of Diamond Wellness Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Diamond Wellness Holdings Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 2.3% points.The greatest weakness of Diamond Wellness Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 177% points.
The company's Economic Capital Ratio, given in the ranking table, is 2.4%, being 144% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001746563_2021_Diamond_Wellness_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "-2.15",
"Liabilities": "-0.325",
"Stockholders Equity": "-177",
"ECR before LimitedLiability": "-106",
"Liabilities, Non-Current": "2.04",
"Other Liabilities": "-0.377",
"Goodwill": "-20.2",
"Assets": "-124",
"Assets, Current": "-75.3",
"Assets, Non-Current": "-14.6",
"Property, Plant and Equipment, Net": "-29.3",
"Other Expenses": "-3.04",
"Expenses": "-16.7",
"Revenues": "2.30",
"Net Income": "-6.49",
"Research and Development": "1.08",
"General and Administrative Expense": "-13.3",
"Other Revenues": "2.30",
"Comprehensive Net Income": "-6.45",
"Other Net Income": "-10.1",
"Economic Capital Ratio": "-144"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001746563_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "710",
"Assets, Non-Current": "0",
"General and Administrative Expense": "9,149",
"Goodwill": "0",
"Liabilities, Current": "511",
"Liabilities, Non-Current": "4,497",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,409",
"Other Liabilities": "0.0010",
"Other Net Income": "-3,707",
"Other Revenues": "9,681",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,007",
"Assets": "710",
"Expenses": "11,558",
"Revenues": "9,681",
"Stockholders Equity": "-4,297",
"Net Income": "-5,585",
"Comprehensive Net Income": "-5,585",
"BaseVar": "15,332",
"ECR before LimitedLiability": "-401%",
"Economic Capital Ratio": "2.4%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.023615220816137386,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001746563.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001746563.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001746563.svg"
},
{
"company_id": "0001078799",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001078799.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001078799.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001078799.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001078799_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001078799_main_keyfigs.svg",
"name": "Marijuana Co of America Inc",
"rank": 47,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001078799.svg",
"report_text": "The relative strengths and weaknesses of Marijuana Co of America Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Marijuana Co of America Inc compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 2.1% points.The greatest weakness of Marijuana Co of America Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 61% points.
The company's Economic Capital Ratio, given in the ranking table, is 2.2%, being 144% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001078799_2021_Marijuana_Co_of_America_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "-0.411",
"Liabilities": "0.868",
"Stockholders Equity": "-38.4",
"ECR before LimitedLiability": "-122",
"Liabilities, Current": "1.08",
"Property, Plant and Equipment, Net": "-5.88",
"Assets": "-45.8",
"Other Assets": "0.660",
"Assets, Current": "-13.6",
"Goodwill": "-3.92",
"Assets, Non-Current": "-2.32",
"Other Expenses": "0.434",
"Expenses": "0.622",
"Revenues": "-3.74",
"Net Income": "-37.0",
"Research and Development": "0.457",
"General and Administrative Expense": "-0.258",
"Other Revenues": "-3.74",
"Comprehensive Net Income": "-36.8",
"Other Net Income": "-24.3",
"Economic Capital Ratio": "-143"
},
"2019": {
"Liabilities, Non-Current": "-0.131",
"Liabilities": "0.134",
"Stockholders Equity": "-41.2",
"ECR before LimitedLiability": "-106",
"Other Liabilities": "-0.0783",
"Liabilities, Current": "0.135",
"Assets, Non-Current": "-0.931",
"Assets": "-45.7",
"Goodwill": "-1.16",
"Property, Plant and Equipment, Net": "-1.66",
"Other Assets": "0.101",
"Assets, Current": "-13.7",
"Research and Development": "0.0523",
"Expenses": "0.0919",
"Revenues": "-0.630",
"Net Income": "-11.1",
"Other Expenses": "0.0519",
"Other Revenues": "-0.630",
"Other Net Income": "-6.96",
"Comprehensive Net Income": "-11.0",
"Economic Capital Ratio": "-136"
},
"2020": {
"Liabilities, Current": "2.12",
"Liabilities": "1.74",
"Stockholders Equity": "-60.5",
"ECR before LimitedLiability": "-106",
"Liabilities, Non-Current": "-0.775",
"Goodwill": "-5.69",
"Assets": "-55.6",
"Other Assets": "2.04",
"Assets, Current": "-32.5",
"Assets, Non-Current": "-4.20",
"Property, Plant and Equipment, Net": "-8.19",
"Other Expenses": "-3.40",
"Expenses": "0.257",
"Revenues": "-4.52",
"Net Income": "-31.6",
"Research and Development": "0.500",
"General and Administrative Expense": "1.32",
"Other Revenues": "-4.52",
"Comprehensive Net Income": "-31.5",
"Other Net Income": "-15.7",
"Economic Capital Ratio": "-144"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001078799_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "1,497",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,062",
"Goodwill": "0",
"Liabilities, Current": "5,054",
"Liabilities, Non-Current": "0",
"Other Assets": "411",
"Other Compr. Net Income": "0",
"Other Expenses": "5.3",
"Other Liabilities": "0",
"Other Net Income": "-7,281",
"Other Revenues": "252",
"Property, Plant and Equipment, Net": "12",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,054",
"Assets": "1,920",
"Expenses": "4,067",
"Revenues": "252",
"Stockholders Equity": "-3,134",
"Net Income": "-11,096",
"Comprehensive Net Income": "-11,096",
"BaseVar": "9,287",
"ECR before LimitedLiability": "-441%",
"Economic Capital Ratio": "1.1%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "418",
"Assets, Non-Current": "0",
"General and Administrative Expense": "7,159",
"Goodwill": "0",
"Liabilities, Current": "11,745",
"Liabilities, Non-Current": "0",
"Other Assets": "719",
"Other Compr. Net Income": "0",
"Other Expenses": "7.3",
"Other Liabilities": "0",
"Other Net Income": "-13,710",
"Other Revenues": "695",
"Property, Plant and Equipment, Net": "7.5",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "11,745",
"Assets": "1,144",
"Expenses": "7,166",
"Revenues": "695",
"Stockholders Equity": "-10,601",
"Net Income": "-20,180",
"Comprehensive Net Income": "-20,180",
"BaseVar": "17,230",
"ECR before LimitedLiability": "-539%",
"Economic Capital Ratio": "0.13%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "538",
"Assets, Non-Current": "0",
"General and Administrative Expense": "1,703",
"Goodwill": "0",
"Liabilities, Current": "7,568",
"Liabilities, Non-Current": "0",
"Other Assets": "1,562",
"Other Compr. Net Income": "0",
"Other Expenses": "3,433",
"Other Liabilities": "0",
"Other Net Income": "-7,290",
"Other Revenues": "281",
"Property, Plant and Equipment, Net": "6.5",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,568",
"Assets": "2,106",
"Expenses": "5,136",
"Revenues": "281",
"Stockholders Equity": "-5,461",
"Net Income": "-12,145",
"Comprehensive Net Income": "-12,145",
"BaseVar": "11,191",
"ECR before LimitedLiability": "-406%",
"Economic Capital Ratio": "2.2%"
}
}
},
"top_rated": false,
"trend": 3.0,
"value": 0.021804505344719033,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001078799.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001078799.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001078799.svg"
},
{
"company_id": "0001691430",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001691430.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001691430.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001691430_main_keyfigs.svg",
"name": "Quanta INC",
"rank": 48,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001691430.svg",
"report_text": "The relative strengths and weaknesses of Quanta INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Quanta INC compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 0.054% points.The greatest weakness of Quanta INC is the variable Assets, reducing the Economic Capital Ratio by 64% points.
The company's Economic Capital Ratio, given in the ranking table, is 0.056%, being 146% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001691430_2021_Quanta_INC.pdf",
"shrinked_graph_json": {
"2019": {
"Liabilities, Non-Current": "-0.265",
"Liabilities": "-0.985",
"Stockholders Equity": "-14.8",
"ECR before LimitedLiability": "-106",
"Other Liabilities": "-0.315",
"Liabilities, Current": "-0.292",
"Assets, Non-Current": "-1.17",
"Assets": "-70.7",
"Goodwill": "-7.79",
"Property, Plant and Equipment, Net": "-3.70",
"Other Assets": "0.198",
"Assets, Current": "-34.5",
"Expenses": "-48.8",
"Revenues": "-0.762",
"Net Income": "-67.3",
"Other Expenses": "-1.99",
"General and Administrative Expense": "-25.2",
"Other Revenues": "-0.762",
"Other Net Income": "-0.154",
"Comprehensive Net Income": "-67.2",
"Economic Capital Ratio": "-135"
},
"2020": {
"Liabilities, Current": "0.0542",
"Liabilities": "0.0482",
"Stockholders Equity": "-37.4",
"ECR before LimitedLiability": "-108",
"Liabilities, Non-Current": "-0.0984",
"Other Liabilities": "0.0229",
"Goodwill": "-1.29",
"Assets": "-64.1",
"Other Assets": "0",
"Assets, Current": "-28.6",
"Assets, Non-Current": "-0.172",
"Property, Plant and Equipment, Net": "-1.46",
"Other Expenses": "-0.142",
"Expenses": "-1.38",
"Revenues": "-0.167",
"Net Income": "-21.1",
"General and Administrative Expense": "-0.445",
"Other Revenues": "-0.167",
"Comprehensive Net Income": "-21.1",
"Other Net Income": "-0.837",
"Economic Capital Ratio": "-146"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001691430_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "591",
"Assets, Non-Current": "333",
"General and Administrative Expense": "5,103",
"Goodwill": "0",
"Liabilities, Current": "705",
"Liabilities, Non-Current": "252",
"Other Assets": "34",
"Other Compr. Net Income": "0",
"Other Expenses": "1,302",
"Other Liabilities": "35",
"Other Net Income": "-300",
"Other Revenues": "1,269",
"Property, Plant and Equipment, Net": "313",
"Research and Development": "352"
},
"output_variables": {
"Liabilities": "993",
"Assets": "1,272",
"Expenses": "6,757",
"Revenues": "1,269",
"Stockholders Equity": "279",
"Net Income": "-5,787",
"Comprehensive Net Income": "-5,787",
"BaseVar": "5,295",
"ECR before LimitedLiability": "-477%",
"Economic Capital Ratio": "0.53%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "161",
"Assets, Non-Current": "362",
"General and Administrative Expense": "4,555",
"Goodwill": "0",
"Liabilities, Current": "2,603",
"Liabilities, Non-Current": "295",
"Other Assets": "17",
"Other Compr. Net Income": "0",
"Other Expenses": "1,537",
"Other Liabilities": "451",
"Other Net Income": "-2,779",
"Other Revenues": "1,158",
"Property, Plant and Equipment, Net": "201",
"Research and Development": "452"
},
"output_variables": {
"Liabilities": "3,349",
"Assets": "741",
"Expenses": "6,544",
"Revenues": "1,158",
"Stockholders Equity": "-2,608",
"Net Income": "-8,164",
"Comprehensive Net Income": "-8,164",
"BaseVar": "7,285",
"ECR before LimitedLiability": "-574%",
"Economic Capital Ratio": "0.056%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 0.0005583717966928419,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001691430.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001691430.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001691430.svg"
},
{
"company_id": "0001709542",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution_0001709542.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2020/graphs/IME_0001709542.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001709542.jpeg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001709542_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001709542_main_keyfigs.svg",
"name": "Electronic Servitor Publication Network Inc",
"rank": 49,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_0001709542.svg",
"report_text": "The relative strengths and weaknesses of Electronic Servitor Publication Network Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Electronic Servitor Publication Network Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 0.0000000085% points.The greatest weakness of Electronic Servitor Publication Network Inc is the variable Assets, reducing the Economic Capital Ratio by 84% points.
The company's Economic Capital Ratio, given in the ranking table, is 0.0000000085%, being 146% points below the market average of 146%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2020/report/0001709542_2021_Electronic_Servitor_Publication_Network_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "36.8",
"Liabilities": "39.3",
"Stockholders Equity": "-156",
"ECR before LimitedLiability": "-2.14",
"Other Liabilities": "30.6",
"Liabilities, Current": "3.97",
"Property, Plant and Equipment, Net": "-44.5",
"Assets": "-89.4",
"Other Assets": "97.8",
"Assets, Current": "-81.7",
"Goodwill": "-36.7",
"Assets, Non-Current": "-27.9",
"Other Expenses": "-10.8",
"Expenses": "-70.2",
"Revenues": "83.8",
"Net Income": "52.3",
"Research and Development": "36.6",
"General and Administrative Expense": "-93.3",
"Other Revenues": "83.8",
"Comprehensive Net Income": "52.5",
"Economic Capital Ratio": "-22.6"
},
"2019": {
"Liabilities, Non-Current": "-1.25",
"Liabilities": "-1.80",
"Stockholders Equity": "-126",
"ECR before LimitedLiability": "-96.9",
"Other Liabilities": "-0.863",
"Assets, Non-Current": "-34.1",
"Assets": "-133",
"Goodwill": "-38.3",
"Property, Plant and Equipment, Net": "-45.7",
"Other Assets": "9.56",
"Assets, Current": "-77.1",
"Research and Development": "4.92",
"Expenses": "-74.2",
"Revenues": "9.29",
"Net Income": "-15.8",
"Other Expenses": "-49.6",
"General and Administrative Expense": "-38.4",
"Other Revenues": "9.29",
"Other Net Income": "2.06",
"Comprehensive Net Income": "-15.7",
"Economic Capital Ratio": "-126"
},
"2020": {
"Liabilities, Current": "0",
"Liabilities": "-0.0155",
"ECR before LimitedLiability": "-108",
"Liabilities, Non-Current": "0",
"Other Liabilities": "0",
"Goodwill": "-0.0838",
"Assets": "-83.6",
"Stockholders Equity": "-1.90",
"Other Assets": "0",
"Assets, Current": "-51.9",
"Assets, Non-Current": "-0.0159",
"Property, Plant and Equipment, Net": "-0.519",
"Other Expenses": "-73.2",
"Expenses": "-56.9",
"Net Income": "-23.3",
"Research and Development": "0",
"Other Revenues": "0",
"Revenues": "0",
"Comprehensive Net Income": "-23.1",
"Other Net Income": "0",
"Economic Capital Ratio": "-146"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/plot_over_time/0001709542_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "611",
"Goodwill": "0",
"Liabilities, Current": "170",
"Liabilities, Non-Current": "0",
"Other Assets": "205",
"Other Compr. Net Income": "0",
"Other Expenses": "109",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "745",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "170",
"Assets": "205",
"Expenses": "720",
"Revenues": "745",
"Stockholders Equity": "35",
"Net Income": "25",
"Comprehensive Net Income": "25",
"BaseVar": "920",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "121%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "730",
"Goodwill": "0",
"Liabilities, Current": "200",
"Liabilities, Non-Current": "0",
"Other Assets": "137",
"Other Compr. Net Income": "0",
"Other Expenses": "395",
"Other Liabilities": "0",
"Other Net Income": "-4.5",
"Other Revenues": "686",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "200",
"Assets": "137",
"Expenses": "1,125",
"Revenues": "686",
"Stockholders Equity": "-62",
"Net Income": "-443",
"Comprehensive Net Income": "-443",
"BaseVar": "1,076",
"ECR before LimitedLiability": "-313%",
"Economic Capital Ratio": "9.6%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "0",
"General and Administrative Expense": "1,068",
"Goodwill": "0",
"Liabilities, Current": "335",
"Liabilities, Non-Current": "0",
"Other Assets": "257",
"Other Compr. Net Income": "0",
"Other Expenses": "2,966",
"Other Liabilities": "0",
"Other Net Income": "-15",
"Other Revenues": "1,138",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "335",
"Assets": "257",
"Expenses": "4,034",
"Revenues": "1,138",
"Stockholders Equity": "-78",
"Net Income": "-2,911",
"Comprehensive Net Income": "-2,911",
"BaseVar": "2,890",
"ECR before LimitedLiability": "-1,018%",
"Economic Capital Ratio": "0.0000000085%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 8.478040723170004e-11,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2020/industry_indexes/0001709542.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/equity/0001709542.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2020/analytics/profit_loss/0001709542.svg"
}
],
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_distribution/feature_distribution.svg",
"final_var_label": "Economic Capital Ratio",
"industry_box": [
[
"Revenues",
"33.7 B"
],
[
"Assets",
"65.1 B"
],
[
"Expenses",
"34.9 B"
],
[
"Stockholders Equity",
"30.1 B"
]
],
"industry_id": "us_medicinal_products",
"industry_label": "Medicinal Products",
"num_companies": 49,
"num_top_companies": 12,
"ecr_records": {
"2009": {
"0000794172": {
"rank": 1,
"ecr": "278"
},
"0000037785": {
"rank": 2,
"ecr": "225"
},
"0001056358": {
"rank": 3,
"ecr": "145"
}
},
"2010": {
"0000899923": {
"rank": 1,
"ecr": "304"
},
"0000794172": {
"rank": 2,
"ecr": "279"
},
"0000037785": {
"rank": 3,
"ecr": "209"
},
"0000874716": {
"rank": 4,
"ecr": "203"
},
"0001056358": {
"rank": 5,
"ecr": "150"
},
"0000074303": {
"rank": 6,
"ecr": "149"
},
"0001315695": {
"rank": 7,
"ecr": "132"
},
"0001145460": {
"rank": 8,
"ecr": "130"
},
"0001307954": {
"rank": 9,
"ecr": "115"
},
"0000722104": {
"rank": 10,
"ecr": "102"
}
},
"2011": {
"0000885462": {
"rank": 1,
"ecr": "287"
},
"0000899923": {
"rank": 2,
"ecr": "285"
},
"0000794172": {
"rank": 3,
"ecr": "276"
},
"0000736822": {
"rank": 4,
"ecr": "270"
},
"0000787253": {
"rank": 5,
"ecr": "256"
},
"0000711377": {
"rank": 6,
"ecr": "253"
},
"0000353569": {
"rank": 7,
"ecr": "250"
},
"0000768408": {
"rank": 8,
"ecr": "238"
},
"0000896264": {
"rank": 9,
"ecr": "235"
},
"0000811641": {
"rank": 10,
"ecr": "224"
},
"0000037785": {
"rank": 11,
"ecr": "221"
},
"0001054905": {
"rank": 12,
"ecr": "219"
},
"0001086303": {
"rank": 13,
"ecr": "216"
},
"0000810509": {
"rank": 14,
"ecr": "213"
},
"0001050007": {
"rank": 15,
"ecr": "208"
},
"0001374328": {
"rank": 16,
"ecr": "199"
},
"0000722830": {
"rank": 17,
"ecr": "183"
},
"0000874716": {
"rank": 18,
"ecr": "180"
},
"0000722104": {
"rank": 19,
"ecr": "176"
},
"0001063665": {
"rank": 20,
"ecr": "175"
},
"0001141240": {
"rank": 21,
"ecr": "168"
},
"0000074303": {
"rank": 22,
"ecr": "154"
},
"0000744218": {
"rank": 23,
"ecr": "152"
},
"0001315695": {
"rank": 24,
"ecr": "148"
},
"0001407038": {
"rank": 25,
"ecr": "146"
},
"0000949858": {
"rank": 26,
"ecr": "132"
},
"0001145460": {
"rank": 27,
"ecr": "127"
},
"0001307954": {
"rank": 28,
"ecr": "115"
},
"0001056358": {
"rank": 29,
"ecr": "104"
},
"0001402785": {
"rank": 30,
"ecr": "85"
},
"0000926617": {
"rank": 31,
"ecr": "84"
},
"0001124608": {
"rank": 32,
"ecr": "80"
},
"0001346526": {
"rank": 33,
"ecr": "80"
},
"0001386570": {
"rank": 34,
"ecr": "73"
},
"0000776008": {
"rank": 35,
"ecr": "34"
},
"0001037649": {
"rank": 36,
"ecr": "24"
},
"0001310630": {
"rank": 37,
"ecr": "20"
},
"0001119643": {
"rank": 38,
"ecr": "0.99"
},
"0001134765": {
"rank": 39,
"ecr": "0.077"
},
"0000880242": {
"rank": 40,
"ecr": "0.028"
},
"0000907654": {
"rank": 41,
"ecr": "0.0000000000000000000015"
}
},
"2012": {
"0000899923": {
"rank": 1,
"ecr": "282"
},
"0000885462": {
"rank": 2,
"ecr": "278"
},
"0000794172": {
"rank": 3,
"ecr": "275"
},
"0000073290": {
"rank": 4,
"ecr": "263"
},
"0000009326": {
"rank": 5,
"ecr": "260"
},
"0000353569": {
"rank": 6,
"ecr": "256"
},
"0000711377": {
"rank": 7,
"ecr": "254"
},
"0000787253": {
"rank": 8,
"ecr": "246"
},
"0000768408": {
"rank": 9,
"ecr": "245"
},
"0000722830": {
"rank": 10,
"ecr": "240"
},
"0001374328": {
"rank": 11,
"ecr": "239"
},
"0000896264": {
"rank": 12,
"ecr": "234"
},
"0000811641": {
"rank": 13,
"ecr": "233"
},
"0001054905": {
"rank": 14,
"ecr": "232"
},
"0000037785": {
"rank": 15,
"ecr": "219"
},
"0001086303": {
"rank": 16,
"ecr": "211"
},
"0001050007": {
"rank": 17,
"ecr": "209"
},
"0001510518": {
"rank": 18,
"ecr": "204"
},
"0001063665": {
"rank": 19,
"ecr": "199"
},
"0000949858": {
"rank": 20,
"ecr": "196"
},
"0001028215": {
"rank": 21,
"ecr": "194"
},
"0000874716": {
"rank": 22,
"ecr": "191"
},
"0000744218": {
"rank": 23,
"ecr": "163"
},
"0001056358": {
"rank": 24,
"ecr": "146"
},
"0001124608": {
"rank": 25,
"ecr": "146"
},
"0001134765": {
"rank": 26,
"ecr": "144"
},
"0000074303": {
"rank": 27,
"ecr": "142"
},
"0001315695": {
"rank": 28,
"ecr": "138"
},
"0000776008": {
"rank": 29,
"ecr": "137"
},
"0001145460": {
"rank": 30,
"ecr": "129"
},
"0001307954": {
"rank": 31,
"ecr": "118"
},
"0000722104": {
"rank": 32,
"ecr": "87"
},
"0000926617": {
"rank": 33,
"ecr": "84"
},
"0001346526": {
"rank": 34,
"ecr": "77"
},
"0001386570": {
"rank": 35,
"ecr": "72"
},
"0001407038": {
"rank": 36,
"ecr": "50"
},
"0000093314": {
"rank": 37,
"ecr": "46"
},
"0001141240": {
"rank": 38,
"ecr": "46"
},
"0001037649": {
"rank": 39,
"ecr": "23"
},
"0000810509": {
"rank": 40,
"ecr": "22"
},
"0001402785": {
"rank": 41,
"ecr": "21"
},
"0001310630": {
"rank": 42,
"ecr": "18"
},
"0001119643": {
"rank": 43,
"ecr": "2.1"
},
"0001142790": {
"rank": 44,
"ecr": "0.0000013"
}
},
"2013": {
"0000907654": {
"rank": 1,
"ecr": "474"
},
"0000885462": {
"rank": 2,
"ecr": "283"
},
"0000899923": {
"rank": 3,
"ecr": "279"
},
"0000794172": {
"rank": 4,
"ecr": "273"
},
"0000073290": {
"rank": 5,
"ecr": "268"
},
"0000009326": {
"rank": 6,
"ecr": "261"
},
"0000711377": {
"rank": 7,
"ecr": "261"
},
"0000353569": {
"rank": 8,
"ecr": "259"
},
"0000811641": {
"rank": 9,
"ecr": "240"
},
"0001054905": {
"rank": 10,
"ecr": "235"
},
"0000896264": {
"rank": 11,
"ecr": "231"
},
"0001063665": {
"rank": 12,
"ecr": "229"
},
"0000744218": {
"rank": 13,
"ecr": "228"
},
"0000768408": {
"rank": 14,
"ecr": "216"
},
"0001050007": {
"rank": 15,
"ecr": "212"
},
"0000722830": {
"rank": 16,
"ecr": "211"
},
"0000926617": {
"rank": 17,
"ecr": "209"
},
"0000037785": {
"rank": 18,
"ecr": "191"
},
"0001324736": {
"rank": 19,
"ecr": "185"
},
"0001374328": {
"rank": 20,
"ecr": "179"
},
"0000874716": {
"rank": 21,
"ecr": "162"
},
"0001086303": {
"rank": 22,
"ecr": "158"
},
"0001028215": {
"rank": 23,
"ecr": "156"
},
"0001056358": {
"rank": 24,
"ecr": "153"
},
"0000074303": {
"rank": 25,
"ecr": "150"
},
"0001578932": {
"rank": 26,
"ecr": "145"
},
"0001386570": {
"rank": 27,
"ecr": "144"
},
"0001124608": {
"rank": 28,
"ecr": "138"
},
"0000949858": {
"rank": 29,
"ecr": "131"
},
"0000736822": {
"rank": 30,
"ecr": "130"
},
"0001145460": {
"rank": 31,
"ecr": "127"
},
"0001307954": {
"rank": 32,
"ecr": "121"
},
"0001566978": {
"rank": 33,
"ecr": "117"
},
"0001037649": {
"rank": 34,
"ecr": "86"
},
"0001134765": {
"rank": 35,
"ecr": "83"
},
"0001510518": {
"rank": 36,
"ecr": "79"
},
"0000810509": {
"rank": 37,
"ecr": "63"
},
"0001346526": {
"rank": 38,
"ecr": "56"
},
"0000093314": {
"rank": 39,
"ecr": "49"
},
"0001407038": {
"rank": 40,
"ecr": "43"
},
"0001310630": {
"rank": 41,
"ecr": "16"
},
"0000776008": {
"rank": 42,
"ecr": "9.7"
},
"0001141240": {
"rank": 43,
"ecr": "7.6"
},
"0001569737": {
"rank": 44,
"ecr": "6.5"
},
"0001402785": {
"rank": 45,
"ecr": "5.0"
},
"0001504678": {
"rank": 46,
"ecr": "0.42"
},
"0000880242": {
"rank": 47,
"ecr": "0.000030"
}
},
"2014": {
"0000885462": {
"rank": 1,
"ecr": "284"
},
"0000794172": {
"rank": 2,
"ecr": "282"
},
"0000899923": {
"rank": 3,
"ecr": "271"
},
"0000711377": {
"rank": 4,
"ecr": "259"
},
"0000353569": {
"rank": 5,
"ecr": "256"
},
"0000073290": {
"rank": 6,
"ecr": "252"
},
"0001086303": {
"rank": 7,
"ecr": "237"
},
"0000811641": {
"rank": 8,
"ecr": "231"
},
"0000787253": {
"rank": 9,
"ecr": "230"
},
"0001054905": {
"rank": 10,
"ecr": "229"
},
"0001321834": {
"rank": 11,
"ecr": "225"
},
"0001374328": {
"rank": 12,
"ecr": "210"
},
"0001050007": {
"rank": 13,
"ecr": "206"
},
"0000768408": {
"rank": 14,
"ecr": "195"
},
"0000037785": {
"rank": 15,
"ecr": "192"
},
"0000907654": {
"rank": 16,
"ecr": "181"
},
"0000744218": {
"rank": 17,
"ecr": "181"
},
"0001056358": {
"rank": 18,
"ecr": "165"
},
"0000009326": {
"rank": 19,
"ecr": "160"
},
"0001028215": {
"rank": 20,
"ecr": "158"
},
"0000722830": {
"rank": 21,
"ecr": "148"
},
"0001578932": {
"rank": 22,
"ecr": "142"
},
"0001141240": {
"rank": 23,
"ecr": "142"
},
"0000074303": {
"rank": 24,
"ecr": "141"
},
"0000949858": {
"rank": 25,
"ecr": "132"
},
"0000926617": {
"rank": 26,
"ecr": "129"
},
"0001145460": {
"rank": 27,
"ecr": "125"
},
"0000736822": {
"rank": 28,
"ecr": "112"
},
"0001307954": {
"rank": 29,
"ecr": "111"
},
"0000874716": {
"rank": 30,
"ecr": "109"
},
"0001045309": {
"rank": 31,
"ecr": "103"
},
"0001566978": {
"rank": 32,
"ecr": "98"
},
"0001037649": {
"rank": 33,
"ecr": "85"
},
"0001590695": {
"rank": 34,
"ecr": "77"
},
"0001134765": {
"rank": 35,
"ecr": "67"
},
"0001346526": {
"rank": 36,
"ecr": "67"
},
"0001124608": {
"rank": 37,
"ecr": "65"
},
"0001407038": {
"rank": 38,
"ecr": "52"
},
"0000093314": {
"rank": 39,
"ecr": "24"
},
"0000810509": {
"rank": 40,
"ecr": "20"
},
"0001408299": {
"rank": 41,
"ecr": "18"
},
"0001310630": {
"rank": 42,
"ecr": "15"
},
"0001119643": {
"rank": 43,
"ecr": "6.4"
},
"0001569737": {
"rank": 44,
"ecr": "5.9"
},
"0001402785": {
"rank": 45,
"ecr": "5.6"
},
"0000776008": {
"rank": 46,
"ecr": "3.9"
},
"0000880242": {
"rank": 47,
"ecr": "0.00000029"
},
"0001562733": {
"rank": 48,
"ecr": "0.00000012"
}
},
"2015": {
"0000794172": {
"rank": 1,
"ecr": "279"
},
"0000885462": {
"rank": 2,
"ecr": "278"
},
"0000711377": {
"rank": 3,
"ecr": "261"
},
"0000353569": {
"rank": 4,
"ecr": "258"
},
"0000899923": {
"rank": 5,
"ecr": "253"
},
"0000073290": {
"rank": 6,
"ecr": "249"
},
"0001054905": {
"rank": 7,
"ecr": "236"
},
"0000787253": {
"rank": 8,
"ecr": "234"
},
"0000907654": {
"rank": 9,
"ecr": "234"
},
"0000037785": {
"rank": 10,
"ecr": "223"
},
"0001050007": {
"rank": 11,
"ecr": "219"
},
"0000896264": {
"rank": 12,
"ecr": "219"
},
"0000811641": {
"rank": 13,
"ecr": "214"
},
"0001038133": {
"rank": 14,
"ecr": "210"
},
"0000768408": {
"rank": 15,
"ecr": "199"
},
"0000744218": {
"rank": 16,
"ecr": "195"
},
"0000722830": {
"rank": 17,
"ecr": "192"
},
"0001056358": {
"rank": 18,
"ecr": "181"
},
"0001324736": {
"rank": 19,
"ecr": "176"
},
"0000009326": {
"rank": 20,
"ecr": "173"
},
"0001374328": {
"rank": 21,
"ecr": "169"
},
"0001028215": {
"rank": 22,
"ecr": "166"
},
"0000949858": {
"rank": 23,
"ecr": "159"
},
"0001562733": {
"rank": 24,
"ecr": "141"
},
"0001578932": {
"rank": 25,
"ecr": "139"
},
"0001569737": {
"rank": 26,
"ecr": "132"
},
"0000926617": {
"rank": 27,
"ecr": "122"
},
"0000074303": {
"rank": 28,
"ecr": "121"
},
"0000736822": {
"rank": 29,
"ecr": "113"
},
"0001566978": {
"rank": 30,
"ecr": "98"
},
"0001045309": {
"rank": 31,
"ecr": "96"
},
"0000874716": {
"rank": 32,
"ecr": "89"
},
"0001627223": {
"rank": 33,
"ecr": "85"
},
"0001141240": {
"rank": 34,
"ecr": "83"
},
"0001590695": {
"rank": 35,
"ecr": "81"
},
"0000776008": {
"rank": 36,
"ecr": "72"
},
"0000093314": {
"rank": 37,
"ecr": "65"
},
"0001134765": {
"rank": 38,
"ecr": "54"
},
"0001037649": {
"rank": 39,
"ecr": "53"
},
"0001498380": {
"rank": 40,
"ecr": "46"
},
"0000810509": {
"rank": 41,
"ecr": "23"
},
"0000880242": {
"rank": 42,
"ecr": "18"
},
"0001310630": {
"rank": 43,
"ecr": "15"
},
"0001598323": {
"rank": 44,
"ecr": "14"
},
"0001402785": {
"rank": 45,
"ecr": "12"
},
"0001552189": {
"rank": 46,
"ecr": "4.1"
},
"0001408299": {
"rank": 47,
"ecr": "2.6"
},
"0001119643": {
"rank": 48,
"ecr": "0.59"
},
"0001142790": {
"rank": 49,
"ecr": "0.0029"
}
},
"2016": {
"0000885462": {
"rank": 1,
"ecr": "281"
},
"0000711377": {
"rank": 2,
"ecr": "262"
},
"0000899923": {
"rank": 3,
"ecr": "254"
},
"0000353569": {
"rank": 4,
"ecr": "252"
},
"0001054905": {
"rank": 5,
"ecr": "243"
},
"0001652130": {
"rank": 6,
"ecr": "237"
},
"0001351573": {
"rank": 7,
"ecr": "231"
},
"0000811641": {
"rank": 8,
"ecr": "225"
},
"0000073290": {
"rank": 9,
"ecr": "222"
},
"0000896264": {
"rank": 10,
"ecr": "222"
},
"0000787253": {
"rank": 11,
"ecr": "218"
},
"0000037785": {
"rank": 12,
"ecr": "218"
},
"0001050007": {
"rank": 13,
"ecr": "214"
},
"0001141240": {
"rank": 14,
"ecr": "212"
},
"0000794172": {
"rank": 15,
"ecr": "204"
},
"0001038133": {
"rank": 16,
"ecr": "201"
},
"0001374328": {
"rank": 17,
"ecr": "198"
},
"0001028215": {
"rank": 18,
"ecr": "188"
},
"0000093314": {
"rank": 19,
"ecr": "182"
},
"0000009326": {
"rank": 20,
"ecr": "176"
},
"0000907654": {
"rank": 21,
"ecr": "170"
},
"0001056358": {
"rank": 22,
"ecr": "170"
},
"0000744218": {
"rank": 23,
"ecr": "163"
},
"0000768408": {
"rank": 24,
"ecr": "161"
},
"0000074303": {
"rank": 25,
"ecr": "121"
},
"0001552189": {
"rank": 26,
"ecr": "116"
},
"0000949858": {
"rank": 27,
"ecr": "115"
},
"0001653477": {
"rank": 28,
"ecr": "112"
},
"0001578932": {
"rank": 29,
"ecr": "110"
},
"0001642380": {
"rank": 30,
"ecr": "107"
},
"0001045309": {
"rank": 31,
"ecr": "106"
},
"0000874716": {
"rank": 32,
"ecr": "89"
},
"0001627223": {
"rank": 33,
"ecr": "87"
},
"0001590695": {
"rank": 34,
"ecr": "87"
},
"0000722830": {
"rank": 35,
"ecr": "85"
},
"0001644440": {
"rank": 36,
"ecr": "84"
},
"0001504678": {
"rank": 37,
"ecr": "80"
},
"0001134765": {
"rank": 38,
"ecr": "55"
},
"0000926617": {
"rank": 39,
"ecr": "48"
},
"0001037649": {
"rank": 40,
"ecr": "30"
},
"0000810509": {
"rank": 41,
"ecr": "26"
},
"0001310630": {
"rank": 42,
"ecr": "16"
},
"0001408299": {
"rank": 43,
"ecr": "13"
},
"0001498380": {
"rank": 44,
"ecr": "4.1"
},
"0001586554": {
"rank": 45,
"ecr": "2.3"
}
},
"2017": {
"0000810509": {
"rank": 1,
"ecr": "620"
},
"0000885462": {
"rank": 2,
"ecr": "284"
},
"0000711377": {
"rank": 3,
"ecr": "260"
},
"0000787253": {
"rank": 4,
"ecr": "246"
},
"0001141240": {
"rank": 5,
"ecr": "243"
},
"0001054905": {
"rank": 6,
"ecr": "235"
},
"0001652130": {
"rank": 7,
"ecr": "234"
},
"0000073290": {
"rank": 8,
"ecr": "227"
},
"0000037785": {
"rank": 9,
"ecr": "221"
},
"0000896264": {
"rank": 10,
"ecr": "219"
},
"0001038133": {
"rank": 11,
"ecr": "216"
},
"0000794172": {
"rank": 12,
"ecr": "204"
},
"0000009326": {
"rank": 13,
"ecr": "197"
},
"0000811641": {
"rank": 14,
"ecr": "197"
},
"0001697834": {
"rank": 15,
"ecr": "190"
},
"0000899923": {
"rank": 16,
"ecr": "188"
},
"0000744218": {
"rank": 17,
"ecr": "179"
},
"0001351573": {
"rank": 18,
"ecr": "171"
},
"0000768408": {
"rank": 19,
"ecr": "170"
},
"0001056358": {
"rank": 20,
"ecr": "167"
},
"0001644440": {
"rank": 21,
"ecr": "158"
},
"0001522767": {
"rank": 22,
"ecr": "145"
},
"0001653477": {
"rank": 23,
"ecr": "143"
},
"0001708035": {
"rank": 24,
"ecr": "142"
},
"0001606645": {
"rank": 25,
"ecr": "139"
},
"0000074303": {
"rank": 26,
"ecr": "133"
},
"0001578932": {
"rank": 27,
"ecr": "121"
},
"0001028215": {
"rank": 28,
"ecr": "119"
},
"0001627223": {
"rank": 29,
"ecr": "112"
},
"0001045309": {
"rank": 30,
"ecr": "97"
},
"0000874716": {
"rank": 31,
"ecr": "95"
},
"0000949858": {
"rank": 32,
"ecr": "88"
},
"0000093314": {
"rank": 33,
"ecr": "84"
},
"0001632275": {
"rank": 34,
"ecr": "79"
},
"0000907654": {
"rank": 35,
"ecr": "78"
},
"0001590695": {
"rank": 36,
"ecr": "74"
},
"0000926617": {
"rank": 37,
"ecr": "68"
},
"0000722830": {
"rank": 38,
"ecr": "61"
},
"0001374328": {
"rank": 39,
"ecr": "57"
},
"0001642380": {
"rank": 40,
"ecr": "45"
},
"0001134765": {
"rank": 41,
"ecr": "18"
},
"0001310630": {
"rank": 42,
"ecr": "15"
},
"0001119643": {
"rank": 43,
"ecr": "4.1"
},
"0001498380": {
"rank": 44,
"ecr": "2.6"
}
},
"2018": {
"0000711377": {
"rank": 1,
"ecr": "268"
},
"0001742924": {
"rank": 2,
"ecr": "250"
},
"0001141240": {
"rank": 3,
"ecr": "248"
},
"0000885462": {
"rank": 4,
"ecr": "244"
},
"0000899923": {
"rank": 5,
"ecr": "242"
},
"0000787253": {
"rank": 6,
"ecr": "230"
},
"0000896264": {
"rank": 7,
"ecr": "230"
},
"0001054905": {
"rank": 8,
"ecr": "228"
},
"0001038133": {
"rank": 9,
"ecr": "223"
},
"0001652130": {
"rank": 10,
"ecr": "216"
},
"0001522767": {
"rank": 11,
"ecr": "213"
},
"0000794172": {
"rank": 12,
"ecr": "209"
},
"0000037785": {
"rank": 13,
"ecr": "204"
},
"0000073290": {
"rank": 14,
"ecr": "198"
},
"0000811641": {
"rank": 15,
"ecr": "185"
},
"0000768408": {
"rank": 16,
"ecr": "185"
},
"0001028215": {
"rank": 17,
"ecr": "171"
},
"0001606645": {
"rank": 18,
"ecr": "161"
},
"0000949858": {
"rank": 19,
"ecr": "154"
},
"0001374328": {
"rank": 20,
"ecr": "152"
},
"0001708035": {
"rank": 21,
"ecr": "143"
},
"0001307954": {
"rank": 22,
"ecr": "141"
},
"0001644440": {
"rank": 23,
"ecr": "141"
},
"0001142790": {
"rank": 24,
"ecr": "139"
},
"0001056358": {
"rank": 25,
"ecr": "139"
},
"0001653477": {
"rank": 26,
"ecr": "135"
},
"0000074303": {
"rank": 27,
"ecr": "132"
},
"0001586554": {
"rank": 28,
"ecr": "132"
},
"0001697834": {
"rank": 29,
"ecr": "125"
},
"0001709542": {
"rank": 30,
"ecr": "121"
},
"0001731348": {
"rank": 31,
"ecr": "119"
},
"0001627223": {
"rank": 32,
"ecr": "117"
},
"0000874716": {
"rank": 33,
"ecr": "107"
},
"0000744218": {
"rank": 34,
"ecr": "104"
},
"0001045309": {
"rank": 35,
"ecr": "103"
},
"0000907654": {
"rank": 36,
"ecr": "93"
},
"0000093314": {
"rank": 37,
"ecr": "84"
},
"0000926617": {
"rank": 38,
"ecr": "84"
},
"0001321834": {
"rank": 39,
"ecr": "83"
},
"0001590695": {
"rank": 40,
"ecr": "72"
},
"0001632275": {
"rank": 41,
"ecr": "33"
},
"0000810509": {
"rank": 42,
"ecr": "29"
},
"0001134765": {
"rank": 43,
"ecr": "18"
},
"0001086303": {
"rank": 44,
"ecr": "8.3"
},
"0001078799": {
"rank": 45,
"ecr": "1.1"
},
"0001498380": {
"rank": 46,
"ecr": "0.97"
}
},
"2019": {
"0000711377": {
"rank": 1,
"ecr": "269"
},
"0000885462": {
"rank": 2,
"ecr": "252"
},
"0001141240": {
"rank": 3,
"ecr": "247"
},
"0000787253": {
"rank": 4,
"ecr": "243"
},
"0001054905": {
"rank": 5,
"ecr": "230"
},
"0000896264": {
"rank": 6,
"ecr": "228"
},
"0001652130": {
"rank": 7,
"ecr": "213"
},
"0000037785": {
"rank": 8,
"ecr": "209"
},
"0000811641": {
"rank": 9,
"ecr": "207"
},
"0001374328": {
"rank": 10,
"ecr": "205"
},
"0000899923": {
"rank": 11,
"ecr": "199"
},
"0001321834": {
"rank": 12,
"ecr": "196"
},
"0000009326": {
"rank": 13,
"ecr": "195"
},
"0001742924": {
"rank": 14,
"ecr": "192"
},
"0001038133": {
"rank": 15,
"ecr": "185"
},
"0000794172": {
"rank": 16,
"ecr": "184"
},
"0001351573": {
"rank": 17,
"ecr": "183"
},
"0000907654": {
"rank": 18,
"ecr": "171"
},
"0000744218": {
"rank": 19,
"ecr": "170"
},
"0000073290": {
"rank": 20,
"ecr": "163"
},
"0001056358": {
"rank": 21,
"ecr": "155"
},
"0001642380": {
"rank": 22,
"ecr": "154"
},
"0001644440": {
"rank": 23,
"ecr": "151"
},
"0000768408": {
"rank": 24,
"ecr": "150"
},
"0001708035": {
"rank": 25,
"ecr": "149"
},
"0000949858": {
"rank": 26,
"ecr": "145"
},
"0001307954": {
"rank": 27,
"ecr": "141"
},
"0001653477": {
"rank": 28,
"ecr": "129"
},
"0000074303": {
"rank": 29,
"ecr": "122"
},
"0000874716": {
"rank": 30,
"ecr": "120"
},
"0001731348": {
"rank": 31,
"ecr": "117"
},
"0001586554": {
"rank": 32,
"ecr": "109"
},
"0001045309": {
"rank": 33,
"ecr": "102"
},
"0001697834": {
"rank": 34,
"ecr": "101"
},
"0001627223": {
"rank": 35,
"ecr": "99"
},
"0000722830": {
"rank": 36,
"ecr": "86"
},
"0001632275": {
"rank": 37,
"ecr": "84"
},
"0001386570": {
"rank": 38,
"ecr": "84"
},
"0000926617": {
"rank": 39,
"ecr": "82"
},
"0001134765": {
"rank": 40,
"ecr": "79"
},
"0001552189": {
"rank": 41,
"ecr": "77"
},
"0001606645": {
"rank": 42,
"ecr": "68"
},
"0001522767": {
"rank": 43,
"ecr": "60"
},
"0001590695": {
"rank": 44,
"ecr": "28"
},
"0001510518": {
"rank": 45,
"ecr": "19"
},
"0000810509": {
"rank": 46,
"ecr": "18"
},
"0001310630": {
"rank": 47,
"ecr": "10"
},
"0001709542": {
"rank": 48,
"ecr": "9.6"
},
"0001691430": {
"rank": 49,
"ecr": "0.53"
},
"0001078799": {
"rank": 50,
"ecr": "0.13"
}
},
"2020": {
"0000885462": {
"rank": 1,
"ecr": "267"
},
"0001141240": {
"rank": 2,
"ecr": "265"
},
"0000711377": {
"rank": 3,
"ecr": "265"
},
"0001374328": {
"rank": 4,
"ecr": "259"
},
"0001656472": {
"rank": 5,
"ecr": "243"
},
"0000907654": {
"rank": 6,
"ecr": "234"
},
"0001054905": {
"rank": 7,
"ecr": "231"
},
"0001652130": {
"rank": 8,
"ecr": "228"
},
"0000073290": {
"rank": 9,
"ecr": "214"
},
"0000949858": {
"rank": 10,
"ecr": "213"
},
"0000037785": {
"rank": 11,
"ecr": "211"
},
"0000009326": {
"rank": 12,
"ecr": "210"
},
"0001321834": {
"rank": 13,
"ecr": "203"
},
"0001038133": {
"rank": 14,
"ecr": "202"
},
"0000744218": {
"rank": 15,
"ecr": "202"
},
"0001731348": {
"rank": 16,
"ecr": "201"
},
"0000811641": {
"rank": 17,
"ecr": "197"
},
"0000794172": {
"rank": 18,
"ecr": "193"
},
"0001737927": {
"rank": 19,
"ecr": "193"
},
"0001742924": {
"rank": 20,
"ecr": "179"
},
"0000787253": {
"rank": 21,
"ecr": "177"
},
"0000768408": {
"rank": 22,
"ecr": "163"
},
"0001644440": {
"rank": 23,
"ecr": "162"
},
"0001307954": {
"rank": 24,
"ecr": "160"
},
"0001056358": {
"rank": 25,
"ecr": "154"
},
"0001697834": {
"rank": 26,
"ecr": "153"
},
"0000874716": {
"rank": 27,
"ecr": "148"
},
"0001310630": {
"rank": 28,
"ecr": "141"
},
"0001708035": {
"rank": 29,
"ecr": "136"
},
"0001653477": {
"rank": 30,
"ecr": "132"
},
"0001522767": {
"rank": 31,
"ecr": "132"
},
"0001627223": {
"rank": 32,
"ecr": "104"
},
"0000074303": {
"rank": 33,
"ecr": "98"
},
"0000093314": {
"rank": 34,
"ecr": "95"
},
"0001386570": {
"rank": 35,
"ecr": "93"
},
"0001045309": {
"rank": 36,
"ecr": "93"
},
"0001351573": {
"rank": 37,
"ecr": "84"
},
"0000926617": {
"rank": 38,
"ecr": "83"
},
"0001596946": {
"rank": 39,
"ecr": "80"
},
"0001421819": {
"rank": 40,
"ecr": "74"
},
"0001586554": {
"rank": 41,
"ecr": "73"
},
"0000810509": {
"rank": 42,
"ecr": "62"
},
"0001632275": {
"rank": 43,
"ecr": "50"
},
"0001134765": {
"rank": 44,
"ecr": "47"
},
"0001590695": {
"rank": 45,
"ecr": "41"
},
"0001746563": {
"rank": 46,
"ecr": "2.4"
},
"0001078799": {
"rank": 47,
"ecr": "2.2"
},
"0001691430": {
"rank": 48,
"ecr": "0.056"
},
"0001709542": {
"rank": 49,
"ecr": "0.0000000085"
}
}
},
"rating_box": [
[
"Top rated",
"12 of 49"
],
[
"Best, worst rating",
"267 %, < 0.001 %"
],
[
"New companies",
"6"
]
],
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2020/backtesting_correlation/regression_2020.svg",
"scentences": [
"China Foods Holdings Ltd climbed 19 positions from 47 to 28 due to its excellent Liabilities, Non-Current.",
"Pure Harvest Corporate Group Inc lost 20 positions from 17 to 37 due to its bad Liabilities.",
"Cronos Group Inc entered the 2021 ranking at rank 5, making it the best newcomer."
],
"url_segment": "2021-us-medicinal-products",
"year": 2021,
"feature_importance": "https://www.realrate-archive.com/us_medicinal_products/2020/feature_importance/feature_importance.svg",
"obs_ecr": {
"0000037785": {
"2011": {
"obs_EconomicCapitalRatio": 1.9637052598410045
},
"2012": {
"obs_EconomicCapitalRatio": 2.2187352745223867
},
"2013": {
"obs_EconomicCapitalRatio": 2.0998789372222704
},
"2014": {
"obs_EconomicCapitalRatio": 1.641537801830664
},
"2015": {
"obs_EconomicCapitalRatio": 1.0723385245823782
},
"2016": {
"obs_EconomicCapitalRatio": 1.6108835909734713
},
"2017": {
"obs_EconomicCapitalRatio": 1.8056499758638158
},
"2018": {
"obs_EconomicCapitalRatio": 1.2287717494570867
},
"2019": {
"obs_EconomicCapitalRatio": 1.7092843014022376
},
"2020": {
"obs_EconomicCapitalRatio": 1.9284688934634902
},
"2021": {
"obs_EconomicCapitalRatio": 1.6770740146552199
},
"2022": {
"obs_EconomicCapitalRatio": 1.834863173719622
},
"2023": {
"obs_EconomicCapitalRatio": 0.9158901623685305
}
},
"0001056358": {
"2011": {
"obs_EconomicCapitalRatio": 0.18783097649548078
},
"2012": {
"obs_EconomicCapitalRatio": 0.3196597323000155
},
"2013": {
"obs_EconomicCapitalRatio": 0.7370346023559032
},
"2014": {
"obs_EconomicCapitalRatio": 1.0406162753683343
},
"2015": {
"obs_EconomicCapitalRatio": 0.7323625964348088
},
"2016": {
"obs_EconomicCapitalRatio": 0.753066668490597
},
"2017": {
"obs_EconomicCapitalRatio": 0.5232637759318683
},
"2018": {
"obs_EconomicCapitalRatio": 0.7338326629079127
},
"2019": {
"obs_EconomicCapitalRatio": 0.6223996309643847
},
"2020": {
"obs_EconomicCapitalRatio": 0.6307022721006672
},
"2021": {
"obs_EconomicCapitalRatio": 1.4634619355072704
},
"2022": {
"obs_EconomicCapitalRatio": 0.820186420650827
},
"2023": {
"obs_EconomicCapitalRatio": 0.42412588511273297
},
"2024": {
"obs_EconomicCapitalRatio": 0.6963642400059836
},
"2025": {
"obs_EconomicCapitalRatio": 0.47545840734858463
}
},
"0000074303": {
"2011": {
"obs_EconomicCapitalRatio": 0.5221628155371295
},
"2012": {
"obs_EconomicCapitalRatio": 0.5016941351915414
},
"2013": {
"obs_EconomicCapitalRatio": 0.7067485666124749
},
"2014": {
"obs_EconomicCapitalRatio": 0.5800072775923082
},
"2015": {
"obs_EconomicCapitalRatio": 0.26932516949788865
},
"2016": {
"obs_EconomicCapitalRatio": 0.4320388824657905
},
"2017": {
"obs_EconomicCapitalRatio": 0.5856850809511247
},
"2018": {
"obs_EconomicCapitalRatio": 0.3494568183316394
},
"2019": {
"obs_EconomicCapitalRatio": 0.2952768225185927
},
"2020": {
"obs_EconomicCapitalRatio": 0.48260038439530095
},
"2021": {
"obs_EconomicCapitalRatio": 1.1559183950584917
},
"2022": {
"obs_EconomicCapitalRatio": 0.9955682298738215
},
"2023": {
"obs_EconomicCapitalRatio": 0.939616887252673
},
"2024": {
"obs_EconomicCapitalRatio": 0.5703504787209263
},
"2025": {
"obs_EconomicCapitalRatio": 0.3659536949506686
}
},
"0001307954": {
"2011": {
"obs_EconomicCapitalRatio": 0.18938003655153654
},
"2012": {
"obs_EconomicCapitalRatio": 0.3154058367754545
},
"2013": {
"obs_EconomicCapitalRatio": 0.4780017903384275
},
"2014": {
"obs_EconomicCapitalRatio": 0.384792729924332
},
"2018": {
"obs_EconomicCapitalRatio": 0.5095392164405845
},
"2019": {
"obs_EconomicCapitalRatio": 0.6235372978487372
},
"2020": {
"obs_EconomicCapitalRatio": 0.6619386066086855
},
"2021": {
"obs_EconomicCapitalRatio": 0.8463350886179348
},
"2022": {
"obs_EconomicCapitalRatio": 0.7115101902118032
},
"2023": {
"obs_EconomicCapitalRatio": 0.7137373813546445
},
"2024": {
"obs_EconomicCapitalRatio": 0.5244746605193847
},
"2025": {
"obs_EconomicCapitalRatio": 0.3141640811372542
}
},
"0000874716": {
"2011": {
"obs_EconomicCapitalRatio": 5.678189619495421
},
"2012": {
"obs_EconomicCapitalRatio": 6.62985272864075
},
"2013": {
"obs_EconomicCapitalRatio": 5.637583008591172
},
"2014": {
"obs_EconomicCapitalRatio": 5.3378472038789315
},
"2015": {
"obs_EconomicCapitalRatio": 4.359021798706142
},
"2016": {
"obs_EconomicCapitalRatio": 6.735635676724686
},
"2017": {
"obs_EconomicCapitalRatio": 7.882744231502931
},
"2018": {
"obs_EconomicCapitalRatio": 10.363928250251758
},
"2019": {
"obs_EconomicCapitalRatio": 12.865202087427075
},
"2020": {
"obs_EconomicCapitalRatio": 21.31825222425334
},
"2021": {
"obs_EconomicCapitalRatio": 26.268423294328166
},
"2022": {
"obs_EconomicCapitalRatio": 13.828898358817076
},
"2023": {
"obs_EconomicCapitalRatio": 18.252894151087883
},
"2024": {
"obs_EconomicCapitalRatio": 13.560026821642062
},
"2025": {
"obs_EconomicCapitalRatio": 21.570882602865723
}
},
"0000899923": {
"2011": {
"obs_EconomicCapitalRatio": 5.286603114326388
},
"2012": {
"obs_EconomicCapitalRatio": 5.947932077650038
},
"2013": {
"obs_EconomicCapitalRatio": 4.09378437010731
},
"2014": {
"obs_EconomicCapitalRatio": 5.490507086553531
},
"2015": {
"obs_EconomicCapitalRatio": 6.944372988710795
},
"2016": {
"obs_EconomicCapitalRatio": 2.339757271124506
},
"2017": {
"obs_EconomicCapitalRatio": 2.8740508316547966
},
"2018": {
"obs_EconomicCapitalRatio": 3.0914586906825567
},
"2019": {
"obs_EconomicCapitalRatio": 1.9630081673133826
},
"2021": {
"obs_EconomicCapitalRatio": 2.606632146369483
},
"2022": {
"obs_EconomicCapitalRatio": 1.7004450020894173
},
"2023": {
"obs_EconomicCapitalRatio": 2.215290054291016
},
"2024": {
"obs_EconomicCapitalRatio": 1.823931615329854
},
"2025": {
"obs_EconomicCapitalRatio": 1.1682929523136367
}
},
"0000885462": {
"2011": {
"obs_EconomicCapitalRatio": 0.477594589877508
},
"2012": {
"obs_EconomicCapitalRatio": 0.2925556156090612
},
"2013": {
"obs_EconomicCapitalRatio": 0.5361327962905387
},
"2014": {
"obs_EconomicCapitalRatio": 0.2505281175819798
},
"2015": {
"obs_EconomicCapitalRatio": 0.43387267254203915
},
"2016": {
"obs_EconomicCapitalRatio": 0.5022902813318385
},
"2017": {
"obs_EconomicCapitalRatio": 0.34065719753844165
},
"2018": {
"obs_EconomicCapitalRatio": 0.22997496410238202
},
"2019": {
"obs_EconomicCapitalRatio": 0.1659154208060553
},
"2020": {
"obs_EconomicCapitalRatio": 0.26901950354979465
},
"2021": {
"obs_EconomicCapitalRatio": 0.2838385361778253
},
"2022": {
"obs_EconomicCapitalRatio": 0.2067987843408893
},
"2023": {
"obs_EconomicCapitalRatio": 0.11983703427943283
},
"2024": {
"obs_EconomicCapitalRatio": 0.06649192725741328
}
},
"0001054905": {
"2011": {
"obs_EconomicCapitalRatio": 1.4579074706215878
},
"2012": {
"obs_EconomicCapitalRatio": 1.7997149963883579
},
"2013": {
"obs_EconomicCapitalRatio": 1.964317914289097
},
"2014": {
"obs_EconomicCapitalRatio": 1.4734327096252018
},
"2015": {
"obs_EconomicCapitalRatio": 1.8591617658964918
},
"2016": {
"obs_EconomicCapitalRatio": 2.185789648905985
},
"2017": {
"obs_EconomicCapitalRatio": 1.7880006703658458
},
"2018": {
"obs_EconomicCapitalRatio": 1.5318875768219857
},
"2019": {
"obs_EconomicCapitalRatio": 2.6164701172132556
},
"2020": {
"obs_EconomicCapitalRatio": 2.4715120247319406
},
"2021": {
"obs_EconomicCapitalRatio": 2.201354917056966
},
"2022": {
"obs_EconomicCapitalRatio": 2.262740511238834
}
},
"0001141240": {
"2011": {
"obs_EconomicCapitalRatio": 5.502360615827963
},
"2012": {
"obs_EconomicCapitalRatio": 2.4369547526522646
},
"2013": {
"obs_EconomicCapitalRatio": 11.581935819020808
},
"2014": {
"obs_EconomicCapitalRatio": 7.5454875670319685
},
"2015": {
"obs_EconomicCapitalRatio": 5.634514556207966
},
"2016": {
"obs_EconomicCapitalRatio": 5.458003060729301
},
"2017": {
"obs_EconomicCapitalRatio": 6.7960569922086025
},
"2018": {
"obs_EconomicCapitalRatio": 4.351678898468258
},
"2019": {
"obs_EconomicCapitalRatio": 4.24355658618375
},
"2020": {
"obs_EconomicCapitalRatio": 3.6370684560423614
},
"2021": {
"obs_EconomicCapitalRatio": 4.458556769073509
},
"2022": {
"obs_EconomicCapitalRatio": 3.1784879275692157
},
"2023": {
"obs_EconomicCapitalRatio": 3.3273144132655075
},
"2024": {
"obs_EconomicCapitalRatio": 2.3178398698599603
},
"2025": {
"obs_EconomicCapitalRatio": 5.890984282760348
}
},
"0000768408": {
"2011": {
"obs_EconomicCapitalRatio": 5.715133312847765
},
"2012": {
"obs_EconomicCapitalRatio": 2.3017018284798714
},
"2013": {
"obs_EconomicCapitalRatio": 1.425277475641039
},
"2014": {
"obs_EconomicCapitalRatio": 1.8803973873475237
},
"2015": {
"obs_EconomicCapitalRatio": 1.4412650279511978
},
"2016": {
"obs_EconomicCapitalRatio": 1.0071551396713583
},
"2017": {
"obs_EconomicCapitalRatio": 1.1153169457297638
},
"2018": {
"obs_EconomicCapitalRatio": 0.924011890899123
},
"2019": {
"obs_EconomicCapitalRatio": 0.6138635192851674
},
"2020": {
"obs_EconomicCapitalRatio": 0.7664774974857526
},
"2021": {
"obs_EconomicCapitalRatio": 0.871286208388657
},
"2022": {
"obs_EconomicCapitalRatio": 0.27420450138403873
},
"2023": {
"obs_EconomicCapitalRatio": 0.26934082796065434
},
"2024": {
"obs_EconomicCapitalRatio": 0.14158948221183076
}
},
"0000787253": {
"2011": {
"obs_EconomicCapitalRatio": 2.526353775920534
},
"2012": {
"obs_EconomicCapitalRatio": 1.3160543270878733
},
"2014": {
"obs_EconomicCapitalRatio": 1.1960142220158665
},
"2015": {
"obs_EconomicCapitalRatio": 2.1497060764213507
},
"2016": {
"obs_EconomicCapitalRatio": 1.6596075035664513
},
"2017": {
"obs_EconomicCapitalRatio": 1.820275172276164
},
"2018": {
"obs_EconomicCapitalRatio": 1.4250126839098163
},
"2019": {
"obs_EconomicCapitalRatio": 0.8714870157425864
},
"2020": {
"obs_EconomicCapitalRatio": 0.8186963761612863
},
"2021": {
"obs_EconomicCapitalRatio": 0.9963355986876283
},
"2022": {
"obs_EconomicCapitalRatio": 0.4935946735445941
},
"2023": {
"obs_EconomicCapitalRatio": 0.4463203114259345
},
"2024": {
"obs_EconomicCapitalRatio": 0.21764563032603712
}
},
"0000896264": {
"2011": {
"obs_EconomicCapitalRatio": 2.987080353491173
},
"2012": {
"obs_EconomicCapitalRatio": 2.8476111068826424
},
"2013": {
"obs_EconomicCapitalRatio": 4.5724271596679005
},
"2015": {
"obs_EconomicCapitalRatio": 7.320772852461824
},
"2016": {
"obs_EconomicCapitalRatio": 2.5202405198959905
},
"2017": {
"obs_EconomicCapitalRatio": 5.400078197143357
},
"2018": {
"obs_EconomicCapitalRatio": 7.8437625855710635
},
"2019": {
"obs_EconomicCapitalRatio": 5.208661448534275
},
"2022": {
"obs_EconomicCapitalRatio": 2.794889038132937
},
"2023": {
"obs_EconomicCapitalRatio": 2.6884992698433976
},
"2024": {
"obs_EconomicCapitalRatio": 1.4865583930571376
}
},
"0001086303": {
"2012": {
"obs_EconomicCapitalRatio": 0.050408616621473605
},
"2013": {
"obs_EconomicCapitalRatio": 0.3592188918384183
},
"2014": {
"obs_EconomicCapitalRatio": 0.5202291430401021
},
"2018": {
"obs_EconomicCapitalRatio": 75.60385532024324
},
"2023": {
"obs_EconomicCapitalRatio": 5.825073650532234
}
},
"0001134765": {
"2013": {
"obs_EconomicCapitalRatio": 84.83868255676903
},
"2014": {
"obs_EconomicCapitalRatio": 93.1111485713505
},
"2015": {
"obs_EconomicCapitalRatio": 199.2672351710133
},
"2016": {
"obs_EconomicCapitalRatio": 216.93321071912177
},
"2017": {
"obs_EconomicCapitalRatio": 60.02178473917171
},
"2018": {
"obs_EconomicCapitalRatio": 12.822507944414118
},
"2019": {
"obs_EconomicCapitalRatio": 455.3649181791688
},
"2020": {
"obs_EconomicCapitalRatio": 668.0565240083155
},
"2021": {
"obs_EconomicCapitalRatio": 3.604592501252785
},
"2022": {
"obs_EconomicCapitalRatio": 3.9983823737615998
},
"2023": {
"obs_EconomicCapitalRatio": 4.432317616137024
},
"2024": {
"obs_EconomicCapitalRatio": 2.934393508015559
},
"2025": {
"obs_EconomicCapitalRatio": 7.17941906968866
}
},
"0001310630": {
"2011": {
"obs_EconomicCapitalRatio": 118.5920894437218
},
"2012": {
"obs_EconomicCapitalRatio": 90.47339849409984
},
"2013": {
"obs_EconomicCapitalRatio": 72.75975087344283
},
"2014": {
"obs_EconomicCapitalRatio": 60.05301282758653
},
"2015": {
"obs_EconomicCapitalRatio": 46.147679617159916
},
"2016": {
"obs_EconomicCapitalRatio": 37.04924725418156
},
"2017": {
"obs_EconomicCapitalRatio": 30.944660874575487
},
"2019": {
"obs_EconomicCapitalRatio": 85.1712892994052
},
"2020": {
"obs_EconomicCapitalRatio": 24.70852870017063
},
"2023": {
"obs_EconomicCapitalRatio": 90.31718007058653
},
"2024": {
"obs_EconomicCapitalRatio": 18.12427183566627
},
"2025": {
"obs_EconomicCapitalRatio": 15.788052734849284
}
},
"0001374328": {
"2011": {
"obs_EconomicCapitalRatio": 1.843040104492836
},
"2012": {
"obs_EconomicCapitalRatio": 1.406513180725925
},
"2013": {
"obs_EconomicCapitalRatio": 2.5629155706742086
},
"2014": {
"obs_EconomicCapitalRatio": 3.2200542353297674
},
"2015": {
"obs_EconomicCapitalRatio": 1.2965403490667224
},
"2016": {
"obs_EconomicCapitalRatio": 0.9353195843240845
},
"2017": {
"obs_EconomicCapitalRatio": 0.4394415225694401
},
"2018": {
"obs_EconomicCapitalRatio": 0.9423630321081906
},
"2019": {
"obs_EconomicCapitalRatio": 2.6565609559613317
},
"2020": {
"obs_EconomicCapitalRatio": 9.948498907383927
},
"2022": {
"obs_EconomicCapitalRatio": 4.994024545393992
},
"2023": {
"obs_EconomicCapitalRatio": 2.2965761578523303
},
"2024": {
"obs_EconomicCapitalRatio": 3.6843422189586965
},
"2025": {
"obs_EconomicCapitalRatio": 1.821523711080343
}
},
"0001386570": {
"2011": {
"obs_EconomicCapitalRatio": 8.338141326290996
},
"2012": {
"obs_EconomicCapitalRatio": 8.392729648541112
},
"2013": {
"obs_EconomicCapitalRatio": 26.219216155099797
},
"2019": {
"obs_EconomicCapitalRatio": 8.591985092140105
},
"2020": {
"obs_EconomicCapitalRatio": 10.063615397839953
},
"2021": {
"obs_EconomicCapitalRatio": 6.442513704241379
},
"2022": {
"obs_EconomicCapitalRatio": 2.8215640716473835
},
"2023": {
"obs_EconomicCapitalRatio": 2.6556157143776864
},
"2024": {
"obs_EconomicCapitalRatio": 9.237391489557004
},
"2025": {
"obs_EconomicCapitalRatio": 7.630478708487693
}
},
"0000711377": {
"2011": {
"obs_EconomicCapitalRatio": 5.820904874555574
},
"2012": {
"obs_EconomicCapitalRatio": 7.7503288458074415
},
"2013": {
"obs_EconomicCapitalRatio": 10.377788751403328
},
"2014": {
"obs_EconomicCapitalRatio": 9.392743252183534
},
"2015": {
"obs_EconomicCapitalRatio": 10.034849829461312
},
"2016": {
"obs_EconomicCapitalRatio": 10.103194801881472
},
"2017": {
"obs_EconomicCapitalRatio": 14.452119850474038
},
"2018": {
"obs_EconomicCapitalRatio": 8.566992718065048
},
"2019": {
"obs_EconomicCapitalRatio": 9.17563055998759
},
"2020": {
"obs_EconomicCapitalRatio": 9.88631712937769
},
"2021": {
"obs_EconomicCapitalRatio": 9.735723882656965
},
"2022": {
"obs_EconomicCapitalRatio": 5.856026588966056
}
},
"0000744218": {
"2011": {
"obs_EconomicCapitalRatio": 1.8965131603685095
},
"2012": {
"obs_EconomicCapitalRatio": 5.333855573956268
},
"2013": {
"obs_EconomicCapitalRatio": 10.230725112264693
},
"2014": {
"obs_EconomicCapitalRatio": 11.553522232787866
},
"2015": {
"obs_EconomicCapitalRatio": 8.22074780222265
},
"2016": {
"obs_EconomicCapitalRatio": 1.4980547705405713
},
"2017": {
"obs_EconomicCapitalRatio": 2.021188969442516
},
"2018": {
"obs_EconomicCapitalRatio": 0.3696518300152486
},
"2019": {
"obs_EconomicCapitalRatio": 0.48016381910130834
},
"2020": {
"obs_EconomicCapitalRatio": 5.262656817463394
},
"2021": {
"obs_EconomicCapitalRatio": 7.793666490988671
},
"2022": {
"obs_EconomicCapitalRatio": 10.883731101898258
},
"2023": {
"obs_EconomicCapitalRatio": 7.286143405813059
}
},
"0000811641": {
"2011": {
"obs_EconomicCapitalRatio": 2.136690390726703
},
"2012": {
"obs_EconomicCapitalRatio": 1.849039798017059
},
"2013": {
"obs_EconomicCapitalRatio": 2.010189247495304
},
"2014": {
"obs_EconomicCapitalRatio": 2.34474040567545
},
"2015": {
"obs_EconomicCapitalRatio": 2.4785461696903734
},
"2016": {
"obs_EconomicCapitalRatio": 1.9865134449583703
},
"2017": {
"obs_EconomicCapitalRatio": 1.6949100276813254
},
"2018": {
"obs_EconomicCapitalRatio": 1.7852801061870174
},
"2019": {
"obs_EconomicCapitalRatio": 1.5240857269328754
},
"2020": {
"obs_EconomicCapitalRatio": 1.7195565413895542
},
"2021": {
"obs_EconomicCapitalRatio": 2.367024189117178
},
"2022": {
"obs_EconomicCapitalRatio": 1.6292353884860042
},
"2023": {
"obs_EconomicCapitalRatio": 1.1622002191801761
},
"2025": {
"obs_EconomicCapitalRatio": 1.9024392280197613
}
},
"0000907654": {
"2011": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 2.2151696375266194
},
"2014": {
"obs_EconomicCapitalRatio": 1.8158262418443614
},
"2015": {
"obs_EconomicCapitalRatio": 1.28497308211443
},
"2016": {
"obs_EconomicCapitalRatio": 1.0818389503384735
},
"2017": {
"obs_EconomicCapitalRatio": 1.3032495591532267
},
"2018": {
"obs_EconomicCapitalRatio": 0.6794655548784231
},
"2019": {
"obs_EconomicCapitalRatio": 1.027889384231902
},
"2020": {
"obs_EconomicCapitalRatio": 0.7572061787169263
},
"2021": {
"obs_EconomicCapitalRatio": 0.6116995115921646
},
"2022": {
"obs_EconomicCapitalRatio": 0.8326777832489594
}
},
"0000926617": {
"2011": {
"obs_EconomicCapitalRatio": 0.936747166508658
},
"2012": {
"obs_EconomicCapitalRatio": 3.2987773210340476
},
"2013": {
"obs_EconomicCapitalRatio": 3.310250104657181
},
"2014": {
"obs_EconomicCapitalRatio": 4.317801092124128
},
"2015": {
"obs_EconomicCapitalRatio": 7.655824111431128
},
"2016": {
"obs_EconomicCapitalRatio": 8.900428301796273
},
"2017": {
"obs_EconomicCapitalRatio": 20.503758003717643
},
"2018": {
"obs_EconomicCapitalRatio": 3.2888488055796508
},
"2019": {
"obs_EconomicCapitalRatio": 8.83333842031845
},
"2020": {
"obs_EconomicCapitalRatio": 45.47327065656971
},
"2021": {
"obs_EconomicCapitalRatio": 7.933579854593867
},
"2022": {
"obs_EconomicCapitalRatio": 2.857163597552752
},
"2023": {
"obs_EconomicCapitalRatio": 3.901740100848714
},
"2024": {
"obs_EconomicCapitalRatio": 1.8703748454852225
}
},
"0000949858": {
"2011": {
"obs_EconomicCapitalRatio": 0.0
},
"2012": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 2.518997627887442
},
"2018": {
"obs_EconomicCapitalRatio": 0.7422482465262066
},
"2019": {
"obs_EconomicCapitalRatio": 0.35343147435010663
},
"2020": {
"obs_EconomicCapitalRatio": 1.3239430629183255
},
"2021": {
"obs_EconomicCapitalRatio": 2.1718168400927897
},
"2022": {
"obs_EconomicCapitalRatio": 0.9346116862802668
}
},
"0000009326": {
"2012": {
"obs_EconomicCapitalRatio": 5.656587982913678
},
"2013": {
"obs_EconomicCapitalRatio": 7.79966708407013
},
"2014": {
"obs_EconomicCapitalRatio": 2.9084764827636236
},
"2015": {
"obs_EconomicCapitalRatio": 2.8483648673741246
},
"2016": {
"obs_EconomicCapitalRatio": 3.648755401436501
},
"2017": {
"obs_EconomicCapitalRatio": 3.787889348418163
},
"2019": {
"obs_EconomicCapitalRatio": 4.035821822778718
},
"2020": {
"obs_EconomicCapitalRatio": 4.735832660774467
},
"2021": {
"obs_EconomicCapitalRatio": 6.878840843345401
},
"2022": {
"obs_EconomicCapitalRatio": 3.32579266803479
},
"2023": {
"obs_EconomicCapitalRatio": 4.327515096253764
},
"2024": {
"obs_EconomicCapitalRatio": 5.341740174720832
},
"2025": {
"obs_EconomicCapitalRatio": 4.797400698850301
}
},
"0000073290": {
"2012": {
"obs_EconomicCapitalRatio": 1.8838244732270972
},
"2013": {
"obs_EconomicCapitalRatio": 1.6432390281123206
},
"2014": {
"obs_EconomicCapitalRatio": 1.9239557658497293
},
"2015": {
"obs_EconomicCapitalRatio": 2.669474942212977
},
"2016": {
"obs_EconomicCapitalRatio": 5.686234008415378
},
"2017": {
"obs_EconomicCapitalRatio": 12.426535116483144
},
"2018": {
"obs_EconomicCapitalRatio": 6.023112230267755
},
"2019": {
"obs_EconomicCapitalRatio": 8.71810270966778
},
"2020": {
"obs_EconomicCapitalRatio": 5.758603861413226
},
"2021": {
"obs_EconomicCapitalRatio": 7.171288908839465
},
"2022": {
"obs_EconomicCapitalRatio": 6.5820905271862715
},
"2023": {
"obs_EconomicCapitalRatio": 2.3689702399551757
},
"2024": {
"obs_EconomicCapitalRatio": 0.8328246370864223
}
},
"0000093314": {
"2012": {
"obs_EconomicCapitalRatio": 17.719277991697727
},
"2013": {
"obs_EconomicCapitalRatio": 16.172791954794842
},
"2014": {
"obs_EconomicCapitalRatio": 17.12412941207431
},
"2015": {
"obs_EconomicCapitalRatio": 17.094853012648368
},
"2016": {
"obs_EconomicCapitalRatio": 7.646119704869701
},
"2017": {
"obs_EconomicCapitalRatio": 7.835630820870826
},
"2018": {
"obs_EconomicCapitalRatio": 5.69389490958303
},
"2020": {
"obs_EconomicCapitalRatio": 10.494231213006202
},
"2021": {
"obs_EconomicCapitalRatio": 9.325363829987609
},
"2022": {
"obs_EconomicCapitalRatio": 7.038632118707036
},
"2023": {
"obs_EconomicCapitalRatio": 1.692739776873626
},
"2024": {
"obs_EconomicCapitalRatio": 2.538095829463765
},
"2025": {
"obs_EconomicCapitalRatio": 1.267911014322384
}
},
"0001504678": {
"2021": {
"obs_EconomicCapitalRatio": 21.761860501462678
},
"2023": {
"obs_EconomicCapitalRatio": 7.712264043121101
},
"2024": {
"obs_EconomicCapitalRatio": 4.273885183694472
}
},
"0001321834": {
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2019": {
"obs_EconomicCapitalRatio": 0.0
},
"2020": {
"obs_EconomicCapitalRatio": 0.0
},
"2021": {
"obs_EconomicCapitalRatio": 0.0
},
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 0.25079529133050554
},
"2025": {
"obs_EconomicCapitalRatio": 0.6661650116856921
}
},
"0001627223": {
"2015": {
"obs_EconomicCapitalRatio": 0.11531512461593406
},
"2016": {
"obs_EconomicCapitalRatio": 0.5041107353269599
},
"2017": {
"obs_EconomicCapitalRatio": 0.9792616137942283
},
"2018": {
"obs_EconomicCapitalRatio": 0.5037929444305274
},
"2019": {
"obs_EconomicCapitalRatio": 0.33457321143007535
},
"2020": {
"obs_EconomicCapitalRatio": 0.5470460275521768
},
"2021": {
"obs_EconomicCapitalRatio": 0.6499364328629865
},
"2022": {
"obs_EconomicCapitalRatio": 0.5809502304277893
}
},
"0001552189": {
"2022": {
"obs_EconomicCapitalRatio": 0.051966645127577905
},
"2023": {
"obs_EconomicCapitalRatio": 0.16744960403999323
}
},
"0001653477": {
"2016": {
"obs_EconomicCapitalRatio": 2.9965230053381644
},
"2017": {
"obs_EconomicCapitalRatio": 3.7915367442390675
},
"2018": {
"obs_EconomicCapitalRatio": 2.922808947052789
},
"2019": {
"obs_EconomicCapitalRatio": 1.959253575073628
},
"2020": {
"obs_EconomicCapitalRatio": 1.5143708031469667
},
"2021": {
"obs_EconomicCapitalRatio": 1.3249257731828572
},
"2022": {
"obs_EconomicCapitalRatio": 1.1004777222391815
},
"2023": {
"obs_EconomicCapitalRatio": 0.7369191018660393
},
"2024": {
"obs_EconomicCapitalRatio": 0.7736223011953498
},
"2025": {
"obs_EconomicCapitalRatio": 1.3076730606119293
}
},
"0001586554": {
"2016": {
"obs_EconomicCapitalRatio": 0.48058259081278015
},
"2018": {
"obs_EconomicCapitalRatio": 1.4962619054091728
},
"2019": {
"obs_EconomicCapitalRatio": 0.891464023479221
},
"2020": {
"obs_EconomicCapitalRatio": 0.5424015614406267
},
"2021": {
"obs_EconomicCapitalRatio": 0.4143393157324369
},
"2022": {
"obs_EconomicCapitalRatio": 0.23894685685583492
},
"2023": {
"obs_EconomicCapitalRatio": 0.10261033505859418
}
},
"0001642380": {
"2016": {
"obs_EconomicCapitalRatio": 21.72207919293821
},
"2017": {
"obs_EconomicCapitalRatio": 21.3709545386487
},
"2019": {
"obs_EconomicCapitalRatio": 4.529546805842379
},
"2021": {
"obs_EconomicCapitalRatio": 1.6309746744371012
},
"2022": {
"obs_EconomicCapitalRatio": 0.4521509520900019
},
"2023": {
"obs_EconomicCapitalRatio": 0.3591924761920325
}
},
"0001652130": {
"2016": {
"obs_EconomicCapitalRatio": 3.199958649296
},
"2017": {
"obs_EconomicCapitalRatio": 3.3067347442937
},
"2018": {
"obs_EconomicCapitalRatio": 2.957402513032481
},
"2019": {
"obs_EconomicCapitalRatio": 4.091879539456148
},
"2020": {
"obs_EconomicCapitalRatio": 9.369785151591545
},
"2021": {
"obs_EconomicCapitalRatio": 12.780171311702386
},
"2022": {
"obs_EconomicCapitalRatio": 3.4031614469183005
}
},
"0001708035": {
"2017": {
"obs_EconomicCapitalRatio": 0.4391634781975079
},
"2018": {
"obs_EconomicCapitalRatio": 0.3838203482983531
},
"2019": {
"obs_EconomicCapitalRatio": 0.48129649674893044
},
"2020": {
"obs_EconomicCapitalRatio": 0.6013288369758395
},
"2021": {
"obs_EconomicCapitalRatio": 0.8978665871292398
},
"2022": {
"obs_EconomicCapitalRatio": 0.7567918532035208
},
"2023": {
"obs_EconomicCapitalRatio": 0.7709750516345434
},
"2024": {
"obs_EconomicCapitalRatio": 0.6033738356189466
},
"2025": {
"obs_EconomicCapitalRatio": 1.152367959333189
}
},
"0001522767": {
"2017": {
"obs_EconomicCapitalRatio": 4.28352597297854
},
"2018": {
"obs_EconomicCapitalRatio": 11.84484946199016
},
"2019": {
"obs_EconomicCapitalRatio": 1.6647152363257145
},
"2020": {
"obs_EconomicCapitalRatio": 1.8939909944990796
},
"2023": {
"obs_EconomicCapitalRatio": 0.7154614969958419
},
"2024": {
"obs_EconomicCapitalRatio": 0.2730915686403338
},
"2025": {
"obs_EconomicCapitalRatio": 0.22748336782703915
}
},
"0001731348": {
"2020": {
"obs_EconomicCapitalRatio": 1.0343902967287055
},
"2021": {
"obs_EconomicCapitalRatio": 0.9151944120269997
},
"2022": {
"obs_EconomicCapitalRatio": 0.5292237994678327
},
"2023": {
"obs_EconomicCapitalRatio": 0.5873188828335296
},
"2024": {
"obs_EconomicCapitalRatio": 0.48595324362468467
}
},
"0001656472": {
"2020": {
"obs_EconomicCapitalRatio": 2.4846037628909143
},
"2021": {
"obs_EconomicCapitalRatio": 2.1068641047612973
},
"2022": {
"obs_EconomicCapitalRatio": 1.5226433295914465
},
"2023": {
"obs_EconomicCapitalRatio": 1.2617458734917226
},
"2024": {
"obs_EconomicCapitalRatio": 1.2298351104750205
},
"2025": {
"obs_EconomicCapitalRatio": 1.6798919218022832
}
},
"0001737927": {
"2020": {
"obs_EconomicCapitalRatio": 2.2413009969523126
},
"2021": {
"obs_EconomicCapitalRatio": 0.722105723732089
},
"2022": {
"obs_EconomicCapitalRatio": 0.49880311487341555
}
},
"0001754195": {
"2025": {
"obs_EconomicCapitalRatio": 0.6572335792654658
}
},
"0001756390": {
"2021": {
"obs_EconomicCapitalRatio": 1.6656381745552173
},
"2022": {
"obs_EconomicCapitalRatio": 0.2766604451340951
},
"2023": {
"obs_EconomicCapitalRatio": 0.2521606213881799
},
"2024": {
"obs_EconomicCapitalRatio": 0.09670274277596863
},
"2025": {
"obs_EconomicCapitalRatio": 0.15693027900478207
}
},
"0001813814": {
"2022": {
"obs_EconomicCapitalRatio": 1.017428702644666
}
},
"0001850902": {
"2021": {
"obs_EconomicCapitalRatio": 5.898441690535421
},
"2022": {
"obs_EconomicCapitalRatio": 1.4117684980890728
}
},
"0001906324": {
"2022": {
"obs_EconomicCapitalRatio": 3.794104483895451
},
"2023": {
"obs_EconomicCapitalRatio": 0.8130511823271402
},
"2024": {
"obs_EconomicCapitalRatio": 0.6055538968322262
},
"2025": {
"obs_EconomicCapitalRatio": 0.4114130862644389
}
}
}
}